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Title: Proteomic profiling of phosphoproteins and secreted proteins from 
mammalian cell lines in order to gain insights into factors affecting cellular growth 
and recombinant protein production. 
Name: Martin Power 
Abstract 
Chinese hamster ovary (CHO) cells are one of the most commonly used cell lines in 
the production of biopharmaceuticals. The reduction of culture temperature during 
the exponential phase of a culture is a strategy that is commonly employed in the 
bioprocessing industry to increase process yield. Lower culture temperature results 
in a marked reduction in cell growth, increased specific productivity and prolonged 
cell viability.  
In order to understand the mechanisms involved at the post-transcriptional level in 
the cellular response to temperature-shift a phosphoproteomic analysis of SEAP 
secreting CHO cells was conducted. Using a liquid-chromatography mass 
spectrometry-based label-free approach in conjunction with Gallium, Iron and 
Titanium phosphopeptide enrichment strategies 1,307 unique phosphopeptides 
(1,480 phosphosites) were identified. Gene Ontology analysis revealed enrichment 
of pathways involved in protein synthesis and cell cycle progression. 92 
phosphopeptides were determined as being significantly differentially-expressed 
36hrs post temperature-shift, including translation initiation factors EIF5B, EIF4G3, 
Transcription activator BRG1 and the tumour suppressor protein, Protein NDRG1. 
Such proteins are potentially involved in controlling growth and recombinant protein 
production in CHO cells. 
While the effects of temperature-shift can result in an increase in overall product 
yield, it can also have implications for the extracellular-milieu from which the 
product must be purified. The second aspect of this thesis identifies changes in the 
host cell protein (HCP) profile of an IgG-producing and non-producing cell line over 
time in culture under both temperature-shifted and non-temperature-shifted 
conditions. This includes the identification of proteases (Cathepsin B, Cathepsin D, 
MMP9) and glycosidases (beta-galactosidase and α-N-acetylgalactosaminidase), that 
could negatively impact product quality. In addition, proteins that could enhance cell 
growth such as vascular endothelial growth factor isoforms A and C and Hepatoma-
derived growth factor were also identified. It was also found that the cell line and 
culture conditions used both impacted on the HCP profile generated. 
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1.0 Introduction 
1.1 Chinese Hamster Ovary cells 
Chinese hamster ovary (CHO) cells are a mammalian epithelial cell line that have 
been genetically engineered to produce recombinant protein products for what is 
now a multi-billion dollar industry (Beausoleil, Labrie, Dubreuil 2002; Rader 2012). 
The Chinese Hamster itself was first used for typing pneumococci as a replacement 
for mice in 1919 (Jayapal et al. 2007). The first CHO cell was isolated in 1957 for 
use in the study of somatic mammalian cell genetics (Puck, Cieciura, Robinson 
1958). The discovery of the relatively low number of chromosomes in Chinese 
hamsters (2n=22) made them ideal for radiation and chemical mutagenesis 
experiments (Chu 2004; Deaven and Petersen 1973).  In 1986, Tissue plasminogen 
activator (tPA, Activase®), became the first therapeutic product approved for 
production using CHO cells. This came just four years after Lilly’s Humulin became 
the first recombinant protein therapeutic to obtain regulatory approval from the FDA 
(Biospectrum 2007).  
Used in the production of seven of the top ten selling biologics in 2011 (Table 1.1.1), 
CHO cells are used to produce nearly 70% of the recombinant therapeutic products 
on today’s market (Huggett and Lähteenmaki 2012; Jayapal et al. 2007; Noh, 
Sathyamurthy, Lee 2013). CHO cells have been the predominant cell line of choice 
by the biopharmaceutical industry for a number of reasons; 1) CHO cells can be 
adapted to grow in suspension which enables high densities of cells to be obtained 
enabling greater product yield; they have a relatively fast growth rate and are 
reasonably robust in nature (Jayapal et al. 2007; Kumar, Gammell, Clynes 2007; 
Rodrigues et al. 2010). 2) The adaptation of CHO cells to grow in serum free media 
is also a significant advantage given the potential risks associated with the use of 
serum in cell culture media for the growth of therapeutic protein producing 
mammalian cell lines (Even, Sandusky, Barnard 2006; Sinacore, Drapeau, Adamson 
2000). 3) Having been used for the production of biologics for over 25 years, CHO 
cells have a well-established record as a safe host for the production of parenteral 
products (Chu and Robinson 2001).  
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4) CHO cells have the ability to produce complex protein structures with correct 
folding patterns and post-translation modifications such as glycosylation which 
enables proper protein function (Hossler, Khattak, Li 2009; Vergara et al. 2012). 5) 
In addition to being stable hosts for the expression of heterologous genes, gene 
amplification techniques such as dihydrofolate reductase (DHFR) or glutamine 
synthetase (GS) mediated systems may also be used to increase cellular productivity 
(Barnes and Dickson 2006; Noh, Sathyamurthy, Lee 2013). DHFR negative CHO 
cells are transfected with a gene for the DHFR enzyme. Through the addition of 
increasing concentrations of the chemotherapeutic agent methotrexate (MTX) copies 
of the DHFR gene are also increased. This results in an increase in the attached gene 
for the therapeutic protein of interest, thus increasing its production (Jayapal et al. 
2007). The GS system operates in a similar manner; in this instance however, the GS 
inhibitor methionine sulfoximine (MSX) is used to suppress endogenous copies of 
the GS gene. Only cells containing high enough copy number of the GS gene, linked 
to the desired recombinant protein product, will be able to proliferate. The addition 
of 20-25µM of MSX to the culture media enables selection of cells containing the 
GS gene, while increasing the concentration to between 100-1000µM results in 
amplification of the gene coding for the product of interest (Agrawal and Bal 2012).  
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Top Selling Biologic Drugs 
Table 1.1.1 Table of the top 10 selling biologic drugs in 2011 of which 7 were 
produced using a CHO host cell line (Noh, Sathyamurthy, Lee 2013). 
 
Product titre has improved significantly over the years, having gone from ~50mg/l in 
the mid-eighties to ~4.7g/l in 2004.  Product titres of >10g/l are now within reach 
(Huang et al. 2010; Wurm 2004). The increase in product yield has largely come 
from improvements in media formulation and process design (De Jesus and Wurm 
2011). Further improvements are required, however, if the cost of these therapeutic 
products are to be brought down to a sustainable level (Dietmair, Nielsen, Timmins 
2011). Herceptin, used for the treatment of breast cancer, costs US$60,000 per 
patient per year (Waltz 2005). Treatment of colon cancer using Avastin costs 
US$50,000, and for rare diseases, costs can be in excess of US$200,000 per patient 
per year (Herper 2010). While manufacturing can play some role in influencing the 
cost of the drug i.e., volume of product produced, expression system used (cheaper 
prokaryotic systems versus more expensive eukaryotic models), such high prices are 
largely attributed to ever increasing cost of R and D including costly clinical trials. 
Although cell engineering strategies have made some contribution towards 
improving cell line characteristics, results from the ‘targeted’ engineering approach 
have so far fallen somewhat short of expectations (Lim et al. 2010; O'Callaghan and 
James 2008). Advances in modern technology are currently enabling unprecedented 
characterisation of CHO cells in the fields of genomics, proteomics and 
metabolomics (Datta, Linhardt, Sharfstein 2013).  
 
Name Product Cell Lines 2011 Worldwide Sales (dollars in billions)
Humira (adalimumab)      Chinese Hamster Ovary 7.932
Enbrel (etanercept) Chinese Hamster Ovary 7.367
Rituxan (rituxan) Chinese Hamster Ovary 6.772
Remicade (infliximab) Mouse Myeloma (NSO) 6.751
Avastin (bevacizumab) Chinese Hamster Ovary 5.968
Herceptin (transtuzumab) Chinese Hamster Ovary 5.924
Neulasta (pegfilgrastim) Escherichia Coli 3.952
Lucentis (ranibizumab) Escherichia Coli 3.769
Avonex (interferon beta-1a) Chinese Hamster Ovary 2.687
Rebif (interferon beta-1a) Chinese Hamster Ovary 2.354
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The recent publication of the CHO genome will undoubtedly play a significant role 
in the quest for true cell line engineering (Lewis et al. 2013; Xu et al. 2011). 
Through better understanding of the mechanisms involved in controlling different 
cellular traits we will be one step closer to finally developing the much sought after 
‘super producer’ (Dietmair, Nielsen, Timmins 2011; Seth et al. 2007). 
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1.2 Temperature-shift 
The reduction of culture temperature towards the end of the exponential phase or 
during the stationary phase of a culture is a strategy that is commonly employed in 
the bioprocessing industry to increase process yield. Temperature reduction results in 
a marked reduction in cell growth, increased specific productivity and prolonged cell 
viability (Bollati‐Fogolín et al. 2005; Rodriguez et al. 2005; Sakurai et al. 2005; 
Schatz et al. 2003). Despite the increases in specific productivity and cell viability, 
overall product yield may be decreased as a result of reduced growth. The effect of 
this temperature reduction can also vary greatly according to the temperature, 
recombinant protein, cell line and even clone (Yee et al. 2008; Yee, Gerdtzen, Hu 
2009; Yoon, Hwang, Lee 2004). While the use of temperature-shift to increase the 
specific productivity of mammalian cells has been investigated (Fox et al. 2004; 
Yoon, Song, Lee 2003) and the effect of cold shock well documented (Al-Fageeh 
and Smales 2006; Al-Fageeh et al. 2006), the precise cellular mechanisms involved 
have only begun to become clear in more recent times. Despite this, there still 
remains a significant gap in our knowledge of the mechanics of reduced culture 
temperature, particularly when compared with that of other biological systems such 
as bacteria or plant. The following section will discuss our current understanding of 
the mechanisms involved in the response of CHO cells to reduced culture 
temperature with respect to (i) cell growth and (ii) specific productivity. 
 
1.2.1 Mechanisms controlling Cell growth rates in temperature-shifted CHO 
cells 
As mentioned previously, cell growth is significantly curtailed under reduced culture 
temperature conditions. This reduction in growth can be attributed to the cell cycle 
arrest with a shift in the proportion of cells from the S to the G1 phase of the cell 
cycle observed at reduced temperatures (Hendrick et al. 2001; Marchant et al. 2008; 
Moore et al. 1997). It should be pointed out that, under mild hypothermic conditions 
(~32˚C) cells may not arrest completely and can continue to proliferate, albeit at a 
reduced rate compared to 37˚C, while under more severe conditions there is almost a 
complete cessation of cell proliferation (Roobol et al. 2009).  
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This reduced growth rate results in a reduced requirement for metabolites and in turn 
decreased production of waste by-products (Wagstaff et al. 2013). It has been shown 
that the cell cycle arrest of CHO cells occurs via the ATR (ataxia telangiectasia 
mutated-and Rad3-related kinase) - p53 – p21 pathway (Roobol et al. 2011). The 
finding that p53 is central to the arrest of temperature-shifted CHO cells is hardly 
surprising given that p53 deficient mammalian cells experiencing mild hypothermia 
do not undergo cell cycle arrest (Matijasevic, Snyder, Ludlum 1998; Ohnishi et al. 
1998). It was proposed that activation of the ATR-p53–p21 pathway is due to 
changes in membrane rigidity as a result of alterations in the membrane lipid 
composition; specifically, an increase in the ratio of polyunsaturated to saturated 
fatty acids upon temperature-shift (Roobol et al. 2011). It has been suggested that a 
change in the fluidity of the nuclear envelop is ‘sensed’ by nuclear localised-ATR 
(Zhang, Zhao, Ma 2007).  In CHO, this leads to the intranuclear translocation of 
ATR and subsequent phosphorylation of p53 at Ser15 (Roobol et al. 2011). The 
phosphorylation of Ser15 is enhanced by the phosphorylation of Ser33 and Ser46 on 
p53 by p38MAPK (Bulavin et al. 1999), also activated by the ATR pathway (Roobol 
et al. 2011). This enhanced Ser15 phosphorylation serves to stabilise and augment 
binding of p53 to the transcription co-activator p300/CBP (Dumaz and Meek 1999), 
thus enabling transcription of p21, resulting in cell cycle arrest.  
 
1.2.2 Mechanisms controlling specific productivity in temperature-shifted 
CHO cells 
Although cell growth is significantly reduced under temperature-shifted compared to 
non-temperature-shifted conditions, extended culture viability coupled with 
increased specific productivity can lead to an increase in overall product yield. The 
effect of mild hypothermia on specific productivity can be cell line specific however 
and as such, may not be a suitable strategy for all cell lines (Table 1.2.1). Despite the 
recent elucidation of the mechanisms involved in cell cycle arrest of CHO cells 
under reduced culture temperature conditions (Roobol et al. 2009), our 
understanding of the pathways controlling specific productivity is a lot less clear. (A 
diagram summarising our understanding of the effect of temperature-shift on CHO 
cells is provided in Figure 1.2.1.).  From the studies conducted so far it would appear 
that the factors facilitating the increases in specific productivity are more complex. 
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Table 1.2.1 Effect of temperature-shift on specific productivity on CHO cells. 
 
 
Figure 1.2.1 Diagram of the key responses to reduced culture temperature conditions 
seen in CHO cells (Diagram reproduced from Masterson et al. 2014) 
 
Product T (˚C) Productivity (fold change) Feed Strategy Author
Antibody 33 1.7 Batch (Yee, Gerdtzen, Hu 2009)
Antibody-IL-2 fusion 30 2.8 Batch (Shi et al. 2005)
Chimeric Fab 28 14 Batch (Schatz et al. 2003)
EPO 30 5.6 Batch (Moore et al. 1997)
EPO 33 4 Batch (Yoon, Song, Lee 2003)
EPO 32 4 Perfusion (Ahn et al. 2008)
FSH 32 13 Perfusion (Yoon, Ahn, Jeong 2007)
hGM-CSF 33 2.1 Batch (Bollati‐Fogolín et al. 2005)
IFN-y 32 4 Fed-batch (Fox et al. 2005)
IgG 30 2 Batch (Kantardjieff et al. 2010)
Pro-urokinase 31 1.3 Batch (Chen et al. 2004)
Pro-urokinase 34 1.5 Perfusion (Chen et al. 2004)
SEAP 30 1.7 Batch (Kaufmann et al. 1999)
SEAP 33 8 Fed-batch (Nam, Ermonval, Sharfstein 2009)
TIMP 34 4 Batch (Jenkins and Hovey 1993)
TNFR-Fc 30 5 Batch (Kou et al. 2011)
tPA 33 1.5 Batch (Berrios et al. 2009)
tPA 32 1.7 Batch (Hendrick et al. 2001)
tPA 33 1.7 Perfusion (Vergara et al. 2009)
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Overall, there is a reduction in protein synthesis as a result of the attenuation of 
transcription and translation processes within the cell. This response appears to be 
common to both bacterial and mammalian systems experiencing mild hypothermia 
(Ermolenko and Makhatadze 2002).  
While this may seem somewhat contradictory given the increase in specific 
productivity, it is generally thought that increased mRNA stability/decreased mRNA 
degradation coupled with the availability of translational and protein folding/ 
secretory machinery, unburdened by task of synthesising endogenous cellular 
proteins, creates increased capacity for the production of more recombinant protein 
product. Again however, a consensus is yet to be reached on precisely how this 
occurs. This is primarily because of a variations in the results reported across 
different cell lines. For example, a 5.5-fold increase in the specific productivity of 
tumour necrosis factor receptor-immunoglobulin G1 Fc fusion (TNFR-Fc) in a 
temperature-shifted CHO cell line was attributed to enhanced mRNA stability, rather 
than the changes in the gene copy number or an increase in the transcription rate 
(Kou et al. 2011). It has also been suggested that an increase in EPO mRNA levels 
under temperature-shift conditions was indicative of an increase in EPO transcription 
therefore providing the means for an increase in EPO productivity (Yoon, Song, Lee 
2003). It is thought that this increased stability is facilitated by the translation of a 
specific group of proteins termed “cold shock proteins”. Two of the most widely 
studied cold shock proteins are cold-inducible RNA binding protein (CIRP) and 
RNA-binding motif protein 3 (RBM3) (Al-Fageeh and Smales 2006). Although 
structurally very similar (Nishiyama et al. 1997), CIRP specifically binds to the 3 ́΄ 
untranslated region (UTR) of RNAs, improving RNA stability and translation 
efficiency at times of cell stress (Yang and Carrier 2001), while it is thought that 
RBM3 binds the 5΄ UTR of mRNA to facilitating cap-independent translation during 
cold shock (Chappell, Owens, Mauro 2001). In addition to this it is also thought that 
the binding of such cold shock proteins (CSPs) to the cis-element of the promoter 
region of certain genes may also enable their transcription during temperature-shift 
(Al-Fageeh and Smales 2006).  
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To add another layer of complexity, the expression of small non-coding RNAs called 
microRNA (miR), which largely bind to the 3 ́΄-UTR of the target mRNA to 
negatively regulate their translation, have been shown to modulate under 
temperature-shift (Barron et al. 2011; Gammell et al. 2007), offering another means 
by which pathways involved in specific productivity could be effected. 
At the post transcriptional level, the decreases in global protein synthesis has been 
attributed to the phosphorylation of the initiation factor eIF2α (Masterton et al. 2010; 
Underhill et al. 2005). It has been shown that upon phosphorylation, eIF2α forms an 
inhibitory complex with eIF2B, which in turn prevents the binding of initiator met-
tRNAi to the 40S ribosomal subunit resulting in the suppression of global protein 
synthesis (Krishnamoorthy et al. 2001; Underhill et al. 2005). Despite this, it does 
stand to reason that other eukaryotic initiation translation factors and their associated 
pathways must in some way be affected by the decrease in culture temperature in 
order to facilitate an increase in specific productivity. This pathway has, as yet, to be 
identified. 
Remodelling of the cytoskeleton has also been observed during temperature-shift of 
CHO cells (Kumar et al. 2008a; Yee, Gerdtzen, Hu 2009). As such, it is likely that 
this may have some impact on translation due to the co-localisation of initiation 
factors with the cytoskeleton (Stapulionis, Kolli, Deutscher 1997). Disruption to the 
cytoskeleton through the disassembly of microtubules can be impeded through the 
expression of stable-tubule-only-polypeptides (STOP) proteins to stabilize the 
microtubule network (Masterton and Smales 2014). The specific mechanisms by 
which this impacts on the translational machinery of the cell also has yet to be 
elucidated. 
In summary, the means by which specific productivity is increased appears to be 
multifaceted; from the expression of CSPs, to the stabilisation of mRNA, the 
induction of miRNAs to modulate mRNA translation and the phosphorylation of 
specific eukaryotic initiation translation factors to facilitate translation of specific 
proteins under reduced culture temperature conditions. 
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1.2.3 Proteomic profiling of temperature-shifted CHO cells 
While targeted approaches have been used to investigate specific pathways / known 
proteins that may be implicated it the cellular response to temperature-shift such as 
those described in sections 1.2.1 and 1.2.2, proteomic profiling has been used 
identify some of the more global changes within the proteome of temperature-shifted 
cells. This section briefly discusses these reports and their key findings. 
It should be noted that a detailed description of the proteomic techniques mentioned 
in this section is provided in section 1.6. 
One of the earliest profiling studies utilized a two dimensional polyacrylamide gel 
electrophoresis (2D PAGE) approach to examine extracts from cells grown at 37˚C 
and 31˚C (Kaufmann et al. 1999). The gels were stained using a sensitive stain for 
the detection of proteins called silver stain and the stained protein spot intensity 
compared between temperature-shifted and non-temperature-shifted samples. The 
identification of 10 spots with altered intensities provided a proof of concept that 
temperature-downshift results in the altered expression of proteins in CHO cells. In 
addition to this, the identification of alterations in the levels of tyrosine 
phosphorylation on a 80 kDa and 180 kDa protein between 37˚C and 31˚C, provided 
the first evidence of CHO cells actively responding at the posttranslational level to 
changes in culture temperature (Kaufmann et al. 1999). 
Also employing silver stained/2D PAGE approach, the proteomic profiling element 
of a combined transcriptome and proteome analysis of EPO producing CHO cells 
identified 13 spots as having at least a twofold change in spot intensity upon 
temperature-shift (Baik et al. 2006). Although spot identification by MALDI-ToF 
and MS/MS revealed only nine proteins to be differentially-expressed, the increase 
in a number of proteins (PDI, ERp57, HSP70) implicated changes in the protein 
folding machinery as attributing factor towards increased EPO productivity.  
In a more sophisticated transcriptomic and proteomic investigation, an expansion of 
the cell’s secretory machinery was also identified as a key component of the increase 
in specific productivity of an IgG producing CHO cell line following temperature-
shift and sodium butyrate treatment (Kantardjieff et al. 2010). 
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Using a metabolic labelling (stable isotope labelling with amino acids in cell culture 
(SILAC)) approach to study the secretion rate of IgG CHO cells grown (i) at 33˚C 
and (ii) at treated with sodium butyrate (NaBu) at 33˚C, it was found that rather than 
faster processing times, an increase in the availability of the light chain molecule 
facilitated more efficient production of the IgG product. This was backed up by 
transcriptome analysis which identified functional classes related to protein secretion 
to be enriched under temperature-shift and NaBu treatments.  
2D difference gel electrophoresis (DIGE) analysis of a non-producing CHO-K1 cell 
line under temperature-shift revealed that proteins predominantly involved in cell 
structure and metabolism altered in expression (Kumar et al. 2008a). Given that this 
study was carried out in a non-producing cell line, few insights into the mechanisms 
involved in the increase in specific productivity seen in many temperature-shifted 
cell lines could be obtained. Nonetheless, among the 201 differentially-expressed 
proteins identified (118 up-regulated at 31˚C), a number of those likely to be 
involved in important cellular pathways were also observed including; 
Heterogeneous nuclear ribonucleoprotein C (HNRPC) (regulation of growth), EIF4A 
(cap-independent translation), importin-α (apoptosis), Vimentin (structural) and 
alpha glucosidase 2 (glycoprotein quality control) (Kumar et al. 2008a). 
 
1.3 Proteomic profiling of desirable cell phenotypes 
A wide range of proteomic profiling studies have been carried out on CHO cells in 
an effort to decipher the mechanics of the recombinant protein producing cell. By 
profiling cells displaying desirable phenotypic traits such as fast growth rate, high 
productivity, low lactate/ammonic production, delayed onset of apoptosis etc, it is 
hoped that this information can one day be used to engineer a ‘super producer’ (Seth 
et al. 2007). While our knowledge of the CHO proteome has vastly improved over 
the last number of years (Baycin-Hizal et al. 2012), a deeper understanding is 
required in order to select cell engineering targets with a view to improving cellular 
phenotype in a more efficient manner (Dietmair, Nielsen, Timmins 2011). This 
section provides a brief overview of some of the ‘desirable’ characteristics that could 
be engineered into a cell in Table 1.3.1 and summarises some of the proteomic 
profiling investigations conducted to date in Table 1.3.2 
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Table 1.3.1 Overview of some ‘desirable’ characteristics in a recombinant protein 
producing cell line. 
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Table 1.3.2 Table summarising some of the proteomic profiling investigations conducted date in CHO cells that have furthered our 
understanding of some of the cellular mechanisms involved in important cell attributes such as growth rate, productivity, apoptosis and 
metabolic shift. 
 
Cell 
line Cellular Trait
Proteomic 
Technique Comparison Product Key Findings Reference
CHO Apoptosis 2D DIGE
Analysis of CHO cells 
undergoing apoptosis IgG
Although no direct apoptosis-regulating proteins were 
identified, the potential importance of UPR and energy 
metabolism in prolonged cultures and apoptotic cell 
death was established. In addition to the type of 
apoptotic pathway triggered, apoptotic proteins 
associated with ER stress, mitochondrial dysfunction 
and energy metabolism were identified.
(Wei et al. 
2011)
NS0 Productivity 2D PAGE (Ruby stained)
Analysis of four NS0 cell 
lines with different specific 
productivities
IgG
Proteins exhibiting a significant increase in abundance 
with increasing qMab included molecular chaperones 
known to interact directly with nascent immunoglobulins 
during their folding and assembly (e.g., BiP, 
endoplasmin, protein disulfide isomerase).
(Smales et al. 
2004)
NS0 Productivity 2D PAGE (Ruby stained)
Analysis of four NS0 cell 
lines with different specific 
productivities if particular 
cell lines have distinct 
functional capabilities
IgG
Significant increase in the abundance of proteins in the 
ER chaperone, non-ER chaperone and cytoskeletal 
categories, while proteins categorised as being involved 
in protein synthesis, protein degradation and nucleic 
acid synthesis remained unchanged.
(Dinnis et al. 
2006)
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CHO Productivity 2D DIGE
Analysis of two CHO cell 
line pairs, with each pairing 
differing in their ability to 
sustain high productivity 
over a ten day culture 
period
IgG
Overlap comparisons between the two sets of cell line 
pairs identified 12 proteins, involved in processes such 
as protein folding and protein translation were 
differentially expressed in the same direction.
(Meleady et al. 
2011)
CHO Growth rate QLF-LC/MS
miRNA, mRNA and 
protein expression analysis 
of 'fast' and 'slow' growing 
clones
IgG
Biological processes driving proliferation including 
mRNA processing and translation, in addition, the 
upregulation of numerous ribosomal proteins (RP) was 
observed (e.g. RPL14, RPS15 and RPL15).
(Clarke et al. 
2012)
CHO Growth rate 2D DIGE
Genomic and proteomic 
analysis of 'fast' and 'slow' 
growing clones
IgG
Genomic/proteomic analysis identified 21 high-priority 
cell engineering targets. Functional validation found of 
five selected targets found the knockdown of HSPB1, 
ENO1 and VCP all impacted on cell growth.
(Doolan et al. 
2010)
CHO Metabolic shift 2D PAGE (Silver stained)
Lactate consuming 
compared to non-lactate 
consuming cell line
IgG
Proteins involved in glycolysis, protein processing and 
cell structure were differentially expressed. How low 
lactate conditions are generated e.g. through different 
feed strategies, can impact on the proteome of the cell.
(Pascoe et al. 
2007)
CHO Productivity iTRAQ (LC/MS)
Transcriptomic and 
proteomic analysis of high 
and low producing CHO 
cells
Fusion 
protein
Differential expression of genes and proteins include 
carbohydrate metabolism,signal transduction, and 
transport were observed. Upregulation of proteins 
involved in protein metabolism and protein folding in the 
high producer were also identified.
(Nissom et al. 
2006)
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1.4 Host cell proteins (HCPs) 
Host cell proteins (HCPs) are process related impurities derived from a host cell line 
that must be removed from the final drug product. As well as impacting on product 
quality during processing, insufficient removal of these impurities may result in an 
immunogenic response in the patient (Gao et al. 2011; Shankar, Pendley, Stein 
2007). Although no limit has been set by the Regulatory Authorities it is 
recommended that levels of HCPs in the final drug product are “below detectable 
levels using a highly sensitive analytical method” (CBER 1997). It has been 
acknowledged that testing for such impurities is very challenging since the test must 
be capable of detecting fragments of HCPs in a complex sample that may cover a 
large dynamic range (Rathore et al. 2003). One popular means of testing for the 
presence of HCPs is the use of enzyme linked immunosorbent assays (ELISAs) as 
they are capable of detection between 1-100 ppm (Eaton 1995; Hoffman 2000). Such 
assays are generated by raising antibodies against a protein mixture from the host 
cell line. To avoid false positives it is important to ensure that the assay does not 
contain antibodies that have an affinity for the product of interest. For this reason the 
protein mixture is generated from a non-producing cell line. It could be argued that 
proteins that are weakly / non-immunoreactive will not be detected by ELISA. The 
use of an alternative detection method such as silver staining on a 1D or 2D gel may 
be useful in such instances (Champion et al. 2005). 
ELISAs used to test for the presence of HCPs may be categorised as generic, custom 
or multiproduct. The type of ELISA used will depend on a number of factors such as 
product maturity and general suitability. Commercially available generic assays are 
typically employed during the early stages of product development i.e. phase 1 
clinical trials, because they are inexpensive and capable of measuring HCPs present 
in a given cell line (Schwertner and Kirchner 2010). However, results from generic 
assays have been shown to be variable and sometimes lack sufficient sensitivity 
(Schwertner and Kirchner 2010), so once a product reaches phase 3 of clinical trials 
a more specific i.e. custom assay, may be required by the regulatory authorities.  
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Usually taking 9-12 months, custom assay development is a time consuming 
endeavour (Wolter and Richter 2005). It is also costly and may be deemed unsuitable 
if changes to the final purification process are made at a later date (Champion et al. 
2005). A compromise between these two types of assay may be found in the 
multiproduct assay (Schwertner and Kirchner 2010). This assay is developed by the 
company to be used across a number of products which are derived from a specific 
cell line.  
Krawitz et al. (2006) supported the use of multi-product immunoassays for HCP 
analysis in recombinant protein production based on a comparison of the proteomes 
of three different CHO cell lines. Using 2D PAGE stained using a sensitive staining 
method (SPYRO Ruby), this study found no difference in the basal expression of 
proteins in the three cell lines (Krawitz et al. 2006). This is not surprising given that 
other studies have found the proteome of therapeutic producing cell lines to be very 
similar (Champion et al. 1999; Hayduk, Choe, Lee 2004). It can be argued that these 
studies only consider the intracellular proteome and do not take into account subtle 
differences that may exist in the extracellular HCPs (Jin et al. 2010), such as an 
increase in the abundance of acidic proteins in the extracellular proteome (Wimmer 
et al. 1994). Nonetheless the intracellular proteome is regarded as being sufficiently 
similar to the extracellular proteome to make such studies valid (Hoffman 2000).  
In two recent papers, 2D DIGE was used to investigate the HCP profile of IgG 
producing CHO cell lines (Grzeskowiak et al. 2009; Jin et al. 2010). Interestingly, 
the HCP profiles of cells exposed to different culture conditions e.g. inoculation 
density, basal and feed media, temperature-shift strategy, were found to be very 
similar (Jin et al. 2010). The most notable changes came as a result in cell viability 
where HCP content was greatest in low viability cultures (Grzeskowiak et al. 2009), 
while there was minimal change to the HCP profile of cells maintained at high 
viability where (Jin et al. 2010). As a result of this finding, cell culture viability must 
now be a consideration for the generation and use of ELISAs to detect HCPs during 
routine analytic testing.  
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1.4.1 Proteases as part of the HCP matrix 
Proteases are an integral part of the intracellular proteome. They play an important 
role in cellular processes such as DNA replication, cell-cycle progression and cell 
proliferation (López-Otín and Overall 2002). As a result, the presence of proteases in 
the cell culture broth is inevitable be it as a result of secretion from viable cells 
(Elliott, Hohmann, Spanos 2003; Robert et al. 2009; Sandberg et al. 2006; Satoh, 
Hosoi, Sato 1990), dead cells (Satoh, Hosoi, Sato 1990; Teige, Weidemann, 
Kretzmer 1994) or the mechanical lysis of cells during culture or harvest (Kao et al. 
2010; Trexler‐Schmidt et al. 2010). The addition of excipients such as media 
supplements is also a potential source of proteases (Mols et al. 2004). Proteases can 
continue to be a problem right throughout the purification process. Harvest 
operations may cause excessive cell shear, causing intracellular proteases to be 
released into the cell culture fluid (Kao et al. 2010; Trexler‐Schmidt et al. 2010).  
Concentration of the protein product in the early stages of purification may also lead 
to a significant increase in protease activity (Sandberg et al. 2006). Changes in the 
pH of buffers used in the purification process may also lead to the activation of 
proteases such as acidic or aspartic proteases, such as those identified in the 
conditioned media of mAb producing cell lines in other studies (Karl, Donovan, 
Flickinger 1990; Sandberg et al. 2006). HCP proteases can also cleave Protein A 
ligand (Shukla et al. 2007) having the effect of both reducing column performance 
and adding an additional impurity that must also be removed.  
Protease activity in the cell culture can have a detrimental effect on product quality 
(Kao et al. 2010). Degradation of the product by protease activity has been reported 
in some of the most commercially relevant, eukaryotic expression systems, CHO 
(Elliott, Hohmann, Spanos 2003; Robert et al. 2009; Sandberg et al. 2006) and 
Hybridoma cell lines (Karl, Donovan, Flickinger 1990). 
Results from these studies seem to indicate that product degradation as a result of 
protease activity is somewhat cell line and product specific. There may be a number 
of reasons for this; (i) some level of protection may be provided by naturally 
occurring protease inhibitors produced by the cell line (ii) the protease may be 
produced in an inactive form, or (iii) the product may not contain amino acids 
sequences that are sensitive to cleavage by the proteases present in the media (Mols 
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et al. 2004; Trexler, Bányai, Patthy 2001).  Reasons for inhibiting protease activity 
are two-fold: a decrease in product degradation would not only have the effect of 
increasing process productivity but a reduction in in the volume of degraded 
antibody molecules would mean a reduction in the size of the Protein A column 
required (Reid et al. 2010).  
By and large protease inhibition studies have been the mainstay of protease 
identification and product conservation (Elliott, Hohmann, Spanos 2003; Lindskog, 
Svensson, Häggström 2006; Sandberg et al. 2006). On an industrial scale the 
addition of protease inhibitors can be costly and their removal from the final drug 
substance must also be considered. Up to 2011 the lack of a comprehensive CHO 
proteome database has hampered efforts to conclusively identify some proteases 
(Sandberg et al. 2006) and implement potential cell engineering solutions (Robert et 
al. 2009). However, following the release of two CHO proteomic databases 
(Meleady et al. 2012; Xu et al. 2011) one would expect our knowledge of such 
proteases to increase as the host cell proteome comes under greater scrutiny.  
Media formulation could also benefit from insights into protease activity since the 
use of serum free media, as required by the regulatory authorities, may see an 
increase in protease activity due to the absence of protease inhibitors that would be 
present in serum (Teige, Weidemann, Kretzmer 1994). 
None the less, even our limited understanding of these proteases can contribute 
toward making key strategic decisions such as when to harvest the product. How 
long the product spends in the cell culture broth prior to harvest has been shown to 
impact on product quality both in terms of the presence/absence of crucial PTMs and 
structural integrity (Hansen et al. 1997; Reid et al. 2010; Teige, Weidemann, 
Kretzmer 1994).  
Protease activity may also affect cell line choice. It has been suggested that a 
carboxypeptidase B or another basic carboxypeptidase is at least partially responsible 
for a C-terminal lysine variation in Mabs produced in CHO and B cell hybridoma 
cells (Dick Jr et al. 2008). Although it had been hypothesized that a reduction in 
culture temperature could reduce protease activity while at the same time increasing 
overall productivity (Chuppa et al. 1997; Kaufmann et al. 1999), one study found 
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that product quality was similar for both conditions despite an increase in a 69kDa 
protease in the 37˚C culture (Clark, Chaplin, Harcum 2004).   
In terms of product quality much of the emphasis has been placed on the ability of 
the upstream process to produce a consistent recombinant protein structure (Zhou et 
al. 2008). It is only in more recent times that the focus has shifted to the effect of 
downstream processing on product integrity (Gao et al. 2011; Reid et al. 2010). The 
importance of thorough purification of the protein product was highlighted by Gao et 
al (2010) who showed that the presence of residual protease activity in a highly 
purified monoclonal antibody sample can negatively impact product quality. 
 
1.4.2 Growth Factors and Conditioned Media 
Serum is rich source of nutrients that are known to provide cells with protection from 
apoptosis (Zanghi, Fussenegger, Bailey 1999) and support cell proliferation (Liew et 
al. 2010). Its precise constituents, however, remain somewhat unknown. Due to its 
animal origins the components of serum can vary in concentration thus causing 
unpredictable growth and productivity patterns (Even, Sandusky, Barnard 2006). 
There are also regulatory concerns that it may contain viruses making it unsuitable 
for use given the intended market of the therapeutic product (Even, Sandusky, 
Barnard 2006). Serum Free Media (SFM) is a defined media composition containing 
known growth factors and other elements that support cell growth and recombinant 
protein production (Schroder, Matischak, Friedl 2004). The addition of proteins to 
media can be expensive (particularly on an industrial scale) and are often obtained 
from an animal source (Keenan, Pearson, Clynes 2006). Chemically defined media 
has been the gold standard in terms of media formulation (Grillberger et al. 2009). 
One area however that has received very little attention in bioprocessing is the effect 
of autocrine factors on cell proliferation and productivity. Conditioned media can be 
a rich source of such factors (Dowell, Johnson, Li 2009). Conditioned media from 
cancer cell lines is commonly used to identify biomarkers in cancer that correlate 
with characteristics of interest e.g. invasiveness, growth rate, etc. (Xue, Lu, Lai 
2008)(Chenau et al. 2009; Makridakis et al. 2010). It is a source that does not appear 
to have been so thoroughly investigated for bioprocessing cell lines. Such 
information could potentially be used to screen for biomarkers of desirable 
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phenotypes (Woolley and Al‐Rubeai 2009) or to engineer a cell line that secretes 
factors that promote growth and proliferation (Pak et al. 1996).  
The addition of conditioned media to cell cultures has been reported to increase 
growth and productivity of hybridoma cells (Dutton, Scharer, Moo-Young 1999; 
Spens and Häggström 2005). It has been hypothesised that even in media rich in 
nutrients, the depletion of autocrine factors can result in cell death (Spens and 
Häggström 2007). 
The mechanism by which proteins secreted into the media affect cell proliferation 
can be complex. An example of this is the mitogenic effect of IGF-1 on fibroblast 
cells which is controlled by a family of high affinity IGF-I binding proteins 
(IGFBPs) (Baxter and Martin 1989). Specifically, IGFBP-5 plays an important role 
in the release of IGF-I to receptors on the cell surface (Fowlkes et al. 1994; Mohan et 
al. 1995). It has been shown that only a cleaved form of IGFBP-5 can mediate the 
IGF-I receptor activation (Imai et al. 1997).  
It has been reported that a secreted 88kDa serine protease that is responsible for the 
cleavage of IGFBP-5 (Busby et al. 2000). A study carried out in CHO cells revealed 
that while transferrin alone did not promote survival or proliferation and IGF-I 
helped maintain cell viability for an extended period of time, a combination of IGF 
and transferrin greatly improved cell survival and proliferation (Chun et al. 2003; 
Sunstrom et al. 2000).  
To date there have been very few studies that have looked at the secretome of CHO 
cells. One such study however identified 24 proteins as being differentially-regulated 
at different phases of a 6 day growth cycle (Kumar et al. 2008b). Unfortunately due 
to the use of SELDI ToF as the sole means of analysis no protein identification is 
provided. Nonetheless this paper provides an interesting insight into the secretory 
profile of CHO cells. Some proteins accumulate until day four of the culture and 
their expression decreases over the following 3 days either due to them being of 
nutritional value to the cells or proteolytic activity. Other proteins appear only in the 
final days of culture suggesting that their presence is as the result of cell stress 
(Woolley and Al‐Rubeai 2009) or apoptosis (Arden and Betenbaugh 2004).  
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The authors also submit the hypothesis that the appearance of these proteins late in 
the culture could also be as the result of proteolysis of the product or other proteins 
in the media. Sandberg et al. (2006) identified an MMP pro-enzyme of ≥200 kDa 
that was released from the CHO cells during culture, autoproteolysis of which 
yielded several smaller MMPs with non-specific protease activity. Interestingly, in 
an insect cell line, Trichoplusia ni, a secreted 48kDa metalloproteinase was 
identified as having growth promoting effects (Eriksson et al. 2005).  
Although there have been several reports of different  metalloproteinase variants in 
CHO culture media (Elliott, Hohmann, Spanos 2003; Mols et al. 2004; Sandberg et 
al. 2006) no studies to date have made a link between their presence and CHO cell 
proliferation despite it being well established that MMPs are involved in autocrine 
signalling and growth promotion (Fowlkes and Winkler 2002). 
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1.5 Introduction to Proteomics 
The study of proteins is called ‘Proteomics’, which is defined as the system-wide 
characterization of all the proteins in an organism in terms of their sequence, 
localization, abundance, post-translational modifications, and biomolecular 
interactions (Käll and Vitek 2011). While DNA contains all the genetic information 
required to construct an organism, a non-linear relationship often exists between the 
genome and the proteome of a cell as a result of events such as alternative splicing 
and the presence of non-coding RNAs (e.g. miRNAs) (Altelaar, Munoz, Heck 2013). 
Given that proteins are intrinsically linked with biological function, a complete 
knowledge of all the proteins in an organism would provide some of the greatest 
insights into characterising that system (Cox and Mann 2007). This section provides 
a brief overview of some of the techniques commonly used to characterise the 
proteome of some of those biological systems. 
 
1.5.1 Proteomic sample preparation 
To prepare samples for analysis, cells and tissues need to be lysed to release the 
proteins of interest. This may be done either mechanically e.g. using a sonicator, or 
chemically, using a lysis buffer. In either event important consideration must be 
given to the solution that will contain the protein upon cell/tissue lysis. How the 
protein is solubilised will ultimately depend (i) on the nature of the protein – 
membrane proteins, typically hydrophobic in nature, can be more difficult to 
solubilise than proteins that are more hydrophilic in nature and (ii) how the protein 
will be analysed – analysis of the protein sample may either be ‘gel based’ i.e. utilise 
Polyacrylamide Gel Electrophoresis (PAGE) (discussed section 1.5.2.1) or ‘non-gel 
based’ i.e. utilise liquid chromatography/mass spectrometry (LC/MS) (discussed 
section 1.5.3). Where a non-gel based LC/MS approach is used, the preparation of a 
sample is sometimes referred to as ‘in solution’. It should be noted however, that the 
use of LC/MS is not restricted to non-gel based methods and can be used to identify 
proteins initially analysed by PAGE.  
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In order to aid protein solubilisation, the sample buffer may contain a combination of 
detergents and strong chaotropic reagents such as urea and thiourea. Although 
detergents are widely used in the disruption of tissue and cell and are often required 
to solubilise hydrophobic proteins such as membrane proteins (Arachea et al. 2012), 
the presence of a detergent may be unsuitable for certain applications. For example, 
sodium dodecyl sulphate (SDS) is commonly used as a reducing agent for the 
analysis of proteins by 1D polyacrylamide gel electrophoresis (PAGE), it is entirely 
unsuitable for 2D PAGE and (LC/MS) analysis. Although 3-[(3-cholamidopropyl) 
dimethylammonio]-1-propanesulfonate (CHAPS) is suitable for use in both 1D and 
2D PAGE methodologies, like SDS, CHAPS cannot be used for samples that are 
being prepared for ‘in solution’ analysis by LC/MS. It should be noted that in the last 
number of years a number of LC/MS compatible detergents have become available 
for enhanced protein solubilisation and digestion including RapiGest, PPS and 
ProteaseMAX (Chen et al. 2007; Lo et al. 2013). Cleavage of the detergent, usually 
under acidic conditions, prior to sample loading on the LC/MS system, ensures that 
the detergent does not interfere with LC/MS analysis. Compared to SDS and 
CHAPS, however, they are expensive and as such their application is likely to be 
limited to LC/MS analysis for the foreseeable future. 
 
1.5.2 Sample separation 
It is estimated that a single cell contains 10,000 proteins, of which 4,000 – 6,000 can 
currently be routinely identified (Geiger et al. 2012). While the sheer number of 
proteins contained in a cell can itself hinder the identification of all proteins present 
in a single analysis, the fact that the expression of these proteins occurs over a large 
dynamic range adds another layer of complexity to any attempt to characterise a 
proteome (Picotti et al. 2009).  
Given the complex nature of a proteome, some form of sample separation is typically 
required to facilitate its analysis. This section will provide a brief overview of two 
techniques that are commonly used to achieve this reduction in complexity; PAGE 
and liquid chromatography. 
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1.5.2.1 Protein separation by 2D-PAGE 
In two dimensional Polyacrylamide Gel Electrophoresis (2D PAGE), the proteins are 
electrophoretically separated along a pH gradient in the first dimension; this 
fractionates proteins on the basis of their isoelectric point. In the second dimension 
electrophoretic separation of proteins is generally based on the molecular weight of 
the protein, as this step usually occurs in the presence of SDS (Hanash and Taguchi 
2010).  
Although 2D PAGE based techniques are capable of resolving thousands of proteins 
(Li, Seillier-Moiseiwitsch, Korostyshevskiy 2011), it does suffer from a number of 
short comings including not being able to analyse proteins at the extremes of pH or 
molecular weight (Issaq and Veenstra 2008). Despite this, 2D PAGE has been 
successfully employed in the investigation of a wide variety of proteomes including 
human (Hardt et al. 2005), bacterial (Wickström et al. 2011), plant (Sarma, Oehrle, 
Emerich 2008) and CHO (Hayduk, Choe, Lee 2004) 
Proteins separated on a gel may be visualised using a number of different stains, 
these can be fluorescent (e.g. SYPRO red) or colorimetric (e.g. Silver stain, 
Coomassie blue). The choice of stain will depend on a number of factors including 
desired level of sensitivity and ease of use. For example, Silver stain is two orders of 
magnitude more sensitive than Coomassie blue (Issaq and Veenstra 2008); however 
Coomassie is lower in cost and better suited to quantitative analysis (Dong et al. 
2011). Although fluorescent stains such as SYPRO red are highly sensitive (as low 
as 2ng) and have a greater dynamic range than silver staining (Smejkal, Robinson, 
Lazarev 2004), specialist equipment (i.e. fluorescent scanner) is required to view the 
proteins on the gel (Cong et al. 2008). 
Given that the colorimetric intensity of a spot is proportional to the quantity of the 
corresponding protein on the gel, the intensity of staining for each spot can be 
compared between gels containing samples from different conditions, thus relative 
quantitative information can be obtained using specialist software (Li, Seillier-
Moiseiwitsch, Korostyshevskiy 2011).  
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An alternative approach to obtain relative quantitative information when comparing 
gels containing samples from two conditions is the use of a technique called 
Differential In-Gel Electrophoresis (DIGE). In this method the samples from the 
control, test, and a mixture of the control and test (to form an internal standard, 
providing both inter- and intra-gel matching) are pre-labelled with a cyanine dye 
(cy2, cy3 or cy5). The three labelled sample sets are then combined and run on a 
single gel. This means that matching proteins from the different samples will all 
migrate to the same location on the gel, yet each protein in that location will have its 
own unique fluorescent marker. The gel is then scanned at a suitable wavelength to 
facilitate detection of each labelled protein, making this approach more accurate for 
quantitation than the staining methods (Issaq and Veenstra 2008). 
 
1.5.2.2 Protein separation by Liquid chromatography 
The use of liquid chromatography (LC) is another means by which sample 
complexity can be significantly reduced. Separation is based on an interaction 
occurring between stationary phase (typically a resin contained in a column) and the 
analyte (protein/peptide) in a mobile phase (solution that is suitable for the analyte 
and that facilitates the interaction between the analyte and stationary phase). A 
number of different resins may be used in the separation of a sample, each of which 
takes advantage of different characteristics of the sample. These can be broadly 
categorised as affinity (biological interaction), ion-exchange (charge), size exclusion 
(size) and reversed phase (polarity). Referred to as multi-dimensional protein 
identification technology (Mud-PIT) when coupled to a mass spectrometer, the use 
of multiple chromatography columns enabling the further separation of complex 
samples is gaining in popularity (Fränzel and Wolters 2011). The use of liquid 
chromatography in conjunction with mass spectrometry is further discussed in 
section 1.5.3. It should be noted that, with the exception of phosphoprotein 
enrichment and its use for the reduction of the IgG molecule from conditioned media 
samples, the work discussed in this thesis primarily employs liquid chromatography 
for peptide separation.  
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1.5.3 Mass spectrometry for protein identification and characterisation 
Mass spectrometry has become the cornerstone upon which proteomics has come to 
rely. Mass spectrometry is used in a wide range of proteomic applications, from the 
qualitative identification of a single protein in a 2D-gel spot to large scale 
quantitative experiment seeking to decipher the signalling dynamics of a biological 
system (Gygi et al. 2000; Munoz et al. 2011). 
The following section provides a brief overview of how a protein sample is prepared 
for, and analysed by a mass spectrometer culminating in the identification of the 
proteins contained in that sample. 
 
1.5.3.1 Sample preparation for Mass Spectrometry 
Mass spectral proteomic analysis may be referred to as ‘top down’, whereby proteins 
are analysed as intact molecules in the mass spectrometer, or more commonly, 
‘bottom up’, where the proteins are enzymatically digested and the resulting peptides 
are analysed (Armirotti and Damonte 2010). Given the intrinsic structural 
complexity of proteins in their native form, analysis by mass spectrometry is 
challenging; sufficient separation of complex samples and obtaining sufficient 
information to identify the proteins can prove difficult (Yates and Kelleher 2013). 
However, the top down strategy has proven useful for the identification of post 
translational modifications (PTMs) and sample preparation time is shorter compared 
to the bottom up approach (Armirotti and Damonte 2010). For this reason top down 
analysis is typically used for the analysis of samples containing a homogeneous, or 
very small heterogeneous, population of proteins. Despite having a longer sample 
preparation time, the bottom up approach is more established and has been found to 
lend itself well to the analysis of complex protein mixtures (Zhang et al. 2013). 
Assuming the protein sample has been obtained from a cell or tissue source using 
mechanical or chemical means as described in section 1.5.1, sample preparation of 
proteins for analysis at the peptide level follows a typical workflow involving 
protein denaturation, reduction, alkylation and digestion. The presence of LC/MS 
compatible detergents such as ProteaseMax (described in section 1.5.1) and/or the 
chaotropic agent urea in the sample buffer causes the protein to lose its quaternary 
structure to form a single stranded polypeptide.  
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In other words, the protein becomes denatured. It should be remembered however 
that some disulphide bonds may remain intact, causing the protein to retain some of 
its structure. Therefore a reducing agent such as dithiothreitol (DTT) is required for 
the reduction of disulfide bonds on the protein. The free sulfhydryls are then reacted 
with a reagent such as Iodoacetamide to prevent the disulfide bonds reforming; this 
step is commonly referred to as alkylation (Boja and Fales 2001). Lastly, the protein 
is enzymatically digested. Although there are a number of enzymes that can be 
employed, trypsin is perhaps one of the most commonly used enzymes for protein 
digestion (Swaney, Wenger, Coon 2010). This is because it is protease with a 
specificity for cleaving at the C-terminus of lysine and arginine, which tends to 
generate peptides of 7-20 amino acids long, a length well suited to analysis by 
LC/MS (Tran et al. 2010). Other commonly used digestion enzymes include Lys-C 
which specifically cleaves at the c-terminus of lysine residues and Asp-N which 
cleaves at the amine side of aspartic and cysteic acid (Zhang et al. 2013). 
 
1.5.3.2 Nanoflow Liquid Chromatography coupled to Mass Spectrometers 
The enzymatic digestion of a sample, possibly containing hundreds or even 
thousands of proteins, results in tens of thousands of peptides being generated. As 
such, some means of sample separation is often required in order to allow the mass 
spectrometer time to analyse such a large number of peptides. High pressure liquid 
chromatography (HPLC) using a reverse phase (RP) is compatible with mass 
spectrometry, enabling a RP-HPLC system to be directly coupled to a mass 
spectrometer, as a result RP-HPLC is the most common means of reducing this 
sample complexity (Moruz et al. 2013). With RP-HPLC, the peptide mixture 
dissolved in a polar liquid mobile phase, is passed over a non-polar stationary phase 
contained in the chromatography column resulting in the peptides binding to the 
stationary phase based on their hydrophobicity. By increasing the aqueous/organic 
ratio of the mobile phase to form a solvent gradient, peptides are removed (eluted) 
from the column with hydrophilic peptides eluting first and hydrophobic peptides 
eluting towards the end of the gradient (Pitt 2009). Proteomic peptide separations 
generally flow at very low flow rates 200-400nl/min through narrow 
chromatography columns usually 75µm wide and finally leave the HPLC through a 
spray needle/tip between 10-20 µm wide into a mass spectrometer. 
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1.5.3.3 The basic components of a mass spectrometer 
 
 
 
Figure 1.5.1 Schematic of the basic components of a mass spectrometer 
 
The first step in the analysis of a protein sample by mass spectrometry is the loading 
of the sample into the mass spectrometer and whereupon it is ionised by the ion 
source (Figure 1.5.1). Examples of ion sources include Matrix Assisted Laser 
Desorption Ionisation (MALDI) or Electrospray Ionisation (ESI). In the case of 
MALDI, samples are ‘spotted’ onto a plate which is then loaded into the mass 
spectrometer for analysis. It should be noted that samples may be pre-fractionated by 
liquid chromatography prior to spotting onto the plate in order to reduce sample 
complexity (Mirgorodskaya et al. 2005). ESI on the other hand, (referred to as nano 
spray ionisation (NSI) when being sprayed from a nanoHPLC system directly into a 
mass spectrometer), applies a voltage (1.5KV) to the liquid samples which causes an 
evaporating aerosol of single ions which are then drawn into the mass spectrometer 
by the vacuum system.  
Once ionised, the charged molecules accelerate through the system and encounter 
magnetic and/or electrical fields from mass analysers, deflecting their path based on 
their mass-to-charge ratio (m/z). Examples of mass analysers include Ion Traps, 
Quadrupoles and Time of Flight (ToF), each of which has their own specific 
characteristics. Mass analysers may either be used to separate all the ions in a sample 
for global analysis or act as a filter to deflect specific ions for analysis by the 
detector. Ion detectors are electron multipliers or microchannel plates which, on 
contact by an ion, emit a cascade of electrons. The resulting cascade amplifies the 
ion for improved detection sensitivity. This all occurs under a vacuum (10-8 torr) to 
remove any contaminating (i.e. non sample) ions which could collide with the 
sample ion. Software is then used to analyse the ion detector data generated and the 
information is output is typically visualised as a graph that arranges the detected ions 
by their individual m/z and relative abundance.  
Ion source Mass 
Analyser 
Ion 
Detector 
Computer 
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At this point, preliminary mass spectrum (MS1) data has now been acquired from 
the intact peptide (Angel et al. 2012). Further information about the detected ions 
can be obtained by using tandem mass spectrometry (MS/MS). Using this approach, 
a specific ion of interested is selected based on its m/z and is fragmented by colliding 
the ions with a chemically inert gas (Walther and Mann 2010). The fragments 
produced are separated on their individual m/z ratios and detected by the ion 
detector. It should be noted that some instruments are capable of generating 
fragmentation information on the already fragmented ions, this strategy is referred to 
as MS/MS/MS or MSn (further discussed in section 1.5.7).  
There are a number of means by which ion fragmentation can be induced including 
Electron Transfer Dissociation (ETD), High Collision Dissociation (HCD) and 
Electron Capture Dissociation (ECD) but perhaps one of the most commonly used 
methods is Collision-induced dissociation (CID) (Frese et al. 2011). In the case of 
CID, the amide bond along the peptide backbone dissociates resulting in two 
fragments being produced; one containing the N-terminus and the other containing 
the C-terminus. The Roepstorff–Fohlmann nomenclature denotes N-terminal 
fragments with the letters a, b and c and C-terminal fragments with the letters x,y 
and z (Roepstorff and Fohlman 1984; Sadygov, Cociorva, Yates 2004). The use of 
CID in ion traps, triple quadrupoles and quadrupole time of flight instruments tend to 
result in b-ions, y–ions and neutral losses of water and ammonia dominating the 
mass spectrum (Figure 1.5.2) 
 
 
Figure 1.5.2 The proposal for a common nomenclature for sequence ions in mass 
spectra of peptides as put forward by Roepstorff and Fohlman (1984). 
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Another consideration is the charge state of the ion in the spectrometer as this is used 
to determine the m/z ratio of the specific ion. Although ToF instruments only 
produce molecules with a +1 charge, ion traps can produce multiple charged species. 
Therefore the charge state is required to determine the mass of the molecule, 
however it should be noted that it is the use of tandem MS/MS that allows for the 
molecule identification (further discussed in 1.5.3.4). The ion charge can be 
determined by distance between the peaks of the naturally occurring isotopes of 
different masses (1Da) on the m/z scale. If, for example, the distance between peaks 
is one unit on the m/z scale, then the charge of the peptide would also be one (as 
seen with isotopes 842.51 and 843.51 in Figure 1.5.3 A). If however, the distance 
was 0.5, then the charge would be two (as seen with isotopes 421.759 and 422.260 in 
Figure 1.5.3 B). This distance between the peaks results from the 1% probability that 
each carbon atom is a 13C isotope instead of the usual 12C atom (Figure 1.5.3 C). 
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Figure 1.5.3 (A) Full MS of singly charged peptide as denoted by difference of 1Da 
between the isotopic peaks 842.51 and 843.51 (B) Full MS of double charged 
peptide as denoted by difference of 0.5Da between the isotopic peaks 421.759 and 
422.260 (C) Distribution of naturally occurring isotopes of different masses caused 
by the frequency with which 13C occurs in nature. 
 
 
(A) 
 
 
 
 
(B) 
 
 
 
 
 
(C) 
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1.5.3.4 Determining the peptide sequence from mass spectrometry data 
Using the mass of the ions detected following MS/MS, it is possible to deduce the 
amino acid sequence present in a given peptide by calculating the difference in the 
mass between the peptide fragments as they increase in size from the N terminus or 
C terminus. In its simplest form, this series of specific mass differences corresponds 
to a successive amino acid (See Table 1.5.1 for the list of amino acids and their 
associated masses). For example, when a peptide is fragmented in a mass 
spectrometer using CID, a unique pattern is generated creating an ion ladder made up 
of b-ions and y-ions. Figure 1.5.4 (A) shows an example of a series of b-ions from a 
fragmented peptide with an m/z of 883 and associated amino acids (Figure 1.5.4 B). 
Figure 1.5.4 (C) shows an example of a series of the y-ions from the same 
fragmented peptide (m/z of 883) and associated amino acids (Figure 1.5.4 D). The 
information obtained from the detection of b ions complements the data obtained 
from the detection of y ions (Figure 1.5.4 E and F). As such, the b and y series of 
ions observed can be used to determine the amino acid sequence of a given peptide.  
 
Table 1.5.1 List of amino acids, their 1 and 3 letter codes, and associated 
monoisotopic masses. 
Amino Acid 1-letter code 3-letter code monoisotopic mass (Da)
glycine G Gly 57.021464
alanine A Ala 71.037114
serine S Ser 87.032028
proline P Pro 97.052764
valine V Val 99.068414
threonine T Thr 101.047678
cysteine C Cys 103.009184
isoleucine I Ile 113.084064
leucine L Leu 113.084064
aspagine N AsN 114.042927
aspartic acid D Asp 115.026943
glutamine Q GlN 128.058578
lysine K Lys 128.094963
glutamic acid E Glu 129.042593
methionine M Met 131.040485
histidine H His 137.058912
phenylalanine F Phe 147.068414
arginine R Arg 156.101111
tyrosine Y Tyr 163.063329
tryptophan W Trp 186.079313
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Figure 1.5.4 shows an example of the peptide VATVASLPR and the ion ladder 
made up of b-ions and y-ions resulting from its fragmentation. (A) The series of b-
ions from a fragmented peptide with a m/z of 833. (B) Corresponding amino acid to 
the MS/MS fragments generated as determined by the b-ions. (C) The series of y-
ions from the same fragmented peptide shown in (A). (D) Corresponding amino acid 
to the MS/MS fragments generated as determined by the y-ions. (E) Displays the 
overlap between b and y-ions as a result of the peptide fragmentation and (F) how 
the ion series from both b and y-ions complement each other to provide peptide 
sequence information. 
 
(E) (F) 
(C) (D) 
(A) (B) 
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To obtain the mass of every amino acid in a fragmented peptide (i.e. de novo 
sequencing) in a complex protein sample is not currently a realistic goal. Although 
peptide fragmentation may only contain partial sequence information, when coupled 
with information on the mass of the peptide, this may still be sufficient to derive 
protein identification when searched against a well annotated database (Sadygov et 
al., 2004) (the use of proteomic databases is discussed further in section 1.5.8).  
 
1.5.4 Mass spectrometry data output 
During analysis of a sample by LC/MS, data is collected in a ‘file’ on a computer 
connected to the LC/MS system. A mass spectrometry file can contain peak list 
information such as peptide mass value and peak area as well as MSn peak list 
information including intensity values and beginning and end ion information. While 
there are a number of file formats specific to certain vendors e.g. RAW files 
(Thermo Scientific), wiff files (Ab Sciex) or as multiple files within a folder with a 
.raw extension (Waters and Agilent), open source file formats are also available such 
as mzML. Open source formats provide the user with greater freedom to share 
information and develop software for data analysis (Deutsch 2010), while vendor 
specific formats typically require commercially available software to facilitate their 
use (Deutsch 2012). The mass spectra contained in these files may be represented 
either as ‘profile’ data which contains all acquired data points or as ‘centroided’ data 
where only m/z and intensity pairs of the detectable peaks are extracted (Deutsch 
2012). The file size can depend on the complexity of the sample and the nature of the 
data being collected (Patel et al. 2009).  
 
1.5.5 Bioinformatic analysis of mass spectral data 
Once a sample has been analysed on the mass spectrometer, the information gathered 
is then used to identify the proteins present in the analyte. Although manual 
interpretation can identify amino acid sequences from peptides, many proteomics 
experiments utilise the power of protein databases for automated spectrum 
interpretation.  
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Publically available databases such as uniprot-swissprot, NCBI etc, contain the 
amino acid sequence information for all the respective proteins identified in a 
particular species.  
Databases are continuously changing as new information is obtained and added, or 
existing information modified. How well annotated a database is will depend on how 
much experimental work has been carried out in a particular species. For example, 
species such as Homo sapiens, Mus musculus, Drosophila melanogaster, 
Caenorhabditis elegans, Arabidopsis thaliana, and Saccharomyces cerevisiae are 
generally considered to be well annotated (Holt and Yandell 2011). Using a search 
algorithm such as MASCOT or SEQUEST (Cottrell and London 1999; Eng, 
McCormack, Yates 1994), the mass spectral data is searched against a database. The 
objective of a spectral database search is to identify the best sequence match to the 
actual spectrum generated by the mass spectrometer. There are four basic approaches 
that may be used for this comparison, this includes; descriptive, interpretative, 
stochastic and probability-based modelling (Sadygov, Cociorva, Yates 2004). 
A theoretical digestion of the database takes place when the operator of the software 
inputs the enzyme used to digest the protein sample. Therefore, if trypsin was used 
as the digestion enzyme, all the protein sequences in the database will be 
theoretically cleaved at the amino acids lysine and arginine to provide every 
combination of amino acid sequence possible including miss cleaved events. 
Naturally searches become more complex as static or dynamic modifications are 
added to the search criteria (Savitski, Nielsen, Zubarev 2006). How the mass spectral 
data is then compared against this theoretical digest depends on the software used. 
For example, SEQUEST, described as a descriptive model, compares fragment ions 
against the MS/MS spectrum and generates a preliminary score for each amino acid 
sequence. A cross correlation analysis is then performed against the top 500 
preliminary scoring peptides by correlating theoretical, reconstructed spectra against 
the experimental spectrum and a cross correlation score is given to any peptide 
match (Xcorr) (Eng, McCormack, Yates 1994).  
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MASCOT uses a probability-based approach for protein identification by first 
comparing the calculated peptide masses for each entry in the sequence database 
with those identified by the mass spectrometer. Matches using mass values (either 
peptide masses or MS/MS fragment ion masses) are always handled on a 
probabilistic basis. A score is then awarded based on the absolute probability that the 
observed match of either peptide masses or MS/MS fragment ion masses is a random 
event (Cottrell and London 1999).  
The use of such programmes such as SEQUEST or MASCOT relies on the 
individual to use their discretion to select a cut-off score that will prevent the 
inclusion erroneous results while at the same time not excluding correctly assigned 
identifications (Cooper 2011).  
 
1.5.5.1 CHO specific proteomic databases 
Historically, due to the limited number of proteins available in the CHO database, 
studies relied on sequence homology between CHO and well annotated mammalian 
databases such as Human, mouse or rat (Baik et al. 2011; Carlage et al. 2009; Doolan 
et al. 2010; Kantardjieff et al. 2010; Lee et al. 2010). It is only more recently that 
two CHO specific databases have become available (Meleady et al. 2012; Xu et al. 
2011). The first, released by Xu et al. in 2011, was generated following genomic 
sequencing of CHO-K1 cells (Xu et al. 2011). 
A year later data from the expression of cDNA in CHO cells growing under different 
conditions was used to produce a second database (Meleady et al. 2012). Growing 
the cells under different conditions resulted in the expression of a greater variety of 
genes, as such it was found that the use of both CHO databases provided increased 
coverage of the CHO proteome of CHO (Meleady et al. 2012). Although CHO 
specific databases have been desired for some time, this recent advance in CHO 
proteomics is clearly a significant step forward as proteins will be identified with 
increased confidence and new, previously unidentified proteins are discovered. As 
more information about the CHO genome becomes available (Lewis et al. 2013), it is 
likely that even greater proteome coverage will be possible in the near future. 
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1.5.6 Post Translational Modifications (PTM) Analysis using Mass 
Spectrometry 
Much work has been carried out on the development of different peptide 
fragmentation methodologies, understanding their basic mechanics and 
implementing their use. A significant development over the past few years has been 
the development of the “high-high” strategy (Mann and Kelleher 2008) - high 
resolution at both MS and MS/MS levels - which has been particularly useful for the 
analysis of PTMs (Olsen and Mann 2013). An example of one instrument capable of 
implementing this “high-high” strategy is the LTQ-OrbitrapXL from Thermo Fisher 
Scientific which has allowed for high mass accuracy (<2ppm) and high resolution 
analysis (100,000 FHWM). This high resolution capability enables the identification 
of specific amino acid modifications on a given peptide based on the observation of 
the mass difference associated with the particular modification (Table 1.5.2).  
 
 
Table 1.5.2 List of modifications for amino acids and the mass difference associated 
with the modification. 
 
It should also be pointed out that in an instrument such as an LTQ-OrbitrapXL, 
fragmentation can take place either in the ion trap or the Orbitrap of the mass 
spectrometer. Where the fragmentation occurs will depend upon the end application 
as the ion trap uses faster rates of fragmentation but has low resolution while the 
Orbitrap is capable of high resolution, but has slower fragmentation speed compared 
to the ion trap. High resolution is crucial for applications such as a label-free 
experiment where the ability of the mass spectrometer to discern between separate 
peptide peaks is defined by its resolving power (Cox and Mann 2011) (Quantitative 
label-free LC/MS is further discussed in section 1.5.9).  
Modification Amino Acid 
Involved
Context Mass 
Difference (Da)
Oxidation M Sample preparation (Variable-not 
all methionines are modified) 15.995
Carbamidation C Sample preparation (Complete – 
all cystines become modified) 57.021
Phosphorylatio
n
S, T, Y Post translational 79.966
Water loss S, T Mass Spec -18.01
Deamination N,Q Post translational 0.984
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In other words, in instances where peptides are co-eluting, a low resolution mass 
spectrometer may observe the co-eluting peptides as one peak, whereas a high 
resolution mass spectrometer will be able to differentiate between the different 
peptide profiles (Mann and Kelleher 2008). The slow scan speed of the Orbitrap may 
result in less MS/MS data being produced as less fragmentation occurs. MS and 
MS/MS tasks can, however, be divided between the Orbitrap and the ion trap 
enabling high resolution MS and multiple MS/MS fragmentation data to be gathered 
simultaneously (Yates, Ruse, Nakorchevsky 2009).  
 
1.5.7 Identification of phosphopeptides by mass spectrometry 
The identification of proteins through the analysis of their respective peptide was 
outlined in section 1.5.5. The following piece provides an overview of how sites of 
phosphorylation are determined during phosphopeptide analysis by LC/MS.  
The fragmentation pattern of a phosphorylated peptide will appear shifted by a mass 
of +80Da relative to predicted mass of the unphosphorylated species due to the 
presence of the phosphoric acid group as shown in Figure 1.5.5. The use of collision-
induced dissociation to fragment peptides containing phosphorylated threonine and 
serine results in the cleavage of the phosphoester bond and dissociation of 
Phosphoric acid (H3PO4) as a neutral loss (neutral species). This fragmentation, 
particularly with the use of high resolution mass spectrometers, is usually adequate 
to obtain sufficient sequence information to enable peptide identification (Villén, 
Beausoleil, Gygi 2008) 
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Figure 1.5.5 Diagram of a phosphorylated MS/MS sequence in red overlapped with 
the unphosphorylated sequence in black. Phosphopeptides are indicated by peaks 
shifted by an increase of 80Da relative to the predicted unphosphorylated peptide 
mass due to the presence of a phosphate group. This is also shown in the 
accompanying table with the mass of the ions from the phosphorylated peptide 
indicated in red and the unphosphorylated sequence in black. (Phosphorylated serine 
denoted by *)  
 
However it should be pointed out that CID of phosphoric acid from a 
phosphopeptide is usually accompanied by only partial fragmentation of the peptide 
backbone with the fragmented ions being dominated by the neutral loss of 
phosphoric acid which can make peptide identification difficult. In other words, the 
presence of the phosphate group ‘shields’ the peptide from fragmentation resulting in 
the loss of peptide sequence information (Figure 1.5.6) (Villén, Beausoleil, Gygi 
2008). In such instances, multiple fragmentation (MSn) strategies may be used to 
obtain peptide sequence data. This is a useful strategy for the study of PTMs such as 
phosphorylation. In instances where the MS/MS fragmentation results in the loss of a 
phosphate group from the peptide, the loss of this mass is detected by the mass 
spectrometer and triggers a third fragmentation event (MS/MS/MS). (This can result 
in the further loss of a loss of water (−18Da) from serine and threonine residues 
(Steen and Mann 2004)). Frequently this third fragmentation event aids in the 
gathering of further sequence information that would otherwise not have been 
observed due to the ‘shielding’ effect of the phosphate group (Villén, Beausoleil, 
Gygi 2008). Often the triggering of this MS3 event is used as a ‘validation’ of the 
phosphorylation of the peptide of interest (Yu et al. 2007). 
42 
 
 
 
 Figure 1.5.6 (A) MS/MS showing a predominant peak corresponding to the neutral 
loss of H3PO4 from a phosphorylated Serine. However the signal-to-noise ratio of 
the downstream ions are lower (Phosphorylated serine denoted by *). (B) 
MS/MS/MS of neutral loss peak showing increased signal-to-noise ratio of all ions 
and the associated loss of water from serine as indicated in the accompanying table.  
 
The identification of site-specific phosphorylation is not a trivial task, particularly as 
the size of the data sets obtained from large scale phosphoproteomic profiling 
campaigns continue to increase, manual validation becomes increasingly onerous 
(Beausoleil et al. 2006).  Often the use of phosphorylation site localisation scoring 
algorithms to determine which amino acid residue is phosphorylated with confidence 
is required. Ascore, PTM score and PhosphoRS are examples of some of the site 
determining algorithms currently available, each of which uses a different approach 
to identifying the site of phosphorylation (Beausoleil et al. 2006; Olsen et al. 2006; 
Taus et al. 2011). 
(B) 
(A) 
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For example, the Ascore algorithm uses a probability based approach to score the 
likelihood of correct site assignment based on the presence or absence of site-
determining fragment ions (Beausoleil et al. 2006). 
Although PTM-Score also utilises a probability-based approach, unlike Ascore, 
PTM-Score groups potential phosphorylation sites into four categories (class I – 
class IV) based on their distinguishing fragment ions, with class I being the best 
quality (Beausoleil et al. 2004). In this way, rather than using a definitive threshold 
to claim a site has been identified with confidence, the quality of the fragmentation 
pattern is ranked. Despite this, those sites identified as class I are commonly deemed 
confident in phosphoproteomics studies and reported to public databases (Wiese et 
al. 2013). The leading commercially available tool PhosphoRS operates on a similar 
principal to PTM-Score (Collins et al. 2014; Wiese et al. 2013), however PhosphoRS 
distinguishes itself from PTM-Score through its ability to provide site localisation 
information based on data obtained from a number of dissociation methods including 
CID, HCD, and ETD on high resolution instruments (Taus et al. 2011), whereas 
PTM-Score was originally designed for use with CID data obtained from low 
resolution instruments (Chalkley and Clauser 2012).  
 
1.5.8 Phosphoproteomic databases  
Given the important role that phosphorylation plays in many cellular processes such 
as growth and apoptosis, little wonder it has attracted much attention from those 
attempting to gain further insights into the working mechanisms of a cell. The 
presence or absence (or abundance) of phosphorylation on different proteins can 
have dramatic effects on cellular function. Presenting an understanding of all the 
phosphorylation sites and their precise function is well beyond the capabilities of any 
one research group. As such, phosphorylation specific data bases are seen as a useful 
resource to pool all current knowledge on the phosphoproteome of different species. 
Since the creation of the first phospho-specific database in 1998 (Blom, Kreegipuu, 
Brunak 1998), a large number of databases specific to specific species have been 
developed (some of these are further reviewed elsewhere (Xue et al. 2010)).  
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Some of the more well-known databases include PhosphoSitePlus, a manually 
curated database developed by Cell Signalling Technologies and largely contains 
information on PTMs associated with human and mouse proteins (Hornbeck et al. 
2012). PhosphoSitePlus currently contains 155,545 non-redundant phosphorylation 
sites. Phospho.ELM stores in vivo and in vitro phosphorylation data on 42,500 non-
redundant phosphorylation sites extracted from the scientific literature and 
phosphoproteomic analyses of human, mouse, Drosophila and C.elegans proteins 
(Dinkel et al. 2011). Another databsase, PHOSIDA originated from an experiment 
which identified and quantified phosphorylation events in HeLa cells as a result of 
EGF stimulation (Beausoleil et al. 2004), it now contains information on over 70,000 
phosphorylation sites from nine different species (Gnad, Gunawardena, Mann 2011). 
Over the last number of years improvements in sample fractionation, LC/MS 
technologies and search algorithms has led to a dramatic increase in our ability to 
generate vast amounts of data on the phosphoproteome (Dulla et al. 2010; Zhou et al. 
2012). While this represents a huge step forward in terms of profiling different 
biological systems, it also presents a number of problems for the scientific 
community.  
Given that different databases have different acceptance criteria for data regarding 
peptide identification and phosphosite localisation any effort to reduce redundancy is 
going to be a challenge (Rogers and Foster 2009). While there are a number of 
comprehensive databases currently available, no one site as yet contains a full data 
set (Rogers and Foster 2009). This means that there is still a gap in our knowledge of 
the phosphoproteome of any given species. Coupled with the fact that the precise 
number of phosphorylation sites in an organism are based on estimates, just how big 
this gap in our knowledge is has yet to be determined. Even when all 
phosphorylation sites become known, identifying the role each one plays remains an 
enormous challenge (Newman et al. 2013). While phosphoproteomic databases are a 
very useful resource for pooling current knowledge, there is still a significant amount 
of work to do before any phosphoproteome can be said to be fully characterised. 
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1.5.9 Quantitative label-free LC/MS 
Quantitative mass spectrometry based means of proteome quantitation has typically 
relied on the use of labelling in order to obtain quantitative information. Labelling 
strategies such as iTRAQ (Ross et al. 2004), iCAT (Gygi et al. 1999) (chemical 
labelling) or SILAC (metabolic labelling) (Ong et al. 2002) have been used with 
great success in a large number of proteomic studies. The primary advantage of these 
labelling methods is the reduction in both sample to sample variation and mass 
spectrometry analysis time due to the pooling of samples (America and Cordewener 
2008). These methods are not without their limitations, however; aside from expense 
(Grossmann et al. 2010; Winefield, Williams, Himes 2009), poor labelling efficiency 
may mean that not all peptides in the sample are represented leading to a decrease in 
protein sequence coverage (Melanson, Avery, Pinto 2006; Sakai et al. 2005). 
Labelling strategies also often suffer from a limited dynamic range (Ow et al. 2009; 
Wu et al. 2003). 
The number of comparators in a given experiment is also limited by the number of 
labels available. Although this has improved with the advent of increased number of 
labels e.g. iTRAQ 8-plex (Choe et al. 2007) and numerous SILAC isotopes, this may 
lead to other problems as the increase in co-eluting peptides may make data 
acquisition difficult (America and Cordewener 2008). 
One means of overcoming these issues is to use a label-free approach (Patel et al. 
2009). Label-free LC-MS can be conducted using one of two methods; (i) spectral 
counting, or (ii) ion peak intensity. Spectral counting protein quantification is 
calculated using the linear correlation that exists between MS spectra intensity and 
peptide abundance (Liu, Sadygov, Yates III 2004). 
Peak ion intensity uses the chromatographic peak intensity of peptide precursor ions 
to calculate protein abundance in different samples. Since there is no labelling 
involved, each sample must be analysed individually and data from each run collated 
once all the samples have been analysed. So while time may be saved during sample 
preparation (since labelling is not used), time spent analysing all the samples on the 
mass spec may negate any time saved. 
Quantitative label-free LC/MS has successfully been used in a wide a variety of 
proteomic investigations such as cancer, both whole cell (Zhu et al., 200 and 
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secretome (Lawlor et al. 2009), serum (Levin et al. 2007), cardiac membrane 
(Donoghue et al. 2008) and prokaryotic (Zhang et al. 2006).  More recently it has 
been used to study post translational modifications (PTMs) such as phosphorylation 
(Froehlich et al. 2011) and glycosylation (Rebecchi et al. 2009). 
While data normalization and statistical analysis are required for spectral counting 
strategies (Zybailov et al. 2006), their implementation is perhaps more important for 
ion peak intensity techniques which requires normalisation to correct for minor 
variations in sample preparation and sample injection (Chelius and Bondarenko 
2002). High chromatographic reproducibility is a basic prerequisite for this method. 
Poor reproducibility results in changes in retention time and m/z, and can create 
problems when trying to accurately quantitate protein abundance. Many of these 
issues have now been addressed through the use of (i) sophisticated algorithms to 
normalise and allow for slight shifts in retention time (Sandin et al. 2011) and (ii) 
chromatography equipment with improved reproducibility (Qian et al. 2006).  
An interesting potential source of error raised by Turtoi and co-workers is that only a 
limited number of points can be acquired over a peak over a given time (Turtoi, 
Mazzucchelli, De Pauw 2010).  While this does not cause significant problems at the 
moment due to the already fast scan speed of modern mass spectrometers such as the 
LTQ-FTMS or LTQ-Orbitrap, undoubtedly future generations of mass spectrometers 
will offer improved performance. It is perhaps also worth mentioning that a small 
number of studies have used matrix assisted laser desorption ionization (MALDI) for 
label-free quantification (Getie-Kebtie et al. 2011; Hattan and Parker 2006). 
Despite a small number of studies being done, it is difficult to determine which 
method is superior. A comparative study by Old and co-workers found spectral 
counting to be more sensitive for detecting proteins that undergo changes in 
abundance, while ion peak intensity provided more accurate estimates of protein 
ratios (Old et al. 2005).  
However if peptide abundance is low (thus reducing the number of spectral counts as 
a result), spectral counting becomes a less sensitive method (Old et al., 2005).  
Another study found the two methods to be comparable in terms of response 
linearity and reproducibility (Stevenson et al. 2009).  
47 
 
1.6 Analysis of protein phosphorylation 
The reversible phosphorylation of protein is frequently used within cells to control 
signalling events for a wide variety of functions such as growth, cell cycle, 
metabolism, transcription and apoptosis (Dix et al. 2012; Volarević and Thomas 
2000). Generally speaking, phosphorylation of serine, threonine and tyrosine are the 
most widely reported phosphorylated amino acids in a ratio of 1,800:200:1 
(Gronborg et al. 2002). The complexity of the cellular processes that rely upon this 
post translational modification for such signalling events becomes apparent when it 
is realised that roughly one third to one half of all eukaryotic proteins can become 
phosphorylated (Cohen 2001; Olsen et al. 2010). It should be pointed out however 
that although phosphorylation sites in eukaryotic cells are evolutionarily well 
conserved (Gnad et al. 2010), many of these phosphorylation events may be 
physiologically irrelevant and may not be required for cell signalling (Dephoure et 
al. 2013). Despite the frequency with which phosphorylation occurs in the proteome, 
enrichment strategies at the protein level or the peptide level or a combination of the 
two is often required for phosphoproteomic analysis (Beausoleil et al. 2004). This is 
primarily due to the low abundant nature of many phosphoproteins coupled with the 
fact that phosphorylation is often sub-stoichiometric.  
From the perspective of analysis by mass spectrometry, the relatively high 
abundance of the non-phosphorylated peptides often supresses detection of the 
phosphorylated species (Wang et al. 2007). Similarly, the presence of low abundant 
phosphoproteins on a 2D-gel may be masked by high abundant proteins (Chen, 
Southwick, Thulin 2004). For these reasons, enrichment strategies are often utilized 
in the study of phosphorylated proteins (Beltran and Cutillas 2012; Fíla and Honys 
2012). The following sections will discuss some of the enrichment strategies 
commonly used and a table of their associated advantages and disadvantages is 
provided in Table 1.6.1. 
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Table 1.6.1 Table summarising the advantages and disadvantages of phosphoprotein 
/ phosphopeptide enrichment strategies used in the analysis of the phosphoproteome. 
Table adapted from (Harsha and Pandey 2010). 
 
Phosphorylation 
type
Selective 
enrichment/
monitoring 
strategy
Starting 
protein 
amounts
Advantages Disadvantages
Tyrosine
Immunoaffinity 
(anti-pTyr 
antibodies)
20mg–40mg
Selective 
enrichment of 
hundreds of 
tyrosine 
phosphorylated 
peptides 
detectable by high 
resolution and high 
sensitivity mass 
spectrometers
Requirement of more 
starting material limits 
its utility in studying 
clinical samples like 
biopsies
Serine/Threonine/
Tyrosine
TiO2 / IMAC 
Fe (III), 
Gallium (III)
2mg–15mg
Unbiased selective 
enrichment of 
thousands of 
phosphorylation 
sites detectable by 
high resolution and 
high sensitivity 
mass 
spectrometers
Under representation 
of tyrosine phospho 
sites. 
Serine/Threonine/
Tyrosine
SCX 
Fractionation 2mg-20mg
Capable of 
enriching 
thousands of 
phosphopeptides 
detectable by high 
resolution and high 
sensitivity mass 
spectrometers
Technical expertise 
and experience 
required to carry out 
efficient enrichment. 
Starting material 
requirement limits its 
utility. Usually 
coupled with TiO2 / 
IMAC enrichment
Serine/Threonine/
Tyrosine
Antibody 
microarrays
micro gram 
amounts
Low sample 
requirement
A prior knowledge of 
target proteins to be 
assayed. Specific 
antibodies and 
biochemical 
optimization required
49 
 
Aside from the low abundance of phosphoproteins and their associated sub-
stoichiometric nature, there are other challenges that also exist in the analysis of 
phosphoproteomes. The rapid phosphorylation and/or dephosphorylation of a protein 
that may occur as a result of a signalling event can be difficult to capture (Blagoev et 
al. 2004; Nita‐Lazar, Saito‐Benz, White 2008).  
Another issue in ‘large scale’ studies involves the enzymatic digestion of the sample; 
although trypsin is widely regarded as the enzyme of choice for protein digestion 
prior to analysis by LC/MS, it does suffer from certain drawbacks. This includes 
having little or no activity toward arginine-proline and lysine-proline bonds and 
difficulty cleaving residues adjacent to amino acids containing bulky post-
translational modifications or to highly acidic residues (Tran et al. 2010). While a 
number of strategies have been developed to improve the enzymatic digestion of a 
complex protein sample such as (trypsin-trypsin) double digestion (Tran et al. 2010), 
the use of multiple proteases (trypsin and lysine) (Brownridge and Beynon 2011) 
and trypsin enhancing reagents such as ProteaseMax (Orsburn, Stockwin, Newton 
2011), obtaining complete digestion of a proteome is still difficult to achieve.  
A difficulty that can also be encountered is the assignment of a phosphopeptide to 
the correct protein isoform (Engholm‐Keller and Larsen 2013). As peptide sequences 
can be shared between isoforms, accurate identification of a particular isoform relies 
on the detection of a peptide unique to that protein (Stastna and Van Eyk 2012). 
Given that phosphoproteomic analysis often relies on the identification of single 
phosphopeptides, matching this to the correct isoform is fraught with difficulty and 
often requires a second approach (such as western blot) to confidently identify the 
phosphorylated isoform of interest. 
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1.6.1 Protein arrays to study phosphorylation 
Arrays offer a means of simultaneously detecting 10’s to 100’s of proteins in parallel 
in a single experiment on a miniaturised, and sometimes automated, platform (HS Lu 
et al. 2012). Arrays contain a capture protein immobilized onto a surface such as 
glass or nitrocellulose. This enables the detection of a protein of interest from a 
complex sample such as a whole cell lysate. The protein may then be detected either 
through the use of a secondary antibody designed to bind to the protein of interest as 
it is retained by the capture antibody. Alternatively, the starting material may be 
labelled, thus indicating the presence proteins retained by the capture protein after all 
non-binding starting material has been removed following a wash step. An overview 
of the process workflow is provided in Figure 1.6.1.  
Protein arrays have been used for a wide variety of investigations such as proteomic 
profiling, protein-protein interaction, enzyme activity and antibody screening 
(Gordus and MacBeath 2006; Jones et al. 2005; Ptacek et al. 2005; Zhu et al. 2006). 
It has also been used in the in the study of post translational modification such as 
phosphorylation (Lin et al. 2010). For example, one investigation aimed at 
identifying all the potential protein substrates of each yeast kinase detected 4129 
phosphorylation events in 1325 different proteins (Ptacek et al. 2005). The phospho-
kinase array utilized in this thesis has also been successfully employed in a number 
of studies including the identification of activated Erk1/2 and Akt as potential targets 
for the multi-targeted kinase inhibitors, sorafenib and sunitinib in the treatment of 
cholangiocarcinoma (Dokduang et al. 2013). Similarly, stimulation of MAPK, AKT 
and FAK signalling pathways following the activation of the tyrosine receptor 
kinases Mer and Axl as identified through the use of a phosphokinase array 
suggested that Mer and Axl should be investigated further as potential therapeutic 
targets in the treatment of non-small cell lung cancer (Linger et al. 2013). Protein 
arrays are not without their problems however; antibody cross-reactivity resulting in 
false positives or false negatives being one of the main ones. For this reason it is 
important that results are validated using a complementary method such as 
immunoblot or ELISA (Zhang and Pelech 2012). Despite this, the ability of kinase 
arrays to screen large elements of the proteome in a targeted manner means that they 
look set to remain a popular choice for the foreseeable future (Stoevesandt, Taussig, 
He 2009).   
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Figure 1.6.1 Overview of the process workflow for a protein array (Image obtained 
from http://www.baria.cz/apoptosis-array-0). 
 
1.6.2 Staining of phosphoproteins for gel based approaches 
Of course phosphoproteins enriched by an IMAC or immunoprecipitation based 
enrichment do not have to be analysed by LC/MS, they may instead be visualized by 
2D-gel electrophoresis. In such instance, changes in phosphorylation can be detected 
on a 2D-gel through the use of a phosphorylation specific stain such as Pro-Q 
Diamond (Schulenberg et al. 2003); however this will not in itself indicate the 
specific site of phosphorylation.  A second methodology such as western blotting 
using site-specific antibodies or mass spectrometry is frequently employed to 
provide this information. There are of course limitations with both of these follow up 
approaches: the use of western blotting requires prior knowledge of the protein 
present in order to select a suitable antibody for its detection.  
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Reliance on the use of mass spectrometry to identify the protein could be 
complicated by the presence of other proteins that may migrate to the same point on 
the gel, thus leading to incorrect protein identification (D’Ambrosio et al. 2007). 
Nonetheless, Pro-Q diamond has been utilized in the study of the phosphoproteomes 
of a wide variety of species including Bacillus subtilis and Arabidopsis (Chitteti and 
Peng 2007; Eymann et al. 2007) as well as neuronal and breast cell lines (Kang et al. 
2007; Zhang, Wong, Koay 2007). 
 
1.6.3 Chromatography for the enrichment of phosphoproteins and 
phosphopeptides 
A popular means of enriching for phosphorylation at the protein and at the peptide 
level is through the use of chromatography columns that have an affinity for the 
phosphate group. This section provides a brief overview of some of these techniques. 
Broadly speaking, metal affinity columns for phosphoprotein/peptide enrichment fall 
into one of two categories, immobilized metal affinity column (IMAC) or metal 
oxide affinity column (MOAC).  The main difference between the two being that the 
oxidised from of a metal is used for MOAC, while the unoxidised form is used for 
IMAC. In both instances phosphopeptide enrichment works on the basis of 
electrostatic interactions occurring between the phosphate group on the peptide and 
the metal oxide sorbent (Engholm‐Keller and Larsen 2013). It should be noted 
however that the precise chemistry for kit based phosphoprotein enrichment kits is 
generally not revealed by the manufacturer making it difficult to draw inferences 
from the column used and the results obtained. Nonetheless, the use of such columns 
has become more popular and has been reported for the enrichment of 
phosphoproteins in a number of studies. An example of one such study that 
successfully employed phosphoprotein enrichment investigated the tubular epithelial 
to mesenchymal cell transition upon induction by transforming growth factor beta-1 
(Chen et al. 2010). Enriched phosphoproteins were enzymatically digested and 
iTRAQ labelled before undergoing 2D-nano-LC/MS resulting in the identification of 
38 differentially-expressed phosphoproteins.  
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An alternative to analysis of the elution fraction by mass spectrometry is to use 
western blot in conjunction with the phosphoprotein enrichment column to detect 
changes in the abundance of protein phosphorylation. For example, phosphoprotein 
enrichment prior to western blot analysis has been used to identify changes in the 
phosphorylation and / or abundance of the protein under investigation. 
This technique is based on the principle that the phosphorylated form of the protein 
of interest will have been preferentially retained by the enrichment column, while the 
unphosphorylated form will not bind. Following elution of the phosphorylated 
protein from the column, this sample is then analysed by immunoblot. If there has 
been an increase in the abundance of the phosphorylated form of a protein under a 
given condition, this change in abundance will be detected by an antibody specific to 
the protein of interest. One advantage of this methodology is that, in the absence of 
an antibody specific to the phosphorylated form of the protein of interest, antibodies 
raised against the unphosphorylated form of the protein may be utilized.  
Similar to phosphoprotein enrichment, metal affinity chromatography can also be 
used for the enrichment of phosphorylated peptides. Unlike phosphoprotein 
enrichment however, phosphopeptide enrichment strategies are almost always 
referred to by the metal chemistry used in the column. The following sections will 
discuss two of the more common methodologies; IMAC and Titanium dioxide.  
 
1.6.3.1 Titanium dioxide phosphopeptide enrichment 
A MOAC based methodology called titanium dioxide enrichment is perhaps one of 
the most widely used phosphopeptide enrichment methods due to its high capacity 
and high specificity for the phosphate group (Eyrich, Sickmann, Zahedi 2011; 
Larsen et al. 2005). Reports of the phosphopeptide enrichment of samples such as 
whole cell lysates without any prior enrichment strategies have yielded significant 
numbers of phosphopeptides.  
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For example, titanium dioxide was employed in the identification of 937 
phosphopeptides in acute myeloid leukaemia cells treated with sodium pervanadate 
(Montoya et al. 2011).  Of course, phosphoprotein and phosphopeptide enrichment 
techniques can be combined in an effort to obtain further phosphorylation 
information. One such instance of this is provided in a report by Nilsson et al. who 
used phosphoprotein enrichment and titanium dioxide phosphopeptide enrichment to 
measure responses of glioblastoma cancer stem cells (GSC11) to STAT3 
phosphorylation inhibition by WP1193 treatment and IL-6 stimulation under 
normoxic and hypoxic conditions (Nilsson et al. 2009).  
One drawback initially associated with the use of titanium dioxide columns is that in 
addition to the binding of phosphate, they also bind acidic groups with high affinity 
(Gates, Tomer, Deterding 2010). This was overcome however by the use of organic 
acids such as 2,5-DHB, as they bind metal oxides with greater affinity than carboxyl 
groups, but less affinity than phosphate (Aryal and Ross 2010). It is typically 
considered that titanium dioxide phosphopeptide enrichment columns preferentially 
bind monophosphorylated species, while IMAC preferentially binds multiply 
phosphorylated peptides (Aryal, Olson, Ross 2008; Zhao et al. 2013).  It has been 
proposed however that titanium dioxide does not discriminate between multi and 
mono phosphorylated peptides, but multiple phosphorylated species are difficult to 
elute due to the high affinity with which they bind (Thingholm et al. 2008). 
Although the optimisation of experimental conditions for the enrichment of 
phosphopeptide using titanium dioxide columns is on-going (Aryal and Ross 2010), 
as yet there is no one set of conditions that can be used to enrich for the entire 
phosphoproteome (Thingholm et al. 2008). This can be said to be true of all 
phosphopeptide enrichment strategies. The greatest coverage of a phosphoproteome 
is typically provided when methods such as titanium dioxide are used in conjunction 
with other complementary methods such as IMAC (Bodenmiller et al. 2007; 
Carrascal et al. 2008). 
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1.6.3.2 IMAC for phosphopeptide enrichment 
The specificity with which phosphopeptides are enriched using IMAC columns 
depends on (i) the resin used (ii) the metal ion used. Choosing the optimum 
enrichment resin / metal ion is not as straightforward as it might appear. For 
example, a resin of nitrilotriacetic acid (NTA) coupled with an iron (Fe3+) metal ion 
was found to be more specific for the enrichment of phosphopeptides than a resin 
containing iminodiacetic acid (IDA) and Fe3+ (Neville et al. 1997). Conversely, a 
combination of IDA and gallium (Ga3+) was found to outperform NTA combined 
with Ga3+ (Posewitz and Tempst 1999). Despite this, there are a number of other 
IMAC based metal affinity resins such as alumina, zirconium and gallium that have 
also been used for the enrichment of phosphopeptides with great success (Posewitz 
and Tempst 1999; Qiao et al. 2010). 
For example, it has been demonstrated that such phosphopeptide enrichment 
methodologies are capable of obtaining large number of phosphopeptides from 
samples such as whole cell lysates without any prior enrichment strategies; one 
report identified 654 phosphopeptides in the identification of hormone dependent 
signalling pathways in renal medullary thick ascending limb (mTAL) cells using 
gallium phosphopeptide enrichment (Gunaratne et al. 2010). This is hardly 
surprising given that it has been shown that gallium is comparable with the likes of 
titanium, iron, aluminium and zirconium for the enrichment of phosphopeptides 
(Aryal and Ross 2010; Posewitz and Tempst 1999).  Similar to titanium dioxide, 
IMAC also suffers from the non-specific binding of acidic rich glutamic and aspartic 
acid residues. One approach to overcome this involves the acidification of samples 
prior to loading on the IMAC column; this protonates the carboxyl groups on the 
highly acidic amino acid residues and reduces instances of nonspecific binding 
(Posewitz and Tempst 1999). A more recent advance in IMAC based 
phosphopeptide enrichment has been the development of a strategy to sequentially 
elute phosphopeptides from the IMAC column (Thingholm et al. 2008).  
SIMAC (Sequential elution from IMAC) facilitates the elution of 
monophosphorylated and multi-phosphorylated peptides into distinct fractions 
enabling analysis of low abundant multi-phosphorylated peptides that otherwise may 
go undetected due to the relatively high abundance of the monophosphorylated 
species.  
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It has been through the continuous refinement of experimental conditions such as 
this that has made IMAC one of the most popular means of enriching for 
phosphopeptides (Niklew et al. 2010). 
 
1.6.3.3 Strong cation exchange (SCX) 
Strong cation exchange (SCX) has also been used as an additional phosphopeptide 
enrichment step prior to the use of an IMAC or TiO2 column (Beausoleil et al. 2004; 
Villen et al. 2007). SCX operates based on the principle that positively charged 
proteins or peptides will bind to the negatively charged functional groups on the 
SCX resin.  Because phosphorylated peptides possess an additional negative charge 
due to the presence of the phosphate group, these will elute from the column earlier 
than the non-phosphorylated species.  
This technique has been used as part of the enrichment protocol in a number of large 
scale phosphoproteome profiling studies including the identification of 2,002 
phosphorylation sites from HeLa cell nuclear fractions, and 6,600 phosphorylation 
sites in EGF stimulated HeLa cells (Beausoleil et al. 2004; Olsen et al. 2006). SCX 
has been compiled with both immunoprecipitation and IMAC phosphopeptide 
enrichment methodologies to identify 5,635 phosphorylation sites in mouse liver 
(Figure 1.6.2) (Villen et al. 2007). Indeed, the coupling of multiple enrichment 
methodologies has enabled the identification of over 20,000 phosphorylation sites in 
some biological systems (Olsen et al. 2010). Although the use of this technique 
provides enhanced coverage of the phosphoproteome, its implementation requires a 
high level of technical ability on the part of the user (Harsha and Pandey 2010). In 
addition to this, large volumes of starting material are also required to ensure optimal 
recovery of phosphopeptide (Olsen and Macek 2009). 
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Figure 1.6.2 Schematic of phosphopeptide enrichment strategies (SCX coupled with 
immunoprecipitation and IMAC) as used by Villen et al. (2007) in the identification 
of 5,635 phosphorylation sites in mouse liver. 
  
LC / MS 
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Aims 
Phosphoproteomic characterisation of CHO cells subject to temperature-shift 
Our current knowledge of the cellular mechanisms involved in the cell response to 
reduced culture temperature is limited. However, understanding such mechanisms 
could aid in the identification of cell engineering targets to extend cellular viability, 
increase productivity or influence cellular growth rate. This project aims to: 
• To assess the feasibility of phospho-array based technology to characterise 
the phosphoproteome of CHO cells, using antibodies spotted onto a 
nitrocellulose membrane to detect changes in the relative phosphorylation of 
kinases in temperature-shifted CHO cells; 
• Profile the phosphoproteome of CHO cells subjected to temperature-shift 
and identify phosphoproteins that are potentially involved in the cellular 
response to reduced culture temperature. 
• Establish and evaluate a protocol for the study of phosphopeptides in CHO 
cells; 
• Utilise mass spectrometry to obtain site-specific  information on the 
differential-phosphorylation of phosphoproteins occurring in direct response 
to reduced culture temperature conditions. 
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Proteomic profiling of Host Cell Proteins (HCPs) from CHO cells 
The secretome can also be a rich source of information, providing insights into cell-
cell signalling events that effect cell growth and viability. Analysis of the host cell 
protein profile of bioprocess relevant cell lines such as hybridoma and CHO cells 
could further our understanding of how the cell culture environment can impact on 
product quality and cell viability. This project aims to: 
• Characterise the extracellular proteome of CHO cells over time in culture to 
identify proteins that potentially impact cellular growth and viability. In 
addition, identify any proteins that may negatively impact  product yield and 
/ or quality; 
• Determine whether there are significant differences in the secretome of CHO 
cells grown under temperature-shifted and non-temperature-shifted 
conditions;  
• Determine whether there are significant differences in the secretome of a 
recombinant protein-producing and non-producing cell line; 
• Catalogue proteins secreted from IgG-producing, phenotypically distinct and 
fast and slow growing CHO cell lines. 
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Materials & Methods 
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2.0 Materials & Method 
2.1 Preparation for Cell Culture 
2.1.1 Ultrapure water  
Ultrapure water was used in the preparation of all solutions used for cell culture. Pre-
treatment, involving activated carbon, pre-filtration and anti-scaling was first carried 
out. This water was then purified by a reverse osmosis system (Millipore Milli-RO 
10 Plus, Elgastat UHP), which is low in organic salts, organic matter, colloids and 
bacteria with a standard of 12 – 18 MΩ/cm resistance. 
2.1.2 Glassware 
All  glassware and lids used for any cell related work were prepared as follows: all 
glassware and lids were soaked in a 2% (v/v) solution of RBS-25 (AGB scientific, 
cat. 83460) for at least 1 hour. Glassware was scrubbed and rinsed several times in 
tap water; the bottles were then washed by machine using Neodisher detergent. The 
bottles were then rinsed twice with distilled water, once with UHP water and 
sterilised by autoclaving. 
2.1.3 Sterilisation 
Water, glassware and all thermolabile solutions were sterilised by autoclaving at 
121°C for 20 mins under 15 p.s.i. pressure. Thermolabile solutions were filtered 
through a 0.22µm sterile filter (Millipore, cat. SL6V033RB), with low protein 
binding filters used for all protein-containing solutions.  
2.1.4 Subculturing of cell lines suspension cells  
All routine cell culture work was carried out in a class II down flow re-circulating 
laminar flow cabinet (Nuaire Biological Cabinet). Strict aseptic techniques were 
adhered to at all times (see NICB SOP No. 000-01). Laminar flow cabinets were 
swabbed with 70% industrial methylated spirits (IMS) prior to and following all 
work, as well as all equipment used during experiments. Only one cell line was 
worked with at a time in a cabinet, with 15 minutes clearance time given between 
work with individual cell lines. Each week cell culture cabinets and any incubators 
used were cleaned with industrial detergents (Virkon) and IMS.  
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Cell lines adapted to suspension growth were generally grown in either sterile 
disposable 250 ml flasks (Corning, cat. 431144) with a 50 ml working media volume 
or a disposable 50 ml spin-tube (Sartorius, cat. DF-050MB-SSH) with a 5 ml 
working media volume.  
Prior to subculturing cells, a 100µl aliquot was removed from the flask or tube and 
counted using trypan blue (section 2.1.5). The cell suspension was then transferred to 
a 30 ml sterile container (Greiner, cat. 201151) and centrifuged at 170xg for 5 mins. 
The resulting pellet was resuspended in fresh warm growth medium, and an 
appropriate volume used to seed fresh flasks/tubes for further subculture or planned 
experiments. 
Details of all the cell lines used in experiments are given in Table 2.1.1. 
 
 
Table 2.1.1 Table of cell lines used in experiments presented in this thesis.  
  
Cell line Cell line origin
Recombinant 
protein 
product
Media Selective 
reagents
Culture 
format Source
4/2D
Mouse spleen 
cells fused with 
mouse myeloma 
(SP2 ) cells
Non-producing
PHFM-II 
(Gibco, 
12040-077 )
N/A Suspension (T-175)
In-house 
(Moran et 
al. 1996)
CHO K1 CHO K1 Non-producing
OptiCHO 
(Gibco, 
12681-011)
N/A
Suspension 
(Shake 
flask)
ATCC
CHO-K1-
SEAP CHO K1 SEAP
SFM-II 
(Gibco, 
12052-098)
G418
Suspension 
(Shake 
flask)
In-house 
(Dr. Niraj 
Kumar, 
Thesis)
DP12 CHO K1 IgG
OptiCHO 
(Gibco, 
12681-011)
MTX
Suspension 
(Shake 
flask)
ATCC
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2.1.5 Assessment of cell number and viability  
Cell counting and viability estimations were carried out using a trypan blue dye 
exclusion technique. 
First a sample was taken from a cell suspension and mixed 1:1 with trypan blue (i.e. 
100µl cell sample mixed with 100µl trypan blue). This was incubated for 3 mins at 
room temperature, after which a sample was applied to a haemocytometer over 
which a glass coverslip is then placed. Cells in the outer four corners of the chamber 
were counted microscopically using Nikon TS100 microscope and 10x objective 
lens. Non-viable cells were stained blue, while viable cells remained clear.  Non-
viable cells were stained blue, while viable cells remained clear. The following 
formula was used to calculate cell concentration:  
 
2.1.6 Cryopreservation of cells 
To allow for long term storage of cell stocks, cells were cryo-preserved in liquid 
nitrogen. Dimethyl sulphoxide (DMSO) (Sigma, cat. D8418) was used as a 
cryoprotectant. Cells to be frozen down were grown until the exponential phase, 
harvested and counted. Cells were then pelleted by centrifugation at 170xg for 5 
mins and resuspended in media to give a concentration of at least 5 x 106 cells/ml. 
An equal volume of 2X concentrated freezing media (DMSO-7.5% and serum 
92.5%) was then added dropwisedue to the toxicity of the DMSO.The cell 
suspension was then aliquoted into cryovials (Greiner, cat. 12279) and quickly 
placed into a freezer at -80°C overnight before being placed into storage in liquid 
nitrogen. 
2.1.7 Thawing of cryopreserved cells 
Upon removal from liquid nitrogen, the cryovial was thawed in warm water. Once 
slightly thawed, the contents of the cryovial was transferred to the pre-warmed 
media (37°C). This suspension was centrifuged at 170xg for 5 mins. The supernatant 
was then removed and the pellet re-suspended in fresh warm growth medium. This 
thawed cell suspension was then placed in a 5ml spin tube for suspension growth. 
 	
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After 24 hours, the medium was then replaced with fresh growth medium to remove 
any potential traces of DMSO and the cells subcultured if necessary. 
2.1.8 Sterility checks 
Sterility checks were routinely carried out on all media, supplements and trypsin 
used for cell culture (see NICB SOP 002-01). A 1ml sample of the material being 
examined was inoculated into 9mls of both tryptone soya broth (TSB) and 
thioglycollate broth (Thio) and incubated at 37°C for 7 days. Both samples were then 
checked for turbidity and change in colour, indicating contamination.  
2.1.9 Mycoplasma testing 
Cells were regularly checked for the presence of Mycoplasma using the Fluorescent 
Hoechst stain method. Mycoplasma-negative NRK (Normal rat kidney fibroblast) 
cells were used as indicator cells for this analysis. NRK cells were incubated with a 
sample of supernatant from the cell lines being tested for the presence of 
mycoplasma and then stained. Testing was carried out every four months for each 
cell line in use. 
 
2.2 Protein Quantification 
2.2.1 Bradford Assay 
Protein levels were determined using the Bio-Rad Quick Start™ Bradford Dye 
Reagent (Bio-Rad, 500-0205) as follows. A 2 mg/ml bovine serum albumin (BSA) 
solution (Sigma, A9543) was prepared freshly in lysis buffer. A protein standard 
curve (0, 0.125, 0.25, 0.5, 0.75 and 1.0 mg/ml) was prepared from the BSA stock 
with dilutions made in lysis buffer. An aliquot of the protein samples were diluted as 
appropriate (1:2, 1:5 or 1:10) with lysis buffer. 5µl of standards and samples were 
added to a minimum of three separate wells in a 96-well plate. 250µl of the Bio-Rad 
solution was added to each well. After 5 minutes incubation, absorbance was 
measured at 595 nm and the concentration of the protein samples was determined 
from the plot of the absorbance at 595 nm versus concentration of the protein 
standard. 
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2.2.2 ELISA Assay 
An ELISA (Enzyme-linked immunosorbent assay) was used to quantify the 
recombinant Human IgG1 (rHuIgG1) antibodies secreted by the DP12 cell line. 
Conditioned media samples were centrifuged at 170xg for 5min and supernatant was 
aliquoted into an eppendorf tube. Supernatant was then centrifuged a second time at 
19,000xg for 5 min to remove any residual cells and aliquoted into a fresh eppendorf 
tube. 1µl of coating antibody was diluted in 100µl coating buffer (0.05M Carbonate 
Bicarbonate, pH 9.60) for well required (number of samples plus number of 
standards). Coated wells were incubated at 4°C overnight. After incubation, the 
coating buffer was removed and the plate was washed 5 times with wash buffer 
(50mM Tris, 0.14M NaCl, 0.05% Tween20, pH 8.0). 200µl of blocking solution 
(50mM Tris, 0.14M NaCl, 1% BSA, pH 8.0) was then added to each well and 
incubated for 1 hour at RT. During this incubation period samples and standards 
were prepared in sample diluent (50mM Tris, 0.14M NaCl, 1% BSA, 0.05% 
Tween20). Blocking solution was then removed and the plate was washed 5 times 
with wash buffer. 100µl sample/standard was then added to their assigned wells and 
incubated for 1 hour at RT.  
After incubation, the samples were removed and the plate washed 5 times with wash 
buffer. The enzyme (HRP) linked detection antibody was diluted in sample diluent at 
a dilution of 1:100,000 and 100µl added to each well and incubated for 1 hour at RT. 
After an hour the coating buffer was removed and the plate was washed 5 times with 
wash buffer. 100µl of HRP substrate solution (TMB - 3,3',5,5'-
Tetramethylbenzidine) was then added to each well and incubated in the dark for 15 
mins. 100µl of stop solution (0.18M H2SO4) was then added to each well. 
Absorbance of each well was read at a wavelength of 450nm. 
2.2.3 SEAP Assay 
Secreted Alkaline Phosphatase (SEAP) is a secreted enzyme that was used as a 
model recombinant glycoprotein (Lipscomb et al. 2005). CHO SEAP cells were 
generated in house by Dr. Niraj Kumar (Ph.D Thesis 2008). The enzymatic assay for 
quantification of SEAP protein was adapted from the method reported previously by 
Berger et al. (Berger et al. 1988). The following  protocol was used to detect SEAP 
levels in the supernatant of CHO cells transfected with a SEAP containing plasmid.  
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Conditioned medium was collected from CHO SEAP cells and centrifuged at 
19,000xg for 5min. 500µl aliquots of conditioned media were collected and stored at 
-20˚C until such time as the assay was ready to be performed. 50µl of cell-free 
conditioned medium was transferred to individual wells of a 96-well flat bottom 
plate. 50µl of 2x SEAP reaction buffer (solution stock contains 10.50 g 
diethanolamine (100%), 50 µl of 1 M MgCl, and 226 mg of L-homoarginine in a 
total volume of 50 mL) was added to each sample. Plates were incubated for 10 min 
at 37°C and then 10 µl of substrate solution (158 mg of p-nitrophenolphosphate from 
Sigma (P4744) in 5 mL of 1x SEAP reaction buffer, made fresh for each use) was 
then added to each well. The change in absorbance per minute (OD 405/min) of each 
well was monitored by a microplate reader. The change in absorbance per minute 
was considered as indicator of the amount of SEAP present in the sample. 
 
2.3 Proteomic Sample Collection and Preparation 
2.3.1 Cell Lysate Sample Preparation 
Cells were pelleted by centrifugation at 170xg for 5 minutes and the media was 
removed and cells were washed with ice cold 50mM HEPES. The cell suspension 
was then transferred to an eppendorf and centrifuged at 14000xg for one minute at 
4˚C. HEPES was then decanted, the eppendorf containing the cell pellet was 
submersed in liquid nitrogen for 30 seconds before being stored at -80 C˚ until 
required. All procedures from this point forward were performed on ice. Cells were 
lysed using an appropriate volume of lysis buffer (7M Urea, 2M Thiourea, 4% 
CHAPS, 30mM Tris, pH 8.5) and incubated on ice for 20 minutes with occasional 
vortexing. Protease inhibitor (PI-78415 Thermo Scientific), halt phosphatase 
inhibitor (78428 Thermo Scientific) and Nuclease mix (80-6501-42  GE) were also 
added to the lysis buffer to form a final concentration of 1x for each inhibitor. Cells 
were lysed by pipetting up and down and by vortexing. Sample lysates were 
centrifuged at 19,000xg for 15 minutes at 4 C˚. Supernatant containing extracted 
protein was transferred to a fresh chilled eppendorf tube and stored in aliquots at -80 
˚C if they were not going to be used immediately. 
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2.3.2 Conditioned Media Collection 
Media containing cells were placed into a 50ml sterile universal container and 
centrifuged at 2000xg for 6 minutes. Upon completion the media was decanted into a 
fresh sterilin and centrifuged at 2000xg for a further 6 minutes. The media was then 
decanted into a fresh sterilin and filtered using a 0.45µm filter (VWR, 514-0075), 
one filter per 25ml of media. Upon completion, the media underwent further 
filtration through a 0.22µm filter (VWR, 514-0073), one filter per 25ml of media. 
Filtered conditioned media was then either stored at -80˚C for long term storage or 
kept on ice for immediate further processing.  
2.3.3 Conditioned Media Sample Preparation 
Conditioned media sample was concentrated by centrifugation at 3,200xg at 16˚C 
using Vivaspin 20 3,000 MWCO centrifugal concentrators (Sartorius VS2092) until 
samples had decreased in volume ~100-fold. 50-100µg of protein from the sample of 
interest was placed in an eppendorf and underwent a ‘clean up’ using ReadyPrep™ 
2-D Cleanup Kit (Bio-rad, 163-2130) as detailed 2.3.4.  
The protein pellet was then resuspended in 6M Urea, 2M Thiourea, 10mM Tris, pH 
8 (Label-free lysis buffer). The sample was sonicated and vortexed until the 
precipitate was no longer visible and quantified by Bradford assay.  
2.3.4 Sample clean-up for Mass Spectral Analysis 
80µl of conditioned media (≈25µg protein) or 100µl of whole cell lysate (≈500µg 
protein) was cleaned up in order to remove any agents that could interfere with Mass 
Spectral Analysis. Sample clean-up was carried out using ReadyPrep 2D Cleanup 
Kit (BioRad, 163-2130) according to manufacturer’s instructions with the exception 
of the final incubation period where the sample was incubated at -20˚C overnight as 
opposed to 30 minutes. Following the final centrifugation step, the supernatant was 
removed and the pellet was allowed to air dry for 1 minute before being resuspended 
in the appropriate buffer depending on whether the sample was going to be analysed 
by LC/MS or western blot.  
 
2.3.5 In solution digestion for preparation of conditioned media samples 
10µg of protein was placed into a new eppendorf. All samples were then brought up 
to an equal volume using label-free lysis buffer. 1µl of reduction buffer was added to 
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each sample (DTT in 50mM ammonium bicarbonate such that the final 
concentration of DTT will be 5mM). This was incubated at 56˚C for 20 minutes on a 
shaker platform. Once the reduced samples had cooled, 1µl of alkylation buffer was 
added to the sample (Iodoacetamide in 50mM Ammonium Bicarbonate such that the 
final concentration of Iodoacetamide is 55mM), and incubated for 20 minutes at 
room temperature in the dark. 0.2µg of Lys-C (Promega, V1071) was then added to 
each sample and left on a shaking platform for 4 hours at 37ºC. After this incubation 
period, each sample was diluted four volumes of 50mM Ammonium Bicarbonate.  
0.4µg of sequence grade Trypsin (Promega, V5280) was then added and all samples 
were incubated overnight at 37ºC on a shaker platform. After overnight digestion 
PepClean™ C-18 Spin Columns (Pierce, 89870) were used to purify and concentrate 
the resulting peptides as detailed in 2.3.7.  
2.3.6 In solution digestion for preparation of whole cell lysate samples 
100µl of whole cell lysate containing 500µg of protein was cleaned up in order to 
remove any agents that could interfere with mass spectrometry analysis. Sample 
clean-up was carried out using ReadyPrep 2D Cleanup Kit (BioRad)as detailed 2.3.4. 
To prepare protein samples for digestion, samples were resuspended in label-free 
lysis buffer (6M Urea, 2M Thiourea, 10mM Tris, pH 8) and all volumes were 
brought up to 70µl and 20µl of 50mM ammonium bicarbonate added. The samples 
were first incubated with 10µl 50mM dithiothreitol for 30 minutes at 37ºC. 11µl of 
150mM iodoacetamide was then added to each sample and incubated in the dark for 
20 minutes at room temperature. 314µl of 50mM ammonium bicarbonate was then 
added to each sample. Digestion of protein samples was performed with trypsin 
(sequence grade, Pierce) at a ratio of 31.25/1, protein/enzyme w/w, i.e. 500µg of 
protein was digested with 16µg of trypsin. 4.5µl of ProteaseMax (Promega V2071). 
Samples were incubated overnight at 37ºC to allow the digestion to occur.  
2.3.7 Peptide sample clean-up using C18 spin column 
With the exception of two additional wash steps (four washes total) and two 
additional elutions (three elutions total) C18 sample clean-up was carried out as per 
the manufacturer’s instruction using PepClean™ C-18 Spin Columns (Pierce, 
89870).  
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Samples were then placed in a vacuum evaporator until they had dried fully and  re-
suspended in an appropriate volume of 0.1% TFA in 2% ACN with vortexing and 
sonication. 
2.3.8 Peptide sample clean-up using Graphite spin column 
Graphite spin columns (Pierce, 88302) were used to clean up samples containing 
>30µg of peptide. As well as concentrating the samples, this was done to remove any 
agent that may interfere with Mass Spectral analysis. All samples were processed as 
per the manufacturer’s instructions such that the final elution volume was 400µl.  
Samples were then placed in a vacuum evaporator until they had dried fully and re-
suspended in an appropriate solution/volume for the next application e.g. titanium 
phosphopeptide enrichment (2.4.4), iron phosphopeptide enrichment (2.4.5), LC-MS 
analysis (2.4.6). 
 
2.4 Proteomic Enrichment and Depletion Methods 
2.4.1 Phosphoprotein enrichment Pierce 
Enrichment for Phosphoproteins took place using the Pierce Phosphoprotein 
Enrichment Kit (Pierce, 90003). Cell pellets were lysed using the 
Lysis/Binding/Wash buffer provided which was supplemented with CHAPS (0.25%) 
(Sigma, C9426), 1X Halt Protease Inhibitor (EDTA-free) (Thermo Scientific, 
78425), 1X Halt Phosphatase Inhibitor Cocktail (Thermo Scientific, 78420) and 1X 
Nuclease Mix (GE Healthcare, 80-6501-42). Upon addition of cell lysis buffer to the 
cell pellet, cells were passed through an 18-gauge needle 5 five times and then 
vortexed.  
Samples were placed on a rotator (Stuart, SB2) and left spinning at 15rpm for 45 
minutes at 4˚C with periodic vortexing during this period. The lysate was then 
centrifuged at 14,000xg for 20 minutes at 4˚C and the supernatant collected. After 
protein quantification by Bradford assay, phosphoprotein enrichment and 
concentration was carried out as per the manufacturer’s instructions such that the 
final volume of samples was 100-150µl. At this point samples were either stored at -
80˚C or kept on ice for further processing. 
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2.4.2 Phosphoprotein-enriched Label-free sample preparation 
Phosphoprotein-enriched sample fractions from the Pierce Phosphoprotein 
enrichment kit (Pierce, 90003) were quantified by Bradford assay and 120µg of 
protein was placed into a new eppendorf. All samples were then brought up to 50µl 
using the elution buffer supplied in the Pierce Phosphoprotein enrichment kit. This 
volume was then brought up to 93.5µl using 50mM of Ammonium Bicarbonate. 1µl 
of reduction buffer was added to each sample (0.5M DTT in 50mM ammonium 
bicarbonate), vortexed, briefly centrifuged and incubated at 56˚C for 20 minutes on a 
shaker platform. Once the reduced samples had cooled, 2.7µl of alkylation buffer 
was added to the sample (0.55M Iodoacetamide in 50mM Ammonium Bicarbonate). 
The sample was then briefly vortexed and centrifuged before being incubated for 20 
minutes at room temperature in the dark. After this incubation period, 1µl of 1% 
ProteaseMAX™ surfactant trypsin enhancer (Promega, V2071) and 2.2µl of 2µg/µl 
Trypsin was then added and all samples were incubated overnight at 37ºC on a 
shaker platform. A volume of each sample equal to 20µg of peptide was then taken 
and stored at -20˚C for quantitative label-free LC/MS analysis. The remaining 100µg 
of peptide was processed using Graphite spin columns (Pierce, 88302) and 
Phosphopeptide enriched using Swellgel® Gallium spin columns (Pierce, 89853). 
2.4.3 Gallium Phosphopeptide enrichment 
Phosphopeptide enrichment using SwellGel® Gallium chelated discs was carried out 
as per the manufacturer’s instructions (Pierce, 89853).   
2.4.4 TiO2 Phosphopeptide enrichment 
Following clean up using graphite spin columns (detailed 2.3.8) peptides obtained 
from CHO whole cell lysates for TiO2 phosphopeptide enrichment were enriched 
using TiO2 phosphopeptide enrichment columns (Pierce 88303) as per the 
manufacturer’s instructions. Each sample was then cleaned up using graphite spin 
column as detailed 2.3.8. 
2.4.5 Iron Phosphopeptide enrichment 
Following clean up using graphite spin columns (detailed 2.3.8) peptides obtained 
from CHO whole cell lysates for iron phosphopeptide enrichment were enriched 
using iron phosphopeptide enrichment columns (Pierce 88300) as per the 
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manufacturer’s instructions such that the elution fractions were pooled. Samples 
were then cleaned up using graphite spin columns as per 2.3.8. 
2.4.6 LC/MS analysis 
Samples were resolubilised in 25µl of LC-MS grade water with 0.1% TFA and 2% 
ACN. 12.5µl was then transferred to glass vials and the remaining reconstituted 
sample stored at -80˚C. Mass spectrometry was performed by Mr. Michael Henry. 
Nano LC–MS/MS analysis was carried out using an Ultimate 3000 nanoLC system 
(Dionex) coupled to a hybrid linear ion trap/Orbitrap mass spectrometer (LTQ 
Orbitrap XL; Thermo Fisher Scientific). Note, SilicaTip™ Standard Coating Tubing 
OD/ID 360/20 µm Tip ID 10 µm  Length 5cm,  (NewObjective) were used as emitter 
tips for nano electrospray. 
A 2.5µl injection of digested sample were picked up using an Ultimate 3000 nanoLC 
system (Dionex) autosampler using direct injection pickup onto a 20 microlitre 
injection loop.  The sample was loaded onto a C18 trap column (C18 PepMap, 300 
µm ID × 5 mm, 5 µm particle size, 100 Å pore size; Dionex) and desalted for 10 min 
using a flow rate of 25µl/min in 0.1% TFA containing 2% acetonitrile (Loading 
Buffer). The trap column was then switched online with the analytical column 
(PepMap C18, 75 µm ID × 250 mm, 3 µm particle and 100 Å pore size; (Dionex)) 
using a column oven at 35 °C and peptides were eluted with the following binary 
gradients of: 
Mobile Phase Buffer A and Mobile phase buffer B: 0–25% solvent B in 120 min and 
25–50% solvent B in a further 60 min, where solvent A consisted of 2% acetonitrile 
(ACN) and 0.1% formic acid in water and solvent B consisted of 80% ACN and 
0.08% formic acid in water. Column flow rate was set to 350 nL/min.  Data were 
acquired with Xcalibur software, version 2.0.7 (Thermo Fisher Scientific).  
The Hybrid linear ion trap/Orbitrap mass spectrometer (LTQ Orbitrap XL; Thermo 
Fisher Scientific) was operated in data-dependent mode and externally calibrated. 
Survey MS scans were acquired in the Orbitrap in the 400–1800 m/z range with the 
resolution set to a value of 30,000 at m/z 400. Up to three of the most intense ions 
(1+, 2+ and 3+) per scan were CID fragmented in the linear ion trap followed by an 
MS3 event.  
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MS3  was only triggered if a neutral loss of phosphoric acid was detected indicated 
by a -98, -49 or -32.7 Da loss from the parent precursor. Dynamic exclusion was 
enabled with a repeat count of 1, repeat duration of 30 seconds, exclusion list size of 
500 and exclusion duration of 40 seconds. The minimum signal was set to 500.  All 
tandem mass spectra were collected using a normalised collision energy of 35%, an 
isolation window of 2 m/z, activation Q was set to 0.250 with an activation time of 
30. 
2.4.7 Mass Spectrometry Protein Identifications 
Mass spectrometry data is generated as *.RAW files from LTQ XL instruments.  
Data was analysed using the search algorithms TurboSequest (Thermo Fisher 
Scientific) and MASCOT (v2.3.01, Matrix Science, London, UK) through Proteome 
Discover 1.3 (Thermo Fisher Scientific) against Bielefeld-BOKU-CHO database 
(Meleady et al 2011) and CHO-K1 genomic data as published by Xu et al. (2011) for 
all LC/MS analysis of samples originating from CHO cultures. For samples 
originating from Hybridoma cultures, Swissprot-uniprot Mouse databases (fast file 
Jan 2014) were used. 
The search parameters that were used allowed two missed cleavages, fixed 
modification of cysteine (carbamidomethyl-cysteine), variable modifications of 
methionine (oxidised), serine, threonine and tyrosine (phosphorylated) and serine 
and threonine (dehydrated). The Hybrid linear ion trap/Orbitrap mass spectrometer 
used a peptide tolerance of 20ppm and the MS2 and MS3 tolerances were set at 
0.5Da. 
On completion of the database search the peptide results were filtered as follows for 
host cell protein analysis: a MASCOT criteria of 95% confidence interval (C.I.) 
threshold (p<0.05), with a minimum MASCOT score of ≥40 while the following 
TurboSequest filters were applied: for charge state 1, XCorr > 1.9; for charge state 2, 
XCorr > 2.2; for charge state 3, XCorr > 3.75 and a delta CN of 0.1. 
For phosphoproteomic analysis the following filters were applied: a MASCOT 
criteria of 95% confidence interval (C.I.) threshold (p<0.05), with a minimum 
MASCOT score of ≥40 while the following TurboSequest filters were applied: for 
charge state 1, XCorr > 1.9; for charge state 2, XCorr > 2.2; for charge state 3, 
XCorr > 3.75. In addition, PhoshoRS filters were set at >99%. 
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2.4.8 Label-free LC-MS data analysis 
Data analysis was performed using Progenesis LC-MS software available from Non-
Linear Dynamics. Raw MS data files were imported to Progenesis LC-MS software 
package.  
Where specified reference run alignment was carried out twice, once using the 
automatic reference run selection feature on the software and once by means of 
manual reference run selection, otherwise, reference run selection was carried out 
only once by manual reference run selection. A reference run is selected as the 
sample which is most representative of the data, all additional sample runs are then 
aligned to the reference sample run.  
Alignment of sample runs allows correction of variable peptide retention times 
during chromatographic separation thus allowing comparison of the different sample 
runs.  
(In instances where reference run alignment was carried out twice, lists of 
differentially-expressed proteins or phosphopeptides was generated by overlapping 
the list of differentially-expressed proteins obtained from the automatic reference run 
selection with the list of differentially-expressed proteins obtained from the manual 
reference run selection. Proteins / phosphopeptides common to both lists were 
accepted as being differentially-expressed.) Upon alignment of all runs, detected 
features were then filtered based on an anova p-value of less than 0.05 between 
experimental groups. From this list of filtered features a principal component 
analysis (PCA) plot is generated. The MS/MS data from this list of filtered features 
is then exported into the external search engine MASCOT to match these identified 
features to known peptides as detailed in section 2.4.7.  
XML files containing MS/MS identifications were then imported back into 
Progenesis. Conflicting peptides i.e. peptides common to two or more proteins, were 
then sorted; the conflicting peptide with the highest ion score was retained while all 
other peptides for that conflict were removed. In instances where two or more 
conflicting peptides shared a common ‘highest’ ion score, these peptides were 
retained for identification purposes but not used for quantitation. Statistical criteria 
of anova p-value less than 0.05 and fold-change greater than 1.5-fold between 
experimental groups was then applied to the protein lists. 
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2.5 Other Proteomic Techniques 
2.5.1 Gel electrophoresis 
Proteins for analysis by Western blotting were resolved by SDS-polyacrylamide gel 
electrophoresis (SDS-PAGE) using precast 4-12% Bis-Tris gels (Life Technologies, 
NP0322BOX (12 well), NP0321BOX (10 well)). Prior to samples being loaded in 
the relevant sample wells, 8-20 µg of protein was diluted in 2x laemmli loading 
buffer (Sigma, S3401-1VL). Pageruler™ Plus prestained protein ladder (Pierce, 
26619) were loaded alongside samples. The gels were run at constant voltage (200V) 
until the Bromophenol blue dye front reached the end of the gel, at which time 
sufficient resolution of the molecular weight markers was achieved. 
2.5.2 Western blotting 
Once electrophoresis was complete, the SDS-PAGE gel was equilibrated in transfer 
buffer (10% 10X Tris/Glycine (Biorad, 161-0734), 20% Methanol (Romil, H409), 
70% diH2O) for approximately 10 minutes. Six sheets of 3 mm filter paper 
(Whatman, 1001-824) were soaked in freshly prepared transfer buffer and placed on 
the cathode plate of a semi-dry blotting apparatus (Bio-Rad, TransBlotR) after 
excess buffer was removed. Hybond™-P PVDF membrane (GE Healthcare, RPN 
303F), which had been equilibrated in the same transfer buffer, was placed over the 
filter paper on the cathode plate. The gels were then aligned on to the membrane. Six 
additional sheets of transfer buffer soaked filter paper were placed on top of the gel 
and all air pockets removed. The anode was carefully laid on top of the stack and the 
proteins were transferred from the gel to the membrane at a current of 0.24A at 15 V 
for 35 minutes.  
The membranes were then blocked for 2 hours at room temperature using either 5% 
BSA in 0.1% Tris Buffered Saline with Tween 20 (TBSt) for phosphorylated 
proteins or 5% skimmed milk powder (Marvel) in 0.1% TBSt for non-
phosphorylated proteins. Membranes were incubated with primary antibody over-
night at 4˚C . All antibodies were prepared in 0.1% TBST. Primary antibody was 
removed after overnight incubation and the membranes rinsed 3 times with 0.5% 
TBSt for a total of 15-30 minutes. Secondary antibody was added for 30-90 minutes 
at room temperature. The membranes were washed thoroughly in 0.5% TBSt for 15-
30 minutes. 
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Table 2.5.1 List of primary antibodies used in the experiments used in this thesis 
including those used to detect phosphorylated and non-phosphorylated versions of 
the proteins studied. 
2.5.3 Enhanced chemiluminescence (ECL) detection  
Immunoblots were developed using ECL2 Western Blotting Substrate (Pierce, 
80196) which facilitated the detection of bound peroxidase-conjugated secondary 
antibody. Following the final washing membranes were incubated with 2ml of ECL2 
reagent, 5:1 (Buffer A : Buffer B), for 1-5 minutes. The membrane was then placed 
between two sheets of clear acetate and then exposed to autoradiographic film 
(Kodak, X-OMATS) for various times (from 10 seconds to 30 49 minutes depending 
on the signal). The exposed autoradiographic film was developed for 1-5 minutes in 
developer (Kodak, LX-24). The film was then washed in water for 15 seconds and 
transferred to a fixative (Kodak, FX-40) for 5 minutes. The film was then washed 
with water for 15 seconds minutes and left to dry at room temperature. 
Antibody Phospho Site Dilution Supplier Product Number Secondary
Akt NA 1:3000 Cell Signaling 9272 Rabbit
Akt1 Phos Ser473 1:1000 Cell Signaling 9271 Rabbit
Erk NA 1:1000 R&D Systems AF1575 Rabbit
Erk Phos Y204+Y187 1:1000 Abcam Ab76299 Rabbit
Amp Kinase α1 NA 1:1000 Cell Signaling 2795 Rabbit
Amp Kinase α2 NA 1:1000 Cell Signaling 2757 Rabbit
Amp Kinase β1 NA 1:1000 Cell Signaling 4178 Rabbit
Amp Kinase β2 NA 1:1000 Cell Signaling 4148 Rabbit
Amp Kinase γ1 NA 1:1000 Cell Signaling 4187 Rabbit
Amp Kinase γ2 NA 1:1000 Cell Signaling 2536 Rabbit
Amp Kinase γ3 NA 1:1000 Cell Signaling 2550 Rabbit
Amp Kinase α1 
and  α2 Phos Thr172 1:1000 Cell Signaling 2531 Rabbit
JNK1 NA 1:1000 R&D Systems MAB17761 Mouse
JNK Phos Thr183/Tyr185 1:1000 Cell Signaling 4668 Rabbit
SAP/JNK NA 1:1000 Cell Signaling 9258 Rabbit
Mek 6 Phos Ser207 1:1000 Abcam Ab36722 Rabbit
Mek 6 NA 1:2000 R&D Systems AF1604 Rabbit
ATF-2 NA 1:1000 Abcam Ab31483 Rabbit
ATF-2 Phos Thr51/Thr69 1:1000 Abcam Ab131106 Rabbit
NDRG1 NA 1:1000 Cell Signaling 5196 Rabbit
NDRG2 Phos Ser330 1:1000 Cell Signaling 3506 Rabbit
α-Tubulin NA 1:2000 Abcam Ab55611 Mouse
HRP Conjugated 
Goat anti-Human 
IgG-Fc
NA 1:50000 Bethly Laboratories A80-104P N/A
MMP19 NA 1:1000 Abcam Ab53146 Rabbit
BMP1 NA 1:1000 Abcam Ab118520 Rabbit
PSAP NA 1:1000 Abcam Ab68466 Rabbit
GRP87/Bip NA 1:1000 Sigma G8918 Rabbit
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2.5.4 MAP Kinase array 
Samples were analysed on the Human Phospho-MAPK Array Kit (R&D systems, 
ARY002B) as per the manufacturer’s instructions. Table 2.5.2 shows the kinases 
detected by the array. Antibody detection was by ECL as detailed section 2.5.3. 
Exposure time to autoradiographic film was 1 hour. 
 
 
Table 2.5.2 Shows list of kinases and the specific site of phosphorylation detected 
by the kinase array. 
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2.5.5 Depletion of IgG from conditioned media collected from DP12 cell line 
Protein A affinity chromatography work was carried out on an Äktaprime plus using 
a 5ml HiTrap MabSelect SuRe column (GE Healthcare, 11-0034-94).  Each sample 
was processed manually on the Äktaprime plus. It should be noted that all runs used 
a flow rate of 5ml/min and the pressure alarm was set to 1MPa. Equilibration / wash 
buffer consisted of 20mM sodium phosphate, 0.15M sodium chloride pH adjusted to 
7.2 with HCl solution. Elution buffer was 60M sodium citrate pH adjusted to 3.3 
using 1M citric acid. All buffers were made up using LC/MS grade water.  
The column was equilibrated using 5 column volumes (CVs) of equilibration/wash 
buffer. Conditioned media sample was then run through the column and collected in 
a clean tube. The collected conditioned media sample was then returned to the 
original sample tube and run through the Protein A column for a second time. This 
was repeated until the sample had been passed through the column four times. 
Conditioned media samples were then either stored at -80˚C or prepared immediately 
for subsequent analysis (section 2.3.3). The column was then equilibrated for further 
depletion by running an 80% solution of elution buffer through the column for 10 
CV’s followed by a 100% equilibration / wash buffer for 10 CV’s.  
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3.0 Host Cell Protein Analysis 
Chapter overview 
For some time now, engineering of recombinant protein producing cell lines has 
been the primary focus of the bioprocessing community in an effort to create faster 
growing, higher producing cell lines. It is only in more recent times that the host cell 
protein profile has been looked at in greater detail to identify how the cell culture 
process can impact on downstream purification and product quality. In addition to 
this however, the secretome can also be a rich source of information, providing 
insights into cell-cell signalling events that effect cell growth and viability.  
The first study conducted in this thesis looked at changes in the relative abundance 
of proteins between early exponential and early death phase in a hybridoma cell 
culture. Given the widespread use of temperature-shift in industry, the effect of the 
reduction in culture temperature over time (and compared to early and late phases at 
37˚C) were also examined.  
In industry, the primary cell line of choice is the CHO cell. It was therefore decided 
to extend the investigation to include a study of the HCP profile of non-producing 
CHO cells over time in culture under temperature-shifted and non-temperature-
shifted conditions.  
To complement the analysis of the non-producing CHO cells, an IgG-secreting 
CHO-K1 cell line, CHO-DP12, was also selected for analysis. Analysed in a similar 
manner to the CHO-K1 cells, this allowed direct comparisons to be made between 
the two CHO cell lines enabling the identification of proteins with the potential to 
impact on product quality and cell culture viability as well as the confirmation of 
changes in the HCP profile as a direct result of temperature-shift. 
To the best of my knowledge, the work presented in this thesis is the first time that 
the HCP profiling of a hybridoma and CHO cell lines over time in culture under 
temperature-shifted and non-temperature-shifted conditions has been reported. 
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3.1 Characterisation of the host cell protein profile of a non-
producing hybridoma cell line 
Although there have been a number of publications describing some of the proteins 
secreted by hybridoma cell lines, these have almost exclusively focused on specific 
proteases or growth factors. To the best of my knowledge, there have been no reports 
in the literature detailing the proteomic profiling of host cell proteins produced by 
hybridoma cells. In order to facilitate the use of a quantitative, label-free, LC/MS 
method a non-producing hybridoma cell line was selected to generate conditioned 
media samples, as the presence of an actively secreted IgG molecule, the quantity of 
which would change both over time and under different culture conditions, would 
interfere with the accurate quantitation of HCPs. The availability of a well annotated 
mouse protein database would also facilitate identification of any proteins detected 
in the cell culture supernatant of the hybridoma cell line. This chapter reports the 
proteomic analysis of proteins secreted into the cell culture supernatant of a non-
producing hybridoma cell line under both temperature-shifted and non-temperature-
shifted conditions by quantitative label-free mass spectrometry. In addition, this 
chapter will also look at the changes in the HCP profile over the life time of the 
culture from early exponential phase to late stationary phase.  
 
 Growth profiling of non-producing hybridoma cell line 3.1.1
A hybridoma cell line called 4/2D (generated in house by Dr. Annemarie Larkin 
NICB) was grown in 20ml volume of chemically defined protein free PHFM-II™ 
media in T-175 monolayer culture. Cells were seeded at 2x105 cell/ml and after 48 
hours, flasks selected for temperature-shift were placed in a 31˚C incubator for the 
remainder of the culture period. Cell culture supernatants were collected 24, 72 and 
96 hours post-temperature-shift from both temperature-shift and non-temperature-
shifted cultures see Figure 3.1.1 (as per materials and methods 2.3.2). Due to the low 
volumes of media used, conditioned media from two flasks were pooled to provide a 
sufficient sample size for analysis. Media from two pooled flasks was considered 
one replicate. Enough flasks were set up so that three ‘replicates’ from each time 
point at each temperature could be collected.  
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Although a lower cell density is placed under temperature-shift by reducing culture 
temperature at 48hrs, which may be sub-optimal for collecting maximum titre of a 
recombinant therapeutic, it enabled biological inferences to be drawn from 
proteomic analysis of two distinct cultures, thus providing insights into changes 
occurring in temperature-shifted hybridoma cells.  
 
 
 
Figure 3.1.1 Growth curve of a non-producing hybridoma cell line grown under 
temperature-shifted (31˚C) and non-temperature-shifted (37˚C) conditions. 
Temperature-shifted culture was placed at 31˚C after 48hrs in culture. Cell culture 
supernatants were collected 24, 72 and 96 hours post-temperature-shift and analysed 
using mass spectrometry. 
  
Post-temperature-shift 
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 Quantitative label-free LC/MS analysis of conditioned media from a 3.1.2
non-producing hybridoma cell line 
Conditioned media from three biological replicates taken at 24, 72 and 96 hours post 
temperature from cultures grown at 37˚C and 31˚C were prepared for quantitative 
LC/MS analysis as described in materials and methods 2.3.2 and 2.3.3.  
 
 Data analysis of differentially-regulated proteins identified by label-free 3.1.3
LC/MS profiling of conditioned media from a non-producing hybridoma 
cell line 
Data acquired following LC/MS analysis was analysed using Progenesis label-free 
software. A protein was deemed to be differentially-regulated if it has a statistically 
significant fold-change (anova >0.05) greater than 1.5-fold between experimental 
groups, and was identified with an ion protein score >40 (this score is a minimum 
score per peptide and is not based on a cumulative aggregate score between 
peptides).  
Due to the use of multiple time points between two conditions in this experiment, it 
was decided that the data would be analysed as follows: 
• 24hrs vs 96hrs at 37˚C 
• 24hrs vs 96hrs at 31˚C 
• 37˚C vs 31˚C at 24hrs 
• 37˚C vs 31˚C at 96hrs 
Note: The time in hours above is with respect to temperature-shift. i.e. 24hrs is 24hrs 
post-temperature-shift. 
Analysing the data in this way allows (i) changes in the abundance of proteins 
between early stage and late stage culture under temperature-shifted and non-
temperature-shifted conditions and (ii) changes in the abundance of proteins between 
temperature-shifted and non-temperature-shifted cultures at early stage and late stage 
culture, to be captured. 
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In order to identify what role the differentially-regulated proteins might play in the 
cell culture supernatant, the gene symbol for the mouse version of the protein 
identified was obtained and searched in the Uniprot database 
(http://www.uniprot.org/). Proteins classified by uniprot as being a protease, 
glycosidase, apoptotic protein or miscellaneous protein were deemed to be of 
particular interest and, as such, were labelled accordingly. 
 
3.1.3.1 Differential regulation of HCPs 24hrs vs 96hrs at 37˚C 
When using the Progenesis label-free software to analyse the LC/MS data, a 
principal component analysis (PCA) plot was generated showing how the samples 
from 24hr and 96hr cultures at 37˚C clustered. This PCA plot is displayed in Figure 
3.1.2. 
 
 
Figure 3.1.2 PCA plot for the non-producing hybridoma cell line sample groups 
24hrs (pink) and 96hrs (blue) at 37˚C generated during quantitative label-free 
LC/MS data analysis using Progenesis software. 
 
A total of 79 proteins with 1 or more peptides were identified as being differentially-
expressed at 37˚C between early (24hrs) and late (96hrs). Of these, 25 (with 1 or 
more peptides) had increased expression at 96hr (Appendix A, Table 3.1.1), while 54 
were found to be down-regulated (Appendix A, Table 3.1.2).  
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A number of proteins identified in this analysis are of potential interest to the 
bioprocessing community due to the role they may play in affecting culture viability 
or product quality. This includes the up-regulation of the stress protein STIP1 by 
almost 21.0-fold and the down-regulation of the secreted protease Cathepsin D 
(732.7-fold) at 96hrs compared to 24hrs at 37˚C (Figure 3.1.3). The large fold-
change observed in Cathepsin D is likely to be indicative of presence / absence 
scenario, particularly when coupled with the fact that the proteins were identified by 
one peptide.  
 
 
Figure 3.1.3 Shows examples of Progenesis label-free outputs of differentially-
expressed HCPs, such as the upregulation of Stress-induced-phosphoprotein 1 and 
the down-regulation of the secreted protease Cathepsin D. Both proteins were 
identified as being differentially-expressed when 96hrs was compared to 24hrs at 
37˚C in the conditioned media of a non-producing hybridoma cell line. 
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3.1.3.2 Differential regulation of HCPs 24hrs vs 96hrs at 31˚C 
A PCA plot showing how the samples from 24hr and 96hr cultures at 31˚C cluster 
was generated by Progenesis label-free software during analysis of LC/MS data and 
is displayed in Figure 3.1.4. 
 
Figure 3.1.4 PCA plot for non-producing hybridoma cell line sample groups 
compared at 24hrs (pink) and 96hrs (blue) at 31˚C generated during label-free 
LC/MS data analysis using Progenesis software. 
 
A comparison between early (24hrs) and late (96hrs) phases of the temperature-
shifted (31˚C) culture found 65 proteins (with 1 or more peptides) to be 
differentially-expressed. Of these, 31 were up-regulated at 96hrs (Appendix A, Table 
3.1.3) and the remaining 34 were down-regulated (Appendix A, Table 3.1.4). 
Among the differentially-expressed proteins identified in this study were the secreted 
proteins Olfactomedin-like protein 3 (2.4-fold up-regulated) and Calumenin (5.6-fold 
down-regulated) (Figure 3.1.5). Secreted proteins such as these are possibly involved 
in controlling culture growth and viability through cell-cell signalling events. 
Despite the relatively high viability of the cells at 31˚C, the static nature of the 
culture i.e., the cells were grown in monolayer suspension format, would suggest 
that the increase in intracellular proteins is as a result of apoptosis and the 
subsequent release of proteins from dead cells into the culture media.   
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Figure 3.1.5 Shows examples of Progenesis label-free outputs of differentially-
expressed HCPs, such as the upregulation of the intracellular protein Transitional 
endoplasmic reticulum ATPase (VCP) and down-regulation of the secreted protein 
Calumenin. Both proteins were identified as being differentially-expressed when 
96hrs was compared to 24hrs at 31˚C in the conditioned media of the non-producing 
hybridoma cell line 4/2D. 
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3.1.3.3 Differential regulation of HCPs at 24hrs 37˚C vs 31˚C  
A PCA plot generated by Progenesis during data analysis indicates how the samples 
from 37˚C and 31˚C cultures at 24hrs cluster is displayed in Figure 3.1.6. 
 
 
Figure 3.1.6 PCA plot for non-producing hybridoma cell line sample groups 37˚C 
(pink) and 31˚C (blue) after 24hrs in culture generated during label-free LC/MS data 
analysis using Progenesis software. 
 
In order to identify changes in the HCP profile of a non-producing hybridoma cell 
line as a result of temperature-shift, samples taken 24hrs post-temperature-shift from 
37˚C and 31˚C cultures were compared. Of the 27 differentially-expressed proteins 
with 1 or more peptides identified, 4 were deemed to increase in abundance at 31˚C 
(Appendix A, Table 3.1.5) while 23 were down-regulated (Appendix A, Table 3.1.6). 
The Progenesis output from some of the differentially-expressed proteins identified, 
including Laminin subunit gamma-1 (10.5-fold) and Nidogen-2 (7-fold),.are shown 
in Figure 3.1.7. Interestingly, a number of secreted proteins are down-regulated at 
31˚C, these are of particular interest because of the role they play in cell-cell 
signalling events. This raises the question; do secreted proteins play a role in the 
cellular response to temperature-shift? These proteins could warrant further 
investigation to determine whether extracellular-signalling events influence the 
growth of temperature-shifted cells. 
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Figure 3.1.7 Shows examples of Progenesis label-free outputs of differentially-
expressed HCPs, such as the secreted proteins Laminin subunit gamma-1 and 
Nidogen 2, both of which were identified as being down-regulated at 31˚C compared 
to 37˚C 24hrs post-temperature-shift  in the conditioned media of the non-producing 
hybridoma cell line 4/2D. 
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3.1.3.4 Differential regulation of HCPs at 96hrs 37˚C vs 31˚C  
A PCA plot generated by Progenesis label-free software during analysis of LC/MS 
data.is shown in Figure 3.1.8. The PCA plot displays how the samples from 37˚C 
and 31˚C  cultures at 96hrs post-temperature-shift cluster.  
 
 
Figure 3.1.8 PCA plot for non-producing hybridoma cell line sample groups 37˚C 
(pink) and 31˚C (blue) after 120hrs in culture generated during label-free LC/MS 
data analysis using Progenesis software. 
 
A direct comparison of 37˚C and 31˚C cultures 96hrs post culture temperature 
reduction revealed the differential expression of 44 proteins with 1 or more peptides. 
The 31 HCPs identified as being down-regulated in the temperature-shifted culture 
are shown in Appendix A, Table 3.1.7. The 13 proteins that showed an increase in 
abundance are listed in Appendix A, Table 3.1.8.  
Given the reduction of culture viability in the 37˚C culture compared to the 31˚C 
culture, the down-regulation of HCPs in the temperature-shifted culture makes sense 
given the likely increase in the release of intracellular proteins from dead cells at 
37˚C. Among the  proteins identified as down-regulated at 31˚C were a number of 
proteins that could negatively impact on product quality such as the protease 
Endoplasmic reticulum aminopeptidase 1 (2.2-fold) or the secreted protease 
Cathepsin B (27.9-fold), both of which were down-regulated at 31˚C (Figure 3.1.9). 
  
90 
 
 
Figure 3.1.9 Shows examples of Progenesis label-free outputs of differentially-
expressed HCPs, such as the protease Endoplasmic reticulum aminopeptidase 1 and 
the secreted protease Cathepsin B, both of which were identified as being down-
regulated at 31˚C compared to 37˚C, 96hrs post-temperature-shift  in the conditioned 
media of the non-producing hybridoma cell line 4/2D. 
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3.1.3.5 Comparison of differentially-regulated HCPs over time in culture at 
37˚C and 31˚C in a non-producing hybridoma cell line 
Quantitative analysis of conditioned media samples from 24hrs compared to 96hrs at 
37˚C identified 80 differentially-expressed proteins, while a comparison between 
24hrs and 96hrs at 31˚C revealed changes in the relative abundance of 66 proteins.  
In order to compare the effect of temperature-shift on proteins over time in culture 
with those in a non-temperature-shifted culture, lists of differentially-expressed 
proteins from sections 3.1.3.1 and 3.1.3.2 were combined and proteins common to 
both lists compiled in Table 3.1.9. The low number of proteins that overlap between 
the two lists may be as a result of the differential expression of proteins under one 
culture temperature and no change in relative abundance at the other temperature, as 
opposed to a complete absence of the protein from the culture media. As can be seen 
in Table 3.1.9, many of the proteins trend in the same direction over time in culture, 
such as the secreted protein Laminin subunit gamma-1 and the pro-apoptotic protein 
Guanine nucleotide-binding protein subunit beta-2-like 1, both of which were down-
regulated after 96hrs in culture. There are a number of proteins however that show 
opposite trends, such as the intracellular proteins Transitional endoplasmic reticulum 
ATPase (VCP), 60S acidic ribosomal protein P0-like and Elongation factor 1-
gamma. Opposite trends in the differential expression of intracellular proteins in the 
cell culture media may be as a result of differences in the viabilities of the two 
cultures at 96hrs. Functionally, these proteins do not group into specific cellular 
roles. However, information such as this could be useful to the bioprocessing 
community, for example; if a recombinant therapeutic is known to be negatively 
affected by the presence of a specific protease secreted by the cells into the culture 
media, comparing the data as provided in Table 3.1.9, would enable identification of 
the culture conditions that generates the lowest amount of this protease. 
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Table 3.1.9 List of differentially-expressed proteins common to 24hrs vs 96hrs 37˚C and 24hrs vs 96hrs 31˚C from a non-producing hybridoma 
cell line.  
 
Gene 
symbol Description 37C
Total 
Peptide
Quantitative 
Peptides Score Anova (p) Fold
Direction of fold 
change Comparison
2 2 104 0.018 28.9 Dow n at 96hrs 24hrs vs 96hrs 37C
3 3 147 0.0108 3.8 Dow n at 96hrs 24hrs vs 96hrs 31C
1 1 62 0.0217 102.1 Dow n at 96hrs 24hrs vs 96hrs 37C
2 2 88 0.0035 3 Up at 96hrs 24hrs vs 96hrs 31C
1 1 54 3.57E-05 Infinity Up at 96hrs 24hrs vs 96hrs 37C
1 1 55 0.0438 1.7 Up at 96hrs 24hrs vs 96hrs 31C
1 1 52 0.0066 Infinity Dow n at 96hrs 24hrs vs 96hrs 37C
2 2 113 0.0288 2.4 Dow n at 96hrs 24hrs vs 96hrs 31C
1 1 74 0.0318 23 Dow n at 96hrs 24hrs vs 96hrs 37C
1 1 47 0.0196 6.6 Up at 96hrs 24hrs vs 96hrs 31C
1 1 43 0.0126 484.6 Up at 96hrs 24hrs vs 96hrs 37C
1 1 42 0.0023 2.8 Dow n at 96hrs 24hrs vs 96hrs 31C
2 2 92 0.0027 8.7 Dow n at 96hrs 24hrs vs 96hrs 37C
1 1 62 0.0438 21492.2 Dow n at 96hrs 24hrs vs 96hrs 31C
1 1 44 0.0002 17.2 Dow n at 96hrs 24hrs vs 96hrs 37C
1 1 52 0.0125 2.4 Dow n at 96hrs 24hrs vs 96hrs 31C
1 1 43 0.03 1545.6 Dow n at 96hrs 24hrs vs 96hrs 37C
2 2 90 0.0204 4.2 Up at 96hrs 24hrs vs 96hrs 31C
1 1 40 0.0407 12.6 Dow n at 96hrs 24hrs vs 96hrs 37C
2 2 93 0.009 2.5 Dow n at 96hrs 24hrs vs 96hrs 31C
Impdh2 Inosine-5'-monophosphate dehydrogenase 2
G6pdx Glucose-6-phosphate 1-dehydrogenase X
Gnb2l1 Guanine nucleotide-binding protein subunit beta-2-like 1
Hnrnpab Heterogeneous nuclear ribonucleoprotein A/B
Got2 Aspartate aminotransferase, mitochondrial
Eef1g Elongation factor 1-gamma
Erp29 Endoplasmic reticulum resident protein 29
Hspd1 60 kDa heat shock protein, mitochondrial
Rplp0 60S acidic ribosomal protein P0
Alpl Alkaline phosphatase, tissue-nonspecif ic isozyme
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2 2 98 0.0284 214.2 Up at 96hrs 24hrs vs 96hrs 37C
1 1 45 0.0489 7.2 Up at 96hrs 24hrs vs 96hrs 31C
1 1 64 0.0096 16935.2 Dow n at 96hrs 24hrs vs 96hrs 37C
1 1 41 0.0384 3.8 Dow n at 96hrs 24hrs vs 96hrs 31C
1 1 42 0.0017 30 Dow n at 96hrs 24hrs vs 96hrs 37C
1 1 53 0.0307 8.9 Up at 96hrs 24hrs vs 96hrs 31C
1 1 40 0.0295 1336.7 Dow n at 96hrs 24hrs vs 96hrs 37C
1 1 53 0.0201 2.4 Up at 96hrs 24hrs vs 96hrs 31C
1 1 56 3.63E-06 Infinity Up at 96hrs 24hrs vs 96hrs 37C
1 1 60 0.0441 3.8 Up at 96hrs 24hrs vs 96hrs 31C
1 1 47 0.0044 Infinity Dow n at 96hrs 24hrs vs 96hrs 37C
1 1 49 0.0003 3.3 Dow n at 96hrs 24hrs vs 96hrs 31C
1 1 65 0.0017 95.8 Dow n at 96hrs 24hrs vs 96hrs 37C
1 1 50 0.0055 1.9 Dow n at 96hrs 24hrs vs 96hrs 31C
3 3 153 0.0201 323 Dow n at 96hrs 24hrs vs 96hrs 37C
2 2 116 0.0022 2 Up at 96hrs 24hrs vs 96hrs 31C
P4hb Protein disulf ide-isomerase
Pdia4 Protein disulf ide-isomerase A4
Vcp Transitional endoplasmic reticulum ATPase
Nme2 Nucleoside diphosphate kinase B
Olfml3 Olfactomedin-like protein 3
Pafah1b3 Platelet-activating factor acetylhydrolase IB subunit gamma
Lmnb1 Lamin-B1
Lamc1 Laminin subunit gamma-1
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 Qualitative analysis of proteins identified by label-free LC/MS profiling 3.1.4
of conditioned media from a non-producing hybridoma cell line 
Progenesis label-free software provides quantitative information on changes in the 
relative abundance of proteins. This however, ignores the fact that there are also 
proteins present in the sample, the expression of which may not change. Knowledge 
of these proteins may be useful in providing insights into whether significant 
differences exist between temperature-shifted and non-temperature-shifted 
hybridoma cultures. 
The RAW files obtained from LC/MS analysis of the conditioned media samples 
collected in biological triplicate and taken at 24, 72, and 96 hours post-temperature-
shift from 37˚C and 31˚C cultures as per Figure 3.1.1, were searched against the 
mouse UniproKB database using Mascot and SEQUEST search algorithms. These 
searches were conducted in parallel using Proteome Discoverer 1.4. Proteins were 
“identified” if they met the criteria as set out in section 2.4.7.In order for an 
‘identified’ protein to be considered “present” either at 37˚C or 31˚C, it had to be 
observed in the mass spectral data from a minimum of two biological samples at the 
given temperature.  
The following comparisons were made by overlapping the lists of identified proteins: 
• Hybridoma cell line 4/2D - 37˚C vs 31˚C Cultures 
o Proteins identified with 1 or more peptides 
o Proteins identified with 2 or more peptides 
 
As can be seen in Figure 3.1.10 A, 476 proteins with one or more peptides were 
identified in both temperature-shifted and non-temperature-shifted cultures. Of these, 
362 were common to both cultures, 74 unique to the 37˚C culture and 40 unique to 
the 31˚C culture. By using a minimum of two peptides to identify a protein, the 
confidence with which that protein is identified increases. Figure 3.1.10 B shows that 
262 proteins with two or more peptides are common to 37˚C and 31˚C cultures, 
while 59 are unique to the non-temperature-shifted culture and 25 are unique to the 
temperature-shifted culture.  
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This shows that despite increasing the criteria for protein identification, that 
differences exist between the proteins expressed at 37˚C and 31˚C. Lists of the 
proteins identified in Figure 3.1.10 A and Figure 3.1.10 B are available in Appendix 
A Tables 3.1.10 - Table 3.1.14. 
 
Figure 3.1.10 Overlap of the list of proteins identified in the conditioned media of a 
non-producing hybridoma cell line grown at 37˚C and 31˚C over 144 hours in 
stationary suspension culture. Samples were collected in biological triplicate and 
taken at 24, 72 and 96 hours post-temperature-shift. Venn diagram (A) represents 
those proteins identified using a minimum of 1 or more peptides. Venn diagram (B) 
is compiled from those proteins identified using a minimum of 2 or more peptides. 
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While some of the differences seen between temperature-shifted and non-
temperature-shifted cultures could be attributed to a reduction in the viability of the 
37˚C culture and the subsequent release of intracellular proteins from dead cells, 
another possible explanation could be the induced expression of a cohort of proteins 
in the temperature-shift culture as a result of the cells undergoing temperature-shift. 
In either event, the identification of a set of proteins unique to temperature-shift and 
non-temperature-shift culture conditioned has important implications (i) for the 
ability of a generic anti-HCP ELISA to detect contaminating HCPs in the final drug 
product. 
 
 Summary 3.1.5
Attempts to group proteins into cellular functions e.g. protease, growth factor, 
apoptotic etc., and identify trends in the differential-expression of these groups either 
over time in culture or between temperature-shift and non-temperature-shift 
conditions proved inconclusive (data not shown). Despite this, analysis of the HCP 
profile identified changes in the expression of proteases such as Cathepsin B, 
Cathepsin D and Endoplasmic reticulum aminopeptidase 1 as well as the apoptotic 
protein Guanine nucleotide-binding protein subunit beta-2-like 1 under both 
temperature-shifted and non-temperature-shifted conditions over time in culture. 
This provides useful information for the bioprocessing community for the selection 
of culture conditions for the production of a recombinant therapeutic sensitive to 
enzymatic activity. An interesting finding of this investigation was the identification 
of a number of secreted proteins that change in abundance when 37˚C and 31˚C 
cultures are compared at both early and later phases of the growth cycle. This 
possibly indicates an active cell-cell signalling response to reduction in culture 
temperature. Additionally, the identification of a cohort of proteins unique to both 
temperature-shift and non-temperature-shift cultures is a significant finding of this 
work. During the time that this analysis was conducted the CHO genome was 
sequenced and access to a CHO protein database became available. The availability 
of such a database would provide greater coverage of the CHO proteome and 
increased confidence in the assignment of protein identifications.  
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Given that this analysis was carried out in a hybridoma cell line, and we were able to 
successfully identify HCP proteins, it was decided that this investigation should be 
extended to include one of the most commonly used cell line in the production of 
biopharmaceuticals; the CHO cell.  
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3.2 Characterisation of the host cell protein profile of a non-
producing CHO-K1 cell line 
While there have recently been a number of publications discussing the host cell 
protein (HCP) profile of CHO cell lines, they have primarily focused on late 
stationary and death phases of culture. This profiling has also almost exclusively 
been based around the use of (2D) gel based technology. This chapter details the use 
of a quantitative, label-free, mass spectrometry based approach to identify changes in 
the HCP profile of a non-producing cell line over time in culture, from early 
exponential to late stationary phase. In addition to this, the HCP profile of a culture 
under reduced culture temperature conditions is also examined. This allows for direct 
comparisons to be made between temperature-shifted and non-temperature-shifted 
conditions over the cell culture cycle. 
 
 Growth profiling of non-producing CHO-K1 cell line 3.2.1
CHO-K1 cells were grown in triplicate in a 50ml volume of chemically-defined 
protein free OptiCHO™ media in shake flask batch culture. Cells were seeded at 
2x105 cell/ml and after 48 hours in culture flasks selected for temperature-shift were 
placed in a 31˚C incubator for the remainder of the culture period. Cell culture 
supernatants were collected 24, 72, 96 and 120 hours post-temperature-shift from 
both temperature-shifted and non-temperature-shifted cultures Figure 3.2.1 (as per 
materials and methods 2.3.2). While it is recognised that 48 hours may not have been 
an optimum time to place cells under reduced culture conditions from the point of 
obtaining maximum yield of a therapeutic product from the process, it provides 
clarity from a biological perspective in terms of identifying a functional response to 
a change in the culture conditions. 
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Figure 3.2.1 Growth curve of CHO-K1 non-producing cell line grown under 
temperature-shifted (31˚C) and non-temperature-shifted (37˚C) conditions. 
Temperature-shifted culture was placed at 31˚C after 48hrs in culture. Cell culture 
supernatants were collected 24, 72, 96 and 120 hours post-temperature-shift and 
analysed using a quantitative, label-free, mass spectrometry based approach. 
  
Post-temperature-shift 
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 Quantitative Label-free LC/MS analysis of conditioned media from a 3.2.2
CHO-K1 non-producing cell line 
Cell culture supernatants from three biological replicates at time points under both 
temperature-shifted and non-temperature-shifted conditions were concentrated ~100 
fold using centrifugal concentrators with a 3kDa molecular weight cut off.  Protein 
from an aliquot of each sample was then precipitated using a ReadyPrep™ 2D clean 
up kits. 10µg of sample was then prepared for LC/MS analysis as detailed in 
materials and methods 2.3.3. It was established during preliminary studies that a 3hr 
reverse phase gradient was sufficient for LC/MS analysis of conditioned media as 
these samples did not have the same level of complexity as a whole cell lysate, 
which requires a 5hr gradient, however the use of 1hr gradients resulted in loss of 
peptides. After mass spectral analysis of all the samples was complete, inclusion lists 
were generated and analysis for some of the samples was repeated. This was done to 
obtain information on additional peptides to further strengthen protein identifications 
and identify low abundance proteins that were not previously identified in the initial 
analysis.  
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 Data analysis of differentially-regulated proteins identified by 3.2.3
quantitative label-free LC/MS profiling of conditioned media from a 
CHO-K1 non-producing cell line 
Progenesis label-free software was used to analyse the data acquired following 
LC/MS analysis. A protein was considered to be differentially-regulated if it met the 
criteria as set out in 3.1.3.  
Due to the complex sampling nature of the experiment i.e. multiple time points 
between two conditions, it was decided that the data would be analysed as follows: 
• 24hrs vs 120hrs at 37˚C 
• 24hrs vs 120hrs at 31˚C 
• 37˚C vs 31˚C at 24hrs 
• 37˚C vs 31˚C at 120hrs 
• Analysis of differential regulation over 24, 72, 96 and 120 hours at 37˚C 
using Pearson correlation analysis 
• Analysis of differential regulation over 24, 72, 96 and 120 hours at 31˚C 
using Pearson correlation analysis 
Note: The time in hours above is with respect to temperature-shift. i.e. 24hrs is 24hrs 
post-temperature-shift. 
In order to infer a biological function for the differentially-regulated proteins 
identified, the gene symbol for the human version of the protein was obtained and 
searched in the Uniprot database (http://www.uniprot.org/). Proteins involved in in 
roles deemed to be of potential importance were classified as protease, glycosidase, 
apoptotic or miscellaneous. 
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3.2.3.1 Differential regulation of HCPs 24hrs vs 120hrs at 37˚C 
A principal component analysis (PCA) plot generated by Progenesis during data 
analysis showing how the samples from 24hr and 120hr cultures at 37˚C clustered is 
displayed in Figure 3.2.2.  
 
Figure 3.2.2 PCA plot for CHO-K1 non-producing cell line sample groups 24hrs 
(pink) and 120hrs (blue) at 37˚C generated during quantitative label-free LC/MS 
data analysis using Progenesis software. 
 
A total of 322 proteins with 1 or more peptides were identified as being 
differentially-expressed at 37˚C between early (24hrs) and late (120hrs). Of these, 
274 (with 1 or more peptides) had increased expression at 120hr, while 48 were 
found to be down-regulated (Table 3.2.1) (see Appendix B, Table 3.2.2 and Table 
3.2.3 for full lists).   
 
As can be seen in Table 3.2.1 proteins involved in apoptosis increased in abundance 
at 120hrs compared to 24hrs, this most likely reflects the decrease in cell viability 
the later time point. An example of the up-regulation of one such pro-apoptotic 
protein, Guanine nucleotide-binding protein subunit beta-2-like 1 (3.2-fold) is shown 
in Figure 3.2.3. The predominant up-regulation of proteases at 120hrs would suggest 
that recombinant products would be more susceptible to enzymatic activity at the late 
phase of culture. Conversely, another group of proteins likely to negatively impact 
on product quality, glycosidases, are down-regulated at 120hrs compared to 24hrs at 
37˚C. Figure 3.2.3 shows the 1.8-fold down-regulation of the glycosidase Beta-
galactosidase. 
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Table 3.2.1 Number of differentially-expressed proteins at 24hrs compared to 120hrs at 37˚C in a CHO-K1 non-producing cell culture 
supernatant. Using Uniprot protein database, proteins of biological relevance have been identified and the number of differentially-expressed 
proteins under the relevant classification included in the table. The protein count indicates the number of proteins identified by ≥1 peptides or ≥2 
peptides. 
 
 
≥1 Peptide ≥2 Peptides ≥1 Peptide ≥2 Peptides ≥1 Peptide ≥2 Peptides
Protein Count 322 112 274 96 48 16
5 2 5 2 0 0
GNB2L1, CLU, API5, 
PDCD6IP, PPM1F
GNB2L1, CLU GNB2L1,CLU,API5,
PDCD6IP,PPM1F
GNB2L1, CLU
20 5 14 2 6 3
DPP7, THOP1, C1ra, 
Otub1, CTSZ, BMP1, 
ADAM10, ADAM15, 
ADAM17, EIF3F, PSMA3, 
PSMA4, PSMB1, PSMB4, 
PSMB6, UCHL3, 
XPNPEP1, ADAMTS1, 
MMP9, CTSA
DPP7, THOP1, C1ra, 
Otub1, CTSZ
THOP1, Otub1, 
BMP1, ADAM10, 
ADAM15, 
ADAM17, EIF3F, 
PSMA3, PSMA4, 
PSMB1, PSMB4, 
PSMB6, UCHL3, 
XPNPEP1
THOP1, Otub1 DPP7, C1ra, 
CTSZ, ADAMTS1, 
MMP9, CTSA
DPP7, C1ra, 
CTSZ
6 3 2 0 4 3
MAN2B2, NAGA, GLB1, 
NEU1, FUCA1, SMPD1
MAN2B2, NAGA, GLB1 NEU1, FUCA1 MAN2B2, NAGA, 
GLB1, SMPD1
MAN2B2, NAGA, 
GLB1
Protease
Glycosidase
24hrs vs 120hrs at 37˚C
Total Up at 120hrs Down at 120hrs
Apoptosis
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Figure 3.2.3 Shows examples of Progenesis label-free outputs of differentially-
expressed HCPs, such as the apoptotic protein Guanine nucleotide-binding protein 
subunit beta-2-like 1 and the glycosidase Beta-galactosidase, identified as being 
differentially-expressed between 24hrs and 120hrs at 37˚C in the conditioned media 
of a CHO-K1 cell line.  
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3.2.3.2 Differential regulation of HCPs 24hrs vs 120hrs at 31˚C 
A PCA plot generated by Progenesis during data analysis showing how the samples 
from 24hr and 120hr cultures at 31˚C cluster is displayed in Figure 3.2.4.  
 
 
Figure 3.2.4 PCA plot for non-producing CHO-K1 cell line sample groups 24hrs 
(pink) and 120hrs (blue) at 31˚C generated during quantitative label-free LC/MS 
data analysis using Progenesis software. 
 
When early (24hrs) and late (120hrs) phases of the temperature-shifted (31˚C) were 
compared 146 proteins identified with 1 or more peptides were found to change in 
relative abundance (96 up-regulated at 120hrs and 50 down-regulated)  (Table 3.2.4) 
(For full list see Appendix B, Table 3.2.5  and Table 3.2.6). Although there is still an 
overall increase in the expression of proteases at the later time point, there are not as 
many as was observed in the 37˚C (Table 3.2.1). Interestingly, there is an increase 
the number of up-regulated glycosidases at the later time point at 31˚C compared to 
the 37˚C culture. Taken together, this would indicate that while a recombinant 
therapeutic would be less susceptible to protease activity at 31˚C, glycans on the 
molecule would be more prone to cleavage due to the up-regulation of glycosidases 
at 120hrs in the temperature-shifted culture. 
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Table 3.2.4 Number of differentially-expressed proteins at 24hrs compared to 120hrs at 31˚C in a CHO-K1 non-producing cell culture 
supernatant. Using Uniprot protein database, proteins of biological relevance have been identified and the number of differentially-expressed 
proteins under the relevant classification included in the table. The protein count indicates the number of proteins identified by ≥1 peptides or ≥2 
peptides. 
 
 
  
≥1 Peptide ≥2 Peptides ≥1 Peptide ≥2 Peptides ≥1 Peptide ≥2 Peptides
Protein Count 146 38 96 24 50 14
2 0 0 0 2 0
APP, Cycs APP, Cycs
8 2 6 1 2 1
CTSD, C1ra, CTSL1, 
CTSB, PSMB1, PSMB6, 
Otub1, ADAMTS7
CTSD, C1ra CTSD, CTSL1, 
CTSB, PSMB1, 
PSMB6, Otub1
CTSD ADAMTS7, 
C1ra
C1ra
6 3 5 2 1 1
NAGLU, GANAB, NAGA, 
MAN2B2, GAA, IDUA
NAGLU, GANAB, NAGA NAGLU, NAGA, 
MAN2B2, GAA, 
IDUA
NAGLU, NAGA GANAB GANAB
Protease
Glycosidase
24hrs vs 120hrs at 31˚C
Total Up at 120hrs Down at 120hrs
Apoptosis
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Among the differentially-expressed proteins identified in this study at 120hrs 
compared to 24hrs at 31˚C was the protease Cathepsin D (3.1-fold up-regulated) and 
the secreted protein Pentraxin-related protein PTX3 (2.5-fold down-regulated) as 
shown in Figure 3.2.5. 
 
 
Figure 3.2.5 Shows examples of Progenesis label-free outputs of differentially-
expressed HCPs, such as the protease Cathepsin D (up-regulated at 24hrs and 120hrs 
at 31˚C) and the secreted protein Pentraxin-related protein PTX3 (down-regulated at 
24hrs and 120hrs at 31˚C), both of which were identified in the conditioned media of 
a CHO-K1 cell line. 
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3.2.3.3 Differential regulation of HCPs at 24hrs 37˚C vs 31˚C  
A PCA plot generated by Progenesis during data analysis indicates how the samples 
from 37˚C and 31˚C cultures at 24hrs cluster is displayed in Figure 3.2.6. 
 
 
Figure 3.2.6 PCA plot for CHO-K1 non-producing cell line sample groups 37˚C 
(pink) and 31˚C (blue) after 24hrs in culture generated during quantitative label-free 
LC/MS data analysis using Progenesis software. 
 
 
A direct comparison of 37˚C and 31˚C cultures 24hrs post culture temperature 
reduction revealed a significant increase in the relative expression of HCPs in the 
31˚C culture. Of the 211 differentially-expressed proteins with 1 or more peptides 
identified, only 14 were down-regulated at 31˚C while 197 were deemed to increase 
in overall expression. This included up-regulation of 4 apoptotic proteins and 7 
proteases and a decrease in the abundance of 2 glycosidases (Table 3.2.7). (A full list 
of differentially-expressed HCPs is provided in Appendix B Table 3.2.8 and Table 
3.2.9). 
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Table 3.2.7 Number of differentially-expressed proteins between 31˚C and 37˚C at 24hrs post-temperature-shift in a CHO-K1 non-producing 
cell culture supernatant. Using Uniprot protein database, proteins of biological relevance have been identified and the number of differentially-
expressed proteins under the relevant classification included in the table. The protein count indicates the number of proteins identified by ≥1 
peptides or ≥2 peptides. 
 
 
  
≥1 Peptide ≥2 Peptides ≥1 Peptide ≥2 Peptides ≥1 Peptide ≥2 Peptides
Protein Count 211 55 197 52 14 3
5 0 4 0 1 0
CLU, API5, GNB2L1, 
KIAA1967 , PPM1F
API5, GNB2L1, 
KIAA1967, 
PPM1F
CLU
11 5 7 3 4 2
CTSH, DPP7, THOP1, 
UCHL3, Otub1, MMP19, 
TPP1, CNDP2, DPP3, 
LTA4H, PREP
CTSH, DPP7, THOP1, 
UCHL3, Otub1
THOP1, 
UCHL3, Otub1, 
CNDP2, DPP3, 
LTA4H, PREP
THOP1, UCHL3, Otub1 CTSH, DPP7, 
MMP19, TPP1
CTSH, DPP7
3 1 1 1 2 0
GANAB, HEXA, GAA GANAB GANAB GANAB HEXA, GAA
Protease
Glycosidase
37˚C vs 31˚C 24hrs
Total Up at 31˚C Down at 31˚C
Apoptosis
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The Progenesis output from some of the differentially-expressed proteins identified 
are shown in Figure 3.2.7. This includes the up-regulation of the intracellular protein 
GRP78 (3.3-fold) and the 1.9-fold down-regulation of the glycosidase Lysosomal 
alpha-glucosidase at 31˚C when compared to 37˚C after 24hrs. 
 
 
Figure 3.2.7 Shows examples of Progenesis label-free outputs of differentially-
expressed HCPs, such as GRP78, up-regulated at 31˚C and the glycosidase 
Lysosomal alpha-glucosidase, down-regulated at 31˚C, 24hrs post-temperature-shift 
in the conditioned media of a CHO-K1 cell line.  
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3.2.3.4 Differential regulation of HCPs at 120hrs 37˚C vs 31˚C  
A PCA plot generated by Progenesis during data analysis showing how the samples 
from 37˚C and 31˚C cultures at 120hrs cluster is displayed in Figure 3.2.8.  
 
Figure 3.2.8 PCA plot for CHO-K1 non-producing cell line sample groups 37˚C 
(pink) and 31˚C (blue) after 120hrs in culture generated during quantitative label-
free LC/MS data analysis using Progenesis software 
 
 
When 37˚C and 31˚C cultures are compared at the last time point, 120hrs post- 
temperature shift, 228 proteins with 1 or more peptides identified are seen to alter 
their expression, the majority of which are down-regulated in the 31˚C culture (153 
down-regulated, 75 up-regulated at 31˚C compared to 37˚C, 120hrs post-
temperature-shift. See summary Table 3.3.10.) This is a reversal of the trend seen 
when both culture temperatures were compared at the 24hr time point (Table 3.2.7). 
The significant number of down-regulated proteases and glycosidases at 31˚C 
compared to 37˚C suggests that a recombinant product would be less susceptible to 
enzymatic activity in the temperature-shifted culture (Table 3.2.10). As seen in Table 
3.2.10, six of the eight differentially-expressed apoptotic proteins identified are 
down-regulated at 31˚C compared to 37˚C. This could be attributed to the overall 
increased viability of the temperature-shifted culture compared to the non-
temperature-shifted culture. (See Appendix B Table 3.2.11 and Table 3.2.12 for full 
list of differentially-expressed HCPs).  
112 
 
Table 3.2.10 Number of differentially-expressed proteins between 31˚C and 37˚C at 120hrs post-temperature-shift in a CHO-K1 non-producing 
cell culture supernatant. Using Uniprot protein database, proteins of biological relevance have been identified and the number of differentially-
expressed proteins under the relevant classification included in the table. The protein count indicates the number of proteins identified by ≥1 
peptides or ≥2 peptides. 
 
 
≥1 Peptide ≥2 Peptides ≥1 Peptide ≥2 Peptides ≥1 Peptide ≥2 Peptides
Protein Count 228 67 75 18 153 49
6 2 2 0 4 2
GNB2L1, APP, GAPDH, 
API5, DDX3X, Cycs
GNB2L1, APP DDX3X, Cycs GNB2L1, APP, GAPDH, 
API5
GNB2L1, APP
17 5 2 1 15 4
ADAMTS7, MMP19, 
PRSS22, BMP1, DPP7, 
HTRA1, P15156, PLAT, 
ADAM19, MMP9, THOP1, 
CTSZ, ADAM10, C1ra, 
ADAM17, ADAM15, CTSD
ADAMTS7, MMP1,9 
PRSS22, BMP1, DPP7
DPP7 CTSD DPP7 ADAMTS7, MMP19, 
PRSS22, BMP1, HTRA1, 
P15156, PLAT, ADAM19, 
MMP9, THOP1, CTSZ, 
ADAM10, C1ra, ADAM17, 
ADAM15
ADAMTS7, MMP19, 
PRSS22, BMP1
7 1 3 1 4 0
MAN2B2, CTBS, NEU1, 
FUCA1, GBA, GANAB, 
NAGA
MAN2B2 MAN2B2, 
GANAB, NAGA
MAN2B2 CTBS, NEU1, FUCA1, 
GBA
Protease
Glycosidase
37˚C vs 31˚C 120hrs
Total Up at 31˚C Down at 31˚C
Apoptosis
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The Progenesis output indicating the down-regulation of the pro-apoptotic protein 
Guanine nucleotide-binding protein subunit beta-2-like 1 (10.6-fold) and the protease 
Matrix metalloproteinase-19 (4.0-fold) are shown in Figure 3.2.9. 
 
 
Figure 3.2.9 Shows examples of Progenesis label-free outputs of differentially-
expressed HCPs, such as the apoptotic protein Guanine nucleotide-binding protein 
subunit beta-2-like 1 and the protease Matrix metalloproteinase-19, identified as 
being down-regulated at 31˚C 24hrs post-temperature-shift in the conditioned media 
of a CHO-K1 cell line.  
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3.2.3.5 Pearson correlation analysis of differentially-regulated HCPs over 24, 
72, 96 and 120 hours at 37˚C 
Pearson’s correlation analysis was used as a means of measuring the linearity of 
protein expression over time in culture in the 37˚C culture. An Anova cut-off of 0.05 
was applied to add an additional layer of statistical rigour. Using this method of 
analysis 84 proteins were deemed to change over time in culture. See Appendix B, 
Table 3.2.13 for the proteins that decrease over time and Table 3.2.14 for proteins 
that increase over time in culture. An example of the linear increase in the expression 
of a protein, semaphorin-3B, is show in Figure 3.2.10. With a Pearson correlation 
score of 0.995 the tumour suppressor protein Semaphorin-3B increases in expression 
8.9-fold between 24 and 120hrs post-temperature-shift at 37˚C. Expression of the 
secreted protein Suprabasin is also shown to increase linearly between 24 and 120hrs 
post-temperature-shift at 37˚C by 6.0-fold in Figure 3.2.11 (Pearson correlation 
0.974, p-value 0.026). 
 
 
  
115 
 
 
Figure 3.2.10 Progenesis label-free output of the tumour suppressor semaphorin-3B 
showing its increase in expression from 24hrs (Day1) to 120hrs (Day4) at 37˚C (A). 
Output from excel on which Pearson correlation calculation is based (Pearson 
correlation 0.995, p-value 0.005). (B) 
 
Figure 3.2.11 Progenesis label-free output of the secreted protein Suprabasin 
showing its increase in expression from 24hrs (Day1) to 120hrs (Day4) at 37˚C (A). 
Output from excel on which Pearson correlation calculation is based (Pearson 
correlation 0.974, p-value 0.026). (B) 
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3.2.3.6 Pearson correlation analysis of differentially-regulated HCPs over 24, 
72, 96 and 120 hours at 31˚C 
Pearson’s correlation analysis was also used as a means of measuring the linearity of 
protein expression over time in the temperature-shifted culture. This analysis 
identified that 28 proteins increase expression in a linear manner over time in culture 
(Appendix B, Table 3.2.15). Figure 3.2.12 and Figure 3.2.13 shows the increase in 
the secreted proteins Lactadherin (Pearson correlation 0.995, p-value 0.0048.) and 
Neuroblast differentiation-associated protein AHNAK (Pearson correlation 0.956, p-
value 0.0442) over time in culture at 31˚C. 
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Figure 3.2.12 Progenesis label-free output of the secreted protein Lactadherin 
showing its increase in expression from 24hrs (Day1) to 120hrs (Day4) at 31˚C (A). 
Output from excel on which Pearson correlation calculation is based (Pearson 
correlation 0.997, p-value 0.0026). (B)  
 
 
Figure 3.2.13 Progenesis label-free output of the secreted protein Neuroblast 
differentiation-associated protein AHNAK showing its increase in expression from 
24hrs (Day1) to 120hrs (Day4) at 31˚C (A). Output from excel on which Pearson 
correlation calculation is based (Pearson correlation 0.956, p-value 0.0442) (B). 
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3.2.3.7 Comparison of differentially-regulated HCPs over time in culture at 
37˚C and 31˚C in a non-producing CHO-K1 cell line 
This study has identified a significant number of differentially-expressed HCPs over 
time in culture under both temperature-shifted and non-temperature-shifted 
conditions (as detailed in sections 3.1.3.1 and 3.1.3.2). In addition, comparisons 
between 37˚C and 31˚C cultures at both early (24hrs) and late (120hrs) stage has 
provided further information on the differential expression of HCPs as a result of the 
change in culture temperature. In order to obtain a clearer picture of the differences 
in the HCP profile of both cultures data from 24hrs vs 120hrs at 37˚C and 24hrs vs 
120hrs at 31˚C experiments were combined. In this way, the differential expression 
of a given HCP under temperature-shifted and non-temperature conditions could be 
directly compared (Figure 3.2.14). These proteins were not identified as 
differentially-expressed in the 37˚C vs 31˚C at 120hrs protein list, therefore it is 
most likely that the relative abundance of these proteins did not significantly change 
between  temperature-shifted and non-temperature-shifted cultures at a late stage in 
culture.  
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Figure 3.2.14 Shows Progenesis label-free software outputs and a table of proteins common to 24hrs vs 120hrs 37˚C and 24hrs vs 120hrs 31˚C 
differentially-expressed protein lists from non-producing CHO-K1 cell line. 
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As can be seen in Figure 3.2.14, in many instances the differentially-expressed 
protein trends in the same direction irrespective of the culture conditions. It may still 
be useful to know whether the relative expression of the HCP is greatest at 37˚C or 
31˚C. For this reason, the list of proteins common to 24hrs vs 120hrs 37˚C and 24hrs 
vs 120hrs 31˚C lists were then compared to 37˚C vs 31˚C at 120hrs and the data 
from all common proteins combined . This would then provide an indication as to 
which culture had the greatest relative abundance of a given protein after 144hrs 
(Appendix B, Table 3.2.16). Information such as this could be useful for identifying 
culutre conditions that accumulate the greatest concentration of a given protease or 
glycosidase and as such, increase the likelihood of product degradation through 
enzymatic activity. 
To show how the abundance of some of HCPs identified change over time, a number 
of proteins were selected from Table 3.2.16 and, using the output from Progenesis 
label-free software as a  visual  representation, are shown in Figure 3.2.15  and 
Figure 3.2.16. Figure 3.2.15 shows the differential expression of the anti-apoptotic 
protein Endoplasmin and the protease Complement C1r-A subcomponent, while 
Figure 3.2.16 shows the secreted proteins semaphorin-3B and Basement membrane-
specific heparan sulfate proteoglycan core protein (HSPG2). These proteins were 
selected as examples as they may impact on cell viability (Endoplasmin) or product 
quality (Complement C1r-A subcomponent). Knowledge of proteins actively 
secreted into the cell culture supernatant by CHO cells may also be useful as they are 
possibly involved in cell – cell signalling and so, are also included. 
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Figure 3.2.15 Shows the differential expression of the HCPs (A) Endoplasmin and (B) Complement C1r-A subcomponent between early (24hrs) 
and late (120hrs) stages in culture at 37˚C and 31˚C. The differential expression between 37˚C and 31˚C at 120hrs is also shown. 
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Figure 3.2.16 Shows the differential expression of the HCPs (A) Semaphorin-3B and (B) HSPG2 between early (24hrs) and late (120hrs) stages 
in culture at 37˚C and 31˚C. The differential expression between 37˚C and 31˚C at 120hrs is also shown. 
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Using Pearson correlations as described in sections 3.1.3.5 and 3.1.3.6, information 
was gathered on the linearity of the expression of proteins over time at 37˚C and at 
31˚C. The lists generated were compared and any proteins common to both lists are 
shown in Appendix B, Table 3.2.17. To identify which temperature condition has the 
greatest overall abundance of a given protein the list of common proteins was 
compared to 37˚C vs 31˚C at 120hrs (Table 3.2.11 and Table 3.2.12). Based on this 
comparison, no proteins identified as being common to both 37˚C and 31˚C Pearson 
correlation lists were found to be differentially-expressed between 37˚C vs 31˚C at 
120hrs apart from PKM which was found to be 4.6-fold up-regulated at 37˚C 
compared to 31˚C. 
Pearson correlation plots and the outputs from Progenesis label-free software are 
used in Figure 3.2.21 to show the linear increase of the intracellular proteins (A) 
Pyruvate kinase isozymes M1/M2 and (B) Vimentin in the cell culture supernatant of 
CHO-K1 cells. This increase occurs over time in both temperature-shifted and non-
temperature-shifted cultures. While it is possible that these proteins may be secreted 
via some non-classical secretory pathway, it is perhaps more likely that their 
presence in the media is as a result of cell lysis occurring over time. Information on 
the release of intracellular proteins is of interest as not only might they impact on 
culture viability or product quality, but their presence is also an additional burden to 
the purification of the final protein product. 
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Figure 3.2.17 Pearson correlation plots and the outputs from Progenesis label-free software of the intracellular proteins Pyruvate kinase 
isozymes M1/M2 (A) and Vimentin (B) as they increase over time in culture under both temperature-shifted and non-temperature-shifted 
conditions. 
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3.2.3.8 Comparison of quantitative label-free LC/MS CHO-K1 HCP data 
normalised to cell number compared to normalisation by protein 
concentration 
Quantitative information on the differential expression in the cell culture supernatant 
of CHO-K1 cells (as described in sections 3.2.3.1-3.2.3.4) was obtained though the 
LC/MS analysis of equal concentrations of protein from the respective samples and 
applying a series of statistical cut-offs to the data obtained (as described in sections 
3.2.3). A protein was considered to be differentially-regulated if its change in 
relative abundance was >1.5 fold between experimental groups. Another approach 
could consider normalising to cell numbers between the comparisons to take into 
account changes in cell concentration (both viable and non-viable) over time or 
under temperature-shifted and non-temperature-shifted conditions. It was decided 
that a correction factor would be applied to the lists of differentially-expressed 
proteins identified to facilitate normalisation of the data against cell numbers. This 
was achieved by taking the total number of cells per volume of media collected at 
each time point and calculating what this amounted to in HCP concentration in the 
conditioned media samples. The fold-change in protein concentration between 
experimental groups was then calculated and added to the 1.5-fold cut-off to 
establish a new threshold to determine differential expression. As can be seen in 
Table 3.2.18, applying the correction factor resulted in the loss of a small number of 
proteins from two comparisons (24hrs vs 120hrs at 37˚C and 37˚C vs 31˚C at 24hrs). 
In the remaining two comparisons no correction factor was applied as there was no 
change in protein concentration between experimental groups. Due to the similar 
number of differentially-expressed proteins obtained with and without the correction 
factor applied (no change in two instances), it was decided that the 1.5-fold change 
was sufficiently robust as a cut-off for determining whether or not a protein was 
significantly differentially-regulated.  
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Table 3.2.18 The use of a correction factor was investigated to facilitate 
normalisation of the data by cell number (as opposed to normalisation by protein 
concentration). This table show a comparison of the number of differentially-
expressed HCPs identified in the conditioned media of a CHO-K1 cell line with and 
without the correction factor applied.   
 
 Bioinformatic analysis of differentially-regulated protein lists 3.2.4
In order to determine what cellular compartment differentially-expressed proteins 
originated from, the gene symbol from each protein was searched using DAVID 
functional annotation software (http://david.abcc.ncifcrf.gov/).  
DAVID uses gene ontology to classify the differentially-regulated proteins and 
identify enrichment of cellular locations where the proteins would typically be 
found. Protein lists generated from comparing 24hrs to 120hrs at both 37˚C and 31˚C 
were searched against DAVID using an adjusted p-value of ≤0.05 (Benjamini) as a 
statistical cut-off. Benjamini is a conservative correction technique to correct 
enrichment P-values to control gene family-wide false discovery rate under certain 
rate (e.g. ≤0.05). Based on the analysis of 24hrs versus 120hrs at 37˚C using DAVID 
it is immediately obvious that proteins representing a wide variety of cellular 
components are released into the media of CHO-K1 cells (Table 3.2.20 and Figure 
3.2.18). While there is some enrichment of extracellular proteins, it would appear 
that the majority are expected to be intracellularly located, their presence in the 
media possibly as a result of cell lysis or a reduction in cell viability. This becomes 
particularly apparent when compared to the list of enriched cell components obtained 
from analysing 24hrs versus 120hrs at 31˚C where Table 3.2.21 indicates that the 
number of enriched entities is greatly reduced (Figure 3.2.19). This is possibly 
because of the high cell viability that was maintained over time in the 31˚C culture. 
It is still perhaps worth noting that in both instances, the enriched extracellular 
components identified still fall well below the ≤0.05 Benjamini threshold set and that 
Comparison
Normalsiation 
correction 
factor
Normalsiation 
correction factor 
+ 1.5-fold change 
cut-off
Number of differentially 
expressed proteins 
identified using 
correction factor
Number of differentially 
expressed proteins 
identified using 1.5-fold 
cut-off
24hrs vs 120hrs at 37˚C 0.33 1.83 309 322
24hrs vs 120hrs at 31˚C 0 1.50 146 146
37˚C vs 31˚C at 24hrs 0.27 1.77 190 211
37˚C vs 31˚C at 120hrs 0 1.50 228 228
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the Benjamini enrichment value is roughly the same both in 37˚C and 31˚C lists. 
Using the Uniprot protein database, all proteins classified as secreted in the lists of 
differentially-expressed HCPs in this study were identified (Table 3.2.19). 
 
Table 3.2.19 List of tables containing quantitative information on proteins classified 
as secreted by the Uniprot protein database. 
  
Condition Appendix Table
Up at 120hrs when compared to 24hrs at 37˚C Table 3.2.22
Down at 120hrs when compared to 24hrs at 37˚C Table 3.2.23
Up at 120hrs when compared to 24hrs at 31˚C Table 3.2.24
Down at 120hrs when compared to 24hrs at 31˚C Table 3.2.25
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Table 3.2.20 GO cellular component enrichment for differentially-expressed host 
cell proteins identified in the conditioned media of a CHO-K1 non-producing cell 
line at 37˚C when 24hrs was compared to 120hrs (post-temperature-shift for a 
culture grown in parallel) analysed using quantitative label-free LC/MS. An adjusted 
p-value of ≤0.05 (Benjamini) was used as a statistical cut off to generate the list of 
enriched cellular components. 
 
Cellular Component Gene Count P-Value Benjamini
cytosol 99 3.60E-29 1.20E-26
cytosolic part 29 2.10E-18 3.40E-16
ribonucleoprotein complex 48 3.50E-17 3.80E-15
cytosolic ribosome 21 4.40E-16 3.60E-14
cytosolic small ribosomal subunit 14 1.40E-12 9.40E-11
ribosomal subunit 21 4.70E-12 2.60E-10
melanosome 18 7.00E-12 3.30E-10
pigment granule 18 7.00E-12 3.30E-10
ribosome 26 8.40E-12 3.50E-10
small ribosomal subunit 14 8.00E-10 2.90E-08
membrane-bounded vesicle 37 8.70E-09 2.80E-07
cytoplasmic membrane-bounded vesicle 36 1.30E-08 3.90E-07
proteinaceous extracellular matrix 26 3.70E-08 1.00E-06
extracellular matrix 27 4.00E-08 1.00E-06
vesicle 39 6.40E-08 1.50E-06
lysosome 20 1.90E-07 4.20E-06
lytic vacuole 20 1.90E-07 4.20E-06
cytoplasmic vesicle 37 1.90E-07 4.00E-06
extracellular region part 47 3.50E-07 6.60E-06
extracellular matrix part 14 1.60E-06 3.00E-05
vacuole 20 2.90E-06 4.90E-05
chaperonin-containing T-complex 5 7.50E-06 1.20E-04
platelet alpha granule lumen 8 2.70E-05 4.20E-04
platelet alpha granule 9 2.70E-05 4.10E-04
spliceosome 13 3.30E-05 4.60E-04
non-membrane-bounded organelle 86 3.70E-05 5.00E-04
intracellular non-membrane-bounded organelle 86 3.70E-05 5.00E-04
cytoplasmic membrane-bounded vesicle lumen 8 4.30E-05 5.60E-04
basement membrane 10 5.00E-05 6.20E-04
vesicle lumen 8 5.80E-05 7.00E-04
cytosolic large ribosomal subunit 7 1.60E-04 1.90E-03
extracellular region 68 2.00E-04 2.30E-03
actin cytoskeleton 17 2.90E-04 3.20E-03
heterogeneous nuclear ribonucleoprotein complex 5 4.30E-04 4.50E-03
soluble fraction 18 5.40E-04 5.50E-03
proteasome core complex 5 8.30E-04 8.20E-03
membrane-enclosed lumen 60 1.70E-03 1.60E-02
proteasome complex 7 2.10E-03 2.00E-02
large ribosomal subunit 7 3.40E-03 3.10E-02
cortical cytoskeleton 6 4.20E-03 3.70E-02
extracellular space 27 4.50E-03 3.80E-02
lysosomal lumen 3 4.60E-03 3.80E-02
eukaryotic translation elongation factor 1 complex 3 4.60E-03 3.80E-02
basal lamina 4 5.60E-03 4.50E-02
secretory granule 11 6.30E-03 4.90E-02
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Figure 3.2.18 Graphical representation of Table 3.2.20 depicting GO cellular component enrichment and their corresponding adjusted p-value of ≤0.05 
(Benjamini) for differentially-expressed host cell proteins identified in the conditioned media of a CHO-K1 non-producing cell line at 37˚C when 24hrs was 
compared to 120hrs (post-temperature-shift for a culture grown in parallel).  
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Table 3.2.21 GO cellular component enrichment for differentially-expressed host 
cell proteins identified in the conditioned media of a CHO-K1 non-producing cell 
line at 31˚C when 24hrs was compared to 120hrs (post-temperature-shift) analysed 
using quantitative label-free LC/MS. An adjusted p-value of ≤0.05 (Benjamini) was 
used as a statistical cut off to generate the list of enriched cellular components. 
 
 
Cellular Component Gene Count P-Value Benjamini
melanosome 11 9.90E-09 2.20E-06
pigment granule 11 9.90E-09 2.20E-06
extracellular region 44 5.10E-08 5.60E-06
cytosol 31 3.70E-06 2.70E-04
endoplasmic reticulum lumen 8 9.70E-06 5.30E-04
extracellular region part 24 2.50E-05 1.10E-03
proteinaceous extracellular matrix 13 4.60E-05 1.70E-03
extracellular matrix 13 9.50E-05 3.00E-03
lysosome 10 1.60E-04 4.50E-03
lytic vacuole 10 1.60E-04 4.50E-03
cytoplasmic membrane-bounded vesicle 16 1.90E-04 4.70E-03
membrane-bounded vesicle 16 2.70E-04 6.00E-03
vesicle 17 5.20E-04 1.00E-02
vacuole 10 6.10E-04 1.10E-02
cytoplasmic vesicle 16 9.80E-04 1.60E-02
membrane-enclosed lumen 31 1.60E-03 2.60E-02
extracellular space 16 1.90E-03 2.70E-02
organelle lumen 30 2.50E-03 3.40E-02
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Figure 3.2.19 Graphical representation of Table 3.2.21 depicting GO cellular component enrichment and their corresponding adjusted p-value of ≤0.05 
(Benjamini) for differentially-expressed host cell proteins identified in the conditioned media of a CHO-K1 non-producing cell line at 31˚C when 24hrs was 
compared to 120hrs (post-temperature-shift for a culture grown in parallel).   
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 Qualitative analysis of proteins identified by quantitative label-free 3.2.5
LC/MS profiling of conditioned media from a non-producing CHO-K1 
cell line 
The use of Progenesis label-free software will only identify those proteins that are 
deemed to be differentially-expressed under a specific set of conditions. It does not 
provide information on those proteins whose relative abundance does not change. 
Knowledge of all proteins present in a proteome, not just those that are differentially-
expressed, can provide useful information in aiding the identification of differences 
and similarities between proteomes under different environmental conditions.  
The RAW files obtained from LC/MS analysis of each conditioned media sample 
were searched against both the CHO NCBI and CHO BB databases using Mascot 
and SEQUEST search algorithms in a parallel algorithm search on Proteome 
Discoverer 1.4. Proteins were “identified” if they met the following criteria: 
SEQUEST Xcorr ≥1.9/2.2/3.75 (for charges +1/+2/+3), deltaCn ≥0.1 and/or a ion 
score of 40. In addition, in order for a protein to be considered “present” under a 
given condition, it must be identified by the Mass Spectrometer in a minimum of two 
biological samples. Samples were collected in biological triplicate and taken at 24, 
72, 96, and 120 hours post-temperature-shift as per Figure 3.2.1. 
 
The following comparisons were made by overlapping the lists of identified proteins: 
• CHO-K1 37˚C vs 31˚C Cultures 
o Proteins identified with 1 or more peptides 
o Proteins identified with 2 or more peptides 
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3.2.5.1 Qualitative comparison of HCPs identified in temperature-shifted and 
non-temperature-shifted CHO-K1 cultures 
In order to determine whether the cell culture temperature impacted on HCP profile, 
qualitative lists of HCPs identified in 37˚C and 31˚C culture were compared. Direct 
comparison of these lists clearly shows that while there is a large number of proteins 
common to both culture conditions (596 proteins identified using a minimum of one 
peptide, 395 proteins identified using a minimum of two peptides) (Figure 3.2.20), 
there is also a subpopulation of proteins that are unique to each culture temperature. 
In this instance, 113 ‘one hit wonders’ are identified at 37˚C and 155 were identified 
at the lower culture temperature. While increasing the criteria for protein 
identification from one to a minimum of two peptides does slightly reduce the 
number of proteins unique to each condition (as expected), the numbers are still 
significant. 105 HCPs detected were unique to 37˚C and 98 were only expressed at 
31˚C. This result indicates that cell culture temperature can impact on the HCP 
profile of a CHO-K1cell line and that unique HCPs are expressed at lower culture 
temperatures. Lists of the proteins identified in Figure 3.2.20 A and Figure 3.2.20 B 
are available in Appendix B Table 3.2.26 - Table 3.2.30. 
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Figure 3.2.20 Overlap of the list of proteins identified in the conditioned media of a 
non-producing CHO-K1 cell line grown at 37˚C and 31˚C over 168 hours in shake 
flask culture. Samples were collected in biological triplicate and taken at 24, 72, 96 
and 120 hours post-temperature-shift. Venn diagram (A) represents those proteins 
identified using a minimum of 1 or more peptides. Venn diagram (B) is compiled 
from those proteins identified using a minimum of 2 or more peptides. 
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 Summary 3.2.6
Quantitative label-free LC/MS analysis of conditioned media samples from a non-
producing CHO cell line revealed that there was significant changes in the 
abundance of proteins over time in culture under both temperature-shifted and non-
temperature-shifted conditions despite the cultures maintaining high viability. 
Proteins with the potential to negatively impact on product quality (proteases and 
glycosidases) and proteins with the potential to negatively impact on culture viability 
(apoptotic proteins) generally showed an increase in abundance at late stage 
compared to early stage culture in both temperature-shifted and non-temperature-
shifted cultures. However, overall there was a reduction in the relative abundance of 
proteases, glycosidases and apoptotic proteins in the temperature-shifted culture 
compared to the non-temperature-shifted culture at 120hrs. Qualitative analysis of 
conditioned media samples from CHO-K1 cells revealed that while there was a lot of 
commonality between the HCPs found in a 37˚C and a 31˚C culture, there were also 
cohorts of HCPs that were unique to each culture temperature. In order to gather 
further information on the HCP profile of CHO cells and to confirm our initial 
findings, a second CHO cell line, this time an IgG producer, was also analysed by 
LC/MS as detailed in section 3.3. 
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3.3 Characterisation of the host cell protein profile of an IgG 
producing DP12 cell line 
In chapter 3.2 results from profiling the HCP content of conditioned media from a 
non-producing CHO-K1 cell line were detailed. This chapter will outline how an IgG 
depletion technique was coupled with a quantitative label-free LC/MS methodology 
to investigate the HCP profile of an IgG secreting DP12 CHO cell line. Similar to 
the CHO-K1 cell line, the change in the HCP profile under both temperature-shifted 
and non-temperature-shifted conditions over the course of the cell culture cycle, 
from early exponential to late stationary phase is examined. In addition to the use of 
the same quantitative label-free LC/MS based approach that was employed for CHO-
K1 HCP analysis, the similar growth profile of the CHO-K1 and DP12 cell lines 
allowed for direct comparison of the results obtained from each data set as discussed 
later in the thesis. 
 
 Growth curves at 31˚C and 37˚C of IgG producing DP12 cell line 3.3.1
DP12 cells were grown in the same manner as the CHO-K1 cells (as detailed 3.2.1) 
with the exception that the temperature-shift of selected culture flasks took place 
72hrs after inoculation. 72hrs was selected because the DP12 cells displayed an 
extended lag phase compared to the CHO-K1 cell line, however it still allowed a 
clear distinction to be drawn between temperature-shifted and non-temperature-
shifted cultures from a biological perspective in terms of identifying a functional 
response to a change in the cell’s environmental conditions.  
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Figure 3.3.1 Growth curve of an IgG producing DP12 cell line grown under 
temperature-shifted (31˚C) and non-temperature-shifted (37˚C) conditions. 
Temperature-shifted culture was placed at 31˚C after 72hrs in culture. Cell culture 
supernatants were collected 24, 72, 96, 120 and 144 hours post-temperature-shift and 
analysed using a quantitative label-free mass spectrometry based approach. 
  
Post temperature-shift 
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 IgG depletion of conditioned media from IgG producing DP12 CHO cell 3.3.2
line 
In the analysis of cell culture supernatant by LC/MS relatively high levels of IgG 
(compared to the overall concentration of the other HCPs) could present a number of 
problems (i) high levels of IgG could potentially mask the presence of low abundant 
proteins in the sample when analysed by mass spectrometry (ii) differences in IgG 
concentration between samples would adversely affect quantitative results obtained; 
a basic requirement of accurate quantitative label-free LC/MS is that equal 
concentrations of protein are analysed in each sample, the concentration of an 
actively secreted IgG molecule would change both over time and under different 
culture conditions therefore altering the relative concentration of HCPs in each 
sample. In order to circumvent these problems, the use of Protein A chromatography 
to reduce overall IgG abundance and normalise IgG concentration between all 
conditioned media samples was examined. As can be seen in Figure 3.3.2, Protein A 
chromatography significantly reduces the levels of IgG in the cell culture supernatant 
of the DP12 cell line.  
 
 
Figure 3.3.2 Western blot image of IgG secreted by a DP12 cell line. Lane 1 
contains conditioned media pre-protein A chromatography diluted 1:100. Lane 2 
contains conditioned media that was passed through a Protein A column once (flow 
through 1). Lane 3 is the conditioned media from flow through 1 that has been 
passed through the same Protein A column for a second time (flow through 2).  Lane 
4 is flow through 2 after it has been passed through the Protein A column for a third 
time (flow through 3). Note that equal volumes of conditioned media sample were 
loaded onto a 1D-gel and immunoblotted for IgG. 
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Although it was expected that IgG concentration would increase over time in culture, 
this does not appear to be the case (Figure 3.3.3). IgG concentration remains 
relatively constant over time between the two culture conditions. Nonetheless, IgG 
depletion was carried out to ensure a reduction in the overall concentration of IgG 
and to further reduce any difference in IgG concentration between samples (Figure 
3.3.4). Cell culture supernatants from three biological replicates at each time point 
under both temperature-shifted and non-temperature-shifted conditions were 
collected and filtered as detailed methods 2.3.2.  
 
Figure 3.3.3 Concentration of IgG produced by a DP12 cell line grown under 
temperature-shifted (31˚C) and non-temperature-shifted (37˚C) conditions was 
determined by ELISA assay. Temperature-shifted culture was placed at 31˚C after 
72hrs in culture. Cell culture supernatants were collected 24, 72, 96, 120 and 144 
hours post-temperature-shift. 
 
Figure 3.3.4 Concentration of IgG remaining in conditioned media sample from a 
DP12 cell line grown under temperature-shifted (31˚C) and non-temperature-shifted 
(37˚C) conditions post IgG depletion by Protein A chromatography as determined by 
ELISA assay.  
     24               72               96             120           144 
Hours (post temperature-shift) 
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 Quantitative label-free LC/MS analysis of conditioned media from a 3.3.3
DP12 CHO cell line 
IgG depleted cell culture supernatants from three biological replicates at each time 
point under both temperature-shifted and non-temperature-shifted conditions were 
concentrated and prepared for LC/MS analysis as detailed methods 2.3.3. Prior to 
LC/MS analysis 4 pmoles of Cytochrome C was added to each sample to act as an 
internal control. After mass spectral analysis of all the samples was complete, 
inclusion lists were generated (as discussed 3.2.2).  
Due to the complex sampling nature of the experiment i.e. multiple time points 
between two conditions, it was decided that the data would be analysed as follows: 
• 24hrs vs 144hrs at 37˚C 
• 24hrs vs 144hrs at 31˚C 
• 37˚C vs 31˚C at 24hrs 
• 37˚C vs 31˚C at 144hrs 
• Analysis of differential regulation over 24, 72, 96, 120 and 144 hours at 37˚C 
using Pearson correlation analysis 
• Analysis of differential regulation over 24, 72, 96, 120 and 144 hours at 31˚C 
using Pearson correlation analysis 
Note: The time in hours above is with respect to temperature-shift. i.e. 24hrs is 24hrs 
post-temperature-shift. 
Associating biological function with differentially-regulated proteins identified in 
this study was carried out as detailed 3.2.3. 
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 Data analysis of differentially-regulated proteins identified by 3.3.4
quantitative label-free LC/MS profiling of conditioned media from a 
DP12 CHO cell line 
Progenesis label-free software was used to analyse the data acquired following 
LC/MS analysis. A protein was considered to be differentially-regulated if it met the 
criteria as set out in 3.1.3. Although IgG levels in the conditioned media samples had 
been significantly reduced (Figure 3.3.4), there was still the possibility that there 
may not have been uniform reduction of IgG between the samples, and therefore 
accurate protein quantification may be distorted.  
To overcome this, an internal standard, Cytochrome C was added to each sample 
prior to LC/MS analysis. The RAW files were initially normalised to all features, as 
would normally be the case for any label-free experiment. Normalisation is carried 
out by the software to correct for experimental variations such as deviations in the 
quantity of protein loaded onto the LC/MS system or differences in ionization. By 
default the software will normalise all the data to the peptides that don’t change in 
abundance. 
Following this analysis, the files were then normalised to IgG and the data was 
reanalysed. Finally the RAW files were normalised to the internal standard, 
Cytochrome C and the data was analysed for a third time.  
The three sets of data were then compared in terms of proteins identified, number of 
peptides identified, fold-change, direction off old-change and ANOVA score. 
Results from this analysis indicated that when the lists of differentially-expressed 
proteins were compared, the files normalised to IgG was too dissimilar to the other 
means of normalisation and indicated that IgG could not be used as a feature to 
normalise the other proteins to. Although IgG had been greatly reduced in the media, 
the mass spectrometer would still be capable of detecting changes in the abundance 
of IgG between the samples.  
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While the overall abundance of IgG would not have been enough to interfere with 
LC/MS analysis, even subtle changes in the relative abundance of IgG would make it 
unsuitable for normalisation. As can be seen from a direct comparison between 
normalisation using an internal standard (Table 3.3.1) or normalising to proteins that 
did not change in expression (Table 3.3.2) there is great similarity in the results 
obtained both in terms of proteins identified, fold-change and their direction. 
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Table 3.3.1 Top 10 differentially-regulated proteins, based on peptide number, when all features of the protein profile from 24hrs in a DP12 
culture was compared to 144hrs and normalised to an internal standard, Cytochrome C. These proteins were then retrieved from the same 
comparison but where all features were normalised to proteins that did not change in expression. This allowed for direct comparison to be made 
between Cytochrome C Normalisation (C) and the Normal means of Normalisation (N), based on peptide count, ion score, ANOVA, fold-
change and what condition the proteins is most highly expressed in. 
Protein
C N C N C N C N C N C N
13 11 13 11 763 665 0.00178 0.00053 16.3 10.7 24hrs 24hrs Complement C3
12 9 11 9 895 719 0.01068 0.02745 2.9 2.1 24hrs 24hrs laminin subunit alpha-5 isoform 1
11 11 9 9 617 617 7.29E-05 1.14E-05 8.3 12.1 144hrs 144hrs vimentin
10 10 9 9 530 530 0.01183 0.00311 5.6 3.5 24hrs 24hrs Thrombospondin-1
10 1 10 1 567 59 0.00771 0.03689 1.7 2.7 24hrs 144hrs Inter-alpha-trypsin inhibitor heavy chain H5
9 10 9 9 479 539 0.00043 0.00041 5.6 3.8 24hrs 24hrs laminin subunit beta-1
9 9 7 7 437 437 1.37E-05 0.00038 8 11.1 144hrs 144hrs endoplasmin
9 9 9 9 540 540 0.0005 0.00061 4.3 6.1 144hrs 144hrs transketolase-like
9 9 8 8 535 535 0.00205 0.00188 4.7 6.7 144hrs 144hrs Prostaglandin F2 receptor negative regulator
8 8 6 6 405 405 0.00096 1.08E-05 6.1 9.2 144hrs 144hrs 14-3-3 protein epsilon
N = All Feature Normalisation C = Cytochrome C normalisation
DP12 24hrs vs 144hrs 37C All Features Normalised to Cytochrome C
Peptide Peptide Quant Score Anova Fold Up in
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Table 3.3.2 Top 10 differentially-regulated proteins, based on peptide number, when all features of the protein profile from 24hrs in a DP12 
culture was compared to 144hrs and normalised to proteins that did not change in expression. These proteins were then retrieved from the same 
comparison but where all features were normalised to an internal standard, Cytochrome C. This allowed for direct comparison to be made 
between the Normal means of Normalisation (N) and Cytochrome C Normalisation (C), based on peptide count, ion score, ANOVA, fold-
change and what condition the proteins is most highly expressed in. 
Protein
N C N C N C N C N C N C
11 11 9 9 617 617 1.14E-05 7.29E-05 12.1 8.3 144hrs 144hrs vimentin
11 13 11 13 665 763 0.00053 0.00178 10.7 16.3 24hrs 24hrs Complement C3
10 10 9 9 530 530 0.00311 0.01183 3.5 5.6 24hrs 24hrs Thrombospondin-1
10 9 9 9 539 479 0.00041 0.00043 3.8 5.6 24hrs 24hrs Laminin subunit beta-1
9 12 9 11 719 895 0.02745 0.01068 2.1 2.9 24hrs 24hrs laminin subunit alpha-5 isoform 1
9 9 7 7 437 437 0.00038 1.37E-05 11.1 8 144hrs 144hrs endoplasmin
9 9 9 9 540 540 0.00061 0.0005 6.1 4.3 144hrs 144hrs transketolase-like
9 9 8 8 535 535 0.00188 0.00205 6.7 4.7 144hrs 144hrs Prostaglandin F2 receptor negative regulator
8 6 7 5 430 310 0.01328 0.12707 2.7 1.4 144hrs 144hrs peroxidasin homolog
8 7 4 4 459 416 8.75E-06 0.00019 20.7 13.9 144hrs 144hrs 14-3-3 protein eta
N = All Feature Normalisation C = Cytochrome C normalisation
DP12 24hrs vs 144hrs 37C All Features Normalised to Features with no Fold Change
Peptide Peptide Quant Score Anova Fold Up in
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3.3.4.1 Differential regulation of HCPs 24hrs vs 144hrs at 37˚C 
A principal component analysis (PCA) plot generated by Progenesis during data 
analysis showing how the samples from 24hr and 144hr cultures at 37˚C cluster is 
displayed in Figure 3.3.5.  
 
 
Figure 3.3.5 PCA plot for the IgG secreting DP12 conditioned media sample groups 
24hrs (pink) and 144hrs (blue) at 37˚C generated during quantitative label-free 
LC/MS data analysis using Progenesis software. 
 
Of the 375 proteins identified with 1 or more peptides as being differentially-
expressed at 37˚C between early (24hrs) and late (144hrs), 335 had increased 
expression at 144hr, while 40 were down-regulated (Summary Table 3.3.3). Similar 
to 24hrs compared to 120hrs at 37˚C in the CHO-K1 cell line (section 3.2.3.2), there 
is an increase in the abundance of apoptotic proteins at late stage culture (Table 
3.3.3). This is likely to be as a result of a decrease in culture viability at 144hrs in the 
DP12 cell line. Also, the majority of proteases and glycosidases, both of which have 
the potential to negatively impact product quality, are up regulated at the later time 
point. (Full lists of differentially-expressed proteins are provided in Appendix C, 
Table 3.3.4 and Table 3.3.5)   
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Table 3.3.3 Number of differentially-expressed proteins at 24hrs compared to 144hrs at 37˚C in an IgG secreting DP12 cell culture supernatant. 
Using Uniprot protein database, proteins of biological relevance have been identified and the number of differentially-expressed proteins under 
the relevant classification included in the table. 
 
≥1 Peptide ≥2 Peptides ≥1 Peptide ≥2 Peptides ≥1 Peptide ≥2 Peptides
Protein Count 375 162 335 143 40 19
8 2 8 2 0 0
GNB2L1, CLU, HMOX1, 
SHISA5, GAPDH, GAPDH, 
APP, MAPK1
GNB2L1, CLU GNB2L1, CLU, HMOX1, 
SHISA5, GAPDH, GAPDH, 
APP, MAPK1
GNB2L1, CLU
25 9 17 6 8 3
MMP9, HTRA1, PSMB6, 
BMP1, PSMA7, CTSB, C1ra, 
PSMA5, ADAM10, CTSL1, 
TPP1, ADAMTS1, PLAT, 
P15156, PSMA3, PSMB1, 
PSMB8, THOP1, CNDP2, 
PSMB2, PARK7, ADAM17, 
PSMB3, PSMA6, AGA
MMP9, HTRA1, PSMB6, 
BMP1, PSMA7, CTSB, C1ra, 
PSMA5, ADAM10
PSMB6, BMP1, PSMA7, 
CTSB, PSMA5, ADAM10, 
PSMA3, PSMB1, PSMB8, 
THOP1, CNDP2, PSMB2, 
PARK7, ADAM17, PSMB3, 
PSMA6, AGA
PSMB6, BMP1, PSMA7, CTSB, 
PSMA5, ADAM10
MMP9, 
HTRA1, C1ra, 
CTSL1, TPP1, 
ADAMTS1, 
PLAT, P15156
MMP9, HTRA1, 
C1ra
12 4 9 2 3 2
GLB1, GAA, HEX,B GBA, 
GUSB, HEXA, GLA, IDUA, 
GANAB, MAN2A1, NAGLU, 
MAN1A1
GLB1, GAA, HEXB, GBA GAA, GBA, HEXA, GLA, 
IDUA, GANAB, MAN2A1, 
NAGLU, MAN1A1
GAA, GBA GLB1, HEXB, 
GUSB
GLB1, HEXB
Protease
Glycosidase
24hrs vs 144hrs at 37˚C
Total Up at 144hrs Down at 144hrs
Apoptosis
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Examples of some of the differentially-regulated proteins identified in this analysis 
shows the up-regulation of the secreted protein Suprabasin (2.5-fold) and the 
protease Bone morphogenetic protein 1 (2.7-fold) (Figure 3.3.6). 
 
 
Figure 3.3.6 Shows examples of Progenesis label-free outputs of differentially-
expressed HCPs, such as the secreted protein Suprabasin and the growth factor Bone 
morphogenetic protein 1, identified as being differentially-expressed between 24hrs 
and 120hrs at 37˚C in the conditioned media of a DP12 cell line.  
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3.3.4.2 Differential regulation of HCPs 24hrs vs 144hrs at 31˚C 
A PCA plot generated by Progenesis during data analysis illustrating how the 
samples from 24hr and 144hr cultures at 31˚C cluster is displayed in Figure 3.3.7.  
 
 
Figure 3.3.7 PCA plot for the IgG secreting DP12 conditioned media sample groups 
24hrs (pink) and 144hrs (blue) at 31˚C generated during quantitative label-free 
LC/MS data analysis using Progenesis software. 
 
When early (24hrs) and late (144hrs) phases of the temperature-shifted (31˚C) were 
compared 179 were found to change in relative abundance (168 up regulated and 11 
down-regulated at 144hrs with 2 or more peptides (Table 3.3.6). Similar to the 37˚C 
culture, the majority of proteases and glycosidases are up-regulated at the later time 
point. Interestingly, despite the increased viability of the 31˚C, there is a significant 
increase in the number of apoptotic related proteins at 144hrs in the 31˚C compared 
to the 37˚C (Table 3.3.6). (Full lists of differentially-expressed proteins are provided 
in Appendix C, Table 3.3.7 and Table 3.3.8).  
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Table 3.3.6 Number of differentially-expressed proteins at 24hrs compared to 144hrs at 31˚C in an IgG secreting DP12 cell culture supernatant. 
Using Uniprot protein database, proteins of biological relevance have been identified and the number of differentially-expressed proteins under 
the relevant classification included in the table. 
 
≥1 Peptide ≥2 Peptides ≥1 Peptide ≥2 Peptides ≥1 Peptide ≥2 Peptides
Protein Count 391 179 361 168 30 11
7 4 7 4 0 0
GNB2L1, HMOX1, Cyc,s 
APP, DNASE2, GAPDH, 
GAPDH
GNB2L1, HMOX1, Cycs, 
APP
GNB2L1, HMOX1, 
Cycs, APP, 
DNASE2, GAPDH, 
GAPDH
GNB2L1, HMOX1, Cycs, 
APP
24 11 19 9 5 2
C1ra, MMP9, PSMB1, 
PSMA6, PSMA3, PSMB6, 
DPP7, CTSB, CTSA, 
SCPEP1, P15156, PRCP, 
ADAM10, MMP19, PSMA1, 
PSMB2, AGA, PARK7, 
LAP3, PSMA7, CTSZ, 
PSMA5, CTSD, CNDP2
C1ra, MMP9, PSMB1, 
PSMA6, PSMA3, PSMB6, 
DPP7, CTSB, CTSA, 
SCPEP1, P15156
PSMB1, PSMA6, 
PSMA3, PSMB6, 
DPP7, CTSB, 
CTSA, SCPEP1, 
P15156, PSMA1, 
PSMB2, AGA, 
PARK7, LAP3, 
PSMA7, CTSZ, 
PSMA5, CTSD, 
CNDP2
PSMB1, PSMA6, PSMA3, 
PSMB6, DPP7, CTSB, 
CTSA, SCPEP1, P15156
C1ra, MMP9, 
PRCP, 
ADAM10, 
MMP19
C1ra, MMP9
11 6 9 6 2 0
IDUA, NAGLU, GAA, GLA, 
GBA, FUCA1, MAN2A1, 
GUSB, GANAB, NAGA, 
GLB1
IDUA, NAGLU, GAA, GLA, 
GBA, FUCA1
IDUA, NAGLU, GAA, 
GLA, GBA, FUCA1, 
GANAB, NAGA, 
GLB1
IDUA, NAGLU, GAA, GLA, 
GBA , CA1
MAN2A1, 
GUSB
Protease
Glycosidase
24hrs vs 144hrs at 31˚C
Total Up at 144hrs Down at 144hrs
Apoptosis
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The Progenesis output displaying the up-regulated glycosidase Alpha-L-iduronidase 
(3.1-fold) and the apoptotic protein Amyloid beta A4 protein (3.4-fold) are shown in 
Figure 3.3.8. 
 
 
Figure 3.3.8 Shows examples of Progenesis label-free outputs of differentially-
expressed HCPs, such as the glycosidase Alpha-L-iduronidase and the apoptotic 
protein Amyloid beta A4 protein, identified as being up-regulated between 24hrs and 
120hrs at 31˚C in the conditioned media of a DP12 cell line.  
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3.3.4.3 Differential regulation of HCPs at 24hrs 37˚C vs 31˚C  
A PCA plot generated by Progenesis during data analysis indicating how the samples 
from 31˚C and 37˚C cultures at 24hrs cluster is displayed in Figure 3.3.9. 
 
 
Figure 3.3.9 PCA plot for the IgG secreting  DP12 conditioned media sample groups 
37˚C (pink) and 31˚C (blue) after 24hrs in culture generated during quantitative 
label-free LC/MS data analysis using Progenesis software 
 
 
A comparison of 37˚C and 31˚C cultures 24hrs post culture temperature reduction 
revealed 150 HCPs with 1 or more peptides to be differentially-expressed between 
the two temperatures. Of these, 107 were down-regulated at 31˚C, while the 
remaining 43 were up regulated (Table 3.3.9). Perhaps the most striking result is that 
all proteases, glycosidases and proteins involved in the regulation of apoptosis are 
down-regulated at 31˚C (Table 3.3.9). (Full lists of differentially-expressed proteins 
are provided in Appendix C, Table 3.3.10 and Table 3.3.11) 
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Table 3.3.9 Number of differentially-expressed proteins between 31˚C and 37˚C at 24hrs post-temperature-shift in the culture supernatant of an 
IgG producing DP12 cell line. Using Uniprot protein database, proteins of biological relevance have been identified and the number of 
differentially-expressed proteins under the relevant classification included in the table. 
 
≥1 Peptide ≥2 Peptides ≥1 Peptide ≥2 Peptides ≥1 Peptide ≥2 Peptides
Protein Count 150 66 43 11 107 55
3 3 0 0 3 3
CLU, DNASE2, APP CLU, DNASE2, APP CLU, DNASE2, APP CLU, DNASE2, 
APP
20 10 0 0 20 10
DPP7, SCPEP1, TPP1, 
PRCP, PRSS22, HTRA1, 
CTSD, CTSH, C1ra, 
MMP19, MMP9, 
ADAMTS1, ADAM9, CTSZ, 
BMP1, CTSA, ADAM10, 
CTSL1, CTSB, P15156
DPP7, SCPEP1, TPP1, 
PRCP, PRSS22, HTRA1, 
CTSD, CTSH, C1ra, 
MMP19
DPP7, SCPEP1, TPP1, 
PRCP, PRSS22, 
HTRA1, CTSD, CTSH, 
C1ra, MMP19, MMP9, 
ADAMTS1, ADAM9, 
CTSZ, BMP1, CTSA, 
ADAM10, CTSL1, 
CTSB,P15156
DPP7, SCPEP1, 
TPP1, PRCP, 
PRSS22, HTRA1, 
CTSD, CTSH, 
C1ra, MMP19
13 6 0 0 13 6
GLB1, GAA, MAN2A1, 
FUCA1, MAN2B1, HEXA, 
SMPD1, MAN1A1, GLA, 
GUSB, NEU1, HEXB, 
NAGA
GLB1, GAA, MAN2A1, 
FUCA1, MAN2B1, HEXA
GLB1, GAA, MAN2A1, 
FUCA1, MAN2B1, 
HEXA, SMPD1, 
MAN1A1, GLA, GUSB, 
NEU1, HEXB, NAGA
GLB1, GAA, 
MAN2A1, FUCA1, 
MAN2B1, HEXA
Protease
Glycosidase
37˚C vs 31˚C 24hrs
Total Up at 31˚C Down at 31˚C
Apoptosis
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A number of interesting proteins were identified in this analysis including those with 
the potential to affect culture viability or negatively impact on product quality such 
as the growth factor Vascular endothelial growth factor C (2.4-fold) and the 
glycosidase Beta-galactosidase (2.5-fold). Both of which were down-regulated at 
31˚C compared 37˚C to 24hrs (Figure 3.3.10). 
 
 
Figure 3.3.10 Shows examples of Progenesis label-free outputs of differentially-
expressed HCPs, such as the glycosidase Beta-galactosidase and the growth factor 
Vascular endothelial growth factor C, identified as being down-regulated at 31˚C 
24hrs post-temperature-shift in the conditioned media of a DP12 cell line.  
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3.3.4.4 Differential regulation of HCPs at 144hrs 37˚C vs 31˚C  
A PCA plot generated by Progenesis during data analysis showing how the samples 
from 31˚C and 37˚C cultures at 144hrs cluster is displayed in Figure 3.3.11. 
 
 
Figure 3.3.11 PCA plot for the IgG secreting  DP12 conditioned media sample 
groups 37˚C (pink) and 31˚C (blue) after 144hrs in culture generated during label-
free LC/MS data analysis using Progenesis software 
 
144hrs post-temperature-shift 222 proteins with 1 or more peptides are seen to alter 
their expression when temperature-shifted and non-temperature-shifted cultures are 
compared (Table 3.3.12) 127 proteins were up-regulated at 31˚C, while 95 decreased 
in expression (See Appendix C, Table 3.13 and Table 3.14 for full list). As seen in 
Table 3.3.12, three of the four apoptotic proteins identified are down-regulated at 
31˚C compared to 37˚C at 144hrs. Similar to the CHO-K1 cell line (section 3.2.3.5), 
this could be attributed to the overall increased viability of the temperature-shifted 
culture compared to the non-temperature-shifted culture at 144hrs. It is also worth 
noting that the number of differentially-expressed proteases and glycosidases are 
relatively evenly spread between the two culture conditions. This would indicate that 
enzymatic activity at late stage culture under temperature-shift or non-temperature-
shift conditions could negatively impact on product quality. 
 
  
155 
 
Table 3.3.12 Number of differentially-expressed proteins between 31˚C and 37˚C at 144hrs post-temperature-shift in the culture supernatant of 
an IgG producing DP12 cell line. Using Uniprot protein database, proteins of biological relevance have been identified and the number of 
differentially-expressed proteins under the relevant classification included in the table. 
 
  
≥1 Peptide ≥2 Peptides ≥1 Peptide ≥2 Peptides ≥1 Peptide ≥2 Peptides
Protein Count 222 77 127 46 95 31
4 2 1 1 3 1
CLU, HMOX1, PPID, MAPK1 CLU, HMOX1 HMOX1 HMOX1 CLU, PPID, 
MAPK1
CLU,
9 5 4 2 5 3
BMP1, HTRA1, DPP7, 
P15156, THOP1, MMP19, 
ADAM17, PSMA5, MMP9
BMP1, HTRA1, DPP7, 
P15156, THOP1
DPP7, P15156, 
PSMA, MMP9
DPP7, P15156 BMP1, 
HTRA1, 
THOP1, 
MMP19, 
ADAM17
BMP1, HTRA1, 
THOP1
9 6 5 2 4 4
GAA, HEXA, NAGLU, FUCA1, 
MAN2A1, GANAB, GUSB, 
GLB1, HEXB
GAA, HEXA, NAGLU, 
FUCA1, MAN2A1, GANAB
NAGLU, 
FUCA1, GUSB, 
GLB1, HEXB
NAGLU,
FUCA1
GAA, HEXA, 
MAN2A1, 
GANAB
GAA, HEXA, 
MAN2A1, GANAB
Protease
Glycosidase
37˚C vs 31˚C 144hrs
Total Up at 31˚C Down at 31˚C
Apoptosis
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Among the differentially-expressed proteins identified at 31˚C compared to 37˚C at 
144hrs was the secreted growth factor Vascular endothelial growth factor A (4.8-
fold, down-regulated) and the protein Cold-inducible RNA-binding protein (CIRBP) 
(3.1-fold, up-regulated) (Figure 3.3.12).  
 
 
Figure 3.3.12 Shows examples of Progenesis label-free outputs of differentially-
expressed HCPs, such as the secreted growth factors Bone morphogenetic protein 1 
and Vascular endothelial growth factor A, identified as being down-regulated at 
31˚C 144hrs post-temperature-shift in the conditioned media of a DP12 cell line.  
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3.3.4.5 Western blot validation of HCPs identified as differentially-expressed 
following quantitative label-free LC/MS analysis of the cell culture 
supernatant from a CHO-K1 and DP12 cell line 
Western blot analysis was used to validate the results obtained following quantitative 
label-free LC/MS analysis of the cell culture supernatant from CHO-K1 and DP12 
cell lines. Validation was conducted in biological duplicate using 8µg of protein per 
sample. Western blots show the down-regulation of sulfated glycoprotein 1 at 31˚C 
when 31˚C culture is compared to 37˚C culture at 24hrs and 144hrs in the DP12 cell 
line (Figure 3.3.13). The intracellular protein GRP78 is shown to be up-regulated at 
31˚C when non-temperature-shifted culture is compared to temperature-shifted 
culture at 24hrs and at 144hrs in the CHO-K1 cell line in Figure 3.3.14. GRP78 is 
also shown to be up-regulated at 144hrs when 31˚C culture is compared to 37˚C 
culture at 24hrs and when 31˚C culture is compared to 37˚C culture at 144hrs in the 
DP12 cell line (Figure 3.3.15). Validation of the differential-regulation of the 
proteases BMP1 (up-regulated at 120hrs in the CHO-K1 cell line when 120hrs is 
compared to 24hrs at 37˚C) and MMP19 (down-regulated at 31˚C in the CHO-K1 
cell line when the 31˚C culture is compared to the 37˚C culture at 120hrs) are shown 
in Figure 3.3.16 and Figure 3.3.17 respectively. It should be noted that the text cited 
in Figure 3.3.13 to Figure 3.3.17 are based on the results from the label-free LC/MS 
analysis of the conditioned media from the respective CHO cell lines and the western 
blots were used to validate the direction of fold change. 
 
 
Figure 3.3.13 shows a western blot confirming the down-regulation of the 
intracellular protein Sulfated Glycoprotein 1 at 31˚C when temperature-shifted 
culture is compared to non-temperature-shifted culture at 24hrs and 144hrs in the 
conditioned media of the DP12 cell line. 
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Figure 3.3.14 shows a western blot confirming the up-regulation of the intracellular 
protein GRP78 at 31˚C when temperature-shifted culture is compared to non-
temperature-shifted culture at 24hrs and 120hrs in the conditioned media of the 
CHO-K1 cell line. 
 
 
Figure 3.3.15 shows a western blot confirming the up-regulation of the intracellular 
protein GRP78 at 144hrs when 144hrs is compared to 24hrs at 37˚C and at 31˚C in 
the conditioned media of the DP12 cell line. 
 
 
Figure 3.3.16 shows a western blot confirming the up-regulation of the protease 
BMP1 at 120hrs when 120hrs is compared to 24hrs at 37˚C in the conditioned media 
of the CHO-K1 cell line. 
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Figure 3.3.17 shows a western blot confirming the down-regulation of the protease 
MMP19 at 31˚C when temperature-shifted culture is compared to non-temperature-
shifted culture in the conditioned media of the CHO-K1 cell line. 
 
3.3.4.6 Pearson correlation analysis of differentially-regulated HCPs over 24, 
72, 96, 120 and 144 hours at 37˚C 
Pearson’s correlation analysis was used as a means of measuring the linearity of 
protein expression over time in culture in the 37˚C culture. An Anova cut-off of 0.05 
was applied to add an additional layer of statistical rigour. Using this method of 
analysis a total of 227 proteins were deemed to change over time in culture. 167 
correlated positively (increased expression) and 60 correlated negatively (decreased 
in expression) between the 24 and 144hr period. The list of negatively correlating 
proteins is shown in Appendix C, Table 3.3.15 and those proteins displaying an 
increase in expression are shown in Appendix C, Table 3.3.16. 
The linear decrease in the expression of the secreted protein Nidogen-1 (Pearson 
correlation 0.984, p-value 0.0024) between 24hrs and 144hrs at 37˚C is shown in 
Figure 3.3.18. The Progenesis and Pearson correlation outputs from the protein 
Elongation factor 2 (Pearson correlation 0.991, p-value 0.001) showing its increase 
in expression from 24hrs to 144hrs at 37˚C are shown in Figure 3.3.19. 
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Figure 3.3.18 Progenesis label-free output of the secreted protein Nidogen-1 
showing its decrease in expression from 24hrs (Day1) to 144hrs (Day5) at 37˚C (A). 
Output from excel on which Pearson correlation calculation is based (Pearson 
correlation 0.984, p-value 0.0024). (B) 
 
 
Figure 3.3.19 Progenesis label-free output of the protein Elongation factor 2 
showing its increase in expression from 24hrs (Day1) to 144hrs (Day5) at 37˚C (A). 
Output from excel on which Pearson correlation calculation is based (Pearson 
correlation 0.991, p-value 0.001). (B) 
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3.3.4.7 Pearson correlation analysis of differentially-regulated HCPs over 24, 
72, 96, 120 and 144 hours at 31˚C 
This analysis identified that 405 proteins increase expression in a linear manner over 
time in culture with a p-value ≤0.05 (Appendix C, Table 3.3.17), but only 2 proteins 
that decrease in expression meet the same criteria (Appendix C, Table 3.3.18).  
Figure 3.3.20 shows the decrease in the expression of the secreted protein 
Complement C3 (Pearson correlation 0.892, p-value 0.042) between 24hrs and 
144hrs post-temperature-shift at 31˚C while Figure 3.3.21 shows the linear increase 
in the expression of the protease Cathepsin D (Pearson correlation 0.985, p-value 
0.0022) over the same period at 31˚C. 
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Figure 3.3.20 Progenesis label-free output of the secreted protein Complement C3 
showing its decrease in expression from 24hrs (Day1) to 144hrs (Day5) at 31˚C (A). 
Output from excel on which Pearson correlation calculation is based (Pearson 
correlation 0.892, p-value 0.042). (B) 
 
 
Figure 3.3.21 Progenesis label-free output of the protease Cathepsin D showing its 
increase in expression from 24hrs (Day1) to 144hrs (Day5) at 31˚C (A). Output from 
excel on which Pearson correlation calculation is based (Pearson correlation 0.985, 
p-value 0.0022). (B)  
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3.3.4.8 Comparison of differentially-regulated HCPs over time in culture at 
37˚C and 31˚C in a DP12 cell line  
By analysing the conditioned media of a DP12 cell line over time in culture under 
temperature-shifted and non-temperature-shifted conditions (sections 3.3.4.1 and 
3.3.4.2), and by comparing both conditions at early (24hrs) and  late (144hrs) stages 
(sections 3.3.4.3 and 3.3.4.4), a significant number of differentially-expressed HCPs 
have been identified. By combining the results from 24hrs vs 120hrs at 37˚C and 
24hrs vs 120hrs at 31˚C experiments a clearer picture of how culture temperature 
impacts on the HCP expression profile can be seen (Appendix C, Table 3.3.19).  
Proteins identified as differentially-expressed over time in culture common to both 
37˚C and 31˚C that may be of particular interest to the bioprocessing community are 
shown in Figure 3.3.22. As well as providing differential regulation information, 
Figure 3.3.22 shows graphs generated by Progenesis label-free software and the 
changes in the relative abundance of the proteases Cathepsin B and Complement 
C1r-A subcomponent and the glycosidase Glucosylceramidase. The enzymatic 
activity of proteases and glycosidases could negatively impact on the quality of 
products secreted into the media, information on how they change in relative 
abundance between early (24hrs) and late (144hrs) stages in culture under 
temperature-shifted and non-temperature-shifted conditions may be useful for 
identifying culture conditions under which a recombinant therapeutic has an 
increased risk of becoming degraded through the enzymatic activity of proteases 
and/or glycosidases.  
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Figure 3.3.22 Shows changes in the expression of the proteases (A) Cathepsin B and 
(B) Complement C1r-A subcomponent and the glycosidase (C) Glucosylceramidase 
between early (24hrs) and late (144hrs) stages in culture under temperature-shifted 
and non-temperature-shifted conditions. 
 
 
 
  
Fig. Description Total Peptide
Quantitative 
Peptides Score Anova (p) Fold
Direction 
of fold 
change
Comparison
3 2 214 0.018 1.6 Up at 
144hrs
24hrs vs 
144hrs 37C
2 2 117 3.59E-05 4.3 Up at 
144hrs
24hrs vs 
144hrs 31C
2 2 119 0.0001 8.3 Dow n at 
144hrs
24hrs vs 
144hrs 37C
2 2 134 0.0019 4.6 Dow n at 
144hrs
24hrs vs 
144hrs 31C
2 2 91 0.0196 2.2 Up at 
144hrs
24hrs vs 
144hrs 37C
2 2 103 0.0014 2.9 Up at 
144hrs
24hrs vs 
144hrs 31C
A Cathepsin B
B
Complement C1r-A 
subcomponent
C Glucosylcera-
midase
37˚C 31˚C 
24hrs 144hrs 24hrs 144hrs 
(A) 
 
 
 
 
(B) 
 
 
 
(C) 
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As outlined in section 3.1.3.7 many of the differentially-expressed HCPs trend in the 
same direction under both temperature-shifted and non-temperature-shifted 
conditions. In addition, proteins identified as differentially-expressed that were 
common to 24hrs vs 144hrs 37˚C and 24hrs vs 144hrs 31˚C lists, were also 
compared to the list of differentially-expressed proteins from 37˚C vs 31˚C at 
144hrs. A list of proteins common to all three comparisons was then compiled 
(Appendix C, Table 3.3.20). Thus information on how the abundance of the protein 
changes over time and the culture temperature at which the relative abundance of the 
protein is greatest is provided.  
Based on this comparison, a clearer picture of how the expression of HCPs change 
between early (24hrs) and late (144hrs) stages in culture under temperature-shifted 
and non-temperature-shifted conditions as well as how they change in relative 
abundance between 37˚C and 31˚C in late culture is provided. Using the outputs 
from Progenesis label-free software examples of the differential expression of three 
secreted proteins is shown in Figure 3.3.23. Information on secreted proteases such 
as matrix metalloproteinase-9 (Figure 3.3.23) is of obvious benefit as such proteases 
may impact on product quality. 
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Figure 3.3.23 Progenesis label-free outputs and information on the differential 
expression of the secreted proteins (A) Matrix metalloproteinase-9, (B) Sulfated 
glycoprotein 1 and (C) Suprabasin as they change in relative abundance between 
early (24hrs) and late (144hrs) stages in culture. Information from a comparison 
between 37˚C and 31˚C at 144hrs is also provided.  
Fig. Description Total Peptide
Quantitative 
Peptides Score Anova (p) Fold
Direction 
of fold 
change
Comparison
4 4 269 0.0002 7.6
Down at 
144hrs
24hrs  vs  
144hrs  37C
2 2 89 0.0015 4.1
Down at 
144hrs
24hrs  vs  
144hrs  31C
1 1 70 0.0315 1.7 Up at 31C
37C vs  31C 
144hrs
2 2 91 0.0094 27.1
Up at 
144hrs
24hrs  vs  
144hrs  37C
3 3 147 0.009 38
Up at 
144hrs
24hrs  vs  
144hrs  31C
2 2 126 0.0231 5
Down at 
31C
37C vs  31C 
144hrs
6 6 466 0.0022 2.5
Up at 
144hrs
24hrs  vs  
144hrs  37C
4 4 242 0.0443 1.8
Up at 
144hrs
24hrs  vs  
144hrs  31C
2 2 135 0.0064 1.6 Up at 31C
37C vs  31C 
144hrs
A
matrix 
meta l loprotei nas e-
9
B
Sul fated 
glycoprotein 1
C Suprabas in
37˚C 31˚C 144hrs 
24hrs 144hrs 24hrs 144hrs 37˚C 31˚C 
(A) 
 
 
 
 
 
(B) 
 
  
 
 
 
(C) 
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3.3.4.9 Comparison of Pearson correlation analyses of differentially-regulated 
HCPs over time in culture at 37˚C and 31˚C in a DP12 cell line  
Pearson correlations were used to examine the linearity of the expression of proteins 
overtime in temperature-shifted and non-temperature-shifted cultures in sections 
3.2.4.5 and 3.2.4.6. Similar to section 3.1.3.7, proteins common to both 37˚C and 
31˚C Pearson correlation lists are displayed in Appendix C, Table 3.3.21. By 
comparing the data in this manner the effect of culture temperature on the expression 
profiles of HCPs over time in 37˚C and 31˚C cultures can clearly be seen. 
Pearson correlation plots and the outputs from Progenesis label-free software are 
used to show the change in abundance of some proteins from Table 3.3.21 that are of 
particular interest due to their potential ability to impact on cell viability or product 
quality. These examples include the protease ADMTS1 and the reductase TXNDC5 
(Figure 3.3.24). Interestingly, the relative abundance of ADMST1 reduces over time 
in culture at 37˚C and it increases over the same period of time at 31˚C. While the 
linearity with which TXNDC5 increases at 37˚C is poor, it can be clearly seen that 
between 96hrs and 144hrs there is a sharp increase in its abundance. This is 
compared with the 31˚C where it increases in a more linear fashion over the total 
period in culture.  
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Figure 3.3.24 Pearson correlation plots and the outputs from Progenesis label-free software of the protease ADAMTS1 (A) and the reductase 
TXNDC5 (B) show how they change over time in culture under both temperature-shifted and non-temperature-shifted conditions. 
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The proteins list obtained from the comparison of Pearson correlations analysis of 
the expression of proteins over time at 37˚C and at 31˚C was also compared to the 
list of differentially-expressed HCPs identified when 37˚C and 31˚C cultures were 
compared at 144hrs (section 3.2.4.4). Because many of the proteins identified using 
the Pearson correlation approach trend in the same direction, the use of this third list 
helps identify which culture has the highest abundance of a given protein. A 
compilation of this data obtained from the comparison of all three lists is shown in 
Appendix C, Table 3.3.22.  
Pearson correlation plots and the outputs from Progenesis label-free software are 
used to show the changes in the abundance of the secreted protein the fucosidase 
Tissue alpha-L-fucosidase (Figure 3.3.25). While the precise function of these 
secreted proteins in CHO is still unclear it is obvious that temperature affects the 
release of Tissue alpha-L-fucosidase.  
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Figure 3.3.25 Pearson correlation plots and the outputs from Progenesis label-free software of the secreted protein Tissue alpha-L-fuccosidase 
shows how it changes over time in culture under both temperature-shifted and non-temperature-shifted conditions. Information from a 
comparison between 37˚C and 31˚C at 144hrs is also provided. 
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3.3.4.10 Comparison of differentially-regulated HCPs in the cell culture 
supernatant of a CHO-K1 and DP12 cell line. 
A significant number of differentially-expressed HCPs were identified both over 
time in culture and under temperature-shifted and non-temperature-shifted conditions 
in the conditioned media of CHO-K1 (Section 3.2.3.1 – Section 3.2.3.4) and DP12 
cell lines (Section 3.3.4.1 – Section 3.3.4.4). It was therefore decided that the list of 
differentially-expressed HCPs from each cell line should be compared in an effort to 
identify proteins of interest that are common to both cell lines. A summary of the 
number of differentially-expressed HCPs that are common to both cell lines 
compared to the total number of differentially-expressed HCPs identified in each cell 
line is shown in Table 3.3.23. While it can be seen that there is some overlap in the 
differential expression of HCPs between CHO-K1 and Dp12 cells, there is a 
significant proportion of differentially-expressed HCPs that are unique to each cell 
line.  
 
 
Table 3.3.23 Table indicating the number of differentially-expressed HCPs 
identified in a CHO-K1 and DP12 cell line compared to the number of differentially-
expressed HCPs common to both cell lines. A full list of proteins common to each 
cell line is available in Appendix C, Table 3.3.24 - 3.3.27. 
 
A number of examples were selected from the list of common differentially-
regulated proteins and their change in expression visualised using  the output from 
Progenesis label-free software as displayed in Figure 3.3.26. This includes the 
protease Cathepsin D, the secreted protein Sulphated glycoprotein 1 and the 
apoptotic protein GNB2L1. 
Comparison
Number of 
differentially 
expressed HCPs 
in the CHO K1 cell 
line
Number of 
differentially 
expressed HCPs 
in the DP12 cell 
line
Number of 
differentially 
expressed HCPs 
common to CHO K1 
and DP12 cell lines
24hrs vs 120hrs / 144hrs at 37C 322 375 174
24hrs vs 120hrs / 144hrs at 31C 146 391 50
37C vs 31C at 24hrs 211 150 20
37C vs 31C at 120hrs / 144hrs 228 222 55
172 
 
 
Figure 3.3.26 Progenesis label-free outputs and information on HCPs identified as being differentially-expressed in both CHO-K1 and DP12 
cell lines. This includes the apoptotic protein GNB2L1, the protease Cathepsin D, the protein Clusterin which can be found both intracellularly 
and extracellularly and the secreted protein Sulphated glycoprotein 1. 
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3.3.4.11 Comparison of quantitative label-free LC/MS DP12 HCP data 
normalised to cell number compared to normalisation by protein 
concentration 
Correction factors were applied to quantitative label-free LC/MS data on the 
differential expression of HCPs in the conditioned media of DP12 cells. This was 
carried out to account for changes in cell concentration (both viable and non-viable) 
over time or under temperature-shifted and non-temperature-shifted conditions (as 
described in section). As can be seen in Table 3.3.28, applying the correction factor 
resulted in the loss of a small number of proteins from three of the comparisons 
(24hrs vs 144hrs at 37˚C, 24hrs vs 144hrs at 31˚C and 37˚C vs 31˚C at 24hrs). In the 
remaining comparison however (37˚C vs 31˚C at 144hrs), the use of the correction 
factor resulted in the loss more than half the differentially-expressed proteins 
originally identified. Interestingly, when the same correction factor was applied to 
the 24hrs vs 144hrs at 31˚C comparison only 26 proteins were deemed to no longer 
be differentially-expressed. This highlights the high fold-changes (>2.09 fold) of 
proteins over time in culture at 31˚C and the significant number of ‘subtle’ fold-
changes (<2.09 fold) between temperature-shifted and non-temperature-shifted 
conditions at 144hrs in the DP12 cells. Future analysis of this data could consider the 
use of the correction factor as a means of adding further confidence to the list of 
differentially-expressed proteins. 
 
 
Table 3.3.28 The use of a correction factor was investigated to facilitate 
normalisation of the data by cell number (as opposed to normalisation by protein 
concentration). This table show a comparison of the number of differentially-
expressed HCPs identified in the conditioned media of a DP12 cell line with and 
without the correction factor applied. 
 
Comparison
Normalsiation 
correction 
factor
Normalsiation 
correction factor 
+ 1.5-fold change 
cut-off
Number of differentially 
expressed proteins 
identified using 
correction factor
Number of differentially 
expressed proteins 
identified using 1.5-fold 
cut-off
24hrs vs 144hrs at 37˚C 0.16 1.66 369 375
24hrs vs 144hrs at 31˚C 0.59 2.09 365 391
37˚C vs 31˚C at 24hrs 0.17 1.67 138 150
37˚C vs 31˚C at 144hrs 0.59 2.09 105 222
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 Bioinformatic analysis of differentially-regulated proteins 3.3.5
In order to gain an insight into the precise origin of the host cell proteins identified 
i.e. intracellular, secreted, etc. the gene symbol from each protein was searched using 
DAVID functional annotation software (http://david.abcc.ncifcrf.gov/).  
As detailed in section 3.2.4, DAVID was used to classify the differentially-regulated 
proteins and identify enrichment of cellular locations. Protein lists obtained from 
comparing 24hrs to 144hrs at both 37˚C and 31˚C were searched against DAVID 
using an adjusted p-value of ≤0.05 (Benjamini) as a statistical cut-off. Similar to 
section 3.3.4, DAVID GO analysis of differentially-expressed proteins from the cell 
culture supernatant of an IgG producing DP12 cell line examining 24hrs versus 
144hrs at 37˚C found that the majority of the proteins identified were typically 
intracellular in nature and although there was enrichment of the extracellular 
component (adjusted p-value 0.0011), this appears to make up only a small 
proportion of the overall host cell protein population (Table 3.3.30 and Figure 
3.3.27). Interestingly, when 24hrs versus 144hrs at 31˚C was analysed using DAVID 
GO analysis it was found that the extracellular component was also predominantly 
made up by proteins of intracellular origin (Table 3.3.31 and Figure 3.3.28). This 
would appear to indicate that that many of the host cell proteins present in the cell 
culture supernatant are there as a result of some sort of cell lysis, possibly as a result 
of cell death, particularly near the end of culture. Despite this, based on gene count 
alone, there is still a cohort of the host cell protein population made up by 
extracellular proteins, this is also evidenced by the number of proteins classified as 
secreted using Uniprot protein database (Table 3.3.29). It is also possible that the 
reason for such a large intracellular enrichment is that proteins can occupy more than 
one cell component, this may also give rise to the appearance of an increased 
proportion of intracellular proteins.  
 
Table 3.3.29 List of tables containing quantitative information on proteins classified 
as secreted by the Uniprot protein database.  
Conditions Appendix Table
Up at 144hrs when compared to 24hrs at 37°C Table 3.3.32
Down at 144hrs when compared to 24hrs at 37°C Table 3.3.33
Up at 144hrs when compared to 24hrs at 31°C Table 3.3.34
Down at 144hrs when compared to 24hrs at 31°C Table 3.3.35
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Table 3.3.30 GO cellular component enrichment for differentially-expressed host 
cell proteins identified in the conditioned media of a DP12 CHO cell line at 37˚C 
when 24hrs was compared to 144hrs (post-temperature-shift for a culture grown in 
parallel) analysed using quantitative label-free LC/MS. An adjusted p-value of ≤0.05 
(Benjamini) was used as a statistical cut off to generate the list of enriched cellular 
components. 
 
Term Gene Count P-Value Benjamini
cytosol 123 1.00E-39 3.60E-37
melanosome 28 3.30E-22 5.70E-20
pigment granule 28 3.30E-22 5.70E-20
cytosolic part 33 9.00E-21 1.00E-18
cytosolic ribosome 25 1.30E-19 1.20E-17
ribonucleoprotein complex 52 2.80E-17 1.60E-15
cytosolic small ribosomal subunit 18 2.60E-17 1.80E-15
ribosomal subunit 26 1.30E-15 6.10E-14
small ribosomal subunit 19 1.10E-14 4.90E-13
ribosome 27 3.80E-11 1.40E-09
membrane-bounded vesicle 44 1.20E-10 4.10E-09
vesicle 48 2.00E-10 6.20E-09
cytoplasmic membrane-bounded vesicle 42 5.30E-10 1.50E-08
endoplasmic reticulum lumen 16 1.30E-09 3.50E-08
chaperonin-containing T-complex 7 1.80E-09 4.40E-08
cytoplasmic vesicle 44 5.20E-09 1.20E-07
soluble fraction 29 7.20E-09 1.60E-07
proteasome core complex 9 1.50E-08 3.20E-07
proteasome complex 13 3.40E-08 6.60E-07
lytic vacuole 22 9.60E-08 1.80E-06
lysosome 22 9.60E-08 1.80E-06
intracellular non-membrane-bounded organelle 106 1.80E-07 3.10E-06
non-membrane-bounded organelle 106 1.80E-07 3.10E-06
vacuole 22 1.90E-06 3.10E-05
membrane-enclosed lumen 79 3.10E-06 4.80E-05
organelle lumen 77 5.40E-06 8.20E-05
platelet alpha granule lumen 9 7.40E-06 1.10E-04
ER-Golgi intermediate compartment 9 7.40E-06 1.10E-04
cytoplasmic membrane-bounded vesicle lumen 9 1.30E-05 1.80E-04
vesicle lumen 9 1.80E-05 2.30E-04
actin cytoskeleton 21 1.80E-05 2.40E-04
heterogeneous nuclear ribonucleoprotein complex 6 5.00E-05 6.10E-04
platelet alpha granule 9 7.90E-05 9.40E-04
extracellular region part 45 9.50E-05 1.10E-03
basement membrane 10 1.60E-04 1.70E-03
intracellular organelle lumen 70 1.70E-04 1.90E-03
extracellular matrix part 12 1.90E-04 2.00E-03
cortical cytoskeleton 8 2.20E-04 2.30E-03
cell surface 22 2.30E-04 2.30E-03
cytoskeleton 57 2.70E-04 2.60E-03
cytosolic large ribosomal subunit 7 3.60E-04 3.40E-03
spliceosome 12 5.40E-04 4.80E-03
extracellular matrix 21 5.30E-04 4.80E-03
extracellular region 74 7.80E-04 6.70E-03
cell fraction 45 1.20E-03 1.00E-02
large ribosomal subunit 8 1.50E-03 1.20E-02
nucleolus 32 1.80E-03 1.40E-02
secretory granule 13 2.20E-03 1.70E-02
proteinaceous extracellular matrix 18 3.40E-03 2.60E-02
cortical actin cytoskeleton 5 5.20E-03 3.80E-02
cell cortex part 8 5.10E-03 3.80E-02
eukaryotic translation initiation factor 3 complex 4 5.90E-03 4.20E-02
nuclear envelope 13 6.20E-03 4.20E-02
eukaryotic translation elongation factor 1 complex 3 6.10E-03 4.30E-02
endoplasmic reticulum part 18 7.60E-03 5.00E-02
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Figure 3.3.27 Graphical representation of Table 3.3.30 depicting GO cellular component enrichment and their corresponding adjusted p-value of ≤0.05 
(Benjamini) for differentially-expressed host cell proteins identified in the conditioned media of a DP12 cell line at 37˚C when 24hrs was compared to 144hrs 
(post-temperature-shift for a culture grown in parallel).  
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Table 3.3.31 GO cellular component enrichment for differentially-expressed host 
cell proteins identified in the conditioned media of a DP12 cell line at 31˚C when 
24hrs was compared to 144hrs (post-temperature-shift) analysed using quantitative 
label-free LC/MS. An adjusted p-value of ≤0.05 (Benjamini) was used as a statistical 
cut off to generate the list of enriched cellular components. 
 
Term Gene Count P-Value Benjamini
cytosol 128 1.10E-43 3.50E-41
ribonucleoprotein complex 64 2.50E-26 4.10E-24
cytosolic part 37 3.50E-25 3.90E-23
cytosolic ribosome 28 1.80E-23 1.50E-21
melanosome 26 9.10E-20 6.00E-18
pigment granule 26 9.10E-20 6.00E-18
ribosomal subunit 28 9.40E-18 5.20E-16
ribosome 33 3.70E-16 1.60E-14
cytosolic small ribosomal subunit 17 7.00E-16 2.80E-14
lysosome 30 9.00E-14 3.30E-12
lytic vacuole 30 9.00E-14 3.30E-12
small ribosomal subunit 18 1.70E-13 5.70E-12
vacuole 31 1.50E-12 4.60E-11
membrane-bounded vesicle 43 3.70E-10 1.00E-08
cytoplasmic membrane-bounded vesicle 42 4.90E-10 1.20E-08
chaperonin-containing T-complex 7 1.70E-09 4.10E-08
vesicle 45 5.60E-09 1.20E-07
cytoplasmic vesicle 43 1.40E-08 3.00E-07
proteasome complex 13 3.30E-08 6.40E-07
heterogeneous nuclear ribonucleoprotein complex 8 9.90E-08 1.80E-06
intracellular non-membrane-bounded organelle 105 2.90E-07 5.10E-06
non-membrane-bounded organelle 105 2.90E-07 5.10E-06
cytosolic large ribosomal subunit 10 3.30E-07 5.50E-06
proteasome core complex 8 3.70E-07 5.80E-06
membrane-enclosed lumen 81 6.90E-07 1.00E-05
organelle lumen 79 1.30E-06 1.80E-05
endoplasmic reticulum lumen 12 5.20E-06 7.10E-05
large ribosomal subunit 11 6.60E-06 8.70E-05
platelet alpha granule lumen 9 7.20E-06 9.20E-05
cytoplasmic membrane-bounded vesicle lumen 9 1.30E-05 1.50E-04
soluble fraction 23 1.60E-05 1.90E-04
vesicle lumen 9 1.80E-05 1.90E-04
actin cytoskeleton 21 1.70E-05 2.00E-04
intracellular organelle lumen 73 2.70E-05 2.90E-04
spliceosome 14 3.00E-05 3.10E-04
ER-Golgi intermediate compartment 8 6.80E-05 6.80E-04
platelet alpha granule 9 7.70E-05 7.50E-04
nucleolus 36 8.70E-05 8.20E-04
extracellular region part 44 1.80E-04 1.60E-03
extracellular matrix 20 1.30E-03 1.20E-02
cell surface 20 1.40E-03 1.20E-02
cortical cytoskeleton 7 1.40E-03 1.20E-02
perinuclear region of cytoplasm 17 2.70E-03 2.30E-02
basement membrane 8 3.60E-03 2.90E-02
nuclear lumen 54 3.80E-03 3.00E-02
extracellular space 30 4.70E-03 3.60E-02
cell cortex part 8 5.00E-03 3.70E-02
eukaryotic translation elongation factor 1 complex 3 6.10E-03 4.40E-02
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Figure 3.3.28 Graphical representation of Table 3.3.31 depicting GO cellular component enrichment and their corresponding adjusted p-value of ≤0.05 
(Benjamini) for differentially-expressed host cell proteins identified in the conditioned media of a DP12 cell line at 31˚C when 24hrs was compared to 144hrs 
(post-temperature-shift for a culture grown in parallel).   
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 Qualitative analysis of proteins identified by label-free LC/MS profiling 3.3.6
of conditioned media from a DP12 CHO cell line 
As detailed in section 3.3.4, the lists of proteins identified by Progenesis label-free 
software are those that are deemed to change in relative abundance under a given set 
of conditions. However by generating a list of all expressed proteins identified in the 
conditioned media, it is possible to identify differences and similarities between 
proteomes under different environmental conditions or from different cell lines. This 
could have important implications for the ability of generic anti-HCP ELISAs to 
detect contaminating HCPs in the final drug substance of products manufactured 
using different CHO cell lines or culture conditions. 
The RAW files obtained from LC/MS analysis of each conditioned media sample 
were searched against both the CHO NCBI and CHO BB databases using Mascot 
and SEQUEST search algorithms as detailed in section 3.3.5. 
Protein lists obtained as a result of these searches were then combined and, as per 
section 3.3.5, in order for a protein to be considered “present” under a given 
condition, it had to be identified in a minimum of two biological samples by the 
Mass Spectrometer. 
 
The following comparisons were made by overlapping the lists of identified proteins: 
• DP12 37˚C vs 31˚C Cultures 
o Proteins identified with 1 or more peptides 
o Proteins identified with 2 or more peptides 
 
3.3.6.1 Qualitative comparison of HCPs identified in temperature-shifted and 
non-temperature-shifted DP12 cultures 
When a comparison of proteins identified in temperature-shifted and non-
temperature-shifted cultures from a DP12 cell line is made it can be seen that while 
there is a large number of proteins common to culture conditions, there is also a 
cohort of proteins that are also unique to each culture condition (Figure 3.3.29 A).  
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In order to further investigate this observation a second comparison was made based 
on proteins identified using two or more peptides. The use of a minimum of two 
peptides to identify a protein further strengthens the basis on which the identification 
was made. This second comparison (Figure 3.3.29 B) shows a similar result to that 
observed in Figure 3.3.29 A and again identifies a subpopulation of proteins unique 
to both temperature-shifted and non-temperature-shifted cultures. This result 
indicates that cell culture conditions can impact on the HCP profile expressed in a 
DP12 cell line. A full list of all the proteins identified in Figure 3.3.29 A and    
Figure 3.3.29 B are provided in Appendix C, Tables 3.3.36 - 3.3.40. 
 
 
Figure 3.3.29 Overlap of the list of proteins identified in the conditioned media of an 
IgG secreting DP12 CHO cell line grown at 37˚C and 31˚C over 216 hours in shake 
flask culture. Samples were collected in biological triplicate and taken at 24, 72, 96, 
120 and 144 hours post-temperature-shift. Venn diagram (A) represents those 
proteins identified using a minimum of 1 or more peptides. Venn diagram (B) is 
compiled from those proteins identified using a minimum of 2 or more peptides. 
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 Qualitative comparison of HCPs identified in a CHO-K1 and DP12 cell 3.3.7
line  
A list of all HCPs identified in the cell culture supernatant of each cell line was 
generated using both CHO NCBI and CHO BB databases to identify proteins 
expressed under both temperature-shifted and non-temperature-shifted conditions. 
Due to the similar viabilities of CHO-K1 and DP12 cells at 37˚C, as well as CHO-
K1 and DP12 cells at 31˚C, it was felt that protein lists generated from these cultures 
were comparable. With this in mind, both 37˚C and 31˚C lists were compared to 
identify proteins are common or unique to each cell line as follows: 
• DP12 vs CHO-K1 
o Proteins identified with 1 or more peptides 
o Proteins identified with 2 or more peptides 
 
Based on proteins identified using a minimum of one peptide for identification, 
1,181 proteins were identified between both cell lines (Figure 3.3.30 A). Of these, 
662 HCPs were common to both cell lines, 304 were unique to CHO-K1 and the 
DP12 cell line expressed 215 unique HCPs. A similar trend was observed when 
proteins whose identification was based on a minimum of two peptides was used to 
form the basis of the comparison (Figure 3.3.30 B). While 462 proteins were 
common to both cell lines, 154 HCPs were unique to CHO-K1 and 145 were unique 
to the DP12 cell line. Based on this set of results it appears that while there is a large 
number of HCPs expressed by both cell lines, there is also a subpopulation of HCPs 
that are unique to both CHO-K1 and DP12 cell lines. A full list of all the proteins 
identified in Figure 3.3.30 A and Figure 3.3.30 B are provided in Appendix C, 
Tables 3.3.41 - 3.3.45. 
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Figure 3.3.30 Overlap of the list of proteins identified in the conditioned media of an 
IgG secreting DP12 CHO cell line and a non-producing CHO-K1 cell line grown at 
37˚C and 31˚C in shake flask culture. Samples were collected in biological triplicate 
from both cell lines and taken at 24, 72, 96, 120 and 144 hours post-temperature-
shift from the DP12 cell line and 24, 72, 96 and 120hrs from the CHO-K1 cell line. 
Venn diagram (A) represents those proteins identified using a minimum of 1 or more 
peptides. Venn diagram (B) is compiled from those proteins identified using a 
minimum of 2 or more peptides. 
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3.3.7.1 Qualitative comparison of HCPs identified in a CHO-K1 and a DP12 
cell line under temperature-shifted and non-temperature-shifted 
conditions 
In order to decipher the findings in section 3.3.7, further comparisons were made 
between both cell lines based on proteins identified at (i) 37˚C (ii) 31˚C.  
These comparisons were carried out as follows:  
• DP12 vs CHO-K1 37˚C 
o Proteins identified with 1 or more peptides 
o Proteins identified with 2 or more peptides 
• DP12 vs CHO-K1 31˚C 
o Proteins identified with 1 or more peptides 
o Proteins identified with 2 or more peptides 
 
Based on proteins identified using a minimum of two peptides, 390 proteins were 
common to both CHO-K1 and DP12 cell lines at 37˚C (Figure 3.3.31). 110 were 
found to be unique to CHO-K1 and 126 unique to DP12. The second comparison 
overlapped the lists of HCPs identified in CHO-K1 and DP12 grown under 
temperature-shift conditions. This comparison found that of those proteins identified 
using two or more peptides, 157 proteins were unique to the DP12 cell line and 143 
were unique to CHO-K1 while 350 were common to both cell lines (Figure 3.3.32).  
Taken together, this set of results appears to indicate that there are subpopulations of 
HCPs that are unique to different cell lines. In addition to this, these subpopulations 
can be influenced by the environmental conditions under which the cells are grown. 
A full list of all the proteins identified in Figure 3.3.31 and Figure 3.3.32 are 
provided in Appendix C, Tables 3.3.46 - 3.3.55. 
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Figure 3.3.31 Overlap of the list of proteins identified in the conditioned media of an 
IgG secreting DP12 CHO cell line and a non-producing CHO-K1 cell line grown at 
37˚C in shake flask culture. Samples were collected in biological triplicate from both 
cell lines and taken at 24, 72, 96, 120 and 144 hours post-temperature-shift from the 
DP12 cell line and 24, 72, 96 and 120hrs from the CHO-K1 cell line. Venn diagram 
(A) represents those proteins identified using a minimum of 1 or more peptides. 
Venn diagram (B) is compiled from those proteins identified using a minimum of 2 
or more peptides. 
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Figure 3.3.32 Overlap of the list of proteins identified in the conditioned media of an 
IgG secreting DP12 CHO cell line and a non-producing CHO-K1 cell line grown at 
31˚C in shake flask culture. Samples were collected in biological triplicate from both 
cell lines and taken at 24, 72, 96, 120 and 144 hours post-temperature-shift from the 
DP12 cell line and 24, 72, 96 and 120hrs from the CHO-K1 cell line. Venn diagram 
(A) represents those proteins identified using a minimum of 1 or more peptides. 
Venn diagram (B) is compiled from those proteins identified using a minimum of 2 
or more peptides. 
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 Utilisation of CHO specific proteomic databases in the identification of 3.3.8
HCPs in conditioned media samples from a non-producing CHO-K1 cell 
line and an IgG secreting DP12 cell line. 
The work detailed in this thesis has benefited from the relatively recent publication 
of two CHO specific proteomic databases (Meleady et al. 2012; Xu et al. 2011). As 
discussed in section 1.5.5.1, the CHO NCBI proteomic database was generated from 
CHO-K1 genome information while the CHO BB database is primarily based on 
information from cDNA expressed in a variety of CHO cell lines grown under 
different culture conditions, therefore, the use of both databases should result in 
increased coverage of the CHO proteome (Meleady et al. 2012). This section 
outlines the advantages of using both databases in the examination of mass spectral 
data acquired during the proteomic analysis of CHO conditioned media.  
A list of proteins identified in the cell culture supernatant of a CHO-K1 and a DP12 
cell line was compiled following mass spectral analysis. In order for a protein to be 
considered “identified” a search of the RAW data against one of the CHO databases 
previously mentioned must be detect that protein in a minimum of two biological 
samples from both 37˚C and 31˚C cultures. The protein also had to be detected in 
twice in a given database in order to be considered “identified”, proteins that were 
detected only once were removed from further analysis. The protein samples were 
collected in biological triplicate and taken at 24, 72, 96, 120 and 144 hours post- 
temperature-shift as per (Figure 3.3.1). 
Both databases were compared overlapping the lists of identified proteins in the 
CHO-K1 and DP12 cell line as follows: 
• CHO-K1 
o Proteins identified with only 1 peptide 
o Proteins identified with 2 or more peptides 
o Proteins identified with 1 or more peptides 
• DP12  
o Proteins identified with only 1 peptide 
o Proteins identified with 2 or more peptides 
o Proteins identified with 1 or more peptides 
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3.3.8.1 Comparison of CHO NCBI and CHO BB proteomic databases in the 
identification of HCPs from a non-producing CHO-K1 cell line 
As can be seen in Table 3.3.56, when the RAW files obtained from mass spectral 
analysis were searched against the CHO NCBI proteomic database a total of 966 
proteins were identified in the conditioned media of a CHO-K1 cell line. This 
included 364 proteins identified using one peptide and 602 identified using two or 
more peptides. A search of the same files against the CHO BB database identified 
769 proteins, of which 225 were detected by one peptide and 544 were identified 
using two or more peptides. 
A second comparison was then made based on overlapping the list of proteins 
identified in each database irrespective of how many peptides were used in the 
identification of that protein. A comparison between databases solely comparing 
‘one hit wonders’ or proteins identified using two or more peptides was not carried 
out as there may be instances where a protein was identified by two or more peptides 
in one database and that same protein identified by one peptide in the other database. 
This would have led to an inaccurate tabulation of the proteins identified. When the 
lists of proteins identified using the CHO NCBI and CHO BB databases were 
overlapped 598 proteins were found to have been common to both databases (Figure 
3.3.33). 368 proteins identified were unique to the CHO NCBI database and 171 
were only detected using the CHO BB database. A full list of all the proteins 
identified in Figure 3.3.33 are provided in Appendix C Tables 3.3.57 - 3.3.59. 
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Table 3.3.56 Table displaying the number of proteins identified in the conditioned 
media of a CHO-K1 cell line grown under temperature-shift and non-temperature-
shift cultures with samples taken at 24, 72, 96 and 120 hours post-temperature-shift. 
RAW files from the mass spectral analysis were searched against the CHO NCBI 
and CHO BB protein databases. Columns are divided into those proteins identified 
by 1 peptide and proteins identified by 2 or more peptides. 
 
 
Figure 3.3.33 Overlap of the list of proteins identified in the conditioned media of a 
non-producing CHO-K1 cell line. Samples were collected from both temperature-
shift and non-temperature-shift cultures. Samples were taken at 24, 72, 96 and 120 
hours post-temperature-shift. RAW files from mass spectral analysis were searched 
against CHO NCBI and CHO BB proteomic databases. Only proteins that were 
detected in at least two biological samples were counted. The Venn diagram 
represents those proteins identified using a minimum of 1 or more peptides.  
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3.3.8.2 Comparison of CHO NCBI and CHO BB proteomic databases in the 
identification of HCPs from an IgG secreting DP12 cell line 
Similar to section 3.3.8.1, RAW files obtained during mass spectral analysis of cell 
culture supernatant from a DP12 cell line were searched against the CHO NCBI and 
CHO BB proteomic databases. A total of 845 protein identifications were retrieved 
from the CHO NCBI database, including 261 proteins identified using one peptide 
and 584 identified using two or more peptides. A search against the CHO BB 
database identified 204 proteins with one peptide and 532 were identified using two 
or more peptides. This resulted in 736 proteins being identified using the CHO BB 
database (Summary Table 3.3.60). 
The number of proteins identified that were common or unique to each database was 
also compared. As per section 3.3.8.1 the comparison was made based on 
overlapping the list of proteins identified in each database irrespective of how many 
peptides were used in the identification of that protein. When the lists of proteins 
identified using the CHO NCBI and CHO BB databases were overlapped 574 
proteins were found to have been common to both databases (Figure 3.3.34). 271 
proteins identified were unique to the CHO NCBI database and 162 were only 
detected in the CHO BB database. This result shows that the availability of a second 
CHO database has greatly increased the number of HCPs identified in the sample set.  
The number of proteins identified that are common or unique to each database were 
also compared. As per section 3.3.8.1 the comparison was made based on 
overlapping the list of proteins identified in each database irrespective of how many 
peptides were used in the identification of that protein. This comparison found that 
574 of the proteins identified were common to both the CHO NCBI and CHO BB 
databases (Figure 3.3.34). 271 proteins were identified as being unique to the CHO 
NCBI database and 162 were only detected using the CHO BB database.  
These results, coupled with those from section 3.3.8.1 indicate show that the use of a 
second database has increased the number of protein identifications by a minimum of 
171 and 162 proteins respectively (depending on which database is being used). This 
shows that this work has clearly benefited from the availability of a second CHO 
database by greatly increasing the number of HCPs identified in each sample set.  
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Table 3.3.60 Table displaying the number of proteins identified in the conditioned 
media of a DP12 cell line grown under temperature-shift and non-temperature-shift 
cultures with samples taken at 24, 72, 96, 120 and 144 hours post-temperature-shift. 
RAW files from the mass spectral analysis were searched against the CHO NCBI 
and CHO BB protein databases. Columns are divided into those proteins identified 
by 1 peptide and proteins identified by 2 or more peptides. 
 
 
Figure 3.3.34 Overlap of the list of proteins identified in the conditioned media of an 
IgG secreting DP12 CHO cell line. Samples were collected from both temperature-
shift and non-temperature-shift cultures. Samples were taken at 24, 72, 96, 120 and 
144 hours post-temperature-shift. RAW files from mass spectral analysis were 
searched against CHO NCBI and CHO BB proteomic databases. Only proteins that 
were detected in at least two biological samples were counted. The Venn diagram 
represents those proteins identified using a minimum of 1 or more peptides. A full 
list of all the proteins identified in this figure can be found in Appendix C, Table 
3.3.61 - 3.3.63. 
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 Summary 3.3.9
In accordance with our initial findings in the non-producing CHO-K1 cell line, 
quantitative label-free LC/MS analysis of an IgG producing DP12 cell line identified 
an increase in relative abundance of proteins with the potential to negatively affect 
product quality (proteases/glycosidases) at late stage culture compared to early stage 
culture under both temperature-shifted and non-temperature-shifted conditions. In 
addition, proteins with the ability to impact cell viability (apoptotic proteins) were 
found to be down-regulated under temperature-shifted conditions compared to non-
temperature-shifted conditions at 144hrs. Furthermore, it was also shown that 
substantial differences exist in the HCP profile from producing and non-producing 
CHO cells when compared under both temperature-shifted and non-temperature-
shifted conditions. This analysis utilised two CHO specific proteomic databases that 
were recently released. The use of both databases provided increased coverage of the 
secretome of both CHO cell lines allowing a greater number of HCPs to be identified 
than if only one database was available.  
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4.0 Phosphoproteomic Analysis of CHO cells 
Chapter overview 
There have been a number of studies to profile the proteome of the CHO cell that 
have provided insights into the changes that cells undergo in response to 
temperature-shift. Through profiling the phosphoproteome however it was hoped 
that the cell signalling events that result in these changes would be revealed. 
Initially an antibody array based approach was utilised to investigate a panel of 
kinase for changes in phosphorylation under temperature-shifted conditions 
compared to non-temperature-shifted conditions. This array contained antibodies 
specific to the phosphorylation sites of 26 kinases including ERK, AKT, JNK and 
p53, all of which are known to play key roles in controlling cellular function. 
During this study, advances in the sequencing of the CHO genome facilitated the 
release of two CHO proteomic databases. This enabled a more global approach to 
profiling the phosphoproteome to be pursued using quantitative label-free LC/MS. 
Quantitative label-free LC/MS analysis of phosphoprotein enriched CHO SEAP 
whole cell lysates collected from cells under temperature-shifted and non-
temperature shifted conditions was conducted. In order to obtain site specific 
phosphorylation data, this experiment was followed by quantitative label-free 
LC/MS analysis of a Gallium oxide phosphopeptide enrichment of the 
phosphoprotein enriched samples.  
While these label-free experiments provided some information on the differential-
expression of phosphopeptides from proteins involved in cell cycle and translation, 
the data obtained was limited due to the low number of differentially-expressed 
phosphorylation sites identified. 
To increase coverage of the CHO phosphoproteome, phosphopeptide enrichment of 
CHO SEAP whole cell lysate samples using titanium dioxide and iron oxide 
columns were assessed (i) qualitatively for the number of phosphopeptides with site 
specific information identified (ii) quantitatively for the differential expression of 
phosphopeptides. 
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The results show that this approach provided significantly enhanced coverage of the 
phosphoproteome. It was also shown that the availability of two CHO protein 
databases contributed to increased coverage of the phosphoproteome.  
In addition to the identification of the differential expression of phosphopeptides 
from a number of interesting proteins such as NDRG1, eIF4G3 and DNA excision 
repair protein ERCC-6, GO analysis of quantitative data from the three 
phosphopeptide enrichment strategies was pooled together and identified enrichment 
of processes including translation, cell division and membrane organisation in 
temperature-shifted CHO cells.  
The work presented in this thesis is the first time that profiling of the CHO 
phosphoproteome by mass spectrometry has been reported. While future work to 
definitively determine total and phosphorylated protein abundance may be required, 
the application of phosphoproteomic profiling by mass spectrometry to CHO cells 
under temperature-shift has provided useful insights into the active cellular response 
to reduced culture temperature conditions. 
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4.1 Phospho-Kinase Array Analysis of CHO SEAP cells subject to 
temperature-shift 
In order to identify candidates potentially involved in the cellular response to 
temperature-shift an array based technology was used to assess a panel of kinases for 
changes in phosphorylation. This array contained antibodies for 26 different kinases, 
of which 9 were MAP kinases (Figure 4.1.1). (A full list of the kinases detected by 
the array is given in section 2.5.6.)  
In this particular profiling experiment the array was used to detect changes in 
phosphorylation of the different kinases in CHO SEAP cells that had undergone 
temperature-shift (37˚C vs 31˚C). Samples were collected 72hrs after the cell culture 
flasks were seeded, 24hrs post-temperature shift (Figure 4.1.2). This time point was 
selected as it is still relatively early into temperature-shift and was more likely to 
capture changes in phosphorylation that were a direct result of culture temperature 
reduction. Using a later time point as the basis for analysis may have been 
complicated by other signalling events associated with cells entering into stationary 
or death phase. By using this early time point, while the cells were still in 
exponential growth, it was hoped that the signalling event that triggered growth 
arrest and subsequent increase in productivity might be captured. Samples used in 
this experiment for array analysis (CHO SEAP) and validation by western bolt 
(CHO SEAP and DP12) were grown for up to 96 hours post-temperature shift 
(Figure 4.1.2 and Figure 4.1.3). The increased productivity in temperature-shifted 
CHO SEAP cells can be seen in Figure 4.1.4. Western blots were carried out on 
biological duplicates of CHO SEAP cells and once on samples from the DP12 cell 
line. 
The experiment was conducted as a pair-wise comparison using biological 
duplicates. This was done to ensure robustness and reproducibility of the array. 
When a fold-change cut-off of 1.5 was applied to the results, 12 different kinases 
were deemed to have a potential change in phosphorylation status after temperature-
shift (Table 4.1.1). 
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Figure 4.1.1 Image of kinase array containing 26 different kinases including 9 MAP 
kinases. The array was used to look at the change in phosphorylation of the different 
kinases in CHO SEAP cells that had undergone temperature-shift (37C vs 31C) 24 
hrs post-temperature shift. 
 
 
 
Table 4.1.1 12 Kinases identified using a Phosphokinase array as having a potential 
change in phosphorylation status in CHO SEAP cell 24hrs post-temperature shift. 
This table represents the average fold change observed from duplicate biological 
samples analysed on the array (n=2). 
  
MSK2 S360 1.59
MKK6 (MEK6) S207/T211 1.93
Akt 2 S474 1.74
ERK 1 T202/Y204 3.17
HSP27 S78/S82 2.21
JNK pan T183/Y185, T221/Y223 2.23
JNK1 T183/Y185 2.29
JNK3 T221/Y223 2.05
p38α T180/Y182 2.42
p38β T180/Y182 2.09
p38δ T180/Y182 1.74
p53 S46 2.97
Phosphorylation Site
Fold Change 
Up at 31˚C
 196 
 
 
 
 
Figure 4.1.2 Growth curve of CHO SEAP cell line under both temperature-shifted 
and non-temperature shifted conditions. 
 
 
 
Figure 4.1.3 Growth curve of DP12 cell line under both temperature-shifted and 
non-temperature shifted conditions.  
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Figure 4.1.4 Graph showing the final titre of SEAP secreting CHO cells grown 
under temperature-shifted (31˚C) and non-temperature shifted (37˚C) conditions. 
Temperature-shifted culture was placed at 31˚C after 48hrs in culture. Cells were 
collected for proteomic analysis after 24hrs, 48hrs, 72hrs and 96hrs at 31˚C. 
 
From this panel of 12 kinases, two (P38 and P53) had previously been identified as 
being involved in the cellular response to temperature-shift (Roobol et al. 2011). 
This provided an interesting partial validation of this array as the results obtained 
were in agreement with those obtained by Roobol et. al. As both P38 and P53 
proteins had already been reported, this left eight candidates that were of interest, 
due to a potential change in their phosphorylation status as a result of temperature-
shift (after removing P38 α, β, and γ, and P53). From these, ERK, JNK and Mek6 
were initially selected for validation by western blot. The antibodies used for 
validation of each phospho-kinase were specific to the same phosphorylation site as 
the antibody on the array. In fact, the primary reason for the omission of MSK6 from 
validation was that there was no antibody available to detect the phosphorylation of 
S360 on MSK6. Antibodies against the unphosphorylated form of ERK, JNK and 
MEK6 were used to detect the relative abundance of each kinase. From this it could 
be determined whether it was a change in the expression of the kinase or a change in 
phosphorylation that accounted for the results obtained using the array.  
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 Western blot validation of Total and phosphorylated ERK 4.1.1
Based on the results from the array, of all the kinase targets, ERK1 showed the 
greatest increase in phosphorylation. Western blots were conducted in duplicate 
using four time points post-temperature shift, each at 24hr intervals, on CHO SEAP 
whole cell lysates. As can be seen in Figure 4.1.5 (A), the level of phosphorylation in 
ERK1 is clearly increased on day1 at 31˚C compared to the same time point at 37˚C. 
Interestingly, the level of phosphorylation remains increased over the four time 
points at 31˚C compared to 37˚C where it decreases over time. Although the levels 
of phosphorylated ERK at 37˚C are greatly reduced, their decrease appears to 
coincide with the reduction in culture viability. A blot for the total ERK1 appears to 
indicate that its overall levels within the cell remains constant throughout the culture 
(Figure 4.1.5 C). This confirms that in the blot for the phosphorylated form of 
ERK1, it is in fact an increase in phosphorylation that is being observed and not just 
an increase in total protein.  
It should however be noted that the expected molecular weight of total ERK1 does 
not correspond with the band detected. It was expected that a band would be detected 
at ~44kDa, in Figure 4.1.5 (C) it is just above 50kDa. A band at the same molecular 
weight is also detected in the control (MCF7 whole cell lysate). In order to see if this 
response was cell line specific, a western blot of phosphorylated and total ERK was 
also carried out on an IgG secreting CHO cell line (DP12). Although samples had 
been collected at all the time points indicated on the DP12 growth curve (Figure 
4.1.3), samples used for western blot analysis spanned just the 24-96hr range, similar 
to the CHO SEAP samples. The behaviour of phosphorylated ERK in the DP12 cell 
line completely contrasted that observed in CHO SEAP. Phosphorylated ERK 
remained constant over the four time points at 37˚C. After 24hrs at the reduced 
culture temperature, phosphorylated ERK appears slightly reduced compared to the 
same time point at 37˚C (Figure 4.1.6 A). Over time at 31˚C levels of 
phosphorylated ERK appears decrease. It should be noted that the two bands in 
Figure 4.1.5 A and Figure 4.1.6 A correspond to ERK1 (p44) (upper band) and 
ERK2 (p42) (lower band).  
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It is interesting to see that in both figures, the level of phosphorylation of ERK1 and 
ERK2 remains relatively similar indicating that the effect of temperature-shift does 
not appear to cause the cell to preferentially signal through ERK1 or ERK2. Of 
course, only knockout or inhibition based studies could definitively confirm this.  
Although viability remained high over the 24-96hr period investigated, the growth 
rate of the DP12 at 31˚C is almost completely stifled, this is particularly apparent 
when compared to the growth rate of the CHO SEAP cells at the same temperature.  
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Figure 4.1.5 Western blot image of Phosphorylated ERK (A) and total ERK (C) in a 
CHO SEAP cell line over time in culture under both temperature-shifted (31˚C) and 
non-temperature (37˚C) shifted conditions. Alpha tubulin (B and D) was used as a 
loading control. Time is given in hours post culture temperature reduction and Cl is 
whole cell lysate from MCF7 human cancer cell line as a control. 
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Figure 4.1.6 Western blot image of Phosphorylated ERK1/2 (A) and total ERK1/2 
(C) in a DP12 cell line over time in culture under both temperature-shifted (31˚C) 
and non-temperature (37˚C) shifted conditions. Alpha tubulin (B and D) was used as 
a loading control. Time is given in hours post culture temperature reduction and Cl is 
whole cell lysate from MCF7 human cancer cell line as a control. 
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The different responses of the two cell lines to reduced culture temperature could 
underpin the different expression profiles of phosphorylated ERK. To further 
investigate change in phosphorylation of ERK in temperature-shifted CHO SEAP 
cells a western blot was conducted on MEK1/2, a key upstream activator of ERK1. 
Unfortunately, MEK1/2 could not be detected in the CHO SEAP cell line (Figure 
4.1.7 A). A band detected at the expected molecular weight of 45kDa in the control 
MCF7 cell line indicated that the antibody was working. It was hypothesized that the 
failure to detect anything in CHO was possibly due to the antibody being raised 
against the Human version of MEK1/2 which may not have a similar amino acid 
sequence around the same phosphorylation site in CHO. However, by comparing the 
amino acid sequence of Human Mek1/2 against the CHO version it was discovered 
that the sequence for up to 11 amino acids either side of Ser217/221 was completely 
homologous. It therefore remains unclear why Mek1/2 was not detected in CHO. 
Immunoblotting for total MEK1/2 appeared to show the opposite trend to that seen 
in phosphorylated ERK1 i.e. an decrease in abundance at 31˚C compared to 37˚C 
(Figure 4.1.7 C). Without an immunoblot of the active form of MEK1/2 one cannot 
draw any firm conclusions. Due to the absence of an antibody that detects MEK1/2 
in CHO, western blots for phosphorylated and total MEK1/2 were only conducted 
once.  
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Figure 4.1.7 Western blot image of Phosphorylated Mek1/2 (A) and total Mek1/2 
(B) in a CHO SEAP cell line over time in culture under both temperature-shifted 
(31˚C) and non-temperature (37˚C) shifted conditions. Alpha tubulin (C) was used as 
a loading control. Time is given in hours post culture temperature reduction and Cl is 
whole cell lysate from MCF7 human cancer cell line as a control. 
 
  
 204 
 
 Western blot validation of Total and phosphorylated MEK6 4.1.2
Immunoblotting was also used to confirm the differential expression of 
phosphorylation on MEK6. Kinase array analysis indicated that phosphorylation of 
MEK6 increased 1.9-fold at 31˚C. Analysis by western blot was less conclusive 
however. It was expected that a distinct band would be detected between 37-40kDa. 
As can be seen in Figure 4.1.8 (A), despite altering blocking, incubation and washing 
conditions, multiple bands were detected in CHO whole cell lysate samples, while 
western bolts of total MEK6 failed to detect any bands in CHO lysates (data not 
shown).   
 
 
 
Figure 4.1.8 Western blot image of Phosphorylated Mek6 (A) in a CHO SEAP cell 
line over time in culture under both temperature-shifted (31˚C) and non-temperature 
(37˚C) shifted conditions. Alpha tubulin (B) was used as a loading control. Time is 
given in hours post culture temperature reduction and Cl is whole cell lysate from 
MCF7 human cancer cell line as a control. 
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 Western blot validation of Total and phosphorylated JNK 4.1.3
Western blots were conducted on total JNK1 and the phosphorylated form of JNK1 
to determine whether changes in the levels of phosphorylation in JNK reported in the 
kinase array results were as a result of changes in the abundance of the kinase as 
opposed to changes in the levels of actual phosphorylation (Figure 4.1.9). The kinase 
array detected a 2.29-fold increase in phosphorylated JNK1 (T183/Y185), a 2.09-
fold increase in phosphorylated JNK3 (T221/Y223) while the antibody specific for 
pan-phospho-JNK (T183/Y185 and T221/Y223) identified a 2.23-fold upregulation 
for the phosphorylated forms of JNK1/JNK2/JNK3. In Figure 4.1.9 (A) it can be 
seen that bands were detected at multiple molecular weights. The most prominent 
bands are located at ~37kDa, ~43kDa and, to a lesser extent > 70kDa. The predicted 
molecular weight of phosphorylated JNK1is 48kDa, however distinct bands were 
detected at this molecular weight. Similarly in the immunoblot for total JNK1 
numerous bands were detected at different molecular weights (Figure 4.1.9 C). It 
was expected that two well defined bands at 46kDa and 54kDa would be observed in 
accordance with the predicted molecular weight of the kinase. While there is a 
prominent band at ~46kDa, other distinct bands at 40kDa and 49kDa raise questions 
as to the specificity of the antibody. Assuming that the band detected at 46kDa 
corresponds to p46 JNK, then relative abundance of the kinase appears to remain 
constant between both temperatures over all four time points. In the immunoblot of 
phosphorylated JNK (Figure 4.1.9 A) the band at ~43kDa appears to greatest at 
24hrs in 31˚C when compared to its counterpart at 37˚C.  
Since the kinase array was used to detect samples taken at the 24hr time point, it is 
possible that the increased abundance of this detected band accounts for the 2.3-fold 
increase in JNK observed in the initial profiling experiment. However given the 
amount of non-specific binding seen on some of the immunoblots it is possible that 
some of the results obtained were as a result of non-specific binding on the array. 
It should be noted that none of the non-specific binding observed in the JNK or 
MEK6 immunoblots are believed to be caused by the secondary antibody. This is 
because blots incubated with secondary antibody only did not indicate any binding 
was taking place (data not shown).  
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Figure 4.1.9 Western blot image of Phosphorylated JNK (A) and total JNK (C) in a 
CHO SEAP cell line over time in culture under both temperature-shifted (31˚C) and 
non-temperature (37˚C) shifted conditions. Alpha tubulin (B and D) was used as a 
loading control. Time is given in hours post culture temperature reduction and Cl is 
whole cell lysate from MCF7 human cancer cell line as a control. 
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 Western blot validation of Total and phosphorylated AKT1 4.1.4
Although AKT1 did not show any differential expression in phosphorylation during 
array profiling, it was nonetheless worth investigating to see if the results by western 
blot reflected those obtained by the array i.e. no fold change. It was also used to 
determine if AKT1 changed in phosphorylation at a time point beyond that measured 
by the array. Western blots of AKT1 were conducted in both CHO SEAP and DP12 
cell lines as one-off experiments. As can be seen in Figure 4.1.10 the 
phosphorylation of AKT1 remains constant at 24, 48 and 72hrs but then greatly 
reduces at 96hrs at 37˚C. This is in contrast to 31˚C where the phosphorylation of 
AKT1 remains reduced over the 96hrs post-temperature shift. However when the 
total abundance of AKT1 is examined (Figure 4.1.10 B), it can be seen that it is in 
fact a change in the abundance of AKT that is giving rise to the appearance of a 
change in the phosphorylation of the kinase. Similar results were observed in the 
DP12 cell line (Figure 4.1.11). Phosphorylation of AKT1 is greatly reduced for the 
96hrs post- temperature shift at 31˚C compared to 37˚C (Figure 4.1.11 A) and 
relative abundance of total AKT1 remains constant over the four time points at both 
temperatures in the DP12 cell line (Figure 4.1.11 B). This result indicates that there 
is a specific reduction in the phosphorylation of AKT1 in temperature-shifted DP12 
cells. Taken together, both results provide some evidence that either as a 
consequence of reduced phosphorylation or a reduction in total kinase abundance 
that there may be some specific signalling taking place via AKT1 in recombinant 
protein producing CHO cells as a direct response to temperature-shift. 
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Figure 4.1.10 Western blot image of Phosphorylated AKT1 (A) and total AKT1 (B) 
in a CHO SEAP cell line over time in culture under both temperature-shifted (31˚C) 
and non-temperature (37˚C) shifted conditions. Time is given in hours post culture 
temperature reduction and Cl is whole cell lysate from MCF7 human cancer cell line 
as a control. 
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Figure 4.1.11 Western blot image of Phosphorylated AKT1 (A) in a DP12 cell line 
over time in culture under both temperature-shifted (31˚C) and non-temperature 
(37˚C) shifted conditions. Alpha tubulin (B) was used as a loading control. Time is 
given in hours post culture temperature reduction and Cl is whole cell lysate from 
MCF7 human cancer cell line as a control. 
 
 Summary 4.1.5
As a result of this study, a number of kinases including ERK, JNK and AKT were 
identified as being potentially involved in the cellular response to temperature-shift. 
Despite optimising western blot conditions through altering blocking, incubation and 
wash times, efforts to definitively validate these results by western blot were 
hampered however by the non-specific binding of detection antibodies causing 
multiple bands to appear on the blots. While this approach could provide a useful 
platform to analyse changes in the phosphorylation profile of kinases involved in a 
wide range of cellular functions, the reliance on anti-human antibodies to detect 
kinases in CHO has proven to be sub-optimal. The recent sequencing of the CHO 
genome which heralded the advent of a CHO specific database enabled an alternative 
approach to be explored; the use of Mass Spectrometry to analyse the 
phosphoproteome of CHO cells. 
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4.2 Phosphoproteomic profiling of CHO SEAP cells subject to 
temperature-shift 
Phosphoproteomic profiling of CHO SEAP cells subject to temperature-shift was 
conducted in an effort to identify pathways involved in the cellular response to 
reduced culture temperature. Understanding such mechanisms could potentially aid 
in the identification of cell engineering targets to extend cellular viability, increase 
productivity or influence cellular growth rate.  
This chapter details the use of phosphoprotein and phosphopeptide enrichment 
strategies coupled with LC/MS based technology to obtain both qualitative and 
quantitative phosphoproteomic information on CHO SEAP cells under reduced 
culture temperature conditions. 
CHO SEAP cells collected from 37˚C and 31˚C cultures 36hrs post-temperature-
shift were lysed and prepared for LC/MS analysis as follows: 
• Whole cell lysate 
• Phosphoprotein enrichment of whole cell lysate 
• Gallium phosphopeptide enrichment of phosphoprotein enrichment 
• Titanium dioxide phosphopeptide enrichment of whole cell lysate 
• Iron oxide phosphopeptide enrichment of whole cell lysate 
 
 Growth of CHO SEAP cells subject to temperature-shift 4.2.1
Eight shake flasks of CHO SEAP cells seeded at 2x105 cell/ml were set up in a 50ml 
volume of serum free CHO-S-SFMII media in a batch culture. After 48 hours in 
culture, four flasks were selected for temperature-shift and were placed in a 31˚C 
incubator for the remainder of the culture period. After 36hrs at 31˚C CHO SEAP 
cells were collected from both temperature-shifted and non-temperature-shifted 
cultures as detailed in methods section 2.3.1 (Figure 4.2.1). 36hrs was selected 
because this is more than sufficient time for consistent phosphorylation events in 
direct response to culture temperature reduction to take place and allow any changes 
in phosphorylation that may be as a result of shock to subside.  
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Based on other growth profiling experiments, 36hrs post-temperature-shift is also 
still within the exponential phase of growth for this cell line. It was felt that this was 
a good point at which to collect cell samples as cell signalling events as a result of 
temperature-shift may become difficult to decipher from other signalling events later 
in the culture, e.g., reduced growth rate due to cells entering stationary phase. The 
increased productivity in temperature-shifted CHO SEAP cells can be seen in Figure 
4.2.2. 
 
 
 
Figure 4.2.1 Growth curve of SEAP-secreting CHO cell line grown under 
temperature-shifted (31˚C) and non-temperature-shifted (37˚C) conditions. 
Temperature-shifted culture was placed at 31˚C after 48hrs in culture. Cells were 
collected for proteomic analysis after 36hrs at 31˚C.  
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Figure 4.2.2 Graph showing the final titre of SEAP-secreting CHO cells grown 
under temperature-shifted (31˚C) and non-temperature-shifted (37˚C) conditions. 
Temperature-shifted culture was placed at 31˚C after 48hrs in culture. Cells were 
collected for proteomic analysis after 36hrs at 31˚C. 
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 Qualitative analysis of phosphopeptide enrichment of CHO SEAP 4.2.2
In order to obtain further information on the phosphoproteome of temperature-
shifted CHO cells it was decided that a more global profiling approach would be 
required. To achieve this, LC/MS was coupled with phosphoprotein and 
phosphopeptide enrichment strategies. It is only through the creation of two CHO 
specific databases as a result of recent advances in sequencing the CHO genome that 
phosphoproteomic profiling of CHO cells by Mass Spectrometry has been enabled. 
This section assesses the different phosphopeptide enrichment strategies used in this 
study, namely; 
• Gallium phosphopeptide enrichment of phosphoprotein-enriched CHO whole 
cell lysate samples. 
• Titanium dioxide phosphopeptide enrichment of CHO whole cell lysates. 
• Iron oxide phosphopeptide enrichment of CHO whole cell lysates. 
This section also details the contributions made to this study through the use of two 
CHO specific proteomic databases. 
Following mass spectral analysis of all samples enriched using titanium, gallium and 
iron phosphopeptide enrichment methods, a list of phosphopeptides identified was 
compiled and compared as outlined above. Each compilation was based on the use of 
the SEQUEST algorithm to search all RAW data against both CHO NCBI and CHO 
BB databases. SEQUEST search criteria used as detailed in 2.4.6. An algorithm 
called PhosphoRS was used for the assignment of phosphorylation site localisation 
(Taus et al. 2011). Searches performed with PhosphoRS used a site probability of 
0.99 (this corresponds to a false localization rate (FLR) of 1%), peptide to spectrum 
match (PSM) ambiguity was defined as unambiguous and peptide probability was 
<0.05.  
Tallying of phosphopeptides and phosphorylation sites identified was conducted 
using a conservative counting method such that different charge states, oxidation of 
methionine residue and mis-cleaved variations were not considered as unique 
peptides. Unless otherwise stated these are the search parameters used to identify 
phosphopeptides in the comparisons that follow. 
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4.2.2.1 Comparison of enrichment methods - Qualitative analysis of all 
phosphopeptides and phosphosites identified 
The use of different enrichment strategies to profile the phosphoproteome of CHO 
cells in this work significantly increased the number of phosphopeptides identified 
with site-specific information. This section catalogues all the phosphopeptides 
identified in this work and compares the different methods used for their enrichment. 
Lists of identified phosphopeptides were generated by searching the RAW files 
obtained from LC/MS analysis of phosphopeptide enriched CHO SEAP samples as 
detailed in section 4.2.2. In order for a phosphopeptide to be considered identified it 
must have been detected in a minimum of two sample replicates for the respective 
enrichment method from either temperature-shifted or non-temperature-shifted 
cultures. Lists obtained were then compared to determine what phosphopeptides 
were common or unique to each enrichment method.  
As a result of this comparison;  
• 1,307 phosphopeptides were identified resulting in the detection of 1,480 
phosphorylation sites 
• Iron oxide enriched 960 phosphopeptides (1,076 phosphosites)  
• Titanium dioxide enriched 867 phosphopeptides (1,001 phosphosites)  
• Gallium oxide enriched 105 phosphopeptides (120 phosphosites) 
Although Gallium oxide was by far the poorest enrichment method, it should be 
remembered that the starting material used for gallium oxide enrichment were pre-
enriched phosphoprotein samples and not whole cell lysates as was the case with 
titanium or iron enrichment methods. It is therefore difficult to make a direct 
comparison between Gallium oxide and Titanium dioxide / Iron oxide enrichment 
methods.  
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Nonetheless, for the purpose of understanding the contributions made by the three 
enrichment methods, Figure 4.2.3 shows the number of phosphopeptides that are 
common and unique to the different enrichment chemistries.  
• Titanium and iron have the greatest number of shared phosphopeptide 
identification with 556 common to both enrichment methods.  
• 402 phosphopeptides were uniquely identified by iron enrichment, followed 
by titanium with 294 and gallium with 36.  
• 51 phosphopeptides were enriched by all three methods.  
A full list of the phosphopeptides identified in Figure 4.2.3 is available in Appendix 
D Table 4.2.2 – Table 4.2.8. Also identified in this investigation were a number of 
multiply-phosphorylated peptide species (Figure 4.2.4). Singly phosphorylated 
peptides are typically identified using Gallium and Titanium enrichment methods 
while multiply-phosphorylated species are usually enriched using Iron based 
methods. In this instance however no such bias was observed with both methods 
enriching similar numbers of singly and multiply phosphorylated phosphopeptides.  
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Table 4.2.1 Table indicating the total number of phosphopeptides identified using 
each phosphopeptide enrichment method following enrichment of CHO SEAP cells 
grown under temperature-shifted and non-temperature-shifted conditions 
 
 
 
Figure 4.2.3 Venn diagram of the number of phosphopeptides that are common and 
unique to each phosphopeptide enrichment method following enrichment of CHO 
SEAP cells grown under temperature-shifted and non-temperature-shifted 
conditions. A full list of the phosphopeptides identified are available in Appendix D, 
Table 4.2.2 – Table 4.2.8. 
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Figure 4.2.4 Graph of the number of phosphorylation sites per peptide as identified 
by titanium, iron and gallium phosphopeptide enrichment methods following LC/MS 
analysis of CHO SEAP cells subject to temperature-shift.  
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4.2.2.2 Utilisation of CHO specific proteomic databases in the analysis of 
LC/MS data in a phosphoproteomic study 
The relatively recent publication of two CHO specific proteomic databases (Meleady 
et al. 2012; Xu et al. 2011) has enabled the identification of 1,307 phosphopeptides 
and 1,480 sites of phosphorylation in this investigation.  Here, the improvement in 
the number of phosphopeptides identified through the use of a CHO specific 
database is examined. In addition to this, the advantages of using a second database 
are also explored. 
A simple comparison was set up in order to determine whether there were any 
significant differences in the number of phosphopeptides identified using the CHO 
databases compared to searching the data against human, mouse, rat and CHO 
protein information available in the UniProt/Swiss-Prot database. It should be noted 
that the CHO element of the UniProt/Swiss-Prot database is sequence information 
that was available prior to the advent of the either the CHO NCBI or CHO BB 
database. As outlined in introduction section 1.5.5.1, the key difference between the 
two CHO databases is that the CHO NCBI proteomic database is primarily based on 
CHO-K1 genome information while the CHO BB database originates from cDNA 
expressed in a variety of CHO cell lines grown under different culture conditions 
(Meleady et al. 2012). The comparison was based on searching a raw data file from 
the LC/MS analysis of an Iron phosphopeptide enrichment of cells grown at 37˚C 
against both CHO NCBI and CHO BB databases and against a UniProt/Swiss-Prot 
database containing protein sequence information for human, mouse, rat and CHO. 
At the time of analysis, the CHO NCBI database contained 24,383 sequences, CHO 
BB contained 15,285 sequences while 20,273 Human, 16,642 Mouse and 7,875 Rat 
sequences were contained in the UniProt/Swiss-Prot database. A list of identified 
phosphopeptides was generated by searching the RAW file as detailed in section 
4.2.2. As mentioned previously, this file was also searched against a UniProt/Swiss-
Prot database, this search was based on the same search criteria as section 4.2.2. 
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As a result of this search the following were identified;  
• 208 phosphopeptides using both CHO NCBI and CHO BB databases 
• 107 phosphopeptides using the UniProt/Swiss-Prot database 
• 112 phosphopeptides were unique to the CHO specific databases  
This result clearly shows that use of the CHO specific proteomic databases vastly 
improves the number of phosphopeptides identified (Figure 4.2.5). Although 11 
phosphopeptides were unique to the UniProt/Swiss-Prot database, the use of both 
CHO databases identified 95 of the 106 phosphopeptides identified by the 
UniProt/Swiss-Prot database. This indicates that the use of CHO specific proteomic 
databases is not only comparable in the identifications obtained from a search that is 
primarily based on sequence homology, but it significantly increases 
phosphoproteomic coverage.  
 
 
 
Figure 4.2.5 Venn diagram showing the number of phosphopeptides identified when 
the raw file from LC/MS analysis of a phosphopeptide enriched CHO SEAP sample 
was searched against CHO BB, CHO NCBI and Swiss-Prot (human, mouse, rat and 
CHO {downloaded Jan 11}) databases. A full list of the phosphopeptides identified 
are available in Appendix D, Table 4.2.9 – Table 4.2.15. 
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Figure 4.2.6 (A) provides an example of the use of BLAST analysis to identify a 
protein based on sequence homology in a related species whose genomes are 
sequenced and so have a well annotated database. Identified following a search of 
the CHO databases, a phosphopeptide sequence from the protein Transcription 
activator BRG1 is searched against BLAST and is identified as having 100% 
sequence homology with human, mouse and rat. Using traditional search 
methodologies this protein would almost certainly have been identified if the LC/MS 
data file was searched against a database containing sequence information from any 
of these species. A BLAST search of a phosphopeptide sequence from the protein 
“LIM domain only protein 7” shows that while the peptide shares some sequence 
homology with the human version, there are still a number of amino acid 
substitutions which may lead to the peptide not being identified depending on 
database search cut-offs, see Figure 4.2.6(B). Another example of a phosphopeptide 
searched against BLAST is that of a peptide from Eukaryotic translation initiation 
factor 4 gamma 3. Although there is still significant sequence homology between the 
human and CHO version of the protein, an amino acid substitution of a serine for an 
alanine may have lead to an incorrect phosphorylation assignment on the peptide 
Figure 4.2.6 (C). (Symbols for the amino acids Serine, Tyrosine and Threonine are 
shown in Table 4.2.2.) These examples provide further evidence of the benefits of 
availing of a CHO-specific database when using an LC/MS based approach to 
characterise the phosphoproteome of CHO cells. 
 
 
Table 4.2.16 Symbols denoting the amino acids Serine, Tyrosine and Threonine. 
 
 
 
 
 
Amino Acid Symbol
Serine S
Tyrosine Y
Threonine T
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Figure 4.2.6 Example of the use of BLAST analysis to identify a protein based on 
sequence homology in a related species with a well annotated database. (A) shows 
100% sequence homology when a peptide from the CHO protein “Transcription 
activator BRG1”  is searched against Human and mouse databases. (B) shows that 
although the correct protein “LIM domain only protein 7” is identified, a number of 
amino acid substitutions means there is less than 100% homology between the 
peptides. (C) indicates the potential for incorrect assignment of phosphorylation due 
to amino acid substitutions surrounding Threonine 12 (T12). 
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While the improvement in the number of phosphopeptides identified through the use 
of CHO specific databases have just been displayed, the importance of the use of the 
two available databases (from genomic DNA and expressed DNA) will now be 
outlined. 
Lists of phosphopeptides were generated by searching the RAW files obtained from 
LC/MS analysis of phosphopeptide enriched CHO SEAP samples as detailed in 
section 4.2.2. In order for a phosphopeptide to be considered identified in a given 
database it had to be detected in a minimum of two independent samples for the 
respective enrichment method from either temperature-shifted or non-temperature-
shifted cultures. Lists of phosphopeptides identified were then compared to 
determine what phosphopeptides were common or unique to each CHO database. 
The following comparisons were made by overlapping the lists of identified 
phosphopeptides: 
• CHO NCBI vs CHO BB database 
o Gallium phosphopeptide enrichment 
o Titanium phosphopeptide enrichment 
o Iron phosphopeptide enrichment 
Figure 4.2.7 shows the distribution of phosphopeptide identifications between the 
CHO NCBI and CHO BB databases when LC/MS data from CHO SEAP whole cell 
lysate samples were enriched using iron oxide spin columns. Figure 3.3.34 shows the 
distribution of phosphopeptides from the same databases when titanium dioxide spin 
columns were used for phosphopeptide enrichment. Both comparisons show that the 
CHO BB identified a smaller number of unique phosphorylated peptides than the 
CHO NCBI database. Nonetheless, its use contributed an additional 50 
phosphopeptide identifications in the case of iron oxide enrichment and increases 
titanium dioxide enrichment identifications by 44. In both instances the CHO BB 
database was capable of identifying >60% of all phosphopeptides identified. 
Although the number of phosphopeptides identified using gallium oxide enrichment 
is significantly smaller than the two previously mentioned methods, the use of the 
CHO BB database increases the phosphopeptide identification rate by just over 8% 
(Figure 4.2.9).  
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As evidenced by these examples, the use of a second database has provided a 
number of additional identifications that would otherwise not have been obtained. 
The resulting increase in proteome coverage is of obvious benefit for a study such as 
this. A full list of the phosphopeptides identified in Figure 4.2.7, Figure 3.3.34 and 
Figure 4.2.9 are available in Appendix D, Table 4.2.17 – Table 4.2.25. 
 
 
Figure 4.2.7 Overlap of the list of phosphopeptides identified after the iron oxide 
enrichment of a whole cell lysate from a CHO SEAP cell line. Four samples were 
collected from both temperature-shift and non-temperature-shift cultures 36hrs post-
temperature-shift (eight samples total). All eight RAW files from mass spectral 
analysis were searched against CHO NCBI and CHO BB proteomic databases. Only 
phosphopeptides that were detected in at least two independent samples were 
considered to be identified. A full list of the phosphopeptides identified are available 
in Appendix D, Table 4.2.17 - Table 4.2.19. 
 
Figure 4.2.8 Overlap of the list of phosphopeptides identified after the titanium 
dioxide enrichment of a whole cell lysate from a CHO SEAP cell line. Four samples 
were collected from both temperature-shift and non-temperature-shift cultures 36 
hours post-temperature-shift (eight samples total). All eight RAW files from mass 
spectral analysis were searched against CHO NCBI and CHO BB proteomic 
databases. Only phosphopeptides that were detected in at least two independent 
samples were considered to be identified. A full list of the phosphopeptides 
identified are available in Appendix D, Table 4.2.20 - Table 4.2.22. 
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Figure 4.2.9 Overlap of the list of phosphopeptides identified after the gallium oxide 
enrichment of a whole cell lysate pre-enriched for phosphoproteins from a CHO 
SEAP cell line. Three samples were collected from both temperature-shift and non-
temperature-shift cultures 36hrs post-temperature-shift (six samples total). The six 
RAW files from mass spectral analysis were searched against CHO NCBI and CHO 
BB proteomic databases. Only phosphopeptides that were detected in at least two 
independent samples were considered to be identified. A full list of the 
phosphopeptides identified are available in Appendix D, Table 4.2.23 - Table 4.2.25. 
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4.2.2.3 Phosphopeptides uniquely identified in temperature-shifted or non-
temperature-shifted cultures 
Qualitative lists obtained from the titanium dioxide and iron oxide phosphopeptide 
enrichment of CHO SEAP whole cell lysate samples and gallium oxide 
phosphopeptide enrichment of whole cell lysate samples pre-enriched for 
phosphoproteins were compiled. By comparing these lists it was hoped that 
phosphopeptides whose phosphorylation may be unique to temperature-shifted or 
non-temperature-shifted cultures could be identified. These lists may provide 
information on phosphopeptides that are uniquely phosphorylated at either culture 
temperature. This could indicate that a protein and, as a consequence, a pathway is 
turned ‘on’ or ‘off’ at a given temperature. 
Lists of identified phosphopeptides were generated by searching the RAW files 
obtained from the LC/MS analysis of both culture temperatures and each enrichment 
method. In order for a phosphopeptide to be considered as unique to a given culture 
temperature it had to be identified in a minimum of three out of the four samples for 
that temperature for titanium and iron enriched samples and in a minimum of two out 
of the three samples in the case of gallium enriched samples. The lists of 
phosphopeptides that met these criteria were then compared to lists of all the 
phosphopeptides identified by all three enrichment methods at the opposing 
temperature. If any phosphopeptide from the ‘potentially unique’ list was found in 
any of the lists from all the phosphopeptides identified using the three enrichment 
methods at the opposing temperature it was no longer considered ‘potentially 
unique’ and removed from further analysis.  
In addition to this, if a protein of one of the phosphopeptides from the ‘potentially 
unique’ list was identified as a protein of one of the phosphopeptides identified in 
the three enrichment methods at the opposing temperature then this phosphopeptide 
was no longer considered ‘potentially unique’ and removed from further analysis.  
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Based on these criteria, 64 phosphopeptides were identified as being ‘potentially 
unique’ in the 37˚C culture with slightly less than half that number identified in the 
31˚C culture (Table 4.2.26). Interestingly, when Table 4.2.27 and Table 4.2.29 are 
compared it can be seen that titanium and iron enrichment methods both contained 
phosphopeptides from the proteins TBC1 domain family member 17 and PERQ 
amino acid-rich with GYF domain-containing protein 1 that are considered to be 
unique in the 37˚C culture. Similarly, a phosphopeptide from the protein 60S 
ribosomal protein L12, considered to be unique in the 31˚C culture, was also 
enriched using both titanium and iron enrichment methods (Table 4.2.28 and Table 
4.2.30). 
This analysis also identified a number of translation initiation factors as being unique 
to different culture temperatures, such as transcription initiation factor TFIID subunit 
6-like and activating transcription factor 7-interacting protein 1 at 37˚C and 
transcription factor jun-B-like, transcription factor Dp-1 isoform 1 and eukaryotic 
translation initiation factor 3 subunit A-like at 31˚C. 
 
 
Table 4.2.26 This table shows the number of phosphopeptides that are considered to 
be ‘potentially unique’ to temperature-shifted and non-temperature-shifted cultures 
using gallium, titanium and iron enrichment methods. This table also contains the 
table number for the list of potentially unique phosphopeptides from each 
enrichment method and each culture temperature. 
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Table 4.2.27 List of phosphopeptides that were only identified in CHO SEAP cells at 37˚C using titanium dioxide phosphopeptide enrichment. 
Database denotes which CHO proteomic database the phosphopeptide was identified in (N= CHO NCBI) (BB=CHO BB). The table also 
indicates the number of independent biological replicates that the phosphopeptide was identified in. For this list each phosphopeptide was 
identified in a minimum of three biological replicates. 
 
Database
Number of 
times 
identified
Peptide Protein Name Gene symbol
N/BB 3/4 GSQPGPAVESQSSPR Band 4.1-like protein 2 EPB41L2
N/BB 4 TISDGTISASK Formin-binding protein 1-like FNBP1L
N/BB 4 SDSLLSFR Cdc42 effector protein 1 CDC42EP1
N/BB 4 IHRASDPGLPAEEPK CAD protein CAD
N 4 EPSSPSPPISPLPLSTR TBC1 domain family member 17 TBC1D17
N 4 SALLAQNGTSSLPR Pleckstrin-likey-like domain family B member 1 PHLDB1
N 4 LKSPPHSPGNLmDN Snurportin-1 SNUPN
BB 4 ESVPDFPLSPPK Stathmin STMN1
N/BB 3 SKDHFGLEGDEESTmLEDSVSPK Talin-1 TLN1
N/BB 3 GDLSDVEEEEEEEmDVDEATGAPK Paired amphipathic helix protein Sin3a SIN3A
N/BB 3 DTPTSAGPNSFNK PEST proteolytic signal-containing nuclear protein PCNP
N/BB 3 DTSTEALLKSSPEER Transcriptional repressor p66 alpha GATAD2A
N/BB 3 SPGGPGPLTLK Zyxin ZYX
N/BB 3 LSVHDLKPLDSPGR Thyroid receptor-interacting protein 11 TRIP11
N/BB 3 AGSQLGLDHLR Rab3 GTPase-activating protein catalytic subunit RAB3GAP1
N/BB 3 SmEVDLNQAHmEDTPK Maternal embryonic leucine zipper kinase MELK
N/BB 3 VPSVESLFR Golgin subfamily A member 4 GOLGA4
N/BB 3 GPSSVEDIK Nucleophosmin NPM1
N/BB 3 LLHEDLDESDDDVDEK Arf-GAP with SH3 domain, ANK repeat and PH domain-containing protein 2 ASAP2
N 3 VSALESGPHQSPALSK FERM, RhoGEF and pleckstrin domain-containing protein 1-like FARP1
N 3 IASESDEQQWPEEK Sister chromatid cohesion protein PDS5-like B PDS5B
N 3 NPSPNPVTALPK Zinc finger protein 280C ZNF280C
N 3 KHSDPHLLER Serine/threonine-protein kinase Nek10 NEK10
N 3 SPHQLLSPSSFSPSAAPSQK DNA polymerase alpha subunit B-like POLA2
N 3 QDGEKEESLSGV high mobility group nucleosome-binding domain-containing protein 5-like HMGN5
N 3 ASISPmDEPVPDSESPIEK Microtubule-associated protein 1B MAP1B
N 3 SAQASSGSPALPR Tyrosine-protein kinase ABL2 ABL2
N 3 SIEEGDGAFGR PERQ amino acid-rich with GYF domain-containing protein 1 GIGYF1
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Table 4.2.28 List of phosphopeptides that were only identified in CHO SEAP cells at 31˚C using titanium dioxide phosphopeptide enrichment. 
Database denotes which CHO proteomic database the phosphopeptide was identified in (N= CHO NCBI) (BB=CHO BB). The table also 
indicates the number of independent biological replicates that the phosphopeptide was identified in. For this list each phosphopeptide was 
identified in a minimum of three biological replicates. 
 
 
 
Database
Number of 
times 
identified Peptide Protein Name Gene symbol
N/BB 4 SVSVATGLNmmK Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 1 BAIAP2L1
N 4 mQFSFEGPEK IQ motif and SEC7 domain-containing protein 1 IQSEC1
N/BB 4 ASDPGLPAEEPK CAD protein CAD
N/BB 4 GNKSPSPPPDGSPAATPEIR Myc box-dependent-interacting protein 1 BIN1
N/BB 3 VKSLEDEEAPR tRNA pseudouridine synthase A, mitochondrial PUS1
N 3 SYSLSELSVLQAK SH3 domain-binding protein 4-like SH3BP4
N 3 VEKPATIAGENGSPVLR Inner centromere protein INCENP
BB 3 TASGSSVTSLEGPR Protein NDRG1 NDRG1
N/BB 3 GHLSEGLVTK Mitogen-activated protein kinase 6 MAPK6
N/BB 3 SFSPKSPLELGEK NGFI-A-binding protein 2 NAB2
N/BB 3 SQVINVIGSER Dedicator of cytokinesis protein 1 DOCK1
N/BB 3 IGPLGLSPK 60S ribosomal protein L12 - RPL12
N/BB 3 ITSPLmEPSSIEK Proteasome subunit alpha type-5 PSMA5
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Table 4.2.29 List of phosphopeptides that were only identified in CHO SEAP cells at 37˚C using iron oxide phosphopeptide enrichment. 
Database denotes which CHO proteomic database the phosphopeptide was identified in (N= CHO NCBI) (BB=CHO BB). The table also 
indicates the number of independent biological replicates that the phosphopeptide was identified in. For this list each phosphopeptide was 
identified in a minimum of three biological replicates. 
 
Database
Number of 
times 
identified Peptide Protein Name Gene symbol
N/BB 4 RGSISQEITK Biorientation of chromosomes in cell division protein 1-like BOD1L1
N/BB 4 SPLGGGGGSGASSQAAcLK Male-specific lethal 1-like MSL1
N/BB 4 VIAISGDAESPAK Retinoblastoma-like protein 1 RBL1
N 4 EPSSPSPPISPLPLSTR TBC1 domain family member 17 TBC1D17
N 4 AVSTVVVTTAPSPK Nuclear factor related to kappa-B-binding protein NFRKB
N/BB 3 ARSPVQDVLK TRAF-interacting protein TRAIP
N/BB 3 ASDLEDEENATR zinc finger CCCH domain-containing protein 18 isoform 2 ZC3H18
N/BB 3 HSPIKEEPcGSLSETVcK Male-specific lethal 1-like MSL1
N/BB 3 QEAGDSPPPAPGtPK transcription initiation factor TFIID subunit 6-like TAF6
N/BB 3 QDSSASLASPVEIAGK NK-tumor recognition protein NKTR
N/BB 3 DLGSELVR Hepatocyte growth factor receptor MET
N/BB 3 VDPSLMEDSDDGPSLPTK protein RER1-like RER1
N 3 IcSDEEEDEEKGGR ubinuclein-1 UBN1
N 3 SESMPVQLNK TBC1 domain family member 5 TBC1D5
N 3 KAASLTEDR Eukaryotic translation initiation factor 4 gamma 1 EIF4G1
N 3 IQIISTDSAVASPQR nuclear receptor subfamily 2 group C member 2 Nr2c2
N 3 TAVSVAQGGHSR Pre-B-cell leukemia transcription factor 2 PBX2
N 3 IVSPSGAAVScK Filamin-A FLNA
N 3 SIEEGDGAFGR PERQ amino acid-rich with GYF domain-containing protein 1 GIGYF1
N 3 REDSPGPEVQPMDK tripartite motif-containing protein 3 TRIM3
N 3 SLDRDSPGVENK B-cell CLL/lymphoma 9 protein BCL9
BB 3 AQEPSPVPSK Replication factor C subunit 2 RFC2
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Table 4.2.30 List of phosphopeptides that were only identified in CHO SEAP cells at 31˚C using iron oxide phosphopeptide enrichment. 
Database denotes which CHO proteomic database the phosphopeptide was identified in (N= CHO NCBI) (BB=CHO BB). The table also 
indicates the number of independent biological replicates that the phosphopeptide was identified in. For this list each phosphopeptide was 
identified in a minimum of three biological replicates. 
 
 
 
 
Database
Number of 
times 
identified Peptide Protein Name Gene symbol
N/BB 4 LESLNIQR eukaryotic translation initiation factor 3 subunit A-like EIF3A
N 4 DATPPVSPINMEDQER transcription factor jun-B-like JUNB
N/BB 3 DLDPDMVTEDEDDPGSQR bromodomain adjacent to zinc finger domain protein 1A BAZ1A
N/BB 3 INSDDKNLYLTASK ras-related protein Rab-34-like isoform 1 RAB34
N/BB 3 LVDSPVSADALR Protein Spindly SPDL1
N/BB 3 VFIDQNLSPGK transcription factor Dp-1 isoform 1 TFDP1
N/BB 3 LGMLSPEGTcK fatty acid synthase FASN
N/BB 3 IGPLGLSPK 60S ribosomal protein L12 RPL12
N/BB 3 GLSEDTTEETLK nucleolin NCL
N 3 GGGNSEGELETTVDQGGGENQAR Ras and Rab interactor 1 RIN1
N 3 APLTLAGSPTPK Protein Wiz WIZ
N 3 DNNTSLTALEK hypothetical protein I79_019528 N/A
 231 
 
Table 4.2.31 List of phosphopeptides that were only identified in CHO SEAP cells at 37˚C using gallium oxide phosphopeptide enrichment of 
phosphoprotein-enriched CHO SEAP whole cell lysate samples subject to temperature-shift. Database denotes which CHO proteomic database 
the phosphopeptide was identified in (N= CHO NCBI) (BB=CHO BB). The table also indicates the number of independent biological replicates 
that the phosphopeptide was identified in. For this list each phosphopeptide was identified in a minimum of three biological replicates. 
 
 
  
Database
Number of 
times 
identified Peptide Protein Name Gene symbol
N 3 TLSNAEDYIDEEDSD osteoclast-stimulating factor 1-like OSTF1
N 3 GGNVFEALIQDESEEEEEEEEEK ATP-binding cassette sub-family F member 1-like ABCF1
N 3 VDGSDVALKDPDQVAQSDGEESPAAEEQLLGER Protein transport protein Sec31A SEC31A
N 3 GDSLILEHQWELEK Kinesin-like protein KIF1B KIF1B
N 2 EAFLVLSDEEDIScGK Activating transcription factor 7-interacting protein 1 ATF7IP
N 2 SLMSSPEDLTK Microtubule-associated protein 1B MAP1B
BB 2 SLDDLEIGLGHLSSSSFNSEK LIM domain and actin-binding protein 1 LIMA1
BB 2 NASTSFQELEDK DnaJ homolog subfamily C member 2 DNAJC2
BB 2 LDGPVENVSEDEAQSSSQR La-related protein 1B LARP1B
BB 2 VQGEAVSNIQENTQTPTVQEESEEEEVDETGVEVK Nascent polypeptide-associated complex subunit alpha NACA
BB 2 SASPAPADVAPAQEDLR Ras GTPase-activating protein-binding protein 1 G3BP1
BB 2 GAEDDEGSDEEVVHNEDIHFEPIVSLPEVEVK E3 SUMO-protein ligase RanBP2 RANBP2
BB 2 TETVEEPLEEDEAAKEEKEESDDEAAVEEEEEEK Endoplasmin HSP90B1
BB 2 EVTENEQNQLSEPEEGK Band 4.1-like protein 2 EPB41L2
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Table 4.2.32 List of phosphopeptides that were only identified in CHO SEAP cells at 31˚C using gallium oxide phosphopeptide enrichment of 
phosphoprotein-enriched CHO SEAP whole cell lysate samples subject to temperature-shift. Database denotes which CHO proteomic database 
the phosphopeptide was identified in (N= CHO NCBI) (BB=CHO BB). The table also indicates the number of independent biological replicates 
that the phosphopeptide was identified in. For this list each phosphopeptide was identified in a minimum of three biological replicates. 
 
 
 
Database
Number 
of times 
identified Peptide Protein Name Gene symbol
N 3 FAALDSEEEDDEETTEEK ATP-binding cassette sub-family F member 1 ABCF1
N 3 SLDSDESEDEDDDYQQK 28 kDa heat- and acid-stable phosphoprotein PDAP1
N 3 YNLDASEEEDSNK Zinc finger Ran-binding domain-containing protein 2 ZRANB2
N 2 NDSWGSFDLR Nuclear fragile X mental retardation-interacting protein 2 NUFIP2
N 2 RASVcAEAYNPDEEEDDAESR cAMP-dependent protein kinase type II-beta regulatory subunit PRKAR2B
N 2 EVEDKESEGEDEDEDEDLSK Zinc finger Ran-binding domain-containing protein 2 ZRANB2
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4.2.2.4 Summary 
Following the use of three different phosphopeptide enrichment strategies to profile 
the phosphoproteome of CHO cells, the qualitative data obtained from LC/MS 
analysis was collated and 1,307 phosphopeptides and 1,480 phosphosites were 
identified. Titanium dioxide and iron oxide enriched significantly more 
phosphopeptides that gallium; however this is likely to be due to a difference in the 
starting material used prior to phosphopeptide enrichment i.e. phosphoprotein-
enriched sample compared to a whole cell lysate. Titanium dioxide and iron oxide, 
both used to enrich CHO whole cell lysate, were comparable in terms of the numbers 
of singly and multiply phosphorylated species they identified. The recent availability 
of two CHO databases has facilitated the use of a Mass spectrometry based approach 
to analyse the phosphoproteome of CHO cells. This section has shown that both 
databases increase proteome coverage and the confidence with which 
phosphopeptides were identified. 
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 Quantitative Phosphoproteomic label-free LC/MS analysis of CHO 4.2.3
SEAP cells subject to temperature-shift 
Following the successful phosphopeptide enrichment of CHO SEAP cells, the 
LC/MS data gathered was analysed for changes in the abundance of the 
phosphopeptides identified as changes in the abundance of enriched phosphopeptides 
are potentially indicative of changes in the abundance of phosphorylation on that 
peptide. Quantitative information on changes in the phosphorylation status of 
proteins provides significant insights into the active cellular response to reduced 
culture temperature conditions. This section describes the use of a quantitative label-
free LC/MS proteomic profiling approach to quantitatively compare CHO SEAP 
cells collected from 37˚C and 31˚C cultures 36hrs post-temperature-shift. 
Quantitative label-free LC/MS analysis was performed on the following cell lysate 
preparations: 
• Whole cell lysate 
• Phosphoprotein enrichment of whole cell lysate 
• Gallium phosphopeptide enrichment of phosphoprotein enrichment 
• Titanium dioxide phosphopeptide enrichment of whole cell lysate 
• Iron oxide phosphopeptide enrichment of whole cell lysate 
 
 Quantitative label-free LC/MS analysis of CHO SEAP whole cell lysate 4.2.4
Quantitative label-free LC/MS analysis was conducted on CHO SEAP whole cell 
lysates for two main reasons: 
• LC/MS analysis of the ‘starting material’ provided a good indication of how 
successful subsequent phosphoprotein / phosphopeptide enrichments were. 
 
• To date, quantitative label-free LC/MS analysis is a technique that has not 
previously been applied to an investigation of the CHO proteome under 
reduced culture temperature conditions. 
As such, eight CHO SEAP whole cell lysate samples, four from each culture 
condition (37˚C and 31˚C) were prepared for LC/MS analysis. Due to the complex 
nature of the whole cell lysate samples, 5hr reverse phase gradients were used to 
ensure sufficient peptide separation during mass spectrometry analysis.  
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After LC/MS analysis of all the samples was complete, inclusion lists were 
generated and analysis on some of the samples was repeated. This was done to 
obtain information on additional peptides to further strengthen protein identifications 
and identify low abundant proteins that were not previously identified in the initial 
analysis.  
Progenesis label-free software was used to analyse the data acquired following 
LC/MS analysis. Reference run selection was performed on two separate occasions. 
Initially the software chose what it deemed to be the most suitable reference run and 
the analysis was performed to completion. A principal component analysis (PCA) 
plot generated by Progenesis during data analysis showing how the samples from 
37˚C and 31˚C cultures cluster is displayed in Figure 4.2.10. For the second the 
reference run was carried out manually and the analysis was then carried out to 
completion as detailed in section 2.5.8.  
 
Figure 4.2.10 PCA plot for CHO SEAP whole cell lysate sample groups 37˚C (pink) 
and 31˚C (blue) generated during label-free LC/MS data analysis using Progenesis 
software. 
 
The list of differentially-expressed proteins generated from the automatic reference 
run selection and the list of differentially-expressed proteins generated from the 
manual reference run selection were then overlapped and any proteins common to 
both lists were accepted as being differentially-expressed as described in section 
2.5.8. In all instances proteins common to both lists also shared common 
approximate fold-change and fold-change direction. No proteins had to be excluded 
on the basis of differing direction of fold-change.  
 236 
 
A protein was considered to be differentially-regulated if its change in relative 
abundance was >1.5-fold. Lists of differentially-regulated proteins were generated 
based on peptides deemed to have a statically significant fold-change (ANOVA 
<0.05) and an ion score >40 when searched against CHO NCBI and CHO BB 
proteomic databases.  
Using this format for the identification of differentially-expressed proteins, 114 were 
deemed to have a statistically significant fold-change in relative abundance >1.5 
fold. Of these, 42 were down-regulated  (Table 4.2.33), while 72 were up-regulated 
at 31˚C (Table 4.2.34). 
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Table 4.2.33 List of differentially-expressed proteins, down-regulated at 31˚C compared to 37˚C, identified in quantitative label-free LC/MS 
analysis of CHO SEAP whole cell lysates from cells sampled at 36hrs post-temperature-shift. 
 
Gene Symbol Description Total Peptides Quantitative Peptides Score Anova (p) Fold
HSPG2 basement membrane-specific heparan sulfate proteoglycan core protein 5 5 267 0.0002 2.7
SELENBP1 selenium-binding protein 1 4 4 224 0.0001 1.9
FLOT1 flotillin-1 3 3 234 0.0047 1.7
PLIN4 perilipin-4 3 3 213 0.0017 2.4
HYOU1 Hypoxia up-regulated protein 1 3 3 158 0.0001 1.5
AARS Alanyl-tRNA synthetase, cytoplasmic 2 2 121 0.0011 1.6
CAMK2D Calcium/calmodulin-dependent protein kinase type II subunit delta 2 2 116 0.0049 2.0
MET Hepatocyte growth factor receptor 2 2 109 0.0040 2.3
SERPINH1 Serpin H1 2 2 106 0.0006 2.5
RRM1 Ribonucleoside-diphosphate reductase large subunit 2 2 99 0.0002 2.3
CPNE1 Copine-1 2 2 98 0.0139 1.7
ANXA6 Annexin A6 2 2 95 0.0020 1.8
Cald1 Non-muscle caldesmon 2 1 119 0.0039 1.6
IGBP1 Immunoglobulin-binding protein 1 1 1 90 0.0088 1.8
PALLD palladin 1 1 78 0.0003 2.1
DDX17 DEAD (Asp-Glu-Ala-Asp) box polypeptide 17, isoform CRA_a 1 1 72 0.0050 1.6
DNMT1 DNA (cytosine-5)-methyltransferase 1 1 1 70 0.0082 1.6
HTRA1 Serine protease HTRA1 1 1 63 0.0025 2.7
PXDN peroxidasin homolog 1 1 61 0.0001 2.1
PSAT1 Phosphoserine aminotransferase 1 1 61 0.0053 1.6
TPM4 Tropomyosin alpha-4 chain 1 1 60 0.0286 1.6
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PFKL 6-phosphofructokinase, liver type 1 1 60 0.0226 1.6
PTGFRN Prostaglandin F2 receptor negative regulator 1 1 60 0.0086 1.7
TSC22D1 TSC22 domain family protein 1 1 1 58 0.0009 3.1
PCNP PEST proteolytic signal-containing nuclear protein 1 1 57 0.0065 1.6
AP2A2 AP-2 complex subunit alpha-2 1 1 53 0.0019 1.6
STAT5B signal transducer and activator of transcription 5B 1 1 53 0.0010 1.9
HDGFRP2 Hepatoma-derived growth factor-related protein 2 1 1 53 0.0162 1.6
SPC25 Kinetochore protein Spc25 1 1 52 0.0064 2.4
MESDC2 LDLR chaperone MESD 1 1 51 0.0006 1.6
SNAP29 Synaptosomal-associated protein 29 1 1 49 0.0001 2.0
NDUFAF7 Protein midA homolog, mitochondrial 1 1 48 0.0195 1.7
CATSPER2 Cation channel sperm-associated protein 2 1 1 46 0.0249 1.8
PPID Peptidyl-prolyl cis-trans isomerase D 1 1 45 0.0022 1.8
PPP1R2 Protein phosphatase inhibitor 2 1 1 45 0.0006 1.9
MAP1B Microtubule-associated protein 1B 1 1 44 0.0040 2.0
NCAPD2 Condensin complex subunit 1 1 1 44 0.0040 1.6
MYH9 Myosin-9 1 1 43 0.0027 1.6
PAPSS1 Bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1 1 1 43 0.0019 1.7
GPC1 Glypican-1 1 1 41 0.0023 1.6
NID1 Nidogen-1 1 1 40 0.0253 1.7
FABP4 Fatty acid-binding protein, adipocyte 1 1 40 0.0005 1.5
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Table 4.2.34 List of differentially-expressed proteins, up-regulated at 31˚C compared to 37˚C, identified in quantitative label-free LC/MS 
analysis of CHO SEAP whole cell lysates from cells sampled at 36hrs post-temperature-shift. 
 
Gene Symbol Description Total Peptides Quantitative Peptides Score Anova (p) Fold
PLEC Plectin 13 13 801 0.0001 1.5
DHX9 ATP-dependent RNA helicase A 10 10 555 0.0000 2.4
MYBBP1A Myb-binding protein 1A 9 9 556 0.0007 1.6
LMNA Lamin-A/C 7 7 434 0.0002 1.6
MSN Moesin 7 5 398 0.0000 1.5
EZR Ezrin 5 3 252 0.0001 2.4
CAST calpastatin 4 4 247 0.0000 1.7
RPL4 60S ribosomal protein L4 4 4 209 0.0002 2.1
DDX21 Nucleolar RNA helicase 2 4 4 202 0.0026 1.5
NOP56 Nucleolar protein 56 4 4 198 0.0016 1.5
UBAP2L Ubiquitin-associated protein 2 3 3 212 0.0058 1.6
EIF3I Eukaryotic translation initiation factor 3 subunit I 3 3 178 0.0028 1.6
RPL26 60S ribosomal protein L26 3 3 173 0.0002 1.5
GLUD1 Glutamate dehydrogenase 1, mitochondrial 3 3 153 0.0047 1.7
LRRC59 leucine-rich repeat-containing protein 59 3 3 138 0.0072 1.6
AKR1A1 Alcohol dehydrogenase (NADP+) 3 3 137 0.0009 1.5
BZW1 basic leucine zipper and W2 domain-containing protein 1 3 3 135 0.0049 1.6
PSMB8 Proteasome subunit beta type-8 2 2 145 0.0001 1.7
RRP12 RRP12 protein 2 2 139 0.0035 1.6
RPS25 40S ribosomal protein S25 2 2 133 0.0303 1.6
Rpl6 60S ribosomal protein L6 2 2 132 0.0029 3.1
CYP51A1 Lanosterol 14-alpha demethylase 2 2 129 0.0003 1.9
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RUVBL2 RuvB 2 2 2 120 0.0032 1.5
VIM Vimentin 2 2 116 0.0001 1.8
RPS9 40S ribosomal protein S9 2 2 111 0.0004 1.8
GTPBP4 Nucleolar GTP-binding protein 1 2 2 110 0.0004 1.8
HEATR1 HEAT repeat-containing protein 1 2 2 107 0.0254 1.6
DDX18 ATP-dependent RNA helicase DDX18 2 2 104 0.0164 1.5
ANXA1 Annexin A1 2 2 99 0.0149 1.8
PDCD11 protein RRP5 homolog 2 2 84 0.0008 1.6
HUWE1 E3 ubiquitin-protein ligase HUWE1 1 1 85 0.0060 1.5
RPL13A 60S ribosomal protein L13a 1 1 79 0.0003 1.7
TSTA3 GDP-L-fucose synthase 1 1 77 0.0000 2.2
EHD4 EH domain-containing protein 4 1 1 75 0.0458 1.7
ATXN10 Ataxin-10 1 1 74 0.0239 1.7
HMOX1 Heme oxygenase 1 1 1 70 0.0026 4.2
RPL28 60S ribosomal protein L28 1 1 68 0.0005 2.1
TFRC Transferrin receptor protein 1 1 1 67 0.0393 1.6
PUS1 tRNA pseudouridine synthase A, mitochondrial isoform 1 1 1 67 0.0240 1.8
RRM2 Ribonucleoside-diphosphate reductase subunit M2 1 1 65 0.0001 2.0
BAIAP2 Brain-specific angiogenesis inhibitor 1-associated protein 2 1 1 63 0.0053 2.4
SRSF5 Serine/arginine-rich splicing factor 5 1 1 63 0.0166 1.8
HIST1H2AG Histone H2A type 1 1 1 63 0.0001 2.2
TCEA1 Transcription elongation factor A protein 1 1 1 62 0.0104 1.7
XPO5 Exportin-5 1 1 61 0.0123 1.7
IMPDH1 Inosine-5'-monophosphate dehydrogenase 1 1 1 61 0.0173 2.1
GPRC5A Retinoic acid-induced protein 3 1 1 60 0.0088 2.1
RPS8 40S ribosomal protein S8 1 1 58 0.0000 1.8
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RPS6 40S ribosomal protein S6 1 1 58 0.0259 2.8
SRXN1 Sulfiredoxin-1 1 1 57 0.0006 2.3
CDK6 Cyclin-dependent kinase 6 1 1 55 0.0023 1.7
XRN2 5'-3' exoribonuclease 2 1 1 55 0.0079 2.0
FAT1 Protocadherin Fat 1 1 1 54 0.0006 6.4
RPL14 60S ribosomal protein L14 1 1 53 0.0000 2.5
N/A uncharacterized protein C7orf50 homolog 1 1 53 0.0000 2.8
APRT Adenine phosphoribosyltransferase 1 1 51 0.0375 1.6
RPL34 60S ribosomal protein L34 1 1 51 0.0080 2.6
NFKB2 Nuclear factor NF-kappa-B p100 subunit 1 1 50 0.0285 1.9
BCL10 B-cell lymphoma/leukemia 10 1 1 49 0.0019 2.3
HACL1 2-hydroxyacyl-CoA lyase 1 1 1 49 0.0010 2.0
EPS8 Epidermal growth factor receptor kinase substrate 8 1 1 49 0.0037 2.3
LRRC47 Leucine-rich repeat-containing protein 47 1 1 47 0.0303 1.6
PRMT5 Protein arginine N-methyltransferase 5 1 1 46 0.0066 1.6
LXN Latexin 1 1 46 0.0007 3.3
PCNA Proliferating cell nuclear antigen 1 1 46 0.0221 1.7
TAP2 Antigen peptide transporter 2 1 1 45 0.0322 1.7
CD44 CD44 antigen 1 1 42 0.0006 1.7
RPL13 60S ribosomal protein L13 1 1 42 0.0001 2.7
PABPC4 Polyadenylate-binding protein 4 1 1 41 0.0432 1.5
IMP4 U3 small nucleolar ribonucleoprotein protein IMP4 1 1 41 0.0380 1.6
EIF3B Eukaryotic translation initiation factor 3 subunit B 1 1 41 0.0299 1.6
RSL1D1 ribosomal L1 domain-containing protein 1 1 1 41 0.0072 2.1
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4.2.4.1 Bioinformatic analysis of differentially-regulated proteins identified in 
the whole cell lysate of CHO SEAP cells subject to temperature-shift 
While both CHO databases are hugely beneficial, the proteins in the databases lack 
continuity in the way they are presented - they don’t provide a consistent identifier 
e.g. gi number, gene symbol, UniProt accession number etc. This is not just between 
databases, but within each database itself. For this reason, each differentially-
expressed protein identified was searched manually against UniProtKB 
(http://www.uniprot.org/) and the equivalent gene symbol for the human version of 
that protein retrieved. 
The list of gene symbols were then searched using DAVID functional annotation 
tool (publically available software) (http://david.abcc.ncifcrf.gov/). Gene ontology 
was then used to classify the differentially-regulated proteins (both up and down at 
31˚C) and identify enrichment of pathways that may be involved in the cellular 
response to temperature-shift. Using a p-value of ≤0.05, 25 pathways were found to 
be enriched (Table 4.2.35). This list contains a wide range of cellular processes; 
however, in order to refine the number of pathways identified, a more conservative 
approach was adapted and an adjusted p-value (Benjamini) of ≤0.05 was used (Table 
4.2.36). Using an adjusted p-value, 9 pathways of interest were identified. As can be 
seen in Figure 4.2.11, DAVID analysis has identified a clear enrichment of a number 
of pathways including translation and RNA processing at the reduced culture 
temperature. 
The list of gene symbols were also searched using DAVID’s functional annotation 
chart function. Of the 114 gene symbols inputted (corresponding to the 
differentially-expressed proteins identified), 84 of these were identified as 
phosphoproteins (p = 7.7E-16). Interestingly, based on the number of gene symbols, 
this was the most highly enriched entity despite the analysis being based on a whole 
cell lysate that has not undergone any form of enrichment prior to LC/MS.  
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Table 4.2.35 GO biological process (BP) enrichment for differentially-expressed 
proteins identified in quantitative label-free LC/MS analysis of whole cell lysate 
from CHO SEAP cells sampled at 36hrs post-temperature-shift. Enrichment was 
considered significant upon observation of a p-value ≤0.05. Gene Count corresponds 
to the number of gene symbols from the list of differentially-regulated proteins that 
are implicated in a particular GO category. 
 
 
 
 
  
Category Term Count P-Value
GOTERM_BP_FAT translation 18 2.40E-10
GOTERM_BP_FAT translational elongation 12 1.70E-10
GOTERM_BP_FAT rRNA metabolic process 7 0.000072
GOTERM_BP_FAT rRNA processing 7 0.000057
GOTERM_BP_FAT ncRNA processing 9 0.000067
GOTERM_BP_FAT ribosome biogenesis 8 0.000031
GOTERM_BP_FAT ribonucleoprotein complex biogenesis 9 0.000051
GOTERM_BP_FAT RNA processing 15 0.000042
GOTERM_BP_FAT ncRNA metabolic process 9 0.00028
GOTERM_BP_FAT syncytium formation by plasma membrane fusion 3 0.0033
GOTERM_BP_FAT syncytium formation 3 0.0046
GOTERM_BP_FAT regulation of immune effector process 5 0.0064
GOTERM_BP_FAT response to organic substance 13 0.0063
GOTERM_BP_FAT leukocyte adhesion 3 0.018
GOTERM_BP_FAT response to hypoxia 5 0.017
GOTERM_BP_FAT response to oxygen levels 5 0.020
GOTERM_BP_FAT nitrogen compound biosynthetic process 7 0.032
GOTERM_BP_FAT regulation of mast cell cytokine production 2 0.029
GOTERM_BP_FAT extracellular structure organization 5 0.032
GOTERM_BP_FAT positive regulation of immune effector process 3 0.041
GOTERM_BP_FAT response to vitamin A 3 0.038
GOTERM_BP_FAT membrane to membrane docking 2 0.036
GOTERM_BP_FAT healing during inflammatory response 2 0.036
GOTERM_BP_FAT oxidation reduction 10 0.044
GOTERM_BP_FAT extracellular matrix organization 4 0.041
 244 
 
Table 4.2.36 GO biological process (BP) enrichment for differentially-expressed 
proteins identified in quantitative label-free LC/MS analysis of whole cell lysate 
from CHO SEAP cells sampled at 36hrs post-temperature-shift. Enrichment was 
considered significant upon observation of an adjusted p-value ≤0.05 (Benjamini). 
Gene Count corresponds to the number of gene symbols from the list of 
differentially-regulated proteins that are implicated in a particular GO category. 
 
 
Figure 4.2.11 GO biological process enrichment for differentially-expressed proteins 
identified in quantitative label-free LC/MS analysis of whole cell lysate from CHO 
SEAP cells sampled at 36hrs post-temperature-shift. Enrichment was considered 
significant upon observation of an adjusted p-value ≤0.05 (Benjamini). Gene Count 
corresponds to the number of gene symbols from the list of differentially-regulated 
proteins that are implicated in a particular GO category. This graph shows the 
breakdown of the gene counts in those enriched pathways. 
 
 
  
Category Term Count P-Value Benjamini
GOTERM_BP_FAT translation 18 2.40E-10 1.40E-07
GOTERM_BP_FAT translational elongation 12 1.70E-10 2.00E-07
GOTERM_BP_FAT rRNA metabolic process 7 0.000072 0.011
GOTERM_BP_FAT rRNA processing 7 0.000057 0.011
GOTERM_BP_FAT ncRNA processing 9 0.000067 0.012
GOTERM_BP_FAT ribosome biogenesis 8 0.000031 0.012
GOTERM_BP_FAT ribonucleoprotein complex biogenesis 9 0.000051 0.012
GOTERM_BP_FAT RNA processing 15 0.000042 0.013
GOTERM_BP_FAT ncRNA metabolic process 9 0.00028 0.037
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4.2.4.2 Summary 
Quantitative label-free LC/MS analysis of CHO whole cell lysate identified the 
differential expression of 114 proteins, 72 of which were up-regulated at 31˚C (>1.5 
fold-change, ANOVA <0.05). GO analysis of the differentially-expressed proteins 
identified clearly showed enrichment of pathways involved in translation, RNA 
processing and ribosomal biogenesis. While a number of phosphoproteins were 
identified by LC/MS analysis of the whole cell lysate samples, the use of 
phosphoprotein enrichment methodologies could enable the identification of other 
phosphoproteins not identified in this section, thus offering further insights into the 
effects of temperature-shift on the phosphoproteome of CHO cells. 
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 Quantitative label-free LC/MS analysis of phosphoprotein-enriched 4.2.5
CHO SEAP lysate 
While it is estimated that nearly a third of all proteins are phosphorylated, many of 
these proteins are often low in abundance and require enrichment in order to be 
analysed (Delom and Chevet 2006; Goshe 2006). Although a significant proportion 
of the differentially-expressed proteins identified in the CHO SEAP whole cell lysate 
sample were phosphoproteins, the use of a phosphoprotein enrichment strategy could 
potentially further enhance these results through the identification of an additional 
cohort of phosphoproteins not previously identified in section 4.2.4. As such, a 
phosphoprotein enrichment kit from Pierce® was used to enrich for phosphoproteins 
from the temperature-shift CHO SEAP whole cell lysate samples collected as 
described in section 4.2.1. 
Although eight CHO SEAP whole cell lysate samples were available (four from each 
culture condition, 37˚C and 31˚C), six samples were prepared using a Pierce® 
phosphoprotein enrichment kit as detailed in materials 2.4.1. The resulting 
comparison was based on three samples from each culture condition. Following 
phosphoprotein enrichment, all samples were then prepared for label-free LC/MS as 
detailed materials 2.3.5. After LC/MS analysis of all the samples was complete, 
inclusion lists were generated and analysis on some of the samples was repeated as 
described in section 4.2.4.   
Progenesis label-free software was used to analyse the data acquired following 
LC/MS analysis. Reference run selection was performed on two separate occasions. 
A principal component analysis (PCA) plot generated by Progenesis during data 
analysis showing how the phosphoprotein-enriched samples from 37˚C and 31˚C 
cultures cluster is displayed in Figure 4.2.12. As per section 4.2.4, the lists of 
differentially-expressed proteins were then overlapped and any proteins common to 
both lists were accepted as being differentially-expressed. Similarly, all proteins 
common to both lists also shared common approximate fold-change and fold-change 
direction. No proteins had to be excluded on the basis of differing direction of fold-
change.  
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Figure 4.2.12 PCA plot for CHO SEAP phosphoprotein-enriched whole cell lysate 
sample groups 37˚C (pink) and 31˚C (blue) generated during quantitative label-free 
LC/MS data analysis using Progenesis software 
 
Proteins were considered to be differentially-regulated if its change in relative 
abundance was >1.5 fold. Lists of differentially-regulated proteins were generated 
based on peptides deemed to have a statically significant fold-change (ANOVA 
<0.05) and ion scores >40 when searched against CHO NCBI and CHO BB 
proteomic databases.  
Using the DAVID gene ID tool as described in section 3.0.1.1, functional annotation 
was used to identify all the phosphoproteins in the list obtained from Progenesis 
LC/MS analysis. From an initial list of 79 differentially-expressed proteins, DAVID 
classified 53 of these as being phosphoproteins (p=5.6E-8).  
Because the remaining 26 proteins were not identified as phosphoproteins their 
presence was deemed to be as a result of nonspecific binding during the 
phosphoprotein enrichment step. Of the 53 differentially-expressed phosphoproteins 
identified, 32 were down-regulated  (Table 4.2.37) and 21 were up-regulated at 31˚C 
(Table 4.2.38) 
When the list of differentially-expressed proteins from the phosphoprotein 
enrichment and the whole cell lysate analysis were compared it was found that 10 
proteins were common to both lists. All 10 proteins were expressed in the same 
direction in both lists, with 7 down-regulated at 31˚C compared to 37˚C (Table 
4.2.39) and 3 up-regulated at 31˚C compared to 37˚C (Table 4.2.40). 
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This possibly indicates that the change in expression observed in the 10 proteins 
listed is as a result of change in total abundance rather than a change in 
phosphorylation. It is also possible that a change in both phosphorylation and overall 
abundance occurred. Further work would be required to determine whether it was a 
change in abundance, phosphorylation or both that occurred in this instance. In either 
case, label-free analysis of phosphoprotein-enriched CHO SEAP samples indicates 
that there are changes in the phosphoproteome as a result of temperature-shift. 
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Table 4.2.37 List of phosphoproteins (classified using DAVID as detailed 0), the expression of which decreased at 31˚C compared to 37˚C, 
obtained from quantitative label-free LC/MS analysis of CHO SEAP cells sampled at 36hrs post-temperature-shift. Phosphoproteins were 
enriched from CHO SEAP whole cell lysates using a Pierce phosphoprotein enrichment kit. 
 
Gene Symbol Description Total Peptides Quantitative Peptides Score Anova (p) Fold
MAP1B Microtubule-associated protein 1B 4 4 270 0.01028 5.7
TLN2 Talin-2 4 4 243 0.01471 2.4
GTF2I General transcription factor II-I 3 3 206 0.00154 3.5
ANXA6 Annexin A6 3 3 194 0.00758 4.8
CKAP5 cytoskeleton-associated protein 5-like 2 2 129 0.00059 1.7
TRIP10 Cdc42-interacting protein 4 2 2 121 0.02647 2.4
FLNB filamin-B isoform 1 2 2 119 0.01570 1.7
GAPDH Glyceraldehyde-3-phosphate dehydrogenase 2 2 118 0.00916 4.2
SPTBN1 Spectrin beta chain, brain 1 2 2 114 0.01251 1.8
ACTN1 Alpha-actinin-1 1 1 114 0.00610 26.8
WDR5 WD repeat-containing protein 5 1 1 71 0.03418 2.4
GAPDH Glyceraldehyde-3-phosphate dehydrogenase 1 1 68 0.00073 31.4
CPNE1 Copine-1 1 1 59 0.04534 1.8
NAA25 N-alpha-acetyltransferase 25, NatB auxiliary subunit 1 1 56 0.01961 2.2
ST13 Hsc70-interacting protein 1 1 55 0.04640 19.5
MSH2 DNA mismatch repair protein Msh2 1 1 54 0.04275 2.7
HSP90B1 endoplasmin 1 1 52 0.03358 1.6
SMARCC2 SWI/SNF complex subunit SMARCC2 1 1 52 0.01240 7.3
ARRB1 Beta-arrestin-1 1 1 52 0.01873 1.6
TSC22D1 TSC22 domain family protein 1 1 1 50 0.02784 1.9
SF3A3 splicing factor 3A subunit 3 1 1 49 0.03411 1.6
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PALLD Palladin 1 1 49 0.02294 1.6
UGGT1 UDP-glucose:glycoprotein glucosyltransferase 1 1 1 49 0.02278 4.4
ATP6V1B2 V-type proton ATPase subunit B, brain isoform 1 1 48 0.02725 1.9
CBX5 chromobox protein homolog 5 1 1 48 0.00106 2.0
PFKL 6-phosphofructokinase, liver type 1 1 46 0.04257 2.8
HSPA5 78 kDa glucose-regulated protein 1 1 46 0.00485 1.7
FANCI Fanconi anemia group I protein-like 1 1 45 0.03841 2.8
MVP Major vault protein 1 1 45 0.00498 2.2
TGM2 protein-glutamine gamma-glutamyltransferase 2 1 1 44 0.04733 1.6
RRBP1 Ribosome-binding protein 1 1 1 43 0.04434 4.3
Sept6 Septin-6 1 1 41 0.01275 2.3
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Table 4.2.38 List of phosphoproteins (classified using DAVID as detailed 0), the expression of which increased at 31˚C compared to 37˚C, 
obtained from quantitative label-free LC/MS analysis of CHO SEAP cells sampled at 36hrs post-temperature-shift. Phosphoproteins were 
enriched from CHO SEAP whole cell lysates using a Pierce phosphoprotein enrichment kit. 
 
Gene Symbol Description Total Peptides Quantitative Peptides Score Anova (p) Fold
LMNA Lamin-A/C 3 3 192 0.0005 3.7
IQGAP1 Ras GTPase-activating-like protein IQGAP1 3 3 139 0.0054 2.1
TPR Nucleoprotein TPR 2 2 131 0.0300 1.8
MCM6 DNA replication licensing factor MCM6 2 2 97 0.0103 2.4
EZR Ezrin 2 2 96 0.0068 2.1
EMC8 Neighbor of COX4 1 1 68 0.0170 2.1
FASN fatty acid synthase 1 1 68 0.0416 5.7
EIF4G1 Eukaryotic translation initiation factor 4 gamma 1 1 1 59 0.0351 2.0
EIF3B eukaryotic translation initiation factor 3 subunit B 1 1 58 0.0253 2.7
CCT8 T-complex protein 1 subunit theta 1 1 58 0.0433 1.7
BZW2 Basic leucine zipper and W2 domain-containing protein 2 1 1 57 0.0312 1.5
PTGES3 Prostaglandin E synthase 3 1 1 56 0.0487 3.2
EEF1A1 elongation factor 1-alpha 1 1 1 53 0.0284 1.6
KHSRP Far upstream element-binding protein 2 1 1 52 0.0265 17.8
MYH9 Myosin-9 1 1 52 0.0395 2.5
RPLP0 60S acidic ribosomal protein P0 1 1 48 0.0415 1.9
TPM3 Tropomyosin alpha-3 chain 1 1 47 0.0112 2.7
TK1 thymidine kinase, cytosolic 1 1 45 0.0379 7.5
PABPC1 Polyadenylate-binding protein 1 1 1 45 0.0303 3.9
EIF4A3 Eukaryotic initiation factor 4A-III 1 1 44 0.0034 1.8
AHNAK Neuroblast differentiation-associated protein AHNAK 1 1 44 0.0448 1.5
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Table 4.2.39 List of proteins common to two lists of differentially-expressed proteins, down-regulated at 31˚C compared to 37 ˚C, identified in 
quantitative label-free LC/MS analysis of CHO SEAP whole cell lysate and phosphoprotein-enriched CHO SEAP whole cell lysate. 
 
 
  
Description Sample Total Peptides Quantitative Peptides Score Anova (p) Fold
Whole Cell Lysate 2 2 100 0.0017 2.1
Enrichment 4 4 273 0.0047 5.6
Whole Cell Lysate 2 2 96 0.0055 1.7
Enrichment 3 3 178 0.0018 3.8
Whole Cell Lysate 2 2 98 0.0139 1.7
Enrichment 1 1 59 0.0453 1.8
Whole Cell Lysate 1 1 60 0.0226 1.6
Enrichment 1 1 46 0.0426 2.8
Whole Cell Lysate 1 1 43 0.0027 1.6
Enrichment 1 1 52 0.0395 2.5
Whole Cell Lysate 1 1 78 0.0003 2.1
Enrichment 1 1 49 0.0229 1.6
Whole Cell Lysate 1 1 58 0.0009 3.1
Enrichment 1 1 50 0.0278 1.9
TSC22 domain family protein 1
Microtubule-associated protein 1B
Annexin A6
Copine-1
6-phosphofructokinase, liver type
Myosin-9
Palladin
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Table 4.2.40 List of proteins common to two lists of differentially-expressed proteins, up-regulated at 31˚C, identified in quantitative label-free 
LC/MS analysis of CHO SEAP whole cell lysate and phosphoprotein-enriched CHO SEAP whole cell lysate.  
 
 
 
  
Description Sample Total Peptides Quantitative Peptides Score Anova (p) Fold
Whole Cell Lysate 6 6 385 0.0002 1.7
Enrichment 2 2 141 0.0061 4.2
Whole Cell Lysate 5 3 252 0.0001 2.4
Enrichment 2 2 96 0.0068 2.1
Whole Cell Lysate 1 1 41 0.0299 1.6
Enrichment 1 1 58 0.0253 2.7
Lamin-A/C
Ezrin
Eukaryotic translation initiation factor 3 subunit B
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4.2.5.1 Bioinformatic analysis of differentially-regulated phosphoproteins 
As per section 3.0.1.1, DAVID functional annotation tool was used to analyse the 
label-free data in order to identify enrichment of different processes that may be 
involved in the response to reduced culture temperature. Using a ≤0.05 p-value cut-
off 9 pathways were found to be enriched upon temperature-shift (Table 4.2.41). 
When the number of differentially-expressed proteins associated with each process is 
graphed (Figure 4.2.13) it is evident that the pathways identified are not as well 
defined as the results obtained for those from the analysis of the whole cell lysate 
(section 4.2.4.1). Although it is normally the case that all differentially-expressed 
genes/proteins would be analysed together (to account for the fact that up or down-
regulation may have an inhibitory or stimulating effect on the pathway i.e. down-
regulation of a protein may not necessarily correlate with inhibition of a process), it 
must be remembered that DAVID is a piece of software that merely acts as a guide 
and that any results obtained must be interpreted as such. As a result, in an effort to 
identify more a definitive list of pathways, it was decided that the up-regulated 
proteins from each condition would be searched on DAVID independently of each 
other. This approach provided a somewhat clearer insight as to the processes the 53 
differentially-expressed phosphoproteins might be involved in (Table 4.2.42 and 
Table 4.2.43). Analysis of the proteins up-regulated at 31˚C compared to 37˚C 
indicate that pathways involved in translation and RNA processing may be affected 
by temperature-shift while processes including cytoskeleton organization and the 
generation of precursor metabolites and energy are among those predominantly 
down-regulated at 31˚C compared to 37˚C (Table 4.2.42 and Table 4.2.43). 
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Table 4.2.41 GO biological process enrichment for differentially-expressed 
phosphoproteins identified in quantitative label-free LC/MS analysis of 
phosphoprotein-enriched samples from CHO SEAP cells sampled at 36hrs post- 
temperature-shift. Enrichment was considered significant upon observation of a p-
value ≤0.05. Gene Count corresponds to the number of gene symbols from the list of 
differentially-regulated proteins that are implicated in a particular GO category. 
 
 
Figure 4.2.13 GO biological process enrichment for differentially-expressed 
phosphoproteins identified in quantitative label-free LC/MS analysis of 
phosphoprotein-enriched samples from CHO SEAP cells sampled at 36hrs post 
temperature-shift. Enrichment was considered significant upon observation of an 
adjusted p-value ≤0.05 (Benjamini). Gene Count corresponds to the number of gene 
symbols from the list of differentially-regulated proteins that are implicated in a 
particular GO category. This graph shows the breakdown of the gene counts in those 
enriched pathways. 
 
 
Term Count P-Value
cytoskeleton organization 9 0.0001
cytoskeletal anchoring at plasma membrane 3 0.0003
establishment of RNA localization 5 0.0003
nucleic acid transport 5 0.0003
RNA transport 5 0.0003
RNA localization 5 0.0004
nucleobase, nucleoside, nucleotide and nucleic acid transport 5 0.0006
maintenance of location 4 0.0013
mRNA transport 4 0.0032
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Table 4.2.42 GO biological process enrichment for phosphoproteins identified as 
up-regulated at 31˚C compared to 37˚C in quantitative label-free LC/MS analysis of 
phosphoprotein-enriched samples from CHO SEAP cells sampled at 36hrs post- 
temperature-shift. Enrichment was considered significant upon observation of a p-
value ≤0.05. Gene Count corresponds to the number of gene symbols from the list of 
differentially-regulated proteins that are implicated in a particular GO category. 
 
 
 
Table 4.2.43 GO biological process enrichment for phosphoproteins identified as 
down-regulated at 31˚C compared to 37˚C in quantitative label-free LC/MS analysis 
of phosphoprotein-enriched samples from CHO SEAP cells sampled at 36hrs post-
temperature-shift. Enrichment was considered significant upon observation of a p-
value ≤0.05. Gene Count corresponds to the number of gene symbols from the list of 
differentially-regulated proteins that are implicated in a particular GO category. 
 
 
 
  
Term Count P-Value
translation 5 0.00065
posttranscriptional regulation of gene expression 4 0.0022
mRNA transport 3 0.0052
nucleic acid transport 3 0.0065
RNA transport 3 0.0065
establishment of RNA localization 3 0.0065
RNA localization 3 0.0068
nucleobase, nucleoside, nucleotide and nucleic acid transport 3 0.0087
regulation of translation 3 0.013
RNA splicing 3 0.049
Term Count P-Value
cytoskeleton organization 7 0.00022
maintenance of location 3 0.0077
cytoskeletal anchoring at plasma membrane 2 0.016
generation of precursor metabolites and energy 4 0.026
protein localization 6 0.033
negative regulation of apoptosis 4 0.036
negative regulation of programmed cell death 4 0.037
negative regulation of cell death 4 0.037
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4.2.5.2 Summary 
Although a large number of the differentially-expressed proteins identified in the 
label-free analysis of the whole cell lysate were phosphoproteins, phosphoprotein 
enrichment of these samples helped to further increase proteome coverage, 
identifying 36 differentially-expressed phosphoproteins which were not seen in the 
whole cell lysate study (53 differentially-expressed phosphoproteins were identified 
in total, >1.5 fold-change, ANOVA <0.05). The identification of these additional 
proteins revealed enrichment of cytoskeleton organisation pathways by GO analysis. 
To enable identification of site-specific phosphorylation however, further enrichment 
would be required.  
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 Quantitative label-free LC/MS analysis of a Gallium oxide 4.2.6
phosphopeptide enrichment of a phosphoprotein-enriched CHO SEAP 
lysate 
Upon completion of phosphoprotein-enrichment of whole cell lysate CHO SEAP 
samples, 100µg of each sample underwent a phosphopeptide enrichment using 
Gallium Oxide spin columns. It was hoped that by coupling this second methodology 
with phosphoprotein enrichment it would greatly improve the number of 
phosphopeptides identified during LC/MS analysis and allow changes in site-specific 
phosphorylation to be detected.  
Progenesis label-free software was used to analyse the data acquired following 
LC/MS analysis. A principal component analysis (PCA) plot generated by 
Progenesis during data analysis showing how the gallium phosphopeptide-enriched 
samples from 37˚C and 31˚C cultures cluster and is displayed in Figure 4.2.14. A 
phosphopeptide was considered to be differentially-regulated if its change in relative 
abundance was >1.5 fold. Lists of differentially-regulated phosphopeptides were 
generated based on peptides deemed to have a statically significant fold-change 
(ANOVA <0.05) and peptide ion scores >40 when searched against CHO NCBI and 
CHO BB proteomic databases.  
 
Figure 4.2.14 PCA plot for CHO SEAP gallium phosphopeptide enriched whole cell 
lysate, phosphoprotein pre-enriched, sample groups 37˚C (pink) and 31˚C (blue) 
generated during quantitative label-free LC/MS data analysis using Progenesis 
software. It should be noted that the five spots from each condition represent the 
enriched samples that were originally analysed and two subsequent inclusion list 
runs for each condition used to obtain additional peptide information. 
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Quantitative label-free analysis of a gallium oxide phosphopeptide enrichment of 
phosphoprotein-enriched CHO SEAP samples subject to temperature-shift identified 
8 phosphopeptides as being differentially-expressed. Of the 8 phosphopeptides, 1 
showed decreased expression at 31˚C (Table 4.2.44) while the remaining 7 were up-
regulated at 31˚C compared to 37˚C (Table 4.2.45). All differentially-expressed 
phosphopeptides identified came from unique proteins.  
Due to the low number of phosphopeptides identified bioinformatic analysis was not 
carried out as the sample set is too small to obtain meaningful statistically significant 
information. Instead each protein was manually searched against UniProtKB and the 
biological process as described for the human version of the protein was used to infer 
biological function on the CHO version identified. In addition to this, each protein 
was also searched against the literature to confirm the biological function involved.  
As a result of this search, the proteins COP9 signalosome complex subunit 1 and 
PITSLRE serine/threonine-protein kinase CDC2L1, also known as Cyclin-dependent 
kinase 11B, were identified as being involved in cell cycle progression and 
translation initiation factor eIF-2B subunit epsilon-like is known to have roles in 
protein synthesis.  
In order to determine whether the change in phosphopeptide expression was as a 
result of an increase in phosphorylated form of the peptide or an increase in total 
protein abundance, the protein names of the differentially-expressed 
phosphopeptides identified were searched against the list of differentially-expressed 
proteins from the whole cell lysate and phosphoprotein enrichment analysis. As a 
result of this comparison the only protein identified as common to the gallium 
enrichment and whole cell lysate / phosphoprotein enrichment list was DNA 
replication licensing factor MCM2 (as denoted with ^ in Table 4.2.45). A 
comparison between the differentially-expressed protein names and qualitative lists 
of proteins from whole cell lysate and phosphoprotein enrichment analysis were also 
compared. Interestingly, the proteins Nucleolar phosphoprotein p130, COP9 
signalosome complex subunit 1 and 182 kDa tankyrase-1-binding protein were 
identified in the qualitative lists. The presence of these proteins in the qualitative list 
and not in the quantitative proteins lists indicates that the total abundance of these 
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proteins does not change but the phosphorylated form of the peptide did alter in 
abundance.  
Although the remaining phosphopeptides were identified as changing in abundance, 
without further analysis it is unclear whether this is as a result of an increase in total 
protein, phosphorylated peptide or both. It should be noted that further proteomic 
analysis including further fractionation or enrichment would be required to 
determine the total abundance of the remaining proteins, especially if the 
endogenous protein was found to be expressed at low levels within the cell. 
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Table 4.2.44 List of differentially-expressed phosphopeptides, down-regulated at 31˚C compared to 37˚C, obtained from quantitative label-free 
LC/MS analysis of CHO SEAP cells sampled at 36hrs post-temperature-shift. Phosphopeptides were enriched from phosphoprotein-enriched 
CHO SEAP whole cell lysate samples using gallium oxide phosphopeptide enrichment. 
 
Table 4.2.45 List of differentially-expressed phosphopeptides, up-regulated at 31˚C compared to 37˚C, obtained from quantitative label-free 
LC/MS analysis of CHO SEAP cells sampled at 36hrs post-temperature-shift. Phosphopeptides were enriched from phosphoprotein-enriched 
CHO SEAP whole cell lysate samples using gallium oxide phosphopeptide enrichment. (Note: † indicates proteins that don’t change in total 
abundance. ^ denotes proteins that do change in total abundance.) 
 
 
Gene Symbol Sequence Description Score Anova Fold Function
CDK11B DLLSDLQDISDSER PITSLRE serine/threonine-protein kinase CDC2L1 60 0.0225 7.4 Cell cycle
Gene Symbol Sequence Description Score Anova Fold Function
NOLC1 NETAEEAGTPQAK† Nucleolar phosphoprotein p130 55 0.0227 2.2 Mitosis
EIF2B5 AVSPQLDDIK Translation initiation factor eIF-2B subunit epsilon-like 49 0.0429 1.9 Translation
GPS1 EGSQGELTPANSQSR† COP9 signalosome complex subunit 1 47 0.0069 2.0 Cell cycle
MCM2 ISDPLTSSPGR^ DNA replication licensing factor MCM2 44 0.0188 2.0 Cell cycle
CHAMP1 KSSPASLDFSESQK Zinc finger protein 828 42 0.0314 2.0 Structural
TNKS1BP1 SAEEGEVTESK† 182 kDa tankyrase-1-binding protein 42 0.0426 2.6 Miscellaneous
SAFB2 APTASLSPEPQDSK Scaffold attachment factor B2 41 0.0083 2.5 Transcription
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Figure 4.2.15 shows an example of MS/MS fragmentation spectrum output from a 
MASCOT search resulting in the identification of the phosphopeptide 
“DLLSDLQDISDSER” belonging to the protein PITSLRE serine/threonine-protein 
kinase CDC2L1. The file searched on MASCOT contained only those MS features 
deemed by Progenesis label-free LC/MS software as having a statistically significant 
differential expression (ANOVA value <0.05). Figure 4.2.16 is an example of the 
same phosphopeptide, “DLLSDLQDISDSER”, identified following a qualitative 
search of all LC/MS raw files from mass spectral analysis of gallium oxide 
Phosphopeptide-enriched CHO SEAP lysate samples, pre-enriched for 
phosphoproteins, using SEQUEST search algorithm (detailed section 2.4.6). The use 
of phosphorylation site localisation algorithm PhosphoRS during qualitative analysis 
of the mass spectral data also identified phosphorylation of the serine, tenth amino 
acid residue, as being phosphorylated with a >99% level of confidence. When 
enriched samples from 37˚C and 31˚C cultures were analysed using Progenesis 
software, the phosphopeptide “DLLSDLQDISDSER” was identified as being 
differentially-expressed. The large error bars in both 37˚C and 31˚C sample clusters 
are as a result of an outlier in each sample group. Despite this, Progenesis identified 
“DLLSDLQDISDSER” as being 7.4-fold up-regulated at 37˚C (ANOVA 0.0225) 
(Figure 4.2.17).  
The overall number of differentially-expressed phosphopeptides identified was lower 
than expected. A qualitative review of the LC/MS data revealed 105 
phosphopeptides were identified using Gallium oxide phosphopeptide enrichment. 
The number of phosphopeptides identified could potentially be due to the reduced 
protein population present in the sample as a result of phosphoprotein enrichment. 
This cohort was further reduced when the criteria for differential expression was 
introduced. 
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Figure 4.2.15 (A) MS/MS fragmentation spectrum output from a MASCOT search 
of MS features deemed by Progenesis label-free LC/MS software have a statistically 
significant differential expression (ANOVA value ≤0.05) resulting in the 
identification of the phosphopeptide “DLLSDLQDISDSER” belonging to the 
protein PITSLRE serine/threonine-protein kinase CDC2L1. (B) The b-and y-ion 
series used for phosphopeptide identification via MASCOT are indicated. 
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Figure 4.2.16 (A) MS/MS fragmentation spectrum output from a SEQUEST search 
of raw files from the LC/MS analysis of gallium oxide phosphopeptide enriched 
CHO SEAP whole cell lysate subject to temperature-shift, pre-enriched for 
phosphoproteins, resulting in the identification of the phosphopeptide 
“DLLSDLQDISDSER” belonging to the protein PITSLRE serine/threonine-protein 
kinase CDC2L1. (B) The b-and y-ion series used for phosphopeptide identification 
via SEQUEST are indicated. 
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Figure 4.2.17 Progenesis label-free LC/MS output showing normalised abundance 
of the phosphopeptide “DLLSDLQDISDSER” indicating its 7.39-fold down-
regulation at 31˚C compared to 37˚C (ANOVA 0.0225). 
 
 
 
 
 
 
  37˚C            31˚C 
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4.2.6.1 Summary 
While Gallium phosphopeptide enrichment of phosphoprotein-enriched whole cell 
lysate samples facilitated differential expression and site-specific phosphorylation 
information to be gathered, the total number was lower than expected. However, this 
is clearly as a result of the number of phosphoproteins identified in the 
phosphoprotein enrichment sample. Nonetheless, this information was useful in 
forming an overall picture of changes taking place in the phosphoproteome of 
temperature-shifted CHO cells. Phosphopeptide enrichment of a whole cell lysate 
could yield greater numbers of phosphopeptides given that the number of proteins in 
the sample prior to phosphopeptide enrichment would be significantly higher.  
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 Quantitative label-free LC/MS analysis of titanium dioxide 4.2.7
phosphopeptide enriched CHO SEAP whole cell lysate 
Due to the low number of differentially-expressed phosphopeptides identified using 
phosphopeptide enrichment of a sample pre-enriched for phosphopeptides (section 
4.2.6), it was decided that a phosphopeptide enrichment of a whole cell lysate may 
yield better results. As such, 500µg aliquots of the eight CHO SEAP whole cell 
lysate samples collected from shake flask cultures sampled at 36hrs post- 
temperature-shift were enzymatically digested and phosphopeptide enriched using 
titanium dioxide spin columns as detailed in materials 2.4.4. Phosphopeptide 
enriched samples were then prepared for label-free LC/MS as detailed in section 
2.4.6. After mass spectral analysis of all the samples was complete, inclusion lists 
were generated and analysis on some of the samples was repeated as described in 
section 4.2.4.  
Progenesis label-free software was used to analyse the data acquired following 
LC/MS analysis. Reference run selection was performed on two separate occasions 
and phosphopeptides common between the two lists generated were accepted as 
being differentially-regulated as outlined in materials and methods 2.5.8. A principal 
component analysis (PCA) plot generated by Progenesis during data analysis 
showing how the titanium phosphopeptide enriched samples from 37˚C and 31˚C 
cultures cluster and is displayed in Figure 4.2.18.  
 
Figure 4.2.18 PCA plot for CHO SEAP titanium dioxide Phosphopeptide enriched 
whole cell lysate sample groups 37˚C (pink) and 31˚C (blue) generated during 
quantitative label-free LC/MS data analysis using Progenesis software.  
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The list of differentially-expressed phosphopeptides was then compared to the lists 
of differentially-expressed proteins from the two separate CHO SEAP whole cell 
lysate and phosphoprotein-enriched analyses (section 4.2.4 and 4.2.5) and any 
phosphopeptides identified as belonging to a protein that changed in expression in 
the whole cell lysate or the phosphoprotein enrichment analysis were noted 
(indicated by ^ in the tables). Although the phosphopeptides identified changed in 
relative abundance, changes in the abundance of the total protein may also produce 
the same effect. While it is possible that an increase in the level of the total protein 
and the phosphorylated form of the protein may have occurred, these peptides were 
highlighted to indicate that further work may be required to identify the precise 
cause of the change in abundance.  
Conversely, proteins identified in qualitative lists from whole cell lysate and 
phosphoprotein enrichment are indicated by † to denote that while the expression of 
the phosphopeptide does alter, the total protein does not change in abundance as 
outlined in section 4.2.6. 
Phosphopeptides were considered to be differentially-regulated if their change in 
relative abundance was >1.5 fold. Lists of differentially-regulated proteins were 
generated based on peptides deemed to have a statically significant fold-change 
(ANOVA <0.05) and peptide ion scores >40 when searched against CHO NCBI and 
CHO BB proteomic databases. Based on the phosphopeptides found to be common 
from the two independent analyses on Progenesis label-free software, this list 
identified 33 unique phosphopeptides as being differentially-expressed, 18 down-
regulated (Table 4.2.46) and 15 up-regulated at 31˚C (Table 4.2.47). 
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Table 4.2.46 List of differentially-expressed phosphopeptides, down-regulated at 31˚C compared to 37˚C, obtained from quantitative label-free 
LC/MS analysis of CHO SEAP cells sampled at 36hrs post-temperature-shift. Phosphopeptides were enriched from CHO SEAP whole cell 
lysates using titanium dioxide phosphopeptide enrichment. (Note: * denotes phosphopeptides with MS3 information. † indicates proteins that 
don’t change in total abundance. . ^ indicates proteins that do change in total abundance.) 
 
Gene Symbol Sequence Description Score Anova Fold Function
OSBPL11 SFSLASSGNSPISQR* Oxysterol-binding protein-related protein 11 73 0.0041 2.0 Lipid transport
N/A SSSLDALGPSR* Uncharacterized protein C1orf198 homolog 70 0.0000 6.2 Unknown
ANAPC1 SPSISNMAALSR* Anaphase-promoting complex subunit 1 69 0.0258 1.5 Cell division
ARHGEF5 LDSLAEAPGLSSPR Rho guanine nucleotide exchange factor 5 67 0.0016 2.2 Positive regulation of Rho GTPase activity
GAPVD1 SSDIVSSVR* GTPase-activating protein and VPS9 domain-containing protein 1 65 0.0255 1.8 Positive regulation of GTPase activity
TLE3 ESSANNSVSPSESLR* Transducin-like enhancer protein 3-like isoform 1 61 0.0398 1.5 Transcription
RAPH1 TASAGTVSDAEVR* Ras-associated and pleckstrin homology domains-containing protein 1 59 0.0052 1.6 Regulates membrane 
signalling
LSM12 TETPPPLASLNVSK† Protein LSM12 homolog 55 0.0005 2.9 Unknown
SRRM2 SPGMLEPLGSAR*^ Serine/arginine repetitive matrix protein 2 54 0.0027 2.4 mRNA processing
ELMOD3 SSELTEAVETK ELMO domain-containing protein 3 53 0.0003 2.5 Miscellaneous
FRS2 LTSTSTSDTQNINNSAQR Fibroblast growth factor receptor substrate 2 53 0.0019 8.0 Multiple
DENND4C VPSGLFDTNNR* DENN domain-containing protein 4C 51 0.0026 3.4 Protein transport
SH3PXD2A NESLTATDSLR* SH3 and PX domain-containing protein 2A 50 0.0169 2.0 Miscellaneous
EIF4G3 SPVAATVVQR* Eukaryotic translation initiation factor 4 gamma 3 47 0.0060 3.7 Translation
ZYX SPGGPGPLTLK*† Zyxin 42 0.0077 1.5 Cell Adhesion
MPDZ GSLPQVSSPR multiple PDZ domain protein-like isoform 1 42 0.0167 2.0 Miscellaneous
KIF14 ESSLLGSELGDTTTK Kinesin-like protein KIF14 42 0.0190 2.5 Cytokinesis
NUP88 EDAEVAESPLR Nuclear pore complex protein Nup88 40 0.0070 2.0 mRNA transport
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Table 4.2.47 List of differentially-expressed phosphopeptides, up-regulated at 31˚C compared to 37˚C, obtained from label-free LC/MS analysis 
of CHO SEAP cells sampled at 36hrs post-temperature-shift. Phosphopeptides were enriched from CHO SEAP whole cell lysates using titanium 
dioxide phosphopeptide enrichment. (Note: * denotes phosphopeptides with MS3 information. † indicates proteins that don’t change in total 
abundance. . ^ indicates proteins that do change in total abundance.) 
 
  
Gene Symbol Sequence Description Score Anova Fold Function
NDRG1 TASGSSVTSLEGPR* Protein NDRG1 88 4.40E-07 16.5 Miscellaneous
RIN2 QASFLEAEGSAK* Ras and Rab interactor 2 79 0.0006 2.4 Positive regulation of GTPase 
activity
EIF5B VEIFSGSEDDDDSNK* Eukaryotic translation initiation factor 5B-like 71 0.0333 2.4 Translation
TRIM28 SGEGEVSGLMR* Transcription intermediary factor 1-beta 69 0.0447 1.6 Transcription
AGPAT9 NSASVGIIQR* Glycerol-3-phosphate acyltransferase 3 61 0.0105 1.7 Lipid metabolism
VAPB SLTSSLDDAEVKK* Vesicle-associated membrane protein-associated protein B 56 0.0048 3.0 Unfolded protein response
Tmpo QDFESLSPPR^ Lamina-associated polypeptide 2, isoforms alpha/zeta 55 0.0013 2.0 Transcription
TSC22D1 VDVESGSSAAGTPPLSR TSC22 domain family protein 4 54 0.0074 1.5 Transcription
MYBBP1A SPSLLQSVVK*^ Myb-binding protein 1A 52 0.0005 2.3 Transcription
NDRG1 SRTASGSSVTSLEGPR* Protein NDRG1 49 0.0001 39.7 Miscellaneous
BAIAP2L1 SISTVDLTEK Brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 1 46 0.0024 2.0
Regulation of actin 
cytoskeleton reorganization
SMARCA4 EVDYSDSLTEK Transcription activator BRG1 44 0.0001 2.8 Transcription
CDC42EP1 LNFDSSPTSSTDGR Cdc42 effector protein 1 44 0.002 1.7 Multiple
PDCD4 SGVPVPTSPK Programmed cell death protein 4 42 0.0004 2.1 Apoptosis
HUWE1 HADHSSLTLGSGSSTTR^ E3 ubiquitin-protein ligase HUWE1 41 0.0042 2.7 DNA repair
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An example of an MS/MS fragmentation spectrum output from a MASCOT search 
that resulted in the identification of the phosphopeptide “TASGSSVTSLEGPR” 
from Protein NDRG1 is shown in (Figure 4.2.19). The file used in this MASCOT 
search contained only MS/MS information from those features deemed as having a 
statistically significant differential expression (ANOVA value ≤0.05) by Progenesis 
label-free LC/MS software. Following a qualitative search of all LC/MS raw files 
from mass spectral analysis of titanium dioxide phosphopeptide enriched CHO 
SEAP lysates using the SEQUEST search algorithm (detailed section 2.4.6), the 
same phosphopeptide, “TASGSSVTSLEGPR”, was also identified as evidenced by 
the MS/MS output in (Figure 4.2.20 A). Phosphorylation of the third amino acid 
residue, serine, was identified as being phosphorylated with a >99% level of 
confidence by the phosphorylation site localisation algorithm PhosphoRS. 
MS/MS/MS information was also obtained on this peptide during mass spectral 
analysis as can be seen in (Figure 4.2.20 B) providing further proof of the 
phosphorylation of this phosphopeptide.  Figure 4.2.21 shows an output from 
Progenesis label-free analysis identifying “TASGSSVTSLEGPR” as being 16.5-fold 
up-regulated at 31˚C (ANOVA 4.40E-07). 
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Figure 4.2.19 (A) MS/MS fragmentation spectrum output from a MASCOT search 
of MS features deemed by Progenesis label-free LC/MS software have a statistically 
significant differential expression (ANOVA value ≤0.05) resulting in the 
identification of the phosphopeptide “TASGSSVTSLEGPR” belonging to Protein 
NDRG1. (B) The b-and y-ion series used for phosphopeptide identification via 
MASCOT are indicated. 
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Figure 4.2.20 (A) MS/MS fragmentation spectrum output from a SEQUEST search of raw files from the LC/MS analysis of titanium dioxide phosphopeptide enriched CHO 
SEAP whole cell lysate subject to temperature-shift resulting in the identification of the phosphopeptide “TASGSSVTSLEGPR” belonging to Protein NDRG1. (B) The b-and 
y-ion series used for phosphopeptide identification of the MS/MS are indicated. (C) MS/MS/MS fragmentation spectrum of the peptide “TASGSSVTSLEGPR” following the 
loss of phosphate (D) The b-and y-ion series used as further evidence of phosphopeptide identification are indicated.  
(A) 
(C) 
(B) 
(D) 
 274 
 
 
 
 
Figure 4.2.21 Progenesis label-free LC/MS output showing normalised abundance 
of the phosphopeptide “TASGSSVTSLEGPR” from the Protein NDRG1 indicating 
its 16.5-fold up-regulation at 31˚C compared to 37˚C (ANOVA 4.4E-07). 
 
 
  
  37˚C       31˚C 
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4.2.7.1 Bioinformatic analysis of differentially-expressed phosphopeptides 
enriched using titanium dioxide 
Differentially-expressed phosphopeptides identified through the label-free LC/MS 
analysis of titanium dioxide phosphopeptide enrichment of CHO SEAP whole cell 
lysates subject to temperature-shift were analysed using DAVID. This was carried 
out in order to determine what pathways were potentially involved in the cellular 
response to temperature-shift. Unfortunately however, this analysis did not provide 
any further insight into processes that may be involved (data not shown). This could 
possibly be due to the relatively small number of proteins being analysed, as DAVID 
was designed for the analysis of larger data sets involving extensive lists of 
genes/proteins. In addition to this, pathway activation via phosphorylation events can 
be complex and may not be possible to fully interpret using functional annotation 
analysis such as DAVID. 
Through manual searching of protein function through a combination of literature 
mining and using protein databases such as UniProt a number of potentially 
interesting proteins were identified. Transcription activator BRG1 and Programmed 
cell death protein 4, both of which have been linked to negative regulation of cell 
cycle progression, were up-regulated at 31˚C compared to 37˚C (Table 4.2.47). 
Protein NDRG1, also up-regulated at 31˚C, is known to be involved in cell stress 
response and growth arrest (Ellen et al. 2008; Wakisaka et al. 2003). Conversely, 
growth promoting Eukaryotic translation initiation factor 4 gamma 3 was down-
regulated at 31˚C compared to 37˚C (Table 4.2.46). 
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4.2.7.2 Summary 
Phosphopeptide enrichment of CHO SEAP whole cell lysate using titanium dioxide 
significantly improved the number of phosphopeptides identified compared to 
phosphopeptide enrichment of a phosphoprotein-enriched whole cell lysate sample. 
Using quantitative label-free LC/MS 33 differentially-expressed phosphopeptides 
were identified, of which 15 were up-regulated at 31˚C. Despite the larger number of 
phosphopeptides with site-specific information obtained, GO analysis did not reveal 
any enrichment of process pathways. A number of proteins involved in translation 
were identified through literature mining however. The utilization of a second 
phosphopeptide enrichment methodology to complement titanium oxide could 
increase coverage of the phosphoproteome of CHO cells, providing further 
information on the effects of temperature-shift. 
 
 
  
 277 
 
 Quantitative label-free LC/MS analysis of an Iron oxide phosphopeptide 4.2.8
enriched CHO SEAP whole cell lysate 
In order to further profile the phosphoproteome of CHO cells a second 
phosphopeptide enrichment was employed. It was hoped that the use of an Iron oxide 
based phosphopeptide enrichment would complement the titanium dioxide 
enrichment carried out in section 4.2.7 and provide greater coverage of the 
phosphoproteome. Similar to titanium dioxide enrichment described previously, 
500µg of all eight CHO SEAP whole cell lysate samples from temperature-shifted 
and non-temperature-shifted samples were phosphopeptide enriched using Iron oxide 
spin columns as detailed in materials 2.4.5. Phosphopeptide enriched samples were 
then prepared for quantitative label-free LC/MS as detailed in section 2.4.6.  
As detailed in section 4.2.7, to determine whether the differential expression of the 
phosphopeptide could be the result of a change in the abundance of the protein as 
opposed to a change in the level of phosphorylation, the lists of differentially-
expressed phosphopeptides was compared to the lists of differentially-expressed 
proteins from the CHO SEAP whole cell lysate and phosphoprotein-enriched 
analyses (sections 4.2.4 and 4.2.5). Any proteins identified as being differentially-
expressed in both the iron-enriched and whole cell lysate / phosphoprotein-enriched 
analysis were then indicated by ^ in the iron list. As described in section 4.2.6, the 
protein names of the phosphopeptides were also searched against qualitative lists 
from the analysis of whole cell lysate and phosphoprotein enrichment. Proteins 
identified as being common to the differentially-expressed phosphopeptide lists and 
qualitative lists are denoted by an †. This is indicative of a change in the abundance 
of the phosphopeptide as opposed to a change in the abundance of the total protein. 
Progenesis label-free software was used to analyse the LC/MS data in duplicate and 
the same criteria applied to define differentially-expressed phosphopeptides was 
applied as detailed in section 2.5.8. A principal component analysis (PCA) plot 
generated by Progenesis during data analysis showing how the Iron phosphopeptide 
enriched samples from 37˚C and 31˚C cultures cluster and is displayed in Figure 
4.2.22.  
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Figure 4.2.22 PCA plot for CHO SEAP Iron phosphopeptide enriched whole cell 
lysate sample groups 37˚C (pink) and 31˚C (blue) generated during quantitative 
label-free LC/MS data analysis using Progenesis software. It should be noted that the 
five spots from each condition represent the four enriched samples that were 
originally analysed and an additional run based on an inclusion list for each 
condition that was used to obtain additional peptide information 
 
As a result of this analysis 60 unique phosphopeptides were identified as 
differentially-expressed when lists from two independent analyses of LC/MS label-
free data were compared. Of these, 38 were down-regulated at 31˚C (Table 4.2.48), 
while the remaining 22 were up-regulated 31˚C compared to 37˚C (Table 4.2.48). 
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Table 4.2.48 List of differentially-expressed phosphopeptides, down-regulated at 31˚C compared to 37˚C, obtained from quantitative label-free 
LC/MS analysis of CHO SEAP cells sampled at 36hrs post-temperature-shift. Phosphopeptides were enriched from CHO SEAP whole cell 
lysates using iron oxide phosphopeptide enrichment. (Note: * denotes phosphopeptides with MS3 information. † indicates proteins that don’t 
change in total abundance. . ^ indicates proteins that do change in total abundance.) 
 
Gene Symbol Sequence Description Score Anova Fold Function
Nr2c2 IQIISTDSAVASPQR Nuclear receptor subfamily 2 group C member 2 84 0.0011 2.6 Transcription
SAPCD2 SPSADASAAVCK* Protein C9orf140 homolog 79 0.0041 1.8 Unknown
SPAST APSCSGLSMVSGGR* Spastin 78 0.0469 1.8 Cell Division
GIGYF1 SIEEGDGAFGR* PERQ amino acid-rich with GYF domain-containing protein 1 68 0.0348 15.9 Involved in tyrosine kinase 
receptor signalling
ANAPC1 SPSISNMAALSR Anaphase-promoting complex subunit 1 65 0.0250 1.9 cell division
TBC1D5 VEQALSEVASSLQSSAPK Tetratricopeptide repeat protein 7B 62 0.0122 4.7 Unknown
EIF4G3 TSSPTTLAPLAR Eukaryotic translation initiation factor 4 gamma 3 60 0.0182 3.6 Translation
CCDC88A SSSQENLLDEVMK
 † Girdin 60 0.0276 5.1 Cell proliferation
ARID5B AVSPLDPAK AT-rich interactive domain-containing protein 5B 60 0.0461 2.0 Transcription
PHF12 TTSPSSDTDLLDR PHD finger protein 12 59 0.0360 2.0 Transcription
MAP1B SDISPLTPR^ Microtubule-associated protein 1B 57 0.0003 7.6 Structural
ELMOD3 SSELTEAVETK* ELMO domain-containing protein 3 57 0.0024 2.7 Miscellaneous
NEK1 SESMPVQLNK TBC1 domain family member 5 56 0.0125 2.7 Unknown
GOLGA4 SEASPPQSGDTQTFAQK Golgin subfamily A member 4 55 0.0384 1.9 Unknown
URI1 SLSCEEASEGR* Unconventional prefoldin RPB5 interactor 55 0.0001 3.3 Transcription
KMT2D ASQVEPQSPGLGLR Histone-lysine N-methyltransferase MLL2 54 0.0352 3.2 Transcription
EIF4G3 SPVAATVVQR* Eukaryotic translation initiation factor 4 gamma 3 54 0.0001 3.6 Translation
ARHGAP17 SSGTNFQGLPSK Rho GTPase-activating protein 17 54 0.0130 2.1 Positive regulation of GTPase activity
DTD1 SASSGAEGDVSSEREP D-tyrosyl-tRNA(Tyr) deacylase 1 53 0.0012 2.1 DNA replication
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ZNF687 AVVLPGGNVTSPK Zinc finger protein 687 53 0.0471 2.1 Transcription
MYO9A AASTDLGAGEAVVGK Myosin-IXa 51 0.0288 2.7 Positive regulation of GTPase activity
UBN1 ICSDEEEDEEKGGR Ubinuclein-1 51 0.0214 2.8 Miscellaneous
CDCA8 LTAEAIQTPLK Borealin 50 0.0421 3.1 Cell cycle
ACAP2 SSPSTGSLDSGNESK Arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2 49 0.0292 2.9
Positive regulation of 
GTPase activity
ATF2 NDSVIVADQTPTPTR* Cyclic AMP-dependent transcription factor ATF-2 49 0.0000 7.4 Transcription
PUM1 RDSLTGSSDLYK* Pumilio homolog 1 46 0.0184 2.1 Translation
SPAG9 NVSTDSVENEEK C-Jun-amino-terminal kinase-interacting protein 4 45 0.0471 2.0 Activation of JUN kinase 
activity
TLN2 LDEGTPPEPK Talin-2 45 0.0398 1.7 Structural
MAST2 KLSNPDLFSSTGK* Microtubule-associated serine/threonine-protein kinase 2 45 0.0062 3.0 Miscellaneous
FNBP1L TISDGTISASK* Formin-binding protein 1-like 44 0.0112 2.7 Autophagy
NFIB DQDMSSPTTMK Nuclear factor 1 B-type 44 0.0010 3.1 Transcription
AMOTL2 TASLDSVATTR Angiomotin-like protein 2 44 0.0020 4.6 Wnt signalling pathway
HEG1 EAIEMHENGSTK* Protein HEG-like 1 43 0.0436 2.4 Cell membrane
ZKSCAN3 MEDVAPGLSPR Zinc finger protein with KRAB and SCAN domains 3 42 0.0032 7.1 Transcription
OSBPL3 ALVHQLSNESR* Oxysterol-binding protein-related protein 3 41 0.0000 5.3 Lipid transport
BOD1L1 RGSISQEITK* Biorientation of chromosomes in cell division protein 1-like 41 0.0492 1.9 DNA Binding
EMSY LTSPVTSISPIQASEK Protein EMSY 41 0.0156 2.6 Transcription
NEK1 TCSLPDLSK Serine/threonine-protein kinase Nek1 40 0.0076 2.3 Cell division
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Table 4.2.49 List of differentially-expressed phosphopeptides, up-regulated at 31˚C, obtained from quantitative label-free LC/MS analysis of 
CHO SEAP cells sampled at 36hrs post-temperature-shift. Phosphopeptides were enriched from CHO SEAP whole cell lysates using iron oxide 
phosphopeptide enrichment. (Note: * denotes phosphopeptides with MS3 information. † indicates proteins that don’t change in total abundance. . 
^ indicates proteins that do change in total abundance.) 
 
Gene Symbol Sequence Description Score Anova Fold Function
DTL AGLVMVASSQTTPAK Denticleless protein homolog 69 0.0221 1.8 Cell division
CDC42EP1 LNFDSSPTSSTDGR Cdc42 effector protein 1 63 0.0028 1.8 Multiple
KTN1 EIQNGAIHESDSENVLR* † Kinectin 61 0.0059 3.3 Microtubule-based movement
KTN1 KNQNGAIHESDSENVLR† Kinectin 61 0.0059 3.3 Microtubule-based movement
FAT1 DMPAAGSLGSSSR^ Protocadherin Fat 1 59 0.0268 2.2 Cell adhesion.
DDX21 KSPSEDDMEPPK*^ Nucleolar RNA helicase 2 57 0.0119 1.7 RNA processing
N/A VLQPSPVSPSDTDTR Component of  gems 4-like 55 0.0014 3.7 mRNA processing
FAM53B SSSFSLPAR Protein FAM53B-like 53 0.0223 1.8 mRNA processing
NDRG1 SRTASGSSVTSLEGPR Protein NDRG1 52 0.0020 230.5 Miscellaneous
PSMA5 GVNTFSPEGR^ Proteasome subunit alpha type-5 51 0.0004 3.0 Cell cycle
TRIP12 DDSLDLSPQGR* Probable E3 ubiquitin-protein ligase TRIP12 51 0.0167 2.0 Protein degradation
NCL GLSEDTTEETLK*^ Nucleolin 50 0.0036 5.1 Miscellaneous
EFS LPSTESLSR Embryonal Fyn-associated substrate 49 0.0364 2.0 Cell adhesion.
ATF7 TDSVIIADQTPTPTR Cyclic AMP-dependent transcription factor ATF-7 46 0.0098 9.8 Transcription
PSAT1 ASLYNAVTTEDVEK*^ Phosphoserine aminotransferase 46 0.0059 5.0 Miscellaneous
TOP2B KASGSENEGDYNPGR† DNA topoisomerase 2-beta 45 0.0272 4.4 Miscellaneous
VIM TYSLGSALRPSTSR^ Vimentin 44 0.0009 13.2 Miscellaneous
PTPN21 TMSASAADVAPR Tyrosine-protein phosphatase non-receptor type 21 44 0.0397 1.6 Transcription
VAPB SLTSSLDDAEVK† Vesicle-associated membrane protein-associated protein B 42 0.0002 5.8 Unfolded protein response
TTC7B EVDYSDSLTEK Transcription activator BRG1-like 41 0.0004 3.0 Transcription
ERCC6 LPGSVNTSFNSR DNA excision repair protein ERCC-6 41 0.0056 2.0 Transcription
SMARCA4 KIPDPDSDDVSEVDAR Transcription activator BRG1-like 41 0.0144 2.6 Transcription
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The phosphopeptide “SPVAATVVQR” from the protein Eukaryotic translation 
initiation factor 4 gamma 3 was identified following a search of MS/MS information, 
through MASCOT (Figure 4.2.23), of those features identified by Progenesis label-
free LC/MS software as having a statistically significant differential expression 
(ANOVA value ≤0.05). “SPVAATVVQR” was also identified following  a 
qualitative search of all LC/MS raw files from mass spectral analysis of iron oxide 
phosphopeptide enriched CHO SEAP lysates using the SEQUEST search algorithm 
(detailed section 2.4.6). An example of the MS/MS output from this identification in 
SEQUEST is given in (Figure 4.2.24 A). PhosphoRS identified the first amino acid 
residue, serine, as being phosphorylated with a >99% level of confidence. 
MS/MS/MS information on this peptide was also obtained during mass spectral 
analysis as can be seen in (Figure 4.2.24 B) thus providing further evidence of 
phosphorylation of this phosphopeptide. Figure 4.2.25 shows an output from 
Progenesis label-free analysis identifying “SPVAATVVQR” as being 3.6-fold up-
regulated at 37˚C (ANOVA 0.0001). 
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Figure 4.2.23 (A) MS/MS fragmentation spectrum output from a MASCOT search 
of MS features deemed by Progenesis label-free LC/MS software have a statistically 
significant differential expression (ANOVA value ≤0.05) resulting in the 
identification of the phosphopeptide “SPVAATVVQR” from the protein Eukaryotic 
translation initiation factor 4 gamma 3. (B) The b-and y-ion series used for 
phosphopeptide identification via MASCOT are indicated. 
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Figure 4.2.24 (A) MS/MS fragmentation spectrum output from a SEQUEST search of raw files from the LC/MS analysis of titanium dioxide 
phosphopeptide enriched CHO SEAP whole cell lysate subject to temperature-shift resulting in the identification of the phosphopeptide 
“SPVAATVVQR” belonging to Eukaryotic translation initiation factor 4 gamma 3. (B) The b-and y-ion series used for phosphopeptide 
identification of the MS/MS are indicated. (C) MS/MS/MS fragmentation spectrum of the peptide “SPVAATVVQR” following the loss of 
phosphate (D) The b-and y-ion series used as further evidence of phosphopeptide identification are indicated.  
(A) (B) 
(C) 
(D) 
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Figure 4.2.25 Progenesis label-free LC/MS output showing normalised abundance 
of the phosphopeptide “SPVAATVVQR” indicating its 3.6-fold down-regulation at 
31˚C compared to 37˚C (ANOVA 0.0001). 
 
  
     37˚C              31˚C 
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4.2.8.1 Bioinformatic analysis of differentially-expressed phosphopeptides 
enriched using iron oxide 
Identification of differentially-expressed phosphopeptides through quantitative label-
free LC/MS analysis of iron oxide phosphopeptide enriched CHO SEAP whole cell 
lysates subject to temperature-shift were analysed using DAVID. Similar to DAVID 
analysis of titanium dioxide enriched phosphopeptides (section 4.2.7), analysis of 
iron oxide phosphopeptide enriched samples did not identify any pathways of 
interest that may be involved in the cellular response to temperature-shift (data not 
shown). Despite the list of differentially-regulated phosphopeptides identified using 
iron oxide being longer than that obtained using titanium dioxide, the failure to 
identify any obvious processes involved in the response to temperature-shift through 
DAVID is most likely for the same reasons as those discussed previously (Section 
4.2.7).   
Identification of proteins of interest was once again carried out through manual 
searching of protein function using a combination of literature mining and protein 
databases such as UniProt. Interestingly, as well as being identified through titanium 
dioxide enrichment, Transcription activator BRG1, Protein NDRG1 and Eukaryotic 
translation initiation factor 4 gamma 3 were also identified as differentially-
expressed using the iron oxide phosphopeptide enrichment strategy (Table 4.2.50 
and Table 4.2.51). In addition to this, phosphopeptides from the proteins Borealin 
and Serine/threonine-protein kinase Nek1, both of which are known to be involved 
in cell growth and division, were found to be up-regulated at 37˚C.  
It is also interesting to note that when the lists of differentially-expressed 
phosphopeptides from titanium dioxide and iron oxide enrichment methods are 
compared, it can be seen that a number of phosphopeptides are common to both lists. 
Closer examination of these phosphopeptides shows that they also share 
commonality in the condition under which they are up-regulated and the 
approximate fold-change. Proteins containing these commonly identified 
phosphopeptides include ELMO domain-containing protein 3, Eukaryotic translation 
initiation factor 4 gamma 3 (eif4g3), Protein NDRG1 and Vesicle-associated 
membrane protein-associated protein B (Table 4.2.50 and Table 4.2.51). 
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Table 4.2.50 List of proteins and associated differentially-expressed phosphopeptides common to quantitative label-free LC/MS analysis of 
titanium dioxide phosphopeptide enriched (TiO2) and iron oxide phosphopeptide enriched (Fe+) CHO SEAP whole cell lysates subject to 
temperature-shift. This table shows the phosphopeptides that were down-regulated at 31˚C. 
 
 
  
Gene Symbol Protein Enrichment Method Sequence Fold Score Down Anova
TiO2 SPVAATVVQR 3.7 47 31˚C 0.0060
Fe
+
SPVAATVVQR 3.6 54 31˚C 0.0001
Fe
+
TSSPTTLAPLAR 3.6 60 31˚C 0.0182
TiO2 SSELTEAVETK 2.4 53 31˚C 0.0003
Fe
+ SSELTEAVETK 2.7 57 31˚C 0.0024
TiO2 SPSISNMAALSR 1.5 69 31˚C 0.0258
Fe
+
SPSISNMAALSR 1.9 65 31˚C 0.0250
EIF4G3 Eukaryotic translation initiation factor 4 gamma 3
ELMOD3 ELMO domain-containing protein 3
 ANAPC1 Anaphase-promoting complex subunit 1
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Table 4.2.51 List of proteins and associated differentially-expressed phosphopeptides common to quantitative label-free LC/MS analysis of 
titanium dioxide phosphopeptide enriched (TiO2) and iron oxide phosphopeptide enriched (Fe+) CHO SEAP whole cell lysates subject to 
temperature-shift. This table shows the phosphopeptides that were up-regulated at 31˚C. 
 
 
Gene Symbol Protein Enrichment Method Sequence Fold Score High Anova
TiO2 SRTASGSSVTSLEGPR 39.7 49 31˚C 0.0001
Fe
+
SRTASGSSVTSLEGPR 230.5 52 31˚C 0.0020
TiO2 TASGSSVTSLEGPR 16.5 88 31˚C 0.0000
TiO2 EVDYSDSLTEK 2.8 44 31˚C 0.0001
Fe
+
EVDYSDSLTEK 3.0 41 31˚C 0.0004
Fe
+
KIPDPDSDDVSEVDAR 2.6 41 31˚C 0.0144
TiO2 SLTSSLDDAEVKK 3.0 56 31˚C 0.0048
Fe
+
SLTSSLDDAEVK 5.8 42 31˚C 0.0002
TiO2 LNFDSSPTSSTDGR 1.7 44 31˚C 0.0020
Fe
+
LNFDSSPTSSTDGR 1.8 63 31˚C 0.0028
CDC42EP1 Cdc42 effector protein 1
NDRG1 Protein NDRG1
SMARCA4 Transcription activator BRG1
VAPB Vesicle-associated membrane protein-associated protein B
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4.2.8.2 Bioinformatic analysis of all differentially-expressed phosphopeptides 
enriched using gallium oxide, titanium dioxide and iron oxide 
Due to the low number of pathways/processes identified when analysing 
differentially-expressed phosphopeptides obtained using DAVID, it was decided to 
perform analysis on all the phosphopeptides pooled together. This would help 
provide further insight into the biological processes that the identified differentially-
expressed phosphopeptides are involved in because although the phosphopeptides 
were identified using different enrichment methods this is merely as a result of the 
different affinities of each column, the pathways that these phosphopeptides are 
involved in are likely to overlap. Table 4.2.52 shows the list of enriched processes 
identified as a result of using this approach. A breakdown of the number of proteins 
associated with each process is given in Figure 4.2.26. Although the number of 
proteins from each condition are evenly divided across many of the processes e.g. 
regulation of kinase activity and regulation of transferase activity, there are also a 
number of processes that are obviously enriched for each temperature. Membrane 
organisation appears increased at 31˚C compared to 37˚C while processes involved 
in cell division are down-regulated at 31˚C compared to 37˚C. 
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Table 4.2.52 GO biological process enrichment for differentially-expressed 
phosphopeptides identified using quantitative label-free LC/MS analysis of gallium 
oxide, titanium dioxide and iron oxide enriched samples form CHO SEAP cells 
sampled at 36hrs post-temperature-shift. Enrichment was considered significant 
upon observation of a p-value ≤0.05. Gene Count corresponds to the number of gene 
symbols from the list of differentially-regulated proteins that are implicated in a 
particular GO category. 
 
 
  
Term Count P-Value
membrane organization 6 0.045
DNA metabolic process 7 0.044
cell cycle 9 0.043
regulation of transferase activity 6 0.041
mitotic cell cycle 6 0.040
regulation of kinase activity 6 0.035
regulation of translation 4 0.033
regulation of protein kinase activity 6 0.031
organelle fission 5 0.029
M phase of mitotic cell cycle 5 0.027
mitosis 5 0.026
nuclear division 5 0.026
regulation of translational initiation 3 0.018
cell division 6 0.017
DNA replication 5 0.016
regulation of MAP kinase activity 5 0.006
regulation of cellular protein metabolic process 9 0.003
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Figure 4.2.26 GO biological process enrichment for differentially-expressed 
phosphopeptides identified using quantitative label-free LC/MS analysis of gallium 
oxide, titanium dioxide and iron oxide enriched samples form CHO SEAP cells 
sampled at 36hrs post-temperature-shift. Enrichment was considered significant 
upon observation of a p-value ≤0.05. Gene Count corresponds to the number of gene 
symbols from the list of differentially-regulated proteins that are implicated in a 
particular GO category. This graph shows the breakdown of the gene counts in those 
enriched pathways.  
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 Western blot validation of differentially-expressed phosphopeptides 4.2.9
identified by quantitative label-free LC/MS analysis of temperature-
shifted CHO SEAP cells 
Western blot analysis was used to validate the results obtained in 4.2.7 and 4.2.8. 
Despite identifying the differential expression of 82 phosphopeptides, only 
antibodies specific to phosphopeptides from the proteins NDRG1 and ATF2 could 
be sourced. Antibody selection was based on the ability to detect peptides with 
homologous amino acid sequences to those identified in this study in species such as 
Human, mouse and rat. The second requirement was that the antibody was capable 
of detecting the correct site of phosphorylation on the peptide of interest. Based on 
these stipulations, the only antibodies available, suitable for the purpose of validation 
were anti-NDRG1 and anti-ATF2. As such, antibodies raised against the 
phosphorylated form of the peptide identified and the total protein were purchased 
for the proteins NDRG1 and ATF2. 
Following quantitative label-free LC/MS analysis of titanium dioxide 
phosphopeptide enriched temperature-shifted CHO SEAP whole cell lysates, the 
monophosphorylated phosphopeptide TASGSSVTSLEGPR was found to be up-
regulated 16.5-fold at 31˚C compared to 37˚C (Table 4.2.47 in section 4.2.7). 
Western blot validation of the phosphorylated form of NDRG1 clearly shows an 
increase in the phosphorylated form of the protein at 31˚C compared to 37˚C (Figure 
4.2.27). Although total NDRG1 was detected in the control cell line (SKBR3) it was 
not detected in the CHO samples (Figure 4.2.28); This is possibly as a result of the 
antibody for total NDRG1 not being able to detect the CHO form of the protein or 
that the levels of NDRG1 are so low in CHO, that the antibody was unable to detect 
it. It should be noted that a search of the RAW files from the LC/MS analysis of 
CHO whole cell lysate (section 4.2.4) failed to identify the NDRG1 protein in the 
(unenriched) samples, this indicates that NDRG1 is likely to be a low abundance 
protein and lends further weight to the possibility that it could not be detected by the 
antibody due to its low abundant nature. 
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Figure 4.2.29 (i) shows a western blot confirming the down-regulation of the 
phosphopeptide NDSVIVADQTPTPTR from the protein ATF2. This result is in 
keeping with the finding that the phosphopeptide NDSVIVADQTPTPTR was 7.4-
fold down-regulated at 31˚C compared to 37˚C as identified by iron oxide 
phosphopeptide enriched, temperature-shifted CHO SEAP whole cell lysate (shown 
in Table 4.2.48 in section 4.2.7). Conversely, Figure 4.2.29 (ii) shows that the 
expression of total ATF2 is slightly increased by temperature-shift. 
 
 
 
 
 
 
 
 
Figure 4.2.27 (i) Western blot validation of the differential expression of the 
phosphopeptide TASGSSVTSLEGPR from the protein NDRG1 identified as being 
up-regulated at 31˚C compared to 37˚C in both titanium dioxide enriched and iron 
oxide enriched phosphopeptide samples following analysis by quantitative label-free 
LC/MS. (ii) shows western blot of alpha tubulin as a loading control. A breast cancer 
cell line, SKBR3, acts as a positive control (C1). 
 
 
 
 
 
 
 
(i) 
 
(ii) 
Biological replicate: 
Temperature: 
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Figure 4.2.28 (i) Western blot showing that no bands for the total protein NDRG1 
were detected in CHO despite NDRG1 being detected in the positive control, a 
breast cancer cell line, SKBR3. (ii) shows western blot of GAPDH as a loading 
control and SKBR3 acting as a positive control (C1). 
 
 
 
 
 
 
 
 
 
 
Figure 4.2.29 (i) Western blot validation of the differential expression of the 
phosphopeptide NDSVIVADQTPTPTR from the protein ATF2 identified as being 
down-regulated at 31˚C compared to 37˚C in iron oxide enriched phosphopeptide 
samples following analysis by quantitative label-free LC/MS. (ii) shows the up-
regulation of total ATF2 at 31˚C compared to 37˚C. 
  
Temperature: 
Biological replicate: 
 
          37C         31C  C1 
 A    B   C    D    A    B     C   D  
(i) 
(ii) 
Biological replicate: 
Temperature: 
(i) 
 
(ii) 
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4.2.9.1 Summary 
Quantitative label-free LC/MS analysis of Iron oxide phosphopeptide enriched CHO 
SEAP whole cell lysates resulted in the identification of the differential expression of 
60 phosphopeptides, 22 of which were up-regulated at 31˚C. Based on the GO 
analysis of the differentially-expressed phosphopeptides enriched by Iron oxide, no 
process pathways were found to be enriched. A similar result was obtained for GO 
analysis of differentially-expressed phosphopeptides enriched by titanium dioxide. 
When the lists of proteins identified by iron oxide and titanium dioxide enrichment 
strategies are combined however, GO analysis revealed alterations in pathways 
involved in cell division and membrane organisation. 
 
 Overall summary of quantitative label-free LC/MS analysis of CHO 4.2.10
SEAP cells subjected to temperature-shift. 
GO analysis of the 114 differentially-expressed proteins identified by quantitative 
label-free LC/MS analysis of CHO SEAP whole cell lysate samples showed 
enrichment of pathways involved in translation, RNA processing and ribosomal 
biogenesis while cytoskeleton organisation pathways were found to be enriched 
following similar analysis of phosphoprotein-enriched CHO samples. 
While gallium oxide phosphopeptide enrichment of phosphoprotein-enriched whole 
cell lysates provided site-specific phosphorylation information on a number of 
phosphopeptides, by far the greatest contribution came from titanium dioxide and 
iron oxide phosphopeptide enrichment of whole cell lysates. Together, these 
strategies identified 95 differentially-expressed phosphopeptides (41 up-regulated 
and 54 down-regulated at 31˚C compared to 37˚C). GO analysis of the proteins 
identified revealed down-regulation of cell cycle and cell division pathways and up-
regulation of pathways involved in membrane organisation.  
Further protein fractionation or validation by western blot would be required to 
definitively determine whether the changes observed are as a result of changes in 
phosphorylation. However, to the best of my knowledge, this is the first time a 
quantitative label-free LC/MS / phosphopeptide enrichment strategy has been 
applied to the profiling of temperature-shifted CHO cells. 
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4.3 Overall summary of results from phosphoproteomic and host 
cell protein analysis of temperature shifted CHO cell lines 
Qualitative label-free LC/MS analysis of temperature-shifted and non-temperature-
shifted conditioned media samples from an IgG-producing and non-producing cell 
line found that the cell line and culture conditions used both impacted on the HCP 
profile generated. Qualitative analysis of this data identified changes in the 
abundance of proteins, over time in culture under both temperature-shifted and non-
temperature-shifted conditions, that could negatively impact product quality such as 
proteases (Cathepsin B, Cathepsin D, MMP9) and glycosidases (beta-galactosidase 
and α-N-acetylgalactosaminidase). In addition, proteins that could enhance cell 
growth such as vascular endothelial growth factor isoforms A and C and Hepatoma-
derived growth factor were also identified. 
In order to decipher some of the cell-signalling events involved in the response of 
CHO cells to temperature shift, analysis of the phosphoproteome of a SEAP 
secreting CHO cell line was conducted using a quantitative label-free LC/MS based 
approach. The use of Gallium, Iron and Titanium phosphopeptide enrichment 
strategies facilitated the identification of 1,307 unique phosphopeptides (1,480 
phosphosites). Enrichment of pathways involved in protein synthesis and cell cycle 
progression were identified following Gene Ontology analysis of the 92 
phosphopeptides determined as being significantly differentially-expressed 36hrs 
post temperature-shift. Among the proteins identified, many are potentially involved 
in controlling growth and recombinant protein production in CHO cells including 
translation initiation factors EIF5B, EIF4G3, Transcription activator BRG1 and the 
tumour suppressor protein, Protein NDRG1.  
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5.0 Host Cell Protein (HCP) Analysis Overview 
The following section discusses the quantitative label-free LC/MS analysis of host 
cell proteins in the conditioned media of bioprocess relevant mammalian cell lines. 
Initially this work focused on the analysis of cell culture supernatant taken at 
different time points from a non-producing Hybridoma cell line grown under 
temperature-shifted and non-temperature-shifted culture conditions. Based on the 
finding that the HCP content changed in abundance over time and under different 
culture temperatures it was decided that this work would be extended to include 
analysis of what could perhaps be described as the workhorse of the 
Biopharmaceutical industry: the CHO cell. Quantitative label-free LC/MS analysis 
of a non-producing and an IgG secreting CHO cell line also found that the time in 
culture and culture temperature impacted on the HCP profile of both cell lines. This 
analysis revealed the differential expression of proteases such as Cathepsin B and 
MMP-9, and glycosidases including Lysosomal α-glucosidase and α-N-
acetylgalactosaminidase, both of which have the potential to negatively impact on 
product quality. In addition to this, the expression of proteins that could affect 
culture growth and viability such as Clusterin and Hepatoma-derived growth factor 
were also found to alter over time under temperature-shifted and non-temperature-
shifted conditions. Finally, this section looks at the recent release of two CHO 
specific proteomic databases and the benefits associated with the availability of these 
resources to this study.  
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5.1 Characterisation of HCP profiles from a non-producing 
hybridoma cell line using Mass Spectrometry 
 
 Quantitative comparison of HCPs identified between early (24hrs) and 5.1.1
late (96hrs) in temperature-shifted and non-temperature-shifted cultures  
In a comparison between early and late stage culture conditioned media taken from a 
non-producing hybridoma cell line, 79 HCPs at 37˚C (25 up-regulated, 54 down-
regulated at 96hrs) and 65 HCPs at 31˚C (31 up-regulated, 34 down-regulated at 
96hrs) were identified as differentially-expressed following quantitative label-free 
LC/MS analysis (Section 3.1.3.1 and 3.1.3.2). Efforts were made to categorise 
differentially-expressed proteins by biological function e.g. protease, glycosidase, 
growth factor, apoptotic factor etc., and discuss trends in the up-regulation or down-
regulation of these proteins as a group. Where no such trends were observed, 
individual proteins were selected for discussion based on their potential to impact 
culture growth or product quality. 
Among those identified was the secreted protein Olfactomedin-like protein 3 
(OLFML3) which was found to be 2.4-fold up-regulated at 96hrs compared to 24hrs 
at 31˚C and down-regulated at 96hrs under normal temperature conditions (37˚C). 
(Interestingly this protein was also identified as being up-regulated 4.1-fold at 120hrs 
under temperature-shift and 4.3-fold at 120hrs under non-temperature-shifted 
conditions in the CHO DP12 cell line). OLFML3 has been shown to inhibit tumour 
growth by impairing angiogeneisis. It does this by binding the growth factor bone 
morphogenetic protein-4 (BMP4), in turn affecting the SMAD1/5/8 signalling 
pathway (Miljkovic-Licina et al. 2012). On the other hand the overexpression of 
OLFML3 in PC12 rat pheochromocytoma cells increased the growth rate of the cells 
(Lee and Tomarev 2007). Given role OLFML3 plays in regulating growth, it is 
possible that the secretion of this protein may impact on cell growth and / or viability 
recombinant protein producing cell lines. Although there is little known about the 
precise mechanisms by which this particular protein functions, its differential 
expression in both hybridoma and a CHO cell line under temperature-shifted and 
non-temperature-shift conditions possibly make it worthy of further follow up in 
order to define its precise role in recombinant protein producing cell lines. 
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In addition to OLFML3, a number of proteases were also identified as being 
differentially-expressed over time in culture. The serine peptidase Tripeptidyl-
peptidase 2, known to cleave tripeptides from the N-terminus of oligopeptides 
(Usukura et al. 2013), was found to be 3.4-fold up-regulated at 96hrs compared to 
24hrs in the 31˚C culture.  
The zinc metallopeptidase Thimet oligopeptidase was 11.5-fold up-regulated at 
96hrs post temperature-shift compared to 24hrs at 37˚C. Thimet oligopeptidase is 
ubiquitously expressed and, depending on the cell type, has been located both 
intracellularly (in the cytoplasm, nucleus, and membrane) and extracellularly (Ray et 
al. 2004). The primary function of Thimet oligopeptidase is the degradation of 
peptides releases from proteasomes, specifically the metabolism of oligopeptides due 
to its ability to only cleave short peptides (Russo et al. 2012). It is therefore a protein 
of interest due to its proteolytic ability and the potential for it to contribute towards 
the degradation of recombinant therapeutic products.   
In the non-temperature-shifted culture Cathepsin D was found to be 732.7-fold up-
regulated in the late culture phase (96hrs) compared to the early phase (24hrs). 
Cathepsin D was a protease also identified in this thesis as being differentially-
expressed in the cell culture supernatant of CHO cells and is discussed in greater 
detail in section 5.2.1.3. Another protease also identified as being differentially-
expressed in the conditioned media of both hybridoma and CHO cell lines in this 
work was Proteasome subunit beta type-8. In the hybridoma cell line, Proteasome 
subunit beta type-8 increased in expression 3.2-fold at 96hrs compared to 24hrs at 
37˚C and was 2.9-fold down-regulated in the 31˚C culture compared to the 37˚C 
96hrs post-temperature-shift. Similar to Cathepsin D, this protease is also discussed 
in further detail in section 5.1.1.3. Taken together, the up-regulation of these 
proteases at the later time point would indicate that recombinant products would be 
more susceptible to proteolytic activity. 
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 Quantitative comparison of HCPs identified between Temperature-5.1.2
shifted and non-temperature-shifted culture at 24hrs and 96hrs post-
temperature shift 
Following the quantitative label-free LC/MS analysis of conditioned media samples 
collected from a non-producing Hybridoma cell line grown under temperature-
shifted and non-temperature-shifted conditions, a comparison between 31˚C and 
37˚C cultures at 24hrs and 96hrs (post-temperature-shift) revealed the differential 
expression of 27 HCPs at 24hrs (23 down-regulated, 4 up-regulated at 31˚C) and 44 
HCPs at 96hrs (31 down-regulated, 13 up-regulated at 31˚C) (Section 3.1.3.3 and 
3.3.1.4). 
One example of a protein that was found to be differentially-expressed was 
Calreticulin, which was down-regulated 2.4-fold at 31˚C 24hrs post-temperature-
shift. Calreticulin is perhaps best known for its role in the ER where it acts as a 
molecular chaperone for the proper folding of glycoproteins (Molinari et al. 2004). 
However, it has also been shown that Calreticulin can be expressed on the surface of 
apoptotic and pre-apoptotic cells as well as cancer cells (Chao et al. 2010). This is 
thought to promote the phagocytic uptake of such cells in the body (Raghavan et al. 
2013). It is possible that the presence of Calreticulin on the cell surface may also be 
used for other signalling events, but the lack of a transmembrane domain means that 
the precise mechanism for signalling remains unclear (Gold et al. 2010). 
Interestingly, the presence of Calreticulin in the extracellular matrix has also been 
shown to influence the activity of MMP2 and MMP9 (Wu et al. 2007). More 
specifically, in Calreticulin-knockout Mouse embryonic fibroblast cells the activity 
of MMP9 significantly decreased while the activity of MMP2 increased. This was 
thought to be as a result of activation of the PI3 kinase/AKT dependent pathways 
and subsequent alteration of Ras/Raf/MEK activities (Wu et al. 2007). 
Also of note was the differential expression of proteins that have the potential to 
impact on product quality, such as proteases. One such protease is Endoplasmic 
reticulum aminopeptidase 1 (ERAP1). Down-regulated at 31˚C compared to 37˚C 
both at 24hrs (4.4-fold) and 96hrs (2.1-fold) post-temperature-shift, ERAP1 is 
known to be localised to the ER, cytoplasm and cell surface (Cui et al. 2002; Saric et 
al. 2002). ERAP1 is known to alter the adaptive immune response to both host and 
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pathogen derived antigens by trimming peptide precursors in the ER to create or 
destroy antigenic epitopes (Aldhamen et al. 2013).  
Another such protease identified was Cathepsin B. Although not identified as being 
differentially-expressed at 24hrs when temperature-shifted and non-temperature-
shifted cultures are compared, it is however 27.8-fold down-regulated at 31˚C when 
the two culture temperatures are compared 96hrs post-temperature-shift (Cathepsin 
B is discussed in further detail in section 5.1.1.3). The down-regulation of these 
proteases at 31˚C would suggest that recombinant therapeutics are less likely to 
experience proteolytic activity in a temperature-shifted culture compared to a non-
temperature-shifted culture. Reduced protease activity is therefore likely to 
contribute toward the increase in overall product yield often seen following the use 
of the temperature-shift strategy. 
 
 Qualitative assessment of the HCP profile of a non-producing 5.1.3
hybridoma cell line. 
Overall the number of proteins identified in the cell culture supernatant of the 4/2D 
cells is in keeping with the numbers one would typically expect to see when 
profiling the secretome of a eukaryotic cell line (Piersma et al. 2010). When a 
qualitative comparison was made between the proteins identified under temperature-
shift and non-temperature-shifted conditions it could clearly be seen that there were 
proteins specific to the two culture conditions. It should be pointed out that the 
viability of the 37˚C culture was significantly lower than that of the 31˚C and that 
some of the proteins identified as unique to 37˚C may be present as a result of cell 
lysis.  
However this makes the proteins identified as unique to 31˚C even more interesting, 
because one would expect that the list of proteins identified in the low viability 37˚C 
culture would also include all of those released from the more highly viable cells 
maintained at 31˚C and so the only unique proteins found would be in the 37˚C 
culture.  
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However despite the release of a whole myriad of intracellular proteins from the 
dead cells, there is still a significant number only identified in the 31˚C culture. 
Although the use of monolayer flasks for the growth of hybridoma cells is not 
representative of what would be used in industry (Gong et al. 2006), the absence of 
any shear forces (further discussed in section 5.2.2) aids in the identification of 
changes in the HCP profile as a result of the physiological effect of the reduction of 
culture temperature on the cell itself. 
 
5.2 Characterisation of HCP profiles from CHO-K1 and DP12 cell 
lines using Mass Spectrometry 
Proteomic profiling of CHO cells has been underway since the late 90’s in an effort 
to identify the cellular components involved in the makeup of industrially desirable 
characteristics such as increased productivity and extended viability (Champion et al. 
1999; Kaufmann et al. 1999). This is most likely due to the initial emphasis being 
placed on increasing product yield, which has happened, albeit largely from process 
and media optimisation (De Jesus and Wurm 2011; Hacker, De Jesus, Wurm 2009). 
As a result of this increase in product titre, coupled with increases in cell density, a 
bottleneck has been created in downstream processing with purification technologies 
struggling to keep pace with larger volumes of product (Thiel 2004; Thömmes and 
Etzel 2007). It has taken some time, however, for the same global profiling 
approaches to be applied to the characterisation of host cell protein components from 
cell culture supernatant (Grzeskowiak et al. 2009; Jin et al. 2010; Krawitz et al. 
2006). This is not to say that the secretome of CHO cells was never investigated. 
Older studies, however, followed a much more targeted approach to identify specific 
proteases and glycosidases present in the media (Elliott, Hohmann, Spanos 2003; 
Gramer and Goochee 1993).  
Global profiling of cell culture supernatant can provide a wealth of information on 
the impact of process changes on the HCP profile as well as identification of specific 
HCPs of interest such as proteases and growth factors (Baycin-Hizal et al. 2012; 
Grzeskowiak et al. 2009; Jin et al. 2010; Lim et al. 2013; Slade et al. 2012).  
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The HCP profiling presented in this work used quantitative label-free mass 
spectrometry to analyse the cell culture supernatant from a non-producing CHO-K1 
and an IgG producing DP12 cell line, over different phases of the culture cycle from 
both temperature-shifted and non-temperature-shifted cultures. Of the 1,181 host cell 
proteins identified in this study, quantitative information was obtained on 790-fold. 
The quantitative information obtained was based on the analysis of both CHO-K1 
and DP12 cell lines over time in culture at 37˚C and 31˚C, and between the two cell 
culture conditions in both early and late phases of the cell growth cycle. Among 
those identified were 138 known secreted proteins, 23 glycosidases, 58 proteases and 
16 proteins involved in the regulation of apoptosis.  
Normalisation by protein concentration is typically used during quantitative label-
free LC/MS analysis to ensure accurate quantitation of differentially-expressed 
proteins identified. Given that this study is investigating the secretome of CHO cells 
another approach would be to normalise by cell number. This approach takes into 
account the significant differences in cell number between experimental groups and 
the variation in HCP concentration produced by those cells over the course of the 
culture. Applying a correction factor to the data did not result in a significant 
reduction in the number of proteins identified as differentially-expressed in seven of 
the eight comparisons (protein lists were reduced by roughly 5-10%). In one 
comparison however (DP12, 37˚C vs 31˚C at 144hrs), the protein list was reduced 
from 222 to 105. This was due to the significant number of proteins with relatively 
‘small’ fold-changes (<2.09). While this correction factor was not applied to the data 
generated in this study, this result demonstrates a means by which further confidence 
could be added to lists of proteins identified as significantly differentially-expressed 
when analysing the secretome.  
Qualitative analysis of this data revealed unique cohorts of HCPs were expressed in 
both cell lines under temperature-shifted and non-temperature-shifted conditions. 
Taken together this provides evidence that the choice of cell line and culture 
conditions used can have an impact on the HCP profile generated. 
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Many of the profiling studies published to date have used gel based technology 
(Grzeskowiak et al. 2009; Jin et al. 2010; Krawitz et al. 2006; Tait et al. 2012). It is 
only more recently that mass spectrometry based techniques have been used to 
characterise HCPs produced by CHO cells during culture (Doneanu et al. 2012; Lim 
et al. 2013; Slade et al. 2012). Quantitative label-free LC/MS has a number of 
advantages over gel based methods including facilitating the analysis of proteins 
with a broader range of characteristics, such as extremes in pI, size and 
hydrophobicity (Tscheliessnig et al. 2013). It is believed that the benefits inherent to 
quantitative label-free LC/MS enabled this study to characterise a wide spectrum of 
HCPs.  
It should be noted that samples used for LC/MS analysis in this study were obtained 
from shake flask cultures. Although some studies have also used this means of 
culturing cells, many have utilised stirred tank bioreactors (Grzeskowiak et al. 2009; 
Jin et al. 2010; Lim et al. 2013; Slade et al. 2012; Tait et al. 2012).  
While a significant proportion of the changes in the HCP profile has been attributed 
to reduction in culture viability, the use of different cell culture platforms may also 
contribute toward any differences seen given that hydro-mechanical forces in a 
stirred tank bioreactor are approximately 10 times higher than in a shake flask (Peter, 
Suzuki, Büchs 2006; Tait et al. 2012). The use of stirred tank bioreactors would 
potentially negate any differences in the HCP profile of cells under temperature-shift 
conditions due to cellular lysis through mechanical agitation experienced in the 
bioreactor (Tait et al. 2012; Velez‐Suberbie et al. 2012). The low shear stress nature 
of shake flasks allowed this investigation to identify changes in the HCP profile of 
two CHO cell lines as they grew over time in culture under both temperature-shifted 
and non-temperature-shifted conditions, leading to the identification of both secreted 
and intracellular proteins in the cell culture supernatant.  
In a proof of concept investigation, metabolic labelling was used to enable the 
enrichment of secreted proteins from two CHO cell lines (Slade et al. 2012). While 
this application is interesting from the point of view of identifying only those 
proteins secreted by CHO cells under different conditions, it does not consider the 
release of intracellular proteins into the media.  
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Such proteins could have a significant impact on product quality given that the 
intracellular proteome comprises of a large number of proteases and glycosidases 
(Gramer and Goochee 1993; Sandberg et al. 2006). While information on the HCP 
profile of CHO cells gathered from shake flask cultures may not be of direct 
relevance for stirred tank cultures, it is likely to be more directly comparable with 
culture conditions seen in disposable culture systems such as wave bags due to the 
lower shear stress environment they provide (Öncül et al. 2010). This investigation 
has identified differences in the HCP profile of two CHO cell lines and the impact of 
reduced culture temperature conditions on the HCP population. With the use of wave 
bag technologies set to increase, proteomic profiling of HCPs produced by CHO 
cells under different conditions provides valuable information that may be used in 
the selection of CHO cell lines, culture conditions and when to harvest (Shukla and 
Gottschalk 2012; Tait et al. 2012). 
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 Quantitative Label-free LC/MS analysis of conditioned media from 5.2.1
CHO-K1 and DP12 cell lines 
The use of a label-free LC/MS approach enabled quantitative information on the 
HCPs identified to be obtained. This section discusses some of the proteins identified 
using this approach. 
 
5.2.1.1 Growth factors 
Although Biopharmaceutical companies have turned away from the use of fetal 
bovine serum (FBS) due to regulatory concerns for quite some time, chemically 
defined protein free media has typically relied on amino acids, lipids and L-
glutamine as nutritional sources for cell survival (Even, Sandusky, Barnard 2006). 
While there have been several studies in hybridoma, NS0 and insect cell lines to 
identify autocrine factors that may support growth, this has only recently been 
successfully conducted in CHO cells (Dutton, Scharer, Moo-Young 1999; Eriksson 
et al. 2005; Lim et al. 2013; Spens and Häggström 2005; Spens and Häggström 
2009).  
Given the complex nature of extracellular signalling, this section looks at growth 
factors identified in this study on an individual basis. A summary table (Table 5.2.1) 
provides an overview of some of the growth factors identified as differentially-
expressed in the cell culture media of CHO-K1 and DP12 cell lines. Vascular 
endothelial growth factor C (VEFGC), Vascular endothelial growth factor A 
(VEFGA) and Hepatoma-derived growth factor (HGDF) were identified as 
differentially-expressed in the conditioned media of the IgG producing DP12 cell 
line (summary Table 5.2.1). Although not identified as being differentially-
expressed, qualitative searches of LC/MS data revealed these proteins to be present 
in the culture supernatant of the non-producing CHO-K1 cell line. The incorporation 
of growth factors, including VEFGC, into culture media has been shown to increase 
cell growth in CHO-K1 cells (Lim et al. 2013). 
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It is worth noting that VEGFA and VEGFC become down-regulated at 31˚C when 
temperature-shift and non-temperature-shift cultures are compared at 144hrs in the 
DP12 cell line. This down-regulation is interesting given that cell growth was almost 
completely ceased in the 31˚C culture. The lack of differential information on 
VEFGA and VEFGC in the CHO-K1 cell line indicates that these proteins continued 
to be secreted by the cells. This could have led to the continued growth of these 
CHO-K1 cells under temperature-shift conditions albeit at a reduced rate. While it 
has been shown that the cell cycle arrest of CHO cells under temperature-shift occurs 
via the ATR-p53–p21 pathway (Roobol et al. 2011), it does raise the question; is the 
reduced secretion of extracellular proteins (such as VEFGA and VEFGC) 
influencing cell growth under temperature-shift conditions? Further investigations 
would be required to definitively answer this question, future proteomic studies 
could focus on such growth factor signalling pathways as an alternative means of 
regulating cell growth in the bioreactor e.g. through the addition of these proteins to 
the media. 
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Table 5.2.1 Summary table of differentially-expressed growth factors identified following quantitative label-free LC/MS analysis of conditioned 
media from CHO-K1 and DP12 cells. 
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Table 5.2.1 continued. 
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5.2.1.2 Apoptosis 
A number of proteins involved in the regulation of apoptosis were also identified as 
differentially regulated in the conditioned media of CHO-K1 and DP12 cell lines.  
In both cell lines, these proteins were largely identified as being up-regulated at the 
later time points compared to the earlier time points in cultures grown under 
temperature-shift and non-temperature-shift conditions. This result is somewhat 
unsurprising as culture viability begins to decline at the later time points, whether 
through nutrient depravation or a build-up of waste by-products in the media, the 
expression of many of these proteins become increased thereby inducing apoptotic 
signalling pathways (Wei et al. 2011). Intracellular in nature, the presence of 
apoptotic proteins in the cell culture media is almost certainly as a result of their 
release from dead cells. However this many not entirely account for all the proteins 
as some are also secreted e.g., Clusterin. In addition, biological function of each 
protein identified in this study was inferred through manual searches of the Uniprot 
protein database. However this database does not necessarily provide information on 
whether the protein is pro or anti-apoptotic.  This is understandable as many of the 
proteins identified are multi-function proteins and have been found to play either pro 
or anti-apoptotic roles depending on the means by which apoptosis is induced in the 
original study.  
For example Guanine nucleotide-binding protein subunit beta-2-like 1 (GNB2L1), 
also commonly referred to in the literature as Receptor for activated C kinase 
(RACK1), is a scaffold protein that is known to interact with over 100 proteins, as 
such it is involved in a diverse range of functions within the cell such as apoptosis, 
translation and cellular organisation (Gandin et al. 2013). In terms of apoptosis, there 
are a number of mechanisms by which GNB2L1 has been shown to operate. There 
have been contradicting reports as to whether GNB2L1 promotes or inhibits 
apoptosis through its interaction with Bax, Bcl-2 and Bcl-XL. In HeLa and HT-29 
cell lines, as well as disassociating the interaction of Bax with Bcl-XL, GNB2L1 
promotes Bax oligomerization with Bcl-XL thus inducing apoptosis (Wu et al. 
2010a). In human colon cells GNB2L1 inhibits the expression of anti-apoptotic Bcl-
2 and Bcl-XL and translocates pro-apoptotic proteins Bax and Bim to the 
mitochondria (Mamidipudi and Cartwright 2009), thereby causing the mitochondrial 
membrane to becoming porous allowing the release of Cytochrome c, and the 
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activation of Caspase 3 and 9 resulting in cell death. The overexpression of GNB2L1 
in human hepatocellular carcinoma cell lines resulted in the upregulation of Bcl-2, as 
well as other growth and survival promoting proteins such as upregulation of cyclin 
D1, MYC and Survivin (Ruan et al. 2012). While the role of GNB2L1 in apoptosis 
appears to be cell line specific, its involvement in the regulation of Bcl-2 is 
interesting given that the overexpression of Bcl-2 has been used to generate 
‘apoptosis-resistant’ CHO cell lines (Kim et al. 2012; Reynolds et al. 1996). Another 
protein identified in this work that is also known to have both pro and anti-apoptotic 
functionality is Clusterin. The function and mechanisms of Clusterin are further 
discussed in section 5.2.2.2. 
At the later time point in CHO-K1 and DP12 cell lines, when 37˚C and 31˚C cultures 
were directly compared, the number of up-regulated and down-regulated apoptotic 
proteins were evenly divided between the two culture conditions. As such, no firm 
conclusion can be drawn as to the impact of the presence of these proteins in the 
culture media. Whether the secretion of anti-apoptotic proteins helped extend culture 
viability at 31˚C or the secretion of pro-apoptotic proteins lead to the widespread 
induction of apoptosis in the 37˚C culture is unclear from this analysis. However a 
panel of proteins known to be involved in the regulation of apoptosis has been 
identified through this work. Future work could focus on these proteins to determine 
if their secretion impacts on culture viability and whether these should be considered 
for future cell engineering through the knockdown or overexpression of such 
proteins. 
 
5.2.1.3 Proteases 
In addition to the potential for HCPs positively or negatively impacting on cell 
growth and viability, HCPs have also been reported to affect both product yield and 
product quality (Eon‐Duval, Broly, Gleixner 2012). The existence of proteases in the 
cell culture media of a number of bioprocess relevant cell lines has including CHO, 
hybridoma and NS0 has been known for some time (Elliott, Hohmann, Spanos 2003; 
Gao et al. 2011a; Karl, Donovan, Flickinger 1990; Sandberg et al. 2006; Spens and 
Häggström 2005; Van Erp et al. 1991).  
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It is only in more recently published data however that the activity of these enzymes 
negatively impacting on product quality has been reported; this includes the 
degradation of an Fc-fusion recombinant protein by a protease homologous to 
Cathepsin D (Robert et al. 2009), N-terminal clipping of a fusion protein by a serine-
threonine class of protease (Dorai et al. 2011), C-terminal lysine variants on a 
monoclonal antibody as a result of carboxypeptidase B activity (Luo et al. 2012) and 
the degradation of a highly purified monoclonal antibody product due to residual 
protease activity caused by an acidic protease (Gao et al. 2011a).This investigation 
identified 58 differentially-expressed proteases in the cell culture supernatant of a 
CHO-K1 and DP12 cell line as shown in Table 5.2.2. 
In both cell lines proteases were typically found to increase in abundance at the later 
stage in culture relative to the early stage culture in both temperature-shift and non-
temperature-shift cultures. While this may be partly due to the release of intracellular 
proteins from dead cells as cell viability reduces towards the end of the culture. In 
addition, many of the proteases identified are secreted. Therefore, such proteases 
would not only be released from the intracellular components of dead cells, but they 
would also accumulate in the media as a result of their secretion by viable cells. This 
would indicate that recombinant therapeutics would be vulnerable to proteolytic 
activity during cell culture operations, even where culture viability remains high. 
Among the secreted proteases identified were the endopeptidases Cathepsin D, 
Cathepsin B, MMP9 and MMP19 (summarised in Table 5.2.3).  
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Table 5.2.2 List of differentially-expressed proteases identified in the cell culture 
supernatant of a CHO-K1 and DP12 cell line. (Protein function was obtained 
following a search of the protein names against the Uniprot protein database.) 
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Table 5.2.3 Summary table of differentially-expressed proteases identified following quantitative label-free LC/MS analysis of conditioned 
media from CHO-K1 and DP12 cells. 
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Table 5.2.3 continued. 
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Cell engineering strategies could provide a means of alleviating proteolytic 
degradation of the drug substance. The presence of MMP9 in the cell culture 
supernatant of a CHO-K1 cell line has been previously reported and it has been 
noted that its presence can significantly reduce the overall product yield of a 
recombinant therapeutic susceptible to its action (Elliott, Hohmann, Spanos 2003).  
Interestingly, an inhibitor of MMP9, Extracellular matrix protein 1 (ECM1) was also 
identified in the media of CHO-K1 and DP12 cell lines in my study.. The proteolytic 
activity of MMP9 is at least partially inhibited through the interaction of the 
metalloproteinase with the C-terminal second tandem repeat of ECM1. Complete 
inhibition may be achieved through the expression of PTMs on the peptide 
fragments of ECM1 (Fujimoto et al. 2006). Nonetheless, the presence of this 
endogenously expressed MMP inhibitor could be investigated further to ascertain 
whether it has the same protease inhibiting properties in CHO and, if so, could it be 
used to alleviate product degradation caused by MMP9 e.g. possibly though 
overexpression of the ECM1 or its C-terminal second tandem repeat domain coupled 
with the 19 amino acid signal peptide to facilitate its secretion by the 
endoplasmic/Golgi-dependent pathway (Merregaert et al. 2010).  However care must 
be taken when selecting a strategy to protect the protein product from degradation. 
Although engineering of the protein product to make it resistant to cleavage may be 
an attractive alternative (Kinder et al. 2013), this may not always be feasible as 
altering the protein structure may impair its activity (Strome, Sausville, Mann 2007). 
Given that many proteases also operate intracellularly (Wiera et al. 2012), simply 
knocking out the protein may have a negative impact on cell function. In some 
circumstances however, future strategies could consider engineering of the protease 
itself to alter its activity. For example, the zinc dependant metalloproteinase, Bone-
morphogenetic-protein 1 (BMP-1) (summary Table 5.2.3) has CUB and EGF-like 
domains that regulates the specificity with which it cleaves proteins and/or cleavage 
sites (Hintzeb and Aufenvennec 2007). For example, the absence of these domains 
resulted in complete degradation of a truncated form of procollagen VII by the BMP-
1 catalytic domain whereas the full length enzyme produced only two fragments of 
the substrate.  
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It has also been reported that if the CUB domain lacks two of its N-linked glycans 
(Asn332 and Asn599, but not Asn363) BMP-1 appears to exhibit a slower rate of 
cleavage (Garrigue-Antar, Hartigan, Kadler 2002), while the removal of all three 
glycans results in the translocation of BMP-1 to the proteasome for degradation.  
While the inhibition of proteases in the culture media may appear to be an obvious 
alternative, it should be borne in mind that many growth factors require some form 
of cleavage in order for them to function correctly (Khatib and Geraldine 2006). 
Therefore the effect of protease inhibition on cell growth and viability may also need 
to be assessed prior to its implementation as a means of preventing product 
degradation. In addition, the use of protease inhibitors would be costly for large scale 
operations and their removal from the final drug substance must also be considered. 
When temperature-shift and non-temperature-shift cultures were compared in late 
stage culture of the CHO-K1 cell line it was observed that the majority of proteases 
were down-regulated at 31˚C. However, when the same comparison is made in the 
DP12 cell line 4 proteases were up-regulated and 5 were down-regulated at 31˚C. 
Interestingly, despite the majority of proteases being down-regulated, Cathepsin D 
(known to negatively impact product quality as discussed previously) was up-
regulated at 31˚C when 37˚C and 31˚C cultures were compared at 120hrs in CHO-
K1 cells but was not found to be differentially-expressed under the same conditions 
in the DP12 cell line. This shows that the effect of culture conditions on protease 
expression can be cell line dependent and that identifying a cell line and culture 
conditions suitable for the production of a product sensitive to protease activity 
would need to be made on a case-by-case basis.  
 
5.2.1.4 Reductases 
Disulfide bonds are critical for imparting stability and structure to a recombinant 
protein molecule (Liu and May 2012). Reduction of these bonds as a result of the 
introduction of intracellular components to the harvested cell culture liquid from 
cells lysed during the harvest step has recently been reported (Trexler‐Schmidt et al. 
2010).  
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Investigations to identify the component responsible for the reduction of antibody 
disulfide bonds in CHO cell culture revealed TXN1 to be the terminal enzyme 
involved (Koterba, Borgschulte, Laird 2012). In the DP12 cell line, TXN1 was 2.9-
fold up-regulated at 144hrs compared to 24hrs at 31˚C and 5.6-fold up-regulated at 
144hrs compared to 24hrs at 37˚C. The greater upregulation of TXN1 37˚C 
compared to 31˚C is likely to be as a result of the reduction in culture viability in the 
non-temperature-shift culture compared to the temperature-shift culture at 144hrs. 
This result indicates that a recombinant therapeutic would be more likely experience 
disulfide bond reduction over a prolonged period in the cell culture supernatant. 
Strategies to prevent antibody reduction such as the addition of CuSO4, EDTA, 
lowering pH and air sparging of the harvested cell culture liquid have all been 
proposed (Trexler‐Schmidt et al. 2010). Although many of these strategies could not 
be employed during cell culture, information on the differential-regulation of 
reductases could help manufacturers make informed decisions when selecting culture 
conditions and harvest times. 
 
5.2.1.5 Glycosidases 
The presence of a sugar moiety on a protein, called glycosylation, is among one of 
the most common PTMs observed in proteomics (Segu and Mechref 2010). The 
glycosylation pattern of a recombinant therapeutic can affect the protein molecule in 
a variety of ways (summarised Table 5.2.4); for example, one particularly important 
glycan group is situated at arginine 297 in the Fc region of a recombinant therapeutic 
antibody (Jefferis 2005), the presence of this oligosaccharide is required for Fc-
receptor mediated functions such as antibody-dependent cellular cytotoxicity 
(ADCC) and complement-dependent cytotoxicity (Kim et al. 2010). The removal of 
carbohydrate side chains may not only impact on product functionality, but may also 
leave regions of the protein molecule exposed to further proteolytic degradation 
(Waszkiewicz et al. 2013). In addition, the engineering of specific protein glycans 
has been shown to enable targeted delivery of the therapeutic to the desired tissue in 
the body, thus increasing product efficacy (Solá and Griebenow 2010). 
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Table 5.2.4 Table summarising the potential role and effect of the glycocomponent 
of glycoproteins (adapted from (Walsh and Jefferis 2006)). 
While the cleavage of recombinant protein as a result of proteolytic activity has been 
widely reported in literature, little has been presented in the way of the potential 
degradation of important PTMs, such as glycosylation or its associated groups, 
during the culture process. The study presented in this thesis has identified the 
differential expression of a number of glycosidases in the cell culture media of a 
non-producing CHO-K1 and an IgG producing DP12 cell line. In this section a brief 
overview of the mechanisms of action of some of the glycosidases is provided. A 
table of the 23 differentially-expressed glycosidases identified in the cell culture 
supernatant of a CHO-K1 and DP12 cell line are displayed in Table 5.2.5 and a more 
detailed overview of a selection of these is provided in Table 5.2.6. In general, 
glycosidases were identified as being up-regulated at the later time points compared 
to the earlier time points in cultures grown at 37˚C and 31˚C in both cell lines. Given 
that many of the glycosidases are not known to be secreted, their presence is almost 
certainly as a result of their release from dead cells. Therefore, reduced culture 
viability and extended periods of time in culture are two scenarios most likely to 
negatively impact the quality of recombinant therapeutics susceptible to glycosidase 
activity.  
 321 
 
 
Table 5.2.5 List of 23 differentially-expressed glycosidases identified in the cell 
culture supernatant of a CHO-K1 and DP12 cell line. (Protein function was obtained 
following a search of the protein names against the Uniprot protein database.) 
Interestingly, when temperature-shift and non-temperature-shift cultures were 
compared at the later time point in the respective cell lines, the numbers of up-
regulated and down-regulated glycosidases are evenly split between the two culture 
conditions i.e. 3 up-regulated, 4 down-regulated at 31˚C in CHO-K1, 5 up-regulated, 
4 down-regulated at 31˚C in DP12. As such, the selection of culture conditions for 
the production of a glycosidase sensitive product should be made on a case-by-case 
basis.  
 
While the bioprocessing community has primarily focused on the presence of N-
linked glycan’s, the importance of O-glycosidic linkages on future recombinant 
products should not be discounted. Although currently not readily predicted, the 
presence of such O-glycans can modulate important therapeutic protein 
characteristics such as aggregation, protein stability and protease resistance (Zhong 
and Somers 2012). Given their ability to cleave such O-glycosidic linkages, 
glycosidases that may negatively impact on the quality of such future products 
include α-N-acetylgalactosaminidase, Hex A and Hex B.  
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The potential for Hex A and Hex B to enzymatically degrade recombinant 
glycoproteins has previously been reported in a number of insect cell lines, however 
our study is the first report of their presence in the culture media of CHO cells 
(Licari, Jarvis, Bailey 1993). Cell engineering strategies have been previously used 
to modify glycosidases to improve the recombinant protein characteristics (Solá and 
Griebenow 2010). Similar engineering approaches could be used to down regulate or 
eliminate the expression of glycosidases that diminish product quality. 
Similar to proteases, the presence of glycosidases should not only be considered 
during cell culture but also elsewhere during production. For example, the lysosomal 
α-glucosidase (summary Table 5.2.6) is capable of enzymatic activity under acidic 
conditions. This indicates the potential for this glycosidase to negatively impact on 
product quality during downstream purification of the therapeutic protein where it 
may be exposed to buffers of low pH (e.g. Protein A elution) if it is not removed 
prior to such steps. 
The information obtained from this study on the glycosidases identified provides 
important information for the potential degradation of the protein product. The 
presence of such glycosidases in the cell culture media should be considered in 
future cell engineering and product recovery campaigns.   
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Table 5.2.6 Summary of differentially-expressed glycosidases identified following quantitative label-free LC/MS analysis of conditioned media 
from CHO-K1 and DP12 cells. 
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In summary, through the use of a quantitative label-free LC/MS based approach to 
analyse the extracellular proteome of CHO cells, one of the main aims of this thesis 
has been achieved; it has provided information on the differential-expression of 
proteins that could impact on cell growth and viability such as VEGFA and VEGFC 
and Hepatoma-derived growth factor, and the apoptotic proteins GNB2L1 (pro-
apoptotic) and Clusterin (anti-apoptotic). In addition, this analysis has identified an 
overall increase in the abundance of a number of proteases and glycosidases at late 
phase culture compared to early phase culture (under temperature-shift and non-
temperature-shift conditions) and an overall decrease in the abundance of proteases 
and glycosidases under temperature-shift compared to non-temperature-shift 
conditions. The proteases Cathepsin B, MMP19, BMP-1 and the glycosidases, α-N-
acetylgalactosaminidase, Hex A and Hex B have been identified in this study, all of 
which have the potential to adversely affect product quality. 
 
 Qualitative analysis of CHO-K1 and DP12 cell lines under temperature-5.2.2
shifted conditions 
In addition to quantitative proteomic analysis, a qualitative study of mass spectral 
data gathered from the profiling of a CHO-K1 and DP12 cell line was also carried 
out. It was hoped that by comparing the lists of proteins identified in each cell line, 
any similarities and / or differences in the HCP profile of each cell line would be 
revealed. In total, 1,181 proteins (with a minimum of 1 peptide) were identified 
between both cell lines. Of these, 661 had two or more peptides. In both instances a 
significant cohort of proteins were unique to each cell line. 304 proteins with a 
minimum of one peptide, of which, 154 proteins had two or more peptides, were 
uniquely identified in the non-producing CHO-K1 cell line. In the IgG producing 
DP12 cell line, 215 proteins with a minimum of one peptide were uniquely 
identified. This includes 145 proteins that had two or more peptides (Section 3.3.7). 
Given the unfractionated methodology used in this investigation, this figure 
compares favourably with other studies.  
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For example, a recent study used 2D LC prior to LC/MS analysis to fractionate the 
proteome and secretome of a CHO-K1 cell line. Analysing 12 conditioned media 
fractions taken from a CHO-K1 cell line that had been serum starved for 12 hours 
after being grown in media supplemented with 10% FCS to 80% confluence, 1,977 
proteins were identified (Baycin-Hizal et al. 2012).  
It should be pointed out however, that of the proteins identified, the precise number 
of secreted proteins was never specified. A similar fractionation based approach was 
used to identify autocrine factors secreted by CHO cells grown in a 5L bioreactor 
(Lim et al., 2013). Two different mass spectrometry technologies - LTQ Orbitrap 
Velos, a hybrid linear ion trap−orbitrap instrument, and a Synapt G2, quadrupole-
time-of-flight (Q-TOF) instrument were also used to aid in the identification of 2,512 
proteins of which 290 were identified as secreted proteins. It was thought that many 
of the remaining proteins were present as a result of cell lysis occurring during cell 
culture or harvest of the conditioned media (Lim et al. 2013).  
In this investigation both cell lines were also found to maintain unique HCP 
subpopulations independent of temperature. A recent investigation into the 
secretome of DG44 and CHO-S cell lines using a metabolic labelling strategy found 
that there was ‘significant overlap’ in the proteins secreted by the two cell lines 
(Slade et al. 2012). While shake flask cultures were used in the generation of 
conditioned media samples analysed in the report, making it comparable with the 
results discussed in this thesis, it should be pointed out that the investigation only 
compared samples taken from the supernatant day 3 cultures, compared with samples 
taken from multiple time points up to day 7 (168hrs CHO-K1, 120hrs post- 
temperature-shift) and day 9 (216hrs DP12, 144hrs post-temperature-shift) as 
reported in this investigation.  The direct comparison of samples taken from such 
early stages in the culture may therefore account for the similarity of the proteins 
secreted by DG44 and CHO-S cell lines. 
A 2D PAGE analysis of three DHFR negative CHO cell lines (FR4, DP12 and DP7) 
found that there was very little difference in their HCP profiles (Krawitz et al. 2006). 
Similar findings were also reported in other studies that utilized 2D DIGE to 
examine the HCP profile of different clones, under different culture conditions, with 
different levels of viability (Grzeskowiak et al. 2009; Jin et al. 2010).  
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However all three studies analysed conditioned media samples taken from stirred 
tank bioreactors which are known to cause cell damage as a result of the use of 
mechanical agitation (Tait et al. 2012; Velez‐Suberbie et al. 2012). This could lead to 
a situation where, although cell viability is high, the culture media contains a large 
population of the CHO proteome as a result of cell lysis.  
This conclusion appears to be backed up in two of the studies by their findings on 
the impact of cell viability; although they both found that cell viability was the main 
factor in determining HCP profile, dropping from 92% to 10% and from >90% to 
40% respectively, this decrease mostly appeared to affect fold-change of the proteins 
identified as opposed to the actual HCP content (Grzeskowiak et al. 2009; Jin et al. 
2010). One would have expected that if cells were maintaining membrane integrity 
while in a state of high viability that a different HCP profile would be observed upon 
reduction in cell viability and resulting lysing of cells.  
Due to the low shear nature of shake flasks, this study identified HCPs deposited into 
the culture media through secretion or cell leakage as a result of an accumulation of 
dead or damaged cells over the natural progression of the cell growth cycle as 
opposed to the lysis of cells due to shear forces. The findings discussed here are 
therefore most applicable to other low shear environments such as disposable wave 
bag bioreactors (Öncül et al. 2010). It should be pointed out however that this may 
not be true for all disposable technologies as disposable stirred tank bioreactors are 
likely to provide an environment similar to their stainless steel equivalents (Fernald 
et al. 2009; Ullah et al. 2008). 
It should be pointed out that the reduction in cell viability is likely to be as a result of 
a combination of apoptosis and necrosis, despite the relatively low shear 
environment of the shake flask. While the trypan blue staining method employed in 
this study is a well-established technique for the detection of non-viable cells, it 
would not take into account necrotic cells that have lost all membrane integrity 
resulting in the cell becoming fragmented. This may have led to an over-estimation 
of cell viability and would account for the significant proportion of intracellular 
proteins in the culture media.  
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Future studies should consider the use of a cell necrosis assay to facilitate the 
detection of this form of cell death by this means. This would provide a clearer 
understanding of the source of intracellular proteins in the culture media i.e. cell 
death or secretion by viable cells. 
While the differences in the HCP profiles observed in quite striking, it should be 
remembered that a Protein A affinity chromatography column was used to reduce the 
levels of IgG in the DP12 cell culture supernatant samples prior to analysis while the 
CHO-K1 supernatant did not undergo such treatment.  
HCPs have been reported to bind to Protein A columns (Hogwood et al. 2013), 
although such binding has been shown to be low in abundance and by a small cohort 
of proteins (Follman and Fahrner 2004; Shukla and Hinckley 2008), particularly for 
resins with an agarose backbone, such as that used in MabSelect, as used in this 
thesis (Tarrant et al. 2012), especially when compared to resins whose backbones are 
based on alternative materials such as controlled pore glass (Tarrant et al. 2012). 
However, the propensity for HCPs to interact with such Protein A columns is known 
to increase where the overall IgG titre is lower than the maximum binding capacity 
of the column, as was the case in this instance (B. Mullen 2014, personal 
communication). Therefore, the binding of a cohort of the HCPs from the DP12 
culture to the Protein A column may account for the identification of some proteins 
in the CHO-K1 culture that were not identified in the DP12 supernatant. However, 
since CHO-K1 samples were not processed using a Protein A column, this does not 
account for the HCPs identified as being unique to the DP12 culture. This raises 
important questions about the suitability of selecting a non-producing cell line to 
generate antigenic material against which antibodies are raised in host animals for 
the production of anti-HCP ELISAs (further discussed in section 5.2.2.1).  
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5.2.2.1 Effect of temperature-shift on the HCP profile 
Although DP12 cells were grown for 48hrs longer than the non-producing CHO-K1 
cells, both cell lines maintained high cell viability over the selected culture period. 
This is particularly true for the 31˚C culture where both cell lines had viabilities 
>95%.  CHO-K1 and DP12 37˚C cultures were also comparable however, with cell 
viabilities of 95% and 85% respectively. This makes the identification of a sub-
population of HCPs unique to both cell lines quite an interesting result.  
One may have expected that the DP12 cell line, with its longer time in culture and 
slightly reduced viability at 37˚C compared to that of the K1 cells, would have 
produced a HCP profile more closely overlapping that of the non-producing cell line. 
Culture temperature-shift also appears to have an effect on the HCP profile, with 
unique HCPs identified in both cell lines. It is known that temperature-shift can have 
cell line specific effects; these results indicate that this also extends to the HCP 
profile (Kumar, Gammell, Clynes 2007).  
This however does not explain the differences seen in the non-temperature-shifted 
culture. While other studies have found temperature-shift does not significantly 
impact on the HCP profile, these investigations were carried out using stirred tank 
bioreactors as discussed previously (Jin et al. 2010).  Aside from extended time in 
culture and a slightly reduced viability, another reason for the distinct DP12 HCP 
profile could be due to the secretion of an IgG from the cell. Identification of 
intracellular proteins in the culture supernatant of IgG secreting cell line, particularly 
those associated with the production of recombinant protein, has been reported 
previously (Hogwood et al. 2013).  
One reason for the difference in the HCP profiles could be due the production of the 
IgG molecule by the DP12 cell line. The presence of expression machinery in 
addition to cellular stress and alterations in metabolism brought about by burden of 
producing the recombinant therapeutic could result in the expression of proteins not 
seen in the CHO-K1 culture (Dinnis et al. 2006; Tait et al. 2012). 
Although DP12 cells are derived from the CHO-K1 lineage, genetic mutations in the 
IgG producer may create elements of the proteome that are distinct from its CHO-K1 
ancestor (Xu et al. 2011).  
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However since we are using a proteomic database derived from the CHO-K1 cell 
line to profile the HCPs from both cell lines, genetic difference between the non-
producing and IgG producing cell line cannot entirely account for the differences 
seen. In fact, with further iterations of the CHO genome and associated proteomic 
database, it may be possible to identify greater distinctions between the HCP profile 
of the CHO-K1 and DP12 cell lines. 
When the lists of proteins unique to temperature-shifted and non-temperature-shifted 
cultures in CHO-K1 and DP12 cell lines are compared it can be seen that the vast 
majority of the proteins present are intracellular proteins. This appears to indicate 
that the way in which the cell lines lyse, either as a result of shear forces or loss of 
viability, at the respective temperature has the greatest impact on HCP profile rather 
than deliberate secretion by the cell at a given temperature.  
 
5.2.2.2 Qualitative analysis of secreted proteins 
The protein Clusterin was found in both non-producing and IgG producing cell line 
at reduced and non-reduced culture temperatures. In its mature form, Clusterin is a 
secreted glycoprotein of 76-80 kDa that is known to play an anti-apoptotic role in a 
wide variety of cells (Carlage et al. 2012). 
Interestingly, a truncated from of the protein has been implicated in both apoptotic 
(nucleus) and anti-apoptotic (cytoplasm) signalling events depending on their 
cellular translocation (Nuutinen et al. 2009). These localisation dependent roles 
provide an insight into the complex mechanisms through which this protein regulates 
cellular function. Although the precise mechanism by which secreted clusterin 
enhances cell survival is largely unknown it has been shown that overexpression of 
the stress chaperone prevents TNFα mediated induction of p21 (Flanagan et al. 
2010). This may occur either through clusterin binding to TNFα in the media or as a 
result of a truncated form of clusterin being translocated to inhibit Bax activation in 
the mitochondria which in turn prevents the release of cytochrome and subsequent 
caspase activation (Zhang et al. 2005). Clusterin-induced apoptosis has been reported 
to occur through binding of a truncated, non-glycosylated form of the protein 
binding to Ku70/80 in the nucleus inhibiting DNA repair (Leskov et al. 2003). From 
the data obtained in this study it is not possible to definitively determine which form 
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of Clusterin has been identified, although given that it is cell culture supernatant that 
is being analysed it is most likely the secreted protein.  
It would be potentially interesting to perform further studies to investigate 
expression levels of Clusterin in the nucleus and culture media of the CHO-K1 and 
DP12 cell lines under both temperature-shifted and non-temperature-shifted 
conditions over time in culture to identify the role that Clusterin plays in the cell 
culture cycle of CHO cells. 
Another interesting finding was the identification of CIRBP (Cold-inducible RNA-
binding protein) and RBM3 (Putative RNA-binding protein 3) in the conditioned 
media of both temperature-shifted cell lines. CIRBP and RBM3 are both highly 
conserved proteins that belong to a glycine rich RNA-binding protein family (Al-
Fageeh and Smales 2013). CIRBP expression may be induced in response to 
oxidative stress and mild hypothermia (Kumar et al. 2008a). Known to stabilize 
mRNA by binding to the 3'untranslated region of specific transcripts, CIRBP also 
facilitates the transport of mRNAs to the ribosome for translation (Brochu et al. 
2013). It has been hypothesized that CIRBP may play a role in preventing apoptosis 
under mildly hypothermic conditions after showing that the knockdown of CIRBP 
significantly increased apoptosis in temperature-shifted MEB5 stem cells (Saito et al. 
2010). Interestingly, it has also been postulated that CIRBP may have a 
neuroprotective effect on brains that have suffered ischemia under hypothermic 
conditions (Liu et al. 2010). Further work is required however to determine whether 
this is as a result of active gene modulation or activation of the extracellular signal 
regulated protein kinase pathway. Interestingly, while CHO cells overexpressing 
CIRBP showed increased productivity of INF-gamma, neither the overexpression 
nor the down-regulation of CIRBP has been shown to effect growth (Hong et al. 
2007; Tan et al. 2008).  
Similar to CIRBP, RBM3 stabilises RNA under reduced culture temperature 
conditions (Fujita 1999). This facilitates the translation of specific proteins despite 
the overall inhibition of protein synthesis via a cap-independent mechanism 
(Chappell, Owens, Mauro 2001). Given the dampening effect of miRNAs on protein 
synthesis, it has been suggested that RBM3 may inhibit miRNA activity either 
through the blockage of miRNA binding sites on mRNAs, interactions with 
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ribonucleoprotein complexes containing microRNAs or through the regulation of 
miRNA synthesis/degradation pathways (Barron et al. 2011; Dresios et al. 2005).  
More recently however it has been shown that RBM3 actually promotes pre-miRNA 
processing by directly binding to these ~70 nt intermediates and facilitates the 
interaction of ribonucleoproteins with the active Dicer protein complex in neuronal 
cells under mildly hypothermic conditions (Pilotte, Dupont-Versteegden, 
Vanderklish 2011). It is perhaps then interesting to note that the increased expression 
of RBM3 as a result of temperature-shift has also been shown to play an important 
role in the hypothermia-induced neuroprotection of neuronal cells; however the 
precise mechanisms by which this occurs remain unclear (Chip et al. 2011).  
A protease common to both cell lines but unique to 31˚C was also identified; i.e., 
Proteasome subunit beta type-8, also known as Low Molecular Mass Protein 7 
(LMP7).  The 20S (or constitutive) proteasome contains 28 subunits, of which three 
are proteolytically active:  β1, β2 and β5 (Arima et al. 2011; Muchamuel et al. 2009). 
LMP7 (β5i) replaces the β5 subunit upon the expression of the cytokine IFN-γ by 
activated T helper 1 lymphocytes, CD8+ CTLs and natural killer (NK) cells (Kloetzel 
and Ossendorp 2004).  
As such, β5i (along with β1i and β2i which are also induced, replacing their β1 and 
β2 counterparts) are often referred to as ‘immunoproteasome’ subunits. The 
replacement subunits display enhanced cleaving efficiency after basic or 
hydrophobic residues, however their ability to cleave after acidic residues appears 
somewhat diminished (Rock and Goldberg 1999). Specifically, the β5i is said to 
have chymotrypsin-like activities (Borissenko and Groll 2007). This affinity for 
cleaving basic or hydrophobic residues could significantly impact on the product 
yield of recombinant proteins rich in such residues.  
Engineering the product such that these residues would be replaced by neutral, 
hydrophilic ones, would not only make the product more resistant to cleaving by this 
protease, but would also have the added advantage of making the product more 
soluble and less susceptible to aggregation (Wu et al. 2010b). 
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The identification of unique HCP subpopulations has important implications for 
generating antigen material for the preparation of an ELISA. Non-producing cell 
lines are typically used in the creation of anti-HCP antibodies as they do not contain 
the product of interest and therefore will not cross-react with the drug substance 
(Savino et al. 2011a). Any antigenic material generated must be representative of the 
cell line and process that the ELISA will be used for (Savino et al. 2011b).  
One of the aims at the outset of this thesis was to identify whether there were 
differences between (i) temperature-shifted and non-temperature-shifted cultures (ii) 
IgG producing and non-producing cell lines.  
Qualitative analysis of LC/MS data has revealed differences in the HCP profiles of 
non-producing CHO-K1 and IgG producing Dp12 cells under both temperature-
shifted and non-temperature-shifted conditions. Furthermore, comparisons of the 
HCPs profiles of both cell lines resulted in the identification of cohorts of proteins 
that appeared to be unique to each cell line.  
The results discussed show that the choice of cell line and culture temperature can 
have an impact on the HCP profile generated. Given that a significant proportion of a 
HCP profile is made up of intracellular proteins (Hogwood et al. 2013; Tait et al. 
2012), it makes sense that lysates from non-producing host cell lines are used as 
antigenic material for the immunisation of animals to generate anti-HCP antibodies 
for use in ELISAs (Krawitz et al. 2006). However if lysates are obtained from 
cultures grown under conditions different to those in which the ELISA is expected to 
perform e.g., temperature-shift, then the ELISA may not contain antibodies specific 
to proteins that are only expressed under the certain conditions. This also extends to 
the use of cell culture supernatant as anti-genic material for the immunisation of 
animals to generate an ELISA. 
For example, anti-HCP antibodies generated from the cell culture supernatant from 
the CHO-K1 cell line at 37˚C had been used in the been chosen as antigenic material 
for the immunisation of animals to generate anti-HCP antibodies, this would not be 
able to detect a large number of HCP contaminants in the DP12 cell line in either 
temperature-shifted or non-temperature-shifted cultures. It would also be incapable 
of detecting certain HCPs found in the CHO-K1 31˚C culture.  
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Failure to detect such HCPs present in the final drug substance could potentially 
illicit an adverse immune reaction in the patient receiving the contaminated product 
(Savino et al. 2011a). 
Placing such a high emphasis on the ELISA for the identification of HCP impurities 
in the final drug product ignores the fact that a proportion of the HCP population 
may not result in an immune response from the animal being immunised, as such, no 
anti-HCP antibodies will be generated against these proteins (Zhu‐Shimoni et al. 
2014). This could result in the presence of a HCP impurity that could go undetected 
in the final drug product. The application of a mass spectrometry based approach, 
while not as sensitive as an ELISA, provides important information on proteins that 
may go undetected by immunological methods e.g., identification and, in the 
presence of a known standard, abundance. Information such as this advances our 
knowledge of the process and changes the focus from monitoring the presence of 
process related contaminants to being able to define and control the risk factors 
associated with the presence of HCP impurities. 
 
 Utilisation of CHO specific proteomic databases in the analysis of 5.2.3
LC/MS data in a HCP study 
The recent release of two CHO specific databases has filled in a significant gap in 
suite of tools available to study CHO cells. A report by Meleady et al. (2012) 
showed that use of the Bielefeld-BOKU-CHO (BB CHO) expressed protein database 
complemented the use of the CHO NCBI database generated from the CHO-K1 
genomic data as published by Xu et al. (Meleady et al. 2012; Xu et al. 2011). 
Although the CHO-NCBI database accounted for a large proportion of the HCPs 
identified, the BB-CHO database enabled the identification of a number of proteins 
not identified by the CHO-NCBI database. The fact that the BB-CHO database was 
curated from the cDNA of a number of different CHO cell lines grown under 
different processing conditions made this database particularly well suited for the 
proteomic analysis of HCPs generated by two different CHO cell lines grown over 
time in culture under temperature-shifted and non-temperature-shifted conditions. 
The use of both databases has enabled the identification of additional proteins that 
would not otherwise have been identified by one database alone.  
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The resulting increased proteome coverage has provided a wealth of information on 
the make-up of the HCP profile under different processing conditions as well as at 
multiple time points over the culture period. The availability of the two CHO 
databases enabled the identification of a large number of proteins with criteria that 
gave a high level of confidence in the identification.  
Previously proteomics studies relied on sequence homology between the CHO and 
another well annotated species such as human or mouse for the identification of a 
protein (Baik et al. 2006; Baik et al. 2008; Baik et al. 2011; Kantardjieff et al. 2010; 
Kumar et al. 2008a). Relying on sequence homology for the study presented here 
would inevitably have led to the loss of a number of identifications. This may have 
included proteins of interest because of their potential ability to impact on product 
quality or culture viability, such as the protease Cathepsin D or the growth factor 
Hepatoma-derived growth factor. 
 
 Overall Summary 5.2.4
The quantitative LC/MS analysis of a non-producing CHO-K1 and an IgG secreting 
DP12 cell line identified changes in the relative abundance of proteins that could 
negatively impact on product quality such as Cathepsin D, Thioredoxin 1 and α-
galactosidase A through an increase in their abundance at late stage culture under 
both temperature-shift and non-temperature-shift conditions. In addition, proteins 
that could affect cell growth (HGDF and VEGFA) both over time in culture and 
under temperature-shifted and non-temperature-shifted conditions were also 
identified. This study also found that culture temperature and cell line selection can 
both have an effect on the HCP profile. A change in the HCP profile has important 
implications for the ability of an ELISA to detect contaminating HCPs in the final 
drug substance. This investigation shows that LC/MS analysis is a useful tool for 
providing information on HCPs produced by these cells that affect product integrity 
and culture viability. 
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6.0 Phosphoproteomic Analysis of CHO Cells Overview 
This section discusses the findings of the investigation into the phosphoproteome of 
temperature-shifted CHO cells. This investigation initially sought to identify changes 
in the phosphoproteome by using a MAP kinase array to detect changes in 
phosphorylation of 26 kinases. Changes in the phosphorylation of Erk, AKT and Jnk 
are discussed in this section as is the utility of protein arrays for profiling CHO cells. 
The recent availability of two CHO specific proteomic databases made the use of 
mass spectrometry a viable option for profiling the phosphoproteome of CHO cells 
under reduced culture temperature conditions. As a result, LC/MS was utilized to 
obtain a more global overview of the cell signalling events occurring 36hrs post 
temperature-shift. As such, whole cell lysate, phosphoprotein-enriched whole cell 
lysate, gallium oxide phosphopeptide enrichment of phosphoprotein-enriched sample 
and titanium and iron oxide phosphopeptide enrichment of whole cell lysate samples 
were analysed (Figure 6.0.1). The use of different phosphopeptide enrichment 
methods, the identification of signalling events effecting translation and cell 
structure as well as the contribution made by the availability of two CHO specific 
proteomic databases are discussed, as well as the partialities of each method and the 
biological insights gained from their use. 
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Figure 6.0.1 Schematic of the different approaches used to profile the 
phosphoproteome of CHO cells under temperature-shift conditions using mass 
spectrometry. This schematic also includes tables of the number of differentially-
expressed proteins, phosphoproteins and phosphopeptides identified following 
quantitative label-free LC/MS analysis. The table also includes the number of 
phosphopeptides identified from each phosphopeptide enrichment following 
qualitative analysis of the LC/MS data.  
114 53 
Differentially-expressed 
proteins / phosphoproteins 
7 53 29 
Differentially-
expressed 
phosphopeptides 
105 960 867 Phosphopeptides Identified 
Cell Culture 
 
 
 
 
Whole cell lysate 
 
 
Phosphoprotein 
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Protein digestion 
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6.1 Phospho-Kinase Array of SEAP cells subject to temperature-
shift 
Although a number of proteomic profiling studies have been carried out (Gammell et 
al. 2007; Kumar et al. 2008a; Roobol et al. 2009; Underhill et al. 2005; Underhill 
and Smales 2007) the mechanisms behind the cellular response to temperature-shift 
by mammalian cells are poorly understood (Kumar, Gammell, Clynes 2007; Sunley 
and Butler 2010). Given the dynamic response of CHO cells to reduced culture 
temperature it makes sense that phosphorylation would have a role to play as has 
been detailed in a number of studies (Kaufmann et al. 1999; Roobol et al. 2011; 
Underhill et al. 2005). Despite this, there still remains a gap in our knowledge as to 
the precise signalling pathways through which this response occurs. Protein Kinase 
Arrays are one means of profiling such signalling cascades and have been 
successfully employed in a variety of studies involving human cell model systems 
(Lin et al. 2012). They have however yet to be utilised for the profiling of the CHO 
phosphoproteome. In this experiment a kinase array was used to profile the relative 
levels of phosphorylation on 26 kinases in CHO cells subject to temperature-shift.  
MAP Kinase array analysis identified changes in the phosphorylation of 12 kinases. 
This included P53 and three isoforms of P38. Phosphorylation of P53 by P38 whose 
activation was initiated by ATR (ataxia telangiectasia mutated- and Rad3-related 
kinase) had previously been identified as a key signalling pathway involved in cell 
cycle arrest of temperature-shifted cells (Roobol et al. 2011). Agreement between the 
array and findings by Roobol et. al. provided a partial validation of the ability of the 
array to successfully detect alterations in the phosphorylation of different kinases in 
CHO cells. Actual validation was carried out by western blot investigating not only 
the 24hr period post temperature-shift profiled by the array, but also 48, 72 and 96hrs 
after culture temperature reduction. This provided an indication of how 
phosphorylation of the respective kinase behaved at both the time point investigated 
by the array as well as over time in culture.  
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 Phospho-ERK1/2 in Temperature-shifted CHO cells 6.1.1
Immunoblotting of ERK1/2 confirmed the increase in phosphorylation of the kinase 
in the 31˚C culture 24hr post temperature-shift as found by the array. Furthermore it 
provided evidence of a sustained increase in phosphorylation of ERK1/2 over the 
96hr period compared to the 37˚C culture. Follow up western blot studies using 
lysates taken from DP12 cells grown over the same 96hr period post temperature-
shift used in the CHO SEAP culture revealed phosphorylated ERK1/2 to be slightly 
reduced at 31˚C and for this decrease to become more pronounced over time in 
culture. One potential reason for this is that growth of the DP12 cell line is greatly 
reduced by culture temperature reduction. This growth remains stifled with little 
increase in cell number over the growth cycle compared to the CHO SEAP cell 
which continues to grow albeit at a reduced rate. Such a dramatic repression, 
possibly caused by a near complete cell cycle arrest involving other signalling 
pathways, could negatively impact on growth signalling pathways involving ERK 
(Mendoza, Er, Blenis 2011). Reduced culture temperature is also known to affect 
cells lines differently (Yee, Gerdtzen, Hu 2009); this too could account for the 
different phosphorylation profiles of ERK1/2.  
To gain a better understanding of the signalling taking place via the ERK1/2 
pathway western blots were conducted of its well-known upstream regulator; 
MEK1/2 (Figure 6.1.1 and Figure 6.1.2) (Lee Jr and McCubrey 2002). Although 
total ERK abundance remain constant over the course of the time points observed, 
abundance of total MEK decreased upon temperature-shift, and remained 
consistently low throughout the 31˚C culture. Unfortunately no phosphorylated 
MEK could be detected in the CHO samples.  
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Figure 6.1.1 Images shows simplified schematic of MEK – ERK pathway adapted 
from image by (Kim and Bar-Sagi 2004). 
 
Without direct evidence of the phosphorylation status of MEK no firm conclusion 
can be drawn as to whether MEK is directly involved in the activation of ERK, 
although reduction in the overall expression of MEK would suggest that this is not 
the case. 
This leads to the possibility that ERK activation is taking place via some MEK 
independent mechanism (Jiang et al. 2011). Characterising the role that ERK plays in 
temperature-shifted CHO cells would require further work to determine the 
activating kinase. Further profiling may also be necessary in order to identify 
subsequent signalling pathways involved given ERKs ability to transduce multiple 
signals from various sources to specific cellular responses (Ebisuya, Kondoh, 
Nishida 2005). 
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Figure 6.1.2 Image showing the variety of cellular processes that Erk is involved in controlling and the complexity of the related pathways. 
Image adapted from abcam (http://www.abcam.com/index.html?pageconfig=resource&rid=15825 02Dec2013). 
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 Phospho-AKT in Temperature-shifted CHO cells 6.1.2
Kinase array profiling indicated that there was no change in the expression of 
phosphorylated AKT1. Validation by western blot revealed that total AKT1 was in 
fact down-regulated in CHO SEAP and the phosphorylation of AKT1 was down-
regulated in DP12 at 31˚C. While this result is at odds with that of the initial 
profiling, it is possible that non-specific binding on the array could account for this 
as discussed later in this chapter (Section 6.2.3). It has been shown that 
overexpression of constitutively active AKT causes delay in the onset of apoptosis 
and extends culture viability while inhibition of AKT activity causes induction of 
cell cycle arrest and apoptosis during the early G1 phase in CHO cells (Figure 6.1.3) 
(Opstal et al. 2012). CHO cells experiencing culture temperature reduction are also 
known to enter cell cycle arrest at the G1 phase (Chen et al. 2004; Moore et al. 
1997). This suggests that AKT1 may play some role in causing cell cycle arrest in 
temperature-shifted CHO cells. Western blot analysis indicated a reduction but not 
total inhibition of phosphorylated AKT1. Tempering of signalling via AKT1 may 
allow the cells to continue to proliferate, albeit at a reduced rate, but stopping short 
of inducing apoptosis. Although the increase in phosphorylation of AKT2 was not 
validated, this result could potentially point to independent signalling mechanisms 
between AKT1 and AKT2.  
Both AKT isoforms AKT1 and AKT2 have been implicated in biologically distinct 
functions and are known to operate independently of each other (Manning and 
Cantley 2007). Further studies would however be required to confirm such roles in 
temperature-shifted CHO cells.  
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Figure 6.1.3 Schematic of pathways and cellular processes regulated by AKT. Image 
adapted from horizon discovery (http://www.horizondiscovery.com/images/ 
pathways/p13k-akt.jpg 03Dec2013) 
 
 Phospho-JNK and MEK6 in Temperature-shifted CHO cells 6.1.3
Lack of antibody specificity proved problematic not only for the detection of MEK, 
but also for the accurate identification of JNK and MEK6 during western blot 
validation. Due to the poor availability of anti-CHO antibodies immunoblotting of 
CHO samples very often requires the use of anti-human or anti-mouse antibodies for 
the detection of the protein of interest. Successful detection relies on homology 
between specific amino acid sequences in the human or mouse version of the protein 
and its CHO counterpart. In the absence of antibody reactivity between species the 
target protein may not be detected (Farady et al. 2009).  
Conversely inter-species cross reactivity can also result in the detection of proteins 
other than the protein of interest. Non-specific binding is a problem known to be 
associated with protein-protein interaction based technologies such as arrays and 
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other assays (Farajollahi et al. 2012). Results such as those observed in the JNK and 
MEK6 immunoblots raise the possibility that non-specific binding to the array may 
lead to erroneous results. To help increase specificity many arrays utilise a sandwich 
based approach requiring a second labelled detection antibody to bind to a 
recognition site on the kinase that does not overlap with that of the capture antibody 
(Simpson 2007). Therefore, anti-human capture and detection antibodies used in this 
array require a homologous binding site on the CHO kinase without which the 
likelihood of non-specific binding increases. Antibodies used for western blot 
validation are less likely to suffer from non-specific binding as they only require one 
binding site on the target protein since the secondary binds to the primary antibody 
and not the protein of interest. This was potentially in evidence where 
phosphorylation of AKT1 was not deemed to change significantly in the array 
analysis but was found to be down-regulated at 31˚C by western blot.  
 
 Summary 6.1.4
While protein array technology has been around for some time (Tse-Wen Chang 
1983), to the best of our knowledge, this is the first instance of a protein kinase array 
being applied to CHO cells. Although mass spectrometry may be viewed as a more 
comprehensive means of acquiring a global overview of the phosphoproteome of a 
cell, protein array based techniques provide a more targeted approach to 
investigating specific kinases of interest. Future applications would benefit from the 
use of capture and detection antibodies that are specific to CHO as anti-human 
antibodies were found to possibly reduce specificity. Nevertheless, its utilisation 
identified ERK, JNK and AKT as being potential targets of interest in temperature-
shifted CHO cells.   
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6.2 Quantitative Phosphoproteomic label-free LC/MS analysis of 
CHO SEAP cells subject to temperature-shift 
 
 Quantitative label-free LC/MS analysis of CHO SEAP cells subject to 6.2.1
temperature-shift 
A number of proteomic studies have been conducted on CHO cells under 
temperature-shifted conditions in an effort to gain insights into changes that take 
place in the proteome which may contribute to increased productivity, altered growth 
rate and extended cell viability (Baik et al. 2006; Kaufmann et al. 1999; Kumar, 
Gammell, Clynes 2007). To date however, these profiling studies have utilized gel 
based technologies. To the best of my knowledge, this is the first such proteomic 
investigation to use a quantitative label-free mass spectrometry based approach. 
Using this technology to analyse the proteome of temperature-shifted CHO SEAP 
cells 114 proteins were identified as having ≥1.5 fold-change (72 up-regulated, 42 
down-regulated at 31˚C).  
 
6.2.1.1 Differential expression of proteins involved in translation  
GO analysis on the differentially regulated proteins identified revealed significant 
enrichment of processes relating to translation and RNA processing at 31˚C. This is 
partially due to the high number of ribosomal proteins identified as up-regulated at 
31˚C including 60S ribosomal proteins L4, L6, L13, L13a, L14, L26, L28, L34 and 
40S ribosomal proteins S6, S8, S9 and S25. Although reduced culture temperature is 
known to limit global translation initiation (Roobol et al. 2009), it is evident from the 
increase in specific productivity of cells exposed to such conditions that this tightly 
controlled process must still allow relatively high levels of the product’s gene coding 
sequence be translated. It has been reported that the existence of ribosomal 
subpopulation with specific translation properties may allow such an event to occur 
(Xue and Barna 2012). 
In addition to this, cold shock proteins such as CIRP and Rbm3 may play a role as 
RNA chaperones, facilitating transcription and translation, under low culture 
temperature conditions (Ferry, Vanderklish, Dupont-Versteegden 2011; Tong et al. 
2013).  
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While neither of these proteins were identified in this study, it has been shown that 
Rbm3 associates with a number of 40S and 60S ribosomal proteins including 60S 
ribosomal protein L4 (Dresios et al. 2005). 
Two eukaryotic translation initiation factors, eIF3i and eIF3b, were both found to be 
1.6-fold up-regulated upon temperature-shift. It has been reported that eIF3i in CHO-
K1 cells is down-regulated following temperature-shift and is subsequently up-
regulated upon restoration of normal culture temperature conditions (Roobol et al. 
2009). While overexpression of eIF3i has been shown to increase cell proliferation, 
cell size and cell cycle progression its upregulation has also been associated with cell 
lines that maintain high levels of specific productivity over time in culture 
(Ahlemann et al. 2006; Meleady et al. 2011).  
Although eIF3i is known to be involved in mRNA translation and transcription 
studies have found gene expression of eIF3i sufficiently stable to be considered a 
house keeping gene in CHO cells (Bahr et al. 2009). Although eIF3i evolutionarily 
highly conserved between human and yeast, deletion and knockdown studies have  
shown it to be dispensable for active eIF3 complex formation (Bahr et al. 2009; 
Masutani et al. 2007). This would suggest that eIF3i may be involved in translational 
control of specific mRNAs or required under particular cellular conditions (Dong et 
al. 2013; Masutani et al. 2007). Like eIF3i, eIF3b is also part of the eIF3 complex, 
both of which bind concurrently to the spectrin domain of eIF3a. Unlike eIF3i 
however, eIF3b, along with eIF3a and eIF3b, make up the three subunits essential for 
the formation of the active mammalian eIF3 complex, of which, eIF3b is a 
scaffolding subunit (Dong et al. 2013; Liang et al. 2012; Masutani et al. 2007). 
Upregulation of eIF3b has been associated with increased proliferation; conversely 
knockdown of eIF3b has been shown to inhibit proliferation and increase apoptosis 
(Liang et al. 2012; Wang et al. 2012). 
While this is somewhat at odds with the observed phenotype in this instance, it is 
possible that, given the complex crosstalk between different cellular pathway and 
multiple layers of regulation within the cell, eIF3b and eIF3i are in some way 
contributing to the altered cellular state we see in temperature-shifted cells (extended 
viability/increased productivity), however proliferation enhancement is being 
blocked downstream of the eIF3 complex. Although there is not always a direct 
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correlation between transcription and protein synthesis (de Nobel et al. 2001; Gygi et 
al. 1999), a number of studies investigating the transcriptome of temperature-shifted 
CHO cells have shown changes in the gene expression of various cellular processes 
including those related to production of the protein product (Baik et al. 2006; 
Kantardjieff et al. 2010; Yoon, Song, Lee 2003). As a consequence, this could give 
rise to changes in the abundance of RNA levels requiring upregulation of RNA 
processing machinery. Interestingly, the upregulation of proteins involved in mRNA 
translation in high producing cell lines when comparing NS0 cells with varying 
levels of specific productivity has also been previously shown (Dinnis et al. 2006).  
 
6.2.1.2 Comparison of this quantitative label-free LC/MS analysis of 
temperature-shifted CHO cells with other proteomic profiling of 
temperature-shifted CHO cells in the literature 
When the list of differentially-expressed proteins obtained in this study is compared 
to other proteomic studies of temperature-shifted CHO cells (Baik et al. 2006; 
Kumar et al. 2008a), it is clear that using a quantitative label-free LC/MS 
methodology has provided new insights into the effects of temperature-shift on the 
proteome of CHO cells. Although there are some common proteins identified such as 
Vimentin and Annexin A1, both of which are up-regulated at 31˚C, displaying a 
similar trend to previous reports (Baik et al. 2006; Kumar et al. 2008a); many of the 
proteins identified are unique to this study. This is in contrast to the comparison of 
results that Kumar et al. (2008) made with those of Baik et al. (2006) which found a 
number of overlapping proteins. It should however be pointed out that while some 
common proteins were identified, only half of these had a fold-change in the same 
direction. It should also be pointed out that there was also significant difference 
between the two lists of proteins obtained.  
There are a number of potential reasons why there may be such little overlap 
between the proteins identified in this study and those identified in the two studies 
previously mentioned, these are summarised in Table 6.2.1.  
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Table 6.2.1 Summary table comparing quantitative label-free LC/MS analysis of temperature-shifted CHO cells conducted in this thesis with 
other proteomic profiling of temperature-shifted CHO cells in the literature. 
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 Label-free LC/MS analysis of phosphoprotein-enriched lysates from 6.2.2
CHO SEAP cells subject to temperature-shift 
Fractionation of the proteome is often required to obtain further insights into the 
mechanisms involved in the cellular response to a given condition (Lee, Tan, Chung 
2010). This becomes particularly important when trying to study the 
phosphoproteome of a cell due to the low abundant nature of many phosphoproteins 
(Beltran and Cutillas 2012). In order to investigate the phosphoproteome of CHO 
cells subject to temperature-shift, a phosphoprotein enrichment strategy was 
employed to aid in the identification of differentially-expressed proteins that 
otherwise may not be seen due to sample complexity.  
Label-free LC/MS analysis of phosphoprotein-enriched whole cell lysates from 
temperature-shifted CHO SEAP cells identified 53 differentially-expressed 
phosphoproteins, 21 of which were up-regulated upon reduction of culture 
temperature. It is perhaps interesting to note that a significant number of 
differentially-expressed proteins identified in the non-enriched whole cell lysate 
were phosphoproteins (84 out of 114, as classified using Gene Ontology). Although 
there was some overlap between the lists obtained from the two experiments, 
phosphoprotein enrichment provided differential information on a cohort of proteins 
that were not identified in the previous whole cell lysate study.  
 
6.2.2.1 Differential expression of phosphoproteins involved in cell structure 
GO analysis, performed using DAVID, on the differentially-expressed 
phosphoproteins identified significant enrichment of the cytoskeletal organisation 
pathway. The effects of low culture temperature on cell structure have also been 
observed in other studies (Baik et al. 2006; Kumar et al. 2008a). Disassembly of 
cytoskeletal components are known to occur upon exposure to severely reduced 
culture temperatures. While this does not happen under conditions of mild 
hypothermia, it could partially explain the down-regulation of structural proteins 
upon temperature-shift (Al-Fageeh and Smales 2006; Fujita 1999; Roobol et al. 
2009).  
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Although structural proteins such as Vimentin and Annexin A1 were identified using 
whole cell lysate samples, it is clear that without phosphoprotein enrichment this 
cohort of cytoskeletal proteins would not have been identified. Knowledge of these 
proteins has contributed to the overall picture of the effect of temperature-shift on 
CHO SEAP cells. Other structural phosphoproteins identified in this experiment are 
further discussed in sections 6.2.2.1.1 to 6.2.2.1.3. 
The upregulation of Vimentin and Annexin A1 (from analysis of unenriched whole 
cell lysate) is in keeping with transcriptome studies which identified an overall 
upregulation of genes involved in cytoskeletal organisation (Yee, Gerdtzen, Hu 
2009). However the phosphoproteins identified in this thesis are predominantly 
down-regulated (2 up-regulated, 7 down-regulated). The observed down-regulation 
could be due to a reduction in phosphorylation as opposed to a decrease in overall 
protein abundance (as explained section 6.2.2.1.3). Also, changes in the 
transcriptome may not necessarily materialise in the proteome due to the non-linear 
relationship between the genome and the proteome of a cell as a result of events such 
as alternative splicing and the presence of non-coding RNAs (e.g. miRNAs) 
(Altelaar, Munoz, Heck 2013). Nonetheless, changes in the cytoskeleton could be 
indicative of remodelling of vesicle trafficking systems in the cell to facilitate 
increased recombinant protein productivity as reported following transcriptome and 
proteomic studies of temperature-shift CHO cells (Baik et al. 2006; Kantardjieff et 
al. 2010). Given the co-localisation of mRNAs and initiation factors with the 
cytoskeleton (Stapulionis, Kolli, Deutscher 1997), changes in the cytoskeleton are 
also likely to have impacted on other processes such as mRNA transport and 
translation as evidenced by the enrichment of phosphoproteins involved in mRNA 
transport (from phosphoprotein enrichment analysis, table 4.3.41) and proteins 
involved in translation (from unenriched whole cell lysate analysis, table 4.3.35) 
through GO analysis. Therefore, this analysis provides evidence of signalling events 
within the cytoskeleton and how this could result in alterations protein synthesis as a 
result of a reduction in cell culture temperature. Sections 6.2.2.1.1 to 6.2.2.1.3 
discuss some of the specific phosphoproteins identified in further detail. 
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6.2.2.1.1 Ezrin 
Ezrin was identified as being up-regulated at 31˚C following quantitative label-free 
LC/MS analysis of whole cell lysate and phosphoprotein-enriched samples by 2.4 
and 2.1-fold respectively, most likely indicating a change in the total abundance of 
the protein rather than a change in phosphorylation. Despite Ezrin being well 
documented as a structural protein, the specific mechanisms by which it alters 
cellular behaviour are largely unknown (Xie et al. 2009). It has however been 
hypothesised that the membrane cytoskeletal linker protein is activated via 
phosphorylation of Thr567 enabling binding of F-actin and the membrane thus 
regulating cell shape and signal transduction (Zhu et al. 2007).  
 
6.2.2.1.2 Annexin A6 
The down-regulation of Annexin A6 at 31˚C in whole cell lysate (1.8-fold) and 
phosphoprotein-enriched samples (3.4-fold) indicates that there could be a reduction 
in both the overall abundance and phosphorylation of this protein as the fold-changes 
appear to be significantly different. Interestingly, the upregulation of Annexin A6 
has been linked to increased growth and metastasis in a number of different types of 
cancer (Oda et al. 2013). Similar to Ezrin, the precise function of this calcium-
dependent, membrane-binding protein is largely unknown, although there is some 
evidence to suggest that the down-regulation of this protein in cancer cell lines leads 
to increased proliferation and invasiveness (de Muga et al. 2008; Wang et al. 2013). 
This appears to occur, in part, via the EGFR/Ras signalling pathway (de Muga et al. 
2008).  
It is possible however that Annexin A6 may not have the same function in CHO cells 
given that they do not endogenously express EGFR and the overexpression of 
constitutively active Ras in CHO has not been shown to significantly impact on cell 
growth, viability or productivity despite the upregulation of Ras being associated 
with many cancer types (Kim et al. 2011). 
6.2.2.1.3 GAPDH 
It was noticed that the 4.2-fold down-regulation of GAPDH in this study was at odds 
with previous findings in the literature that reported this protein to be up-regulated 
upon temperature-shift (Baik et al. 2006; Kumar et al. 2008a).  
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 Therefore, the list of differentially-expressed proteins observed would be due to 
changes in the abundance of the phosphorylated species rather than overall changes 
in the expression of the total protein itself. If levels of total GAPDH had been 
differentially-expressed then this would most likely have been detected in the 
analysis of the whole cell lysate. Given that this was not the case, a change in the 
abundance of the phosphorylation status of GAPDH is most likely to be account for 
the result obtained.  
Existing as a single copy gene, multiple phosphorylation sites on the enzyme most 
likely enable GAPDH to perform such a diverse range of functions DNA repair and 
replication, cytoskeletal organisation and apoptosis (Sirover 2005; Tisdale and 
Artalejo 2007). One such example is the phosphorylation of GAPDH by PKCι/λ 
resulting in the cytoskeletal remodeling of vesicular tubular clusters between the 
endoplasmic reticulum and the Golgi complex. Specifically, phospho-GAPDH is 
required for microtubule binding to the vesicular tubular cluster sub-compartments 
that contains Rab2 (Tisdale 2002).  
In addition to this, GAPDH also has the ability to auto-phosphorylate (Yogalingam 
et al. 2013). While it has been established that GAPDH will auto-phosphorylate in 
the presence of Mg-ATP, the recipient of this phosphate remains unknown 
(Yogalingam et al. 2013). 
 
6.2.2.2 Differential expression of phosphoproteins involved in translation 
Given the number of proteins involved in translation described in the label-free 
LC/MS analysis of the whole cell lysate (section 4.3.4), it is perhaps interesting to 
note that the organisation of the cytoskeleton has been implicated in regulating 
transcription (Kim and Coulombe 2010).  Phosphoprotein enrichment also aided in 
the identification of several other translation factors including eIF4g1, 2-fold up-
regulated upon temperature-shift.  
A subunit of the scaffolding protein eIF4g in the eIF4f protein complex, eIF4g1 is 
involved in the selective translation of mRNAs involved in mitochondrial function 
(Fujioka et al. 2013). 
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The translation factor eIF4a3, a DEAD-box RNA helicase that forms part of the exon 
junction complex, facilitates the stable binding of spliced RNA enabling its 
modulation, was also identified as being 1.8-fold up-regulated at 31˚C using this 
phosphoprotein enrichment strategy (Budiman et al. 2009). 
 
 Label-free LC/MS analysis of a Gallium oxide phosphopeptide 6.2.3
enrichment of phosphoprotein-enriched CHO SEAP cells subject to 
temperature-shift 
While phosphoprotein enrichment contributed toward the identification of a 
significant number of phosphoproteins that would not otherwise have been observed, 
in order to obtain site-specific information on the phosphorylation status of the 
proteins identified a second enrichment step was required. This second enrichment 
was conducted at the peptide level to enrich for phosphopeptides using a gallium 
oxide column.  
Overall the number of differentially-expressed phosphopeptides was lower than 
expected. This was almost certainly as a consequence of using a phosphoprotein 
enrichment step prior to phosphopeptide enrichment. This is evident from the 
qualitative analysis showing the significantly reduced number of phosphopeptides 
obtained from phosphoprotein-enriched samples compared to phosphopeptide 
enrichment of whole cell lysate samples using titanium or iron. In addition, it should 
be remembered that 120µg of phosphoprotein-enriched sample was analysed 
compared to 500µg of starting material for the titanium dioxide and iron 
phosphopeptide enrichment experiments. It is therefore possible that the quantity of 
starting material may also have impacted on the number of phosphopeptides 
obtained.  
The reduced number of phosphopeptides is unlikely to be as a result of poor affinity 
for gallium as it has been shown to compare favourably with titanium, iron, 
aluminium and zirconium (Aryal and Ross 2010; Posewitz and Tempst 1999). 
Nonetheless this second enrichment strategy provided additional information on the 
abundance of phosphopeptides that had not been previously identified from analysis 
of the whole cell lysate or phosphoprotein-enriched fractions. 
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Gene Ontology (GO) of large profiling datasets using publically available software 
such as DAVID enables the identification of biological processes that have been 
enriched within the comparison undertaken (Gunaratne et al. 2010; Kumar and Mann 
2009). However, this provides limited information on the specific pathways directly 
involved in the alteration of the biological processes observed. Network databases 
such as STRING or Ingenuity® Pathway Analysis can be used to help bridge this gap 
by mapping known and predicted protein interactions (Kumar and Mann 2009). 
Where smaller datasets are obtained, a ‘protein of interest’ may only be identified 
through searches of the literature. Whether the phosphoproteomic dataset is large or 
small however, our ability to interpret them still suffers from the sheer number of 
phosphorylation sites do not yet have any ascribed function (Mayya and Han 2009). 
 
6.2.3.1 PITSLRE serine/threonine protein kinase CDC2L1 
A phosphopeptide from PITSLRE serine/threonine protein kinase CDC2L1 
(p58PITSLRE) was identified as being 7.4-fold down-regulated at 31˚C. p58PITSLRE is a 
p34cdc2_related protein kinase that is known to be involved in cell cycle progression, 
tumorigenesis and pro-apoptotic signalling (Liu et al. 2013). 
Although down-regulation of this kinase has been shown to increase growth rate and 
ectopic expression has been linked with prolonged late telophase, abnormal 
chromosome segregation, and decreased cell growth rates in CHO cells, this 
decreased growth rate was due to apoptosis (Lahti et al. 1995; Zhang et al. 2002). 
While reduced growth rate is a feature of temperature-shifted culture conditions, it is 
also associated with extended culture viability (Kumar, Gammell, Clynes 2007). 
Given the tightly controlled nature of cell cycle progression the observed down-
regulation of the phosphorylated peptide of p58PITSLRE may not necessarily result in 
increased growth under these conditions (Fisher et al. 2012). 
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6.2.3.2 Nucleolar phosphoprotein p130 
Gallium oxide phosphopeptide enrichment also enabled the identification of a 
phosphopeptide from the protein Nucleolar phosphoprotein p130 (Nopp140) which 
was deemed to be 2.2-fold up-regulated at 31˚C. Interestingly this protein is one of 
the most highly phosphorylated proteins found in mammalian cells. Hyper- 
phosphorylated, Nopp140 is 140 kDa while in a completely unphosphorylated state 
its size is reduced to 95 kDa (Kim et al. 2003).  
Initially identified as a shuttle protein between the nucleolus and cytoplasm involved 
in pre-ribosome particle assembly and transport, it is now known that Nopp140 also 
participates in rDNA transcription through co-localization with RNA polymerase I at 
the rDNA transcription active foci in the nucleolus (Gao et al. 2011b; Kim et al. 
2003). This was further confirmed through the knockdown of Nopp140 which 
caused the inhibition of rDNA synthesis (Tsai et al. 2008).  
While investigating the role of nuclear proteins which oscillate in the cell cycle, it 
was reported that endogenous levels of Nopp140 are significantly reduced during 
mitosis compared to interphase (Pai et al. 1995). Interestingly however, 
phosphorylation of Nopp140 actually increases during mitosis despite a reduction in 
overall expression (Pai et al. 1995).  
In order to definitively determine the role that Nopp140 plays in temperature-shifted 
CHO SEAP cells, further analysis would be required to know whether the observed 
up-regulation of the Nopp140 phosphopeptide is as a result of an increase in 
phosphorylation or an increase in total protein abundance. It has been reported that 
CHO cells enter G1 arrest upon temperature-shift (Moore et al. 1997).  
Given the complex mechanism by which Nopp140 operates, it is likely that it could 
be involved in the regulation of cell function on multiple levels and further work 
would be required to elucidate its precise role in the cellular response to culture 
temperature reduction (Gao et al. 2011b). 
One of the aims of this thesis was to identify changes that occur in the 
phosphoproteome of CHO cells subject to temperature-shift. Although the use of 
phosphoprotein enrichment did not initially provide any site-specific information, it 
nonetheless enabled the identification of proteins and their related processes such as 
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translation and cell structure that change in direct response to culture temperature 
reduction. While the number of phosphopeptides identified by Gallium enrichment 
was lower than expected, it did yield some information on the differential expression 
of phosphopeptides with site-specific information on proteins involved in translation 
and the cell cycle thus providing some knowledge of the signalling events that are 
activated in the phosphoproteome of a temperature-shifted CHO cell.  
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 Qualitative assessment of titanium dioxide and iron oxide 6.2.4
phosphopeptide enrichment methods 
Given the nature of the results obtained in section 4.3.3 it was decided that 
phosphopeptide enrichment would provide more information on the changes taking 
place within the phosphoproteome of temperature-shifted CHO cells. Studies have 
shown that the use of different phosphopeptide enrichment methods, such as 
titanium dioxide and iron oxide, has provided increased coverage of the 
phosphoproteome (Bodenmiller et al. 2007; Carrascal et al. 2008; Collins, Yu, 
Choudhary 2007). Titanium and iron phosphopeptide enrichment strategies have also 
proven to be suitable for quantitative label-free LC/MS applications (Casado and 
Cutillas 2011; Montoya et al. 2011). In this study, titanium dioxide and iron oxide 
enrichment of temperature-shifted CHO whole cell lysates permitted the 
identification of 867 and 960 phosphopeptides respectively. The use of two 
complementary enrichment methods has provided a greater overview of the CHO 
phosphoproteome under temperature-shifted conditions enabling the cataloguing of 
1,271 phosphopeptides and providing information on the differential expression of 
83 phosphopeptides.  
Quantitative label-free LC/MS analysis of phosphopeptide enriched whole cell 
lysates has been successfully employed to identify changes in phosphopeptide 
abundance in a number of studies (Casado and Cutillas 2011; Gunaratne et al. 2010; 
Manes et al. 2011). A gallium oxide phosphopeptide enrichment methodology was 
used in the identification of hormone dependent signalling pathways in renal 
medullary thick ascending limb (mTAL) cells (Gunaratne et al. 2010). Using this 
approach, 654 phosphopeptides were identified, of which 76 were differentially 
phosphorylated. Label-free analysis of titanium dioxide phosphopeptide enriched 
acute myeloid leukaemia cells treated with the sodium pervanadate resulted in the 
quantification of 937 phosphopeptides from a total of 1,537 phosphopeptides 
identified (Montoya et al. 2011). It should be remembered however that sodium 
pervanadate causes irreversible tyrosine phosphatase inhibition within the cell. This 
would result in an accumulation of hyper-phosphorylated tyrosine residues and is 
likely to increase the number of phosphopeptides identified (Boeri Erba et al. 2007).  
During the course of this investigation a number of multiple phosphorylated peptide 
species were identified. Generally speaking, monophosphorylated peptides are more 
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commonly identified using Gallium and Titanium enrichment methods while Iron 
based enrichment favours multiply-phosphorylated species (Aryal, Olson, Ross 
2008; Zhao et al. 2013). In this study however no such bias was observed. Both 
titanium and iron based columns enriched similar numbers of singly and multiply 
phosphorylated phosphopeptides.  
Of the 960 phosphopeptides enriched using iron oxide, 471 of these triggered MS3 
events while 537 MS3 events were triggered for the 867 phosphopeptides enriched 
using titanium dioxide. The neutral loss of a phosphate group is widely accepted as a 
form of ‘validation’ of the phosphorylated state of the phosphopeptide (as detailed 
section 1.5.7) (Yu et al. 2007). Although it was somewhat surprising that more MS3 
events were not observed, there may be a number of reasons for this including the 
combined neutral loss of phosphate and water, and no dominant neutral loss of 
phosphate (Sweet et al. 2009). It has been reported that when using high mass 
accuracy instruments, such as the one used in this study, that MS3 offers no 
additional benefit in increasing the overall number of confidently identified 
phosphopeptides and has only limited value in determining the site of 
phosphorylation localization (Villén, Beausoleil, Gygi 2008). Nonetheless, the use of 
MS3 information in this study provides additional confidence in the identification of 
phosphopeptides particularly given the lack of information available on site-specific 
phosphorylation in CHO compared to other species such as Human and Mouse 
(Hornbeck et al. 2012). 
This section demonstrates that the evaluation of a protocol for the enrichment of 
phosphopeptides in CHO cells, as laid out in the aims of this thesis, has been 
successfully completed and that the complementary use of titanium dioxide and iron 
phosphopeptide enrichment methods achieved the largest numbers of 
phosphopeptides with site-specific information.  
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 Differentially-expressed phosphopeptides common to titanium dioxide 6.2.5
and iron oxide phosphopeptide enrichment methods 
Using the complementary approach detailed in this study to obtain relative 
quantitative information on changes in the abundance of phosphopeptides offers a 
unique insight into the active response to reduced culture temperature conditions 
compared to other proteomic profiling studies that simply detail changes in the 
cellular machinery (Baik et al. 2006; Kaufmann et al. 1999; Kumar et al. 2008a; 
Underhill and Smales 2007). Of the 83 differentially-expressed phosphopeptides 
identified using both titanium dioxide and iron oxide enrichment, 29 were up-
regulated and 54 down-regulated  upon temperature-shift. While many differentially-
expressed phosphopeptides were unique to each enrichment method, some of those 
identified were common to both techniques.  
 
6.2.5.1 eIF4g3 
One such protein was eIF4g3 (also called eIF4gII, but not to be confused with 
eIF4g2), was identified as 3.7-fold down-regulated at 31˚C compared to 37˚C. 
eIF4g3, along with eIF4g1, form the two functional homologs of eIF4g, part of the 
cap binding protein complex of eIF4f (Ivanov et al. 2011). 
It has been shown that eIF4g3 becomes phosphorylated during mitosis inhibiting 
cap-dependent translation through a reduction in its interaction with eIF4e (Pyronnet, 
Dostie, Sonenberg 2001). In addition to phosphorylation, cleavage of eIF4g3, 
resulting in loss of function, is also known to cause inhibition of cap-dependent 
translation (Marcet-Palacios et al. 2011). These reports show the pivotal role that 
eIF4g3 plays in initiation of protein translation.  
Transcriptomic analysis of B cell lymphocytes displaying increased proliferation and 
reduced Ig production from transgenic mice expressing a dominant active 
downstream regulatory element antagonist modulator (DREAM) mutation found that 
although increased proliferation was associated with a decrease in the expression of 
the cell cycle regulator Klf9, the reduction in protein synthesis was linked to the 
down-regulation of the eIF4g3 gene (Savignac et al. 2010).  
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Identified by both titanium dioxide and iron oxide phosphopeptide enrichment this 
investigation found phosphorylation of eIF4g3 to decrease upon temperature-shift. 
This would imply that a reduction in the phosphorylation of eIF4g3 would facilitate 
binding with eIF4e, thus enabling cap-dependent translation. Based on the reports 
discussed, this indicates that the reduction in the phosphorylation of eIF4g3 under 
temperature-shifted conditions may form a critical component of the mechanism 
involved in the increased productivity of temperature-shifted CHO cells. 
 
6.2.5.2 Protein NDRG1 
Another protein identified as having increased phosphorylation at 31˚C by both 
titanium dioxide and iron oxide enrichment methodologies was protein NDRG1 (N-
Myc down-regulated gene 1). NDRG1 is highly conserved across a number of 
multicellular organisms, typically expressed in response to cell stress and is known 
as a tumour metastasis suppressor in several different types of cancer including 
breast, colon, pancreatic and prostate (Ghalayini et al. 2013; McCaig et al. 2011). 
Increased expression of NDRG1 has been shown to result in cell cycle arrest (Li and 
Chen 2011). The phosphorylation of NDRG1 also appears to be involved in the cell 
cycle arrest mechanism (Ghalayini et al. 2013; McCaig et al. 2011). In this study, we 
found NDRG1 to have increased phosphorylation upon temperature-shift. Although 
cell cycle arrest in temperature-shifted CHO cells has been attributed to the 
activation of the ATR-p53-p21 pathway (Roobol et al. 2011), cellular stress has been 
shown to result in the expression of NDRG1 in a p53 dependent manner (Roobol et 
al. 2011; Stein et al. 2004). This would suggest that NDRG1 may be involved in the 
cell cycle arrest of temperature-shifted CHO cells, however further work would be 
required to determine the precise mechanisms by which this would occur.  
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6.2.5.3 GO analysis of differentially-expressed phosphopeptides common to 
titanium dioxide and iron oxide phosphopeptide enrichment methods 
Expanded phosphoproteome coverage through the use of two enrichment methods 
was also of benefit for identifying key cellular processes and potential pathways that 
altered as a result of temperature-shift. For example, DAVID analysis of all the 
differentially-expressed phosphopeptides (Section 4.3.8.2) identified was the 
enrichment of the membrane organisation pathways at 31˚C compared to 37˚C. 
Interestingly, changes in the relative abundance of membrane proteins have been 
observed in another study which profiled the proteome of temperature-shift, non-
producing CHO-K1 cells (Kumar et al. 2008a). Alterations in membrane rigidity 
have been cited as a means by which cells may detect the reduction of cell culture 
temperature (Roobol et al. 2011). Such alterations occur as a result of changes in 
membrane lipid composition causing membrane fluidity to decrease as temperature 
is reduced (Los and Murata 2004).  
Changes in the abundance of phosphorylation on membrane organisation proteins are 
an encouraging indicator that active cell signalling events are taking place. DAVID 
analysis also identified the enrichment of proteins involved in cell division 
pathways, all of which were down-regulated at 31˚C. This of course makes sense 
given the substantial reduction in cell growth under reduced culture temperature 
conditions. Among the proteins identified in this GO enrichment were Borealin 
(discussed in more detail in section 6.3.7.3), Anaphase-promoting complex subunit 1 
and Serine/threonine-protein kinase Nek1, all of which showed decreased 
phosphorylation at 31˚C compared to the 37˚C culture.  
 
6.2.5.3.1 Serine/threonine-protein kinase Nek1 
Nek1 was identified as being 2.3-fold down-regulated in the temperature-shifted 
CHO SEAP cells. Although it is known that Nek1 is involved in DNA damage repair 
and cell cycle progression (Fry et al. 2012), reports of the precise mechanisms by 
which Nek1 operates and even its exact function are often conflicting. While the 
silencing of Nek1 has been reported to slow down the repair of DNA as a result of 
exposure to genotoxic agents and blocks DNA damage-induced cell cycle arrest 
(Pelegrini et al. 2010), it has also been shown that the loss of Nek1 caused a severe 
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decrease in cell proliferation, most likely due to increased time spent in the S-phase 
of the cell cycle (Patil et al. 2013). The role of Nek1 as a regulatory kinase for the 
proper activation of ATM/ATR target kinases Chk1 and Chk2 has been reported 
(Chen et al. 2008). It is not clear whether Nek1 regulation of Chk1 and Chk2 is as a 
result of direct or indirect interaction between the kinases.  
Given that Nek1 can shuttle from the cytoplasm to the nucleus (Hilton, White, 
Quarmby 2009), it is possible that Nek1 also aids in the translocation of Chk1/Chk2 
to the nuclei where they function (Chen et al. 2008). Although both Crk1 and Crk2 
are both involved in DNA damage repair, it is Crk1 that plays the greater role in 
DNA damage repair while Chk2 is essential for G2-M arrest (Huang et al. 2008). 
Despite its involvement in DNA damage repair via the ATR pathway (Chen et al. 
2008), it has also been proposed that Nek1 can regulate checkpoint control and DNA 
damage response in pathways independent of ATR (Chen et al. 2011). This serves as 
a prime example of the complexity of trying to decipher signalling pathways within 
the cell. 
 
6.2.5.3.2 Anaphase-promoting complex subunit 1 
Quantitative label-free LC/MS analysis of titanium dioxide and iron oxide 
phosphopeptide enrichments both found ANAPC1 to be down-regulated at 31˚C by 
1.5 and 1.9-fold respectively. ANAPC1 is the largest subunit of anaphase-promoting 
complex/cyclosome (APC/C), a ubiquitin ligase that targets specific proteins for 
proteasomal degradation during mitosis (Acquaviva et al. 2004; Jörgensen et al. 
2001). Two known mitotic cyclins that the APC complex targets for degradation are 
cyclins A and B (Chang, Xu, Luo 2003). 
It has been shown that cyclin B degradation is required for exit from mitosis 
(Skoufias et al. 2007). ANAPC1 acts as a scaffold protein that binds Cdc23, Apc5, 
and Apc4 (Thornton et al. 2006). Once this subunit is formed, it then goes on to bind 
Cdc16, Cdc27and Cdc26. It has been suggested that activation of the complex is 
initiated by phosphorylation (Golan, Yudkovsky, Hershko 2002). In the context of 
this study the down-regulation of phosphorylated ANAPC1 would imply loss of 
proteasomal function and/or disassembly of the complex.  
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6.2.5.3.3 Differential expression of phosphopeptides in proteins involved in 
transcription 
Protein function analysis of all differentially-expressed phosphopeptides also 
identified a significant number of proteins involved in the regulation of transcription. 
This observation also makes sense given the changes that take place in the 
transcriptome of temperature-shifted CHO cells (Baik et al. 2006; Kantardjieff et al. 
2010; Nissom et al. 2006; Yee, Gerdtzen, Hu 2009). 
Among the proteins identified as having increased levels of phosphorylation was 
Cyclic AMP-dependent transcription factor ATF-7, zinc finger protein with KRAB 
and SCAN domains 3 and AT-rich interactive domain-containing protein 5B. Cyclic 
AMP-dependent transcription factor ATF-2, DNA excision repair protein ERCC-6 
and transcription intermediary factor 1-beta displayed decreased levels of 
phosphorylation upon temperature-shift (some of these proteins are discussed further 
in section 6.4.6). Due to the limitations of our current knowledge of many of these 
proteins, whether the changes in phosphorylation will positively or negatively impact 
on transcription remains unclear. 
The identification of signalling events involved in the regulation of transcription 
raises some interesting questions regarding the control of transcription in 
temperature-shifted cells; are such phosphorylation events involved in the increased 
transcription of the recombinant molecule, attenuating the translation of endogenous 
cellular proteins or in some way facilitating the transcription and/or binding of cold 
shock proteins to cis elements in the promoter regions of target genes leading to 
enhanced transcription? Furthering our understanding of these signalling 
mechanisms could provide cell engineering targets that would enable the preferential 
translation of specific gene targets. 
 
6.2.5.3.4 TRIM28 and ZKSCAN3 
Identified as being 1.6-fold up-regulated at 31˚C using titanium dioxide enrichment, 
Transcription intermediary factor 1-beta (TRIM28) is a transcriptional core-repressor 
protein involved in a wide variety of functions such as cell growth, apoptosis and 
DNA repair (Iyengar and Farnham 2011). The precise mechanisms by which 
TRIM28 operates are poorly understood and, given its upregulation in a variety of 
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cancers (such as breast cancer) and its down-regulated in other cancer types 
(including lung cancer), indicates that the role it plays in influencing cellular 
function appears to be cell line specific (Chen et al. 2012a). Despite this, it has been 
shown that phosphorylation of TRIM28 on Ser473 leads to a reduction in its activity 
(King 2013).  
The increase in the phosphorylation TRIM28 at 31˚C potentially points to a 
reduction in its activity at reduced culture temperatures. One of the means by which 
TRIM28 mediates transcriptional control is through interaction with Krüppel 
associated box (KRAB) zinc finger proteins (Fitzgerald et al. 2013).  
Interestingly, Zinc finger protein with KRAB and SCAN domains 3 (ZKSCAN3) 
was identified as being 7.1-fold decreased at 31˚C using iron oxide enrichment. It is 
possible that a reduction in the activity of TRIM28 could lead to a decrease in the 
activity of ZKSCAN3. This could make sense in the context of temperature-shift 
given that ZKSCAN3 has been reported as having increased expression in multiple 
myeloma, prostrate and colorectal cancers and knockout of ZKSCAN 3 in two colon 
cancer cell lines has been shown to inhibit cell growth (Yang et al. 2010; Zhang et al. 
2012),  the exact function of ZKSCAN3 in CHO remains unknown and alterations in 
levels of phosphorylation may results in the activation of alternative pathways.  
It must be remembered that phosphorylation cell signalling events are known to be 
very complex with many layers of regulation (Nguyen, Kolch, Kholodenko 2013). It 
is quite likely that the changes in phosphorylation observed could be as a result of 
other cell signalling events taking place. Of course these too may be of interest, but 
the fact remains that many of these phosphorylation events are uncharacterised and 
knowledge of their end function poorly understood (Hynes et al. 2013). It is 
therefore difficult to provide a definitive blueprint of all phosphorylation signalling 
events and their outcomes based on this investigation alone. Nonetheless proteins 
involved in cellular processes including transcription, translation, negative regulation 
of cell cycle progression and cytoskeletal organisation have been identified through 
the use of GO analysis. Further insights could be obtained through the integration of 
this data set with other published profiling studies to obtain a systems biology 
overview of the cellular response to temperature-shift.  
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Overlapping this data with transcriptomic (Clarke et al. 2011; Kantardjieff et al. 
2010; Yee, Gerdtzen, Hu 2009) and proteomic (Baik et al. 2006; Kumar et al. 2008a; 
Meleady et al. 2011) studies of temperature-shifted CHO cultures could reveal 
regulatory connections and subnetworks that would not be apparent from the 
analysis of this phosphoproteomic dataset alone (Jünger and Aebersold 2014).  
The data obtained in this study could also be used map the peptide sequences 
identified onto positions in the CHO genome that code for them, thus validating the 
expression of a given gene (Kumar and Mann 2009). This is particularly relevant 
given the recent release of the CHO genome (Xu et al. 2011), where many of the 
predicted proteins do not yet have any direct experimental information associated 
with them. The utilisation of the phosphoproteomic data in this thesis, along with 
data from other profiling proteomic studies (Baycin-Hizal et al. 2012; Lim et al. 
2013; Meleady et al. 2011) could ultimately help refine the CHO genome model by 
providing evidence of gene expression at the protein level. 
 
 Differentially-expressed phosphopeptides unique to titanium dioxide 6.2.6
enrichment  
While the previous section discussed differentially-expressed phosphopeptides 
identified in both titanium dioxide and iron oxide enrichment strategies, this section 
will now describe some the of differentially-expressed phosphopeptides that were 
only obtained by titanium dioxide enrichment. Due to the nature of many of the 
proteins identified as a result of titanium dioxide enrichment, the precise role that 
phosphorylation / dephosphorylation of these proteins played in their function and 
the mechanisms which they became phosphorylated were often poorly understood. 
Functional and mechanistic information was however gathered on two 
phosphoproteins uniquely identified by titanium dioxide enrichment as having 
differentially-expressed phosphorylation. 
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6.2.6.1 Programmed cell death 4 (PDCD4) 
2.1-fold up-regulated upon temperature-shift, PDCD4 is phosphorylated and 
regulated by AKT and has been shown to be up-regulated in lung tumours with 
slower growth rate while conversely being down-regulated in an aggressive, fast 
growing cancers such as skin cancer (Matsuhashi et al. 2007; Palamarchuk et al. 
2005). Although upregulation has also been associated with apoptosis, it is possible, 
given the complexity of apoptotic signalling pathways, that PDCD4 may in some 
way be involved in the reduced growth response to temperature-shift without 
impacting on cell viability (Matsuhashi et al. 2007). Whether it is directly involved 
in growth reduction, or its upregulation occurs as a consequence of slowed growth 
rate remains unclear. The precise role of phosphorylated PDCD4 remains largely 
undefined, however it is known that following mitogen stimulation phosphorylation 
of PDCD4 by p70S6K1 has been shown to result in its proteasomal degradation 
(Schmid et al. 2011). While degradation of PDCD4 would potentially lead to an 
increase in the growth of CHO cells, this is clearly not the case in those cells under 
reduced temperature conditions.  
 
6.2.6.2 Zyxin 
Zyxin, an actin regulatory protein that stabilizes sites of actin-membrane interaction, 
was identified as being 1.5-fold down-regulated at 31˚C (Call et al. 2011). In 
addition to being found at focal adhesion sites, zyxin can also translocate to the 
nucleus; in this way zyxin regulates cell-cell adhesion, cytoskeleton organisation and 
signal transduction (Keicher et al. 2004; Nix and Beckerle 1997). Given its role as a 
‘mechanotransducer’, zyxin is said to be involved in the active cellular respond to 
environmental conditions (Crone et al. 2011). Mutation studies inhibiting 
phosphorylation of zyxin by acinus-S resulted in the loss of its head tail release 
mechanism leaving a cell unable to disassociate itself from another cell or other 
substrate once bound (Call et al. 2011).Conversely, AKT-induced phosphorylation 
of zyxin enabling binding to acinus-S, thus preventing cleavage of acinus-S by 
caspases, results in inhibition of apoptotic chromatin condensation (Chan et al. 
2007). The functional description provided of this phosphoprotein provides further 
evidence of active changes occurring in the cytoskeleton of temperature-shifted CHO 
cells. 
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 Differentially-expressed phosphopeptides unique to iron oxide 6.2.7
enrichment  
Label-free LC/MS analysis of iron oxide phosphopeptide enriched CHO SEAP cells 
enabled the identification of 60 differentially-expressed phosphopeptides of which 
22 were up-regulated at 31˚C. The following section outlines the role that 
phosphorylation plays in the function of some of the phosphoproteins uniquely 
identified by iron oxide enrichment. 
 
6.2.7.1 ATF-2 and ATF-7 
ATF-2 was identified as 7.4-fold down-regulated and ATF-7 was found to be 9.8-
fold up-regulated at 31˚C compared to 37˚C. ATF-2 and ATF-7 are highly conserved 
members of the AP-1 transcription factor family (Diring et al. 2011). Cellular stress 
is known to induce both ATF-2 and ATF-7 (Bogoyevitch and Kobe 2006; 
Walczynski et al. 2013). This occurs via SAPK/JNK and p38 signalling cascades in 
the case of ATF-2 and only by p38, but not JNK, in the case of ATF-7 (Bogoyevitch 
and Kobe 2006; Walczynski et al. 2013). 
While phosphorylation of ATF-2 can result in its degradation as well as induction of 
activity the observed decrease in phosphorylation of Thr-69 would appear to suggest 
that reduced culture temperature conditions results in a reduction of the active form 
of ATF-2 (Fuchs, Tappin, Ronai 2000). The increased phosphorylation of ATF-7 
indicates that this transcription factor is likely to play a different role in the 
regulation of transcription to ATF-2. This is highly possible given the diverse range 
of functions that both ATF-2 and ATF-7 are known to be involved in (Diring et al. 
2011). 
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6.2.7.2 DNA excision repair protein ERCC-6 
Phosphorylation of DNA excision repair protein ERCC-6 was decreased 2-fold at 
31˚C. DNA excision repair protein ERCC-6, a ubiquitin-regulated nucleotide 
excision repair factor, is involved in the repair of DNA damaged as a result of 
exposure to UV or oxidative stress (Baas et al. 2010). Oxidative stress has been 
shown to be reduced in cells grown under mildly hypothermic conditions (Slikker et 
al. 2001). This reduction in oxidative stress may therefore cause a down-regulation 
of oxidative stress induced DNA repair mechanisms.  
 
6.2.7.3 Differential expression of phosphopeptides in proteins involved in cell 
division 
Girdin, increased 5.1-fold at 31˚C, associates with actin and tubulin in the 
cytoskeleton to help regulate cell shape (Enomoto, Ping, Takahashi 2006; Liu et al. 
2012). Silencing of girdin results in disassembly of stress filaments which, 
interestingly, zyxin also plays a role in the formation of (discussed section 6.3.6.2) 
(Kitamura et al. 2006). Phosphorylation of Girdin by AKT plays an important role in 
cytoskeletal reorganisation by regulating its association with the cell membrane. As 
such, girdin plays an essential role in cell division (Enomoto et al. 2005; Mao et al. 
2012). 
Another phosphoprotein known to be involved in cell division was Borealin. 
Decreased 3.3-fold at 31˚C, Borealin is a regulator of chromosome alignment, 
spindle assembly and cytokinesis (Ruchaud, Carmena, Earnshaw 2007). Knockout of 
Borealin results in delayed mitotic progression, incorrect spindle assembly and 
restricts chromosome disassembly in anaphase (Gassmann et al. 2004). Expression 
of Borealin is cell cycle- dependent with levels peaking during the G2/M phases of 
the cell cycle (Date et al. 2012). 
Upon exiting the M phase of the cell cycle, Borealin becomes dephosphorylated, 
however the precise phosphatase involved in this event is as yet unknown (Date et al. 
2012; Kumar, Gammell, Clynes 2007) 3.3-fold down-regulation of Borealin 
phosphorylation is an interesting result; it provides further evidence of alterations in 
the cell cycle mechanisms of temperature-shifted CHO cells. 
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p58PITSLRE and Nek1 were among a number of proteins with differentially-expressed 
phosphopeptides that were identified as being involved in the regulation of cell cycle 
progression through GO analysis. Transcriptome analysis of temperature-shift and 
NaBu treated CHO cells has previously shown down-regulation of a number of 
genes involved in cell cycle regulation (Kantardjieff et al. 2010). Analysis of the 
phosphoproteomic data presented in this thesis shows the proteins involved in the 
cell cycle are evenly split between those with increased phosphorylation and those 
with decreased phosphorylation. While this is in contrast to the proteins involved in 
cell division, all of which displayed reduced phosphorylation, the fact that not all cell 
cycle related proteins became phosphorylated or dephosphorylated is likely to be as a 
result of the sheer complexity of cell cycle signalling events. 
One of the main objectives of this thesis was to identify site-specific changes in the 
phosphorylation of phosphoproteins occurring in direct response to reduced culture 
temperature conditions. The identification of the differential expression of 
phosphopeptides in proteins such as eIF4g3, NDRG1, Zyxin and AFT-2 using a 
combination of titanium dioxide and iron phosphopeptide enrichment strategies 
shows that this has been achieved, thus providing further insights into the cellular 
response to reduced culture temperature. 
 
 Utilisation of CHO specific proteomic databases in the analysis of 6.2.8
LC/MS data in a phosphoproteomic study 
Until recently proteomic profiling studies of CHO cell lines relied on sequence 
homology between CHO and other well annotated species in a protein database such 
as human, mouse and rat, when searching raw mass spectral data (Baik et al. 2006; 
Kaufmann et al. 1999; Kumar et al. 2008a). This was due to the lack of CHO 
genome sequence information available, the absence of which was noted in a number 
of papers at the time (Griffin et al. 2007; Seth et al. 2007; Wlaschin and Hu 2007). 
Reliance on sequence homology means that potentially interesting proteins may go 
unidentified thus frustrating efforts to decipher signalling pathways (Meleady et al. 
2012). Amino acid substitutions are common modifications found in proteins when 
direct comparisons are made of the same protein between different species (Liska 
and Shevchenko 2003; Meleady et al. 2012).  
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In terms of the detection of post translational modifications such as phosphorylation, 
correct amino acid sequence information is vital for peptide (and subsequent protein) 
identification.  Accurate amino acid identification becomes even more critical when 
trying to obtain site-specific phosphorylation information, particularly in instances 
where a peptide contains a number of amino acids that may be phosphorylated as this 
requires the correct assignment of ‘site determining ions’ (Boersema, Mohammed, 
Heck 2009). The availability of two complementary CHO protein databases has 
undoubtedly been a significant asset to this investigation.  
It has for the first time enabled the identification of 1,307 phosphopeptides and 1,480 
phosphorylation sites in a CHO cell line. Reliance on sequence homology would 
almost certainly have offered reduced coverage of the phosphoproteome and limited 
the information obtained on the differential regulation of phosphorylation in 
temperature-shifted CHO cells.  
 Summary 6.2.9
GO analysis of the 114 differentially-expressed proteins identified by quantitative 
label-free LC/MS analysis of CHO SEAP whole cell lysate samples showed 
enrichment of pathways involved in translation, RNA processing and ribosomal 
biogenesis while cytoskeleton organisation pathways were found to be enriched 
following similar analysis of phosphoprotein-enriched CHO samples. 
Although gallium oxide phosphopeptide enrichment of phosphoprotein-enriched 
whole cell lysates provided site-specific phosphorylation information on a number of 
phosphopeptides, by far the greatest contribution came from titanium dioxide and 
iron oxide phosphopeptide enrichment of whole cell lysates. This strategy identified 
82 differentially-expressed phosphopeptides (29 up-regulated and 53 down-regulated 
at 31˚C compared to 37˚C). GO analysis of the proteins identified revealed down-
regulation of cell cycle and cell division pathways and upregulation of pathways 
involved in membrane organisation.  
Further protein fractionation or validation by western blot would be required to 
definitively determine whether the changes observed are as a result of changes in 
phosphorylation.  
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Conclusions and Future Plans 
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Conclusions 
Chapter 1: Host Cell Protein 
• This work shows that culture temperature and time in culture can result in the 
increased expression of enzymes with the potential to negatively impact on 
product quality. This included the identification of Proteases such as 
MMP19, MMP9 and Cathepsin D and the glycosidases Alpha-glucosidase 
and α-N-acetyl-galactosaminidase in both cultures. In general, proteases were 
found to be up-regulated at the late phase in culture compared to early culture 
in both the IgG producing and non-producing CHO cell lines. The 
accumulation of proteases at this time point could negatively impact on 
product quality. Furthermore, proteases were identified as being down-
regulated in the temperature shifted culture compared to the non-temperature-
shifted culture indicating that the use of temperature shift could help reduce 
product loss in instances where products were susceptible to proteolytic 
activity. 
 
• One important finding from this work was that significant differences in the 
HCP profile of a non-producing CHO-K1 cell line and an IgG secreting 
DP12 cell line. In addition, the reduction of culture temperature, was found to 
result in changes in the HCP profile of both IgG-secreting and non-secreting 
CHO cell lines and a non-secreting hybridoma cell line. This result has 
implications for the ability of HCP ELISA assays to detect contaminating 
HCPs in the final drug substance across diverse CHO cell lines and different 
culture conditions. 
 
• The utilization of two CHO specific databases in this investigation enabled 
the identification of 1,136 HCPs produced by two CHO cell lines. The use of 
the BOKU- Bielefeld CHO specific proteomic database in addition to the 
NCBI CHO database in this profiling study enabled an additional 171 
proteins to be identified in the secretome of the CHO-K1 cell line and an 
additional 162 were identified in the DP12 cell line.  
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Therefore, this study supports the use of both databases in the analysis of 
conditioned media samples from CHO cells as it increases proteome 
coverage and the level of confidence in the proteins identified. Ultimately, a 
merged database would be of value. 
 
Chapter 2: Phosphoproteomic analysis of CHO cells subject to temperature 
shift 
• Phosphoproteomic profiling of CHO cells subject to temperature shift using 
antibody array based technology initially provided some interesting leads, 
possibly implicating the phosphorylation of Erk, Jnk and AKT in response to 
temperature shift. Subsequent follow up studies by western blot proved 
problematic due to non-specific binding and, in some instances, failure to 
identify the correct protein of interest. Thereby demonstrating the lack of 
hamster specific antibodies available to validate this work. Some targets, 
such as Erk, warrant further investigation based on the results obtained in this 
study, but it may be interesting to generate hamster specific antibodies as the 
anti-human antibodies available often gave poor results in CHO. 
 
• GO analysis of differentially regulated phosphoproteins identified through 
quantitative label-free LC/MS analysis of phosphoprotein-enriched CHO 
SEAP samples indicated enrichment of pathways involved in cell cycle 
progression, protein biosynthesis and protein transport. In addition, GO 
analysis of differentially-expressed phosphopeptides identified following 
LC/MS analysis of titanium dioxide and iron oxide phosphopeptide enriched 
samples from temperature-shifted CHO whole cell lysate samples showed 
enrichment of pathways involved in transcription, translation, negative 
regulation of cell cycle progression and cytoskeletal organisation. Taken 
together, these results show some of the biological processes that are 
involved in the cellular response to temperature shift.  
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• Until the recent advent of CHO specific proteomic databases, reliable 
identification of site-specific phosphorylation was difficult. Identification 
was reliant on homology between the location of a specific phosphosite and 
the surrounding amino acid sequence in a CHO protein and its location in the 
same protein from another well annotated species. The use of two CHO 
specific data bases in this thesis has enabled greater coverage of the CHO 
phosphoproteome leading to the accurate identification of site-specific 
phosphorylation on 1,307 phosphopeptides (1,480 phosphosites in total). 
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Future work 
Proteomic profiling of Host Cell Proteins (HCPs) from CHO cells 
• An important finding of this work was the differential expression of proteases 
and glycosidases over time in culture and between temperature-shifted and 
non-temperature-shifted conditions. A follow up investigation to examine the 
impact that these enzymes have on product quality would be beneficial 
Initially, zymography and glycosidase activity assays would be used to 
identify proteases and glycosidases that are functionally active in the 
conditioned media of CHO cells. A panel of well characterised recombinant 
therapeutics could be individually exposed to the enzymatic activity of each 
protease/glycosidase found to be active in the media of the CHO cell. Each 
‘model’ product could then be analysed by LC/MS, capillary electrophoresis 
and SDS PAGE to assess the effect of the exposure to respective 
proteases/glycosidases on product integrity.  
 
Phosphoproteomic characterisation of CHO cells subject to temperature shift 
• The phosphoproteomic profiling of CHO cells identified a number of 
phosphoproteins potentially involved in the response to temperature shift. 
Further insights into the cellular response to temperature shift could be 
obtained through the amalgamation of this data set with published datasets 
from other profiling studies. Overlapping the phosphoproteomic data in this 
thesis with datasets from transcriptomic (Clarke et al. 2011; Kantardjieff et 
al. 2010; Yee, Gerdtzen, Hu 2009) and proteomic (Baik et al. 2006; Kumar et 
al. 2008a; Meleady et al. 2011) analysis of temperature shifted CHO cells 
could help identify cell signalling mechanisms involved in the reduced 
growth rate and/or increased specific productivity seen in many temperature 
shifted CHO cell cultures. 
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